
<html lang="en"     class="pb-page"  data-request-id="b12208ef-042d-48fd-b9a5-8aea525121fc"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/acs.jmedchem.0c01257;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2020.63.issue-22"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Developing a Novel Gold(III) Agent to Treat Glioma Based on the Unique Properties of Apoferritin Nanoparticles: Inducing Lethal Autophagy and Apoptosis" /></meta><meta name="dc.Creator" content="Juzheng  Zhang" /></meta><meta name="dc.Creator" content="Zhenlei  Zhang" /></meta><meta name="dc.Creator" content="Ming  Jiang" /></meta><meta name="dc.Creator" content="Shanhe  Li" /></meta><meta name="dc.Creator" content="Haoliang  Yuan" /></meta><meta name="dc.Creator" content="Hongbin  Sun" /></meta><meta name="dc.Creator" content="Feng  Yang" /></meta><meta name="dc.Creator" content="Hong  Liang" /></meta><meta name="dc.Description" content="Effective delivery of anticancer agents across the blood–brain barrier (BBB) required innovative strategies to achieve glioma regression. To resolve this problem, we proposed to develop a metal age..." /></meta><meta name="Description" content="Effective delivery of anticancer agents across the blood–brain barrier (BBB) required innovative strategies to achieve glioma regression. To resolve this problem, we proposed to develop a metal age..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="November 13, 2020" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c01257" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2020 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01257" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c01257" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01257" /></link>
        
    
    

<title>Developing a Novel Gold(III) Agent to Treat Glioma Based on the Unique Properties of Apoferritin Nanoparticles: Inducing Lethal Autophagy and Apoptosis | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c01257" /></meta><meta property="og:title" content="Developing a Novel Gold(III) Agent to Treat Glioma Based on the Unique Properties of Apoferritin Nanoparticles: Inducing Lethal Autophagy and Apoptosis" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01257/20201120/images/large/jm0c01257_0011.jpeg" /></meta><meta property="og:description" content="Effective delivery of anticancer agents across the blood–brain barrier (BBB) required innovative strategies to achieve glioma regression. To resolve this problem, we proposed to develop a metal agent that target and treat glioma based on the unique property of apoferritin (AFt) nanoparticles (NPs). Thus, we synthesized a series of Au(III) 3-(4-metyl piperidine)thiosemicarbazides compounds and analyzed their structure–activity relationships, obtaining a Au agent (C6) with remarkable cytotoxicity in glioma. Moreover, we confirmed that C6 kills glioma cells by inducing lethal autophagy and apoptosis. Importantly, our results revealed that the successfully constructed apoferritin-C6 NPs (AFt-C6 NPs) can effectively cross the BBB, inhibit glioma growth, and selectively accumulate in tumors." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c01257"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01257">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c01257&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c01257&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c01257&amp;href=/doi/10.1021/acs.jmedchem.0c01257" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 22</span><span class="cit-fg-pageRange">, 13695-13708</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/22" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c01201" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.0c01202" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Developing a Novel Gold(III) Agent to Treat Glioma Based on the Unique Properties of Apoferritin Nanoparticles: Inducing Lethal Autophagy and Apoptosis</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Juzheng Zhang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Juzheng Zhang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory for the Chemistry and Molecular Engineering of Medicinal Resources, Ministry of Science and Technology of China. Guangxi Normal University, Guilin, Guangxi 541003, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Juzheng++Zhang">Juzheng Zhang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Zhenlei Zhang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Zhenlei Zhang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory for the Chemistry and Molecular Engineering of Medicinal Resources, Ministry of Science and Technology of China. Guangxi Normal University, Guilin, Guangxi 541003, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Zhenlei++Zhang">Zhenlei Zhang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ming Jiang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ming Jiang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory for the Chemistry and Molecular Engineering of Medicinal Resources, Ministry of Science and Technology of China. Guangxi Normal University, Guilin, Guangxi 541003, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ming++Jiang">Ming Jiang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Shanhe Li</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Shanhe Li</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory for the Chemistry and Molecular Engineering of Medicinal Resources, Ministry of Science and Technology of China. Guangxi Normal University, Guilin, Guangxi 541003, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Shanhe++Li">Shanhe Li</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Haoliang Yuan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Haoliang Yuan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Jiangsu Key Laboratory of Drug Discovery for Metabolic Disease, China Pharmaceutical University, Nanjing, Jiangsu 210009, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Haoliang++Yuan">Haoliang Yuan</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hongbin Sun</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hongbin Sun</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Jiangsu Key Laboratory of Drug Discovery for Metabolic Disease, China Pharmaceutical University, Nanjing, Jiangsu 210009, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hongbin++Sun">Hongbin Sun</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Feng Yang</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Feng Yang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory for the Chemistry and Molecular Engineering of Medicinal Resources, Ministry of Science and Technology of China. Guangxi Normal University, Guilin, Guangxi 541003, China</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#7d1b041c131a3d101c14111f1205531a05130853181908531e13"><span class="__cf_email__" data-cfemail="a6c0dfc7c8c1e6cbc7cfcac4c9de88c1dec8d388c3c2d388c5c8">[email protected]</span></a>. Phone/Fax: 86-773-212-0958.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Feng++Yang">Feng Yang</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4201-1416" title="Orcid link">http://orcid.org/0000-0002-4201-1416</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Hong Liang</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hong Liang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory for the Chemistry and Molecular Engineering of Medicinal Resources, Ministry of Science and Technology of China. Guangxi Normal University, Guilin, Guangxi 541003, China</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#731b1f1a121d14331e121a1f111c0b5d140b1d065d1617065d101d"><span class="__cf_email__" data-cfemail="ea8286838b848daa878b8386888592c48d92849fc48f8e9fc48984">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hong++Liang">Hong Liang</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01257&amp;href=/doi/10.1021%2Facs.jmedchem.0c01257" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 22</span><span class="cit-pageRange">, 13695–13708</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">November 13, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>19 July 2020</li><li><span class="item_label"><b>Published</b> online</span>13 November 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 25 November 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c01257" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01257</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D13695%26pageCount%3D14%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DJuzheng%2BZhang%252C%2BZhenlei%2BZhang%252C%2BMing%2BJiang%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D22%26contentID%3Dacs.jmedchem.0c01257%26title%3DDeveloping%2Ba%2BNovel%2BGold%2528III%2529%2BAgent%2Bto%2BTreat%2BGlioma%2BBased%2Bon%2Bthe%2BUnique%2BProperties%2Bof%2BApoferritin%2BNanoparticles%253A%2BInducing%2BLethal%2BAutophagy%2Band%2BApoptosis%26numPages%3D14%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D13708%26publicationDate%3DNovember%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c01257"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">823</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">4</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c01257" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Developing a Novel Gold(III) Agent to Treat Glioma Based on the Unique Properties of Apoferritin Nanoparticles: Inducing Lethal Autophagy and Apoptosis&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Juzheng&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Zhenlei&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Ming&quot;,&quot;last_name&quot;:&quot;Jiang&quot;},{&quot;first_name&quot;:&quot;Shanhe&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Haoliang&quot;,&quot;last_name&quot;:&quot;Yuan&quot;},{&quot;first_name&quot;:&quot;Hongbin&quot;,&quot;last_name&quot;:&quot;Sun&quot;},{&quot;first_name&quot;:&quot;Feng&quot;,&quot;last_name&quot;:&quot;Yang&quot;},{&quot;first_name&quot;:&quot;Hong&quot;,&quot;last_name&quot;:&quot;Liang&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;11&quot;,&quot;day&quot;:&quot;13&quot;,&quot;issue&quot;:&quot;22&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;13695-13708&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c01257&quot;},&quot;abstract&quot;:&quot;Effective delivery of anticancer agents across the blood–brain barrier (BBB) required innovative strategies to achieve glioma regression. To resolve this problem, we proposed to develop a metal agent that target and treat glioma based on the unique property of apoferritin (AFt) nanoparticles (NPs). Thus, we synthesized a series of Au(III) 3-(4-metyl piperidine)thiosemicarbazides compounds and analyzed their structure–activity relationships, obtaining a Au agent (C6) with remarkable cytotoxicity in glioma. Moreover, we confirmed that C6 kills glioma cells by inducing lethal autophagy and apoptosis. Importantly, our results revealed that the successfully constructed apoferritin-C6 NPs (AFt-C6 NPs) can effectively cross the BBB, inhibit glioma growth, and selectively accumulate in tumors.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01257&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01257" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01257&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01257" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01257&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01257" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01257&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01257&amp;href=/doi/10.1021/acs.jmedchem.0c01257" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c01257" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c01257" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (11 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c01257%26sid%3Dliteratum%253Aachs%26pmid%3D33185442%26genre%3Darticle%26aulast%3DZhang%26date%3D2020%26atitle%3DDeveloping%2Ba%2BNovel%2BGold%2528III%2529%2BAgent%2Bto%2BTreat%2BGlioma%2BBased%2Bon%2Bthe%2BUnique%2BProperties%2Bof%2BApoferritin%2BNanoparticles%253A%2BInducing%2BLethal%2BAutophagy%2Band%2BApoptosis%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D22%26spage%3D13695%26epage%3D13708%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=291918" title="Gold">Gold</a>,</li><li><a href="/action/doSearch?ConceptID=292527" title="Autophagy">Autophagy</a>,</li><li><a href="/action/doSearch?ConceptID=292153" title="Tumors">Tumors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/22" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/jmcmar.2020.63.issue-22/20201125/jmcmar.2020.63.issue-22.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01257/20201120/images/medium/jm0c01257_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01257/20201120/images/large/jm0c01257_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01257&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Effective delivery of anticancer agents across the blood–brain barrier (BBB) required innovative strategies to achieve glioma regression. To resolve this problem, we proposed to develop a metal agent that target and treat glioma based on the unique property of apoferritin (AFt) nanoparticles (NPs). Thus, we synthesized a series of Au(III) 3-(4-metyl piperidine)thiosemicarbazides compounds and analyzed their structure–activity relationships, obtaining a Au agent (C6) with remarkable cytotoxicity in glioma. Moreover, we confirmed that C6 kills glioma cells by inducing lethal autophagy and apoptosis. Importantly, our results revealed that the successfully constructed apoferritin-C6 NPs (AFt-C6 NPs) can effectively cross the BBB, inhibit glioma growth, and selectively accumulate in tumors.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00117" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00117" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Glioma is a type of malignant tumor that easily spreads into the normal tissue space around the brain.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Unfortunately, the few drugs currently available for the treatment of brain tumors are not sufficiently effective, and they are limited by drug resistance and serious side effects.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Moreover, the blood–brain barrier (BBB) prevents the accumulation of approximately 98% of the administered hydrophilic and lipophilic drugs in the brain parenchyma, which significantly inhibits their therapeutic efficacy.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3,4)</a> Thus, it is imperative to develop effective, novel drugs and treatment strategies that can circumvent these limitations.</div><div class="NLM_p">Autophagy in tumor cells is an adaptive process, and considering the rapid metabolism of tumor cells compared to normal cells, the autophagy levels in the former are higher.<a onclick="showRef(event, 'ref5 ref6 ref7 ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7 ref8 ref9 ref10">(5−10)</a> Currently, the diverse roles of autophagy in cancer treatment have attracted considerable interest in clinical settings.<a onclick="showRef(event, 'ref11 ref12 ref13 ref14 ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13 ref14 ref15 ref16">(11−16)</a> However, it should be noted that depending on the interactions between the apoptotic pathway and endoplasmic reticulum (ER) stress as well as on the duration and strength of autophagy, the mechanism of autophagy may promote the survival of cells instead of destroying them.<a onclick="showRef(event, 'ref13 ref17'); return false;" href="javascript:void(0);" class="ref ref13 ref17">(13,17)</a> Therefore, to effectively treat glioma, it is necessary to modulate autophagy to promote its lethal activity.<a onclick="showRef(event, 'ref10 ref18'); return false;" href="javascript:void(0);" class="ref ref10 ref18">(10,18)</a> This subject has been extensively researched, and the studies published thus far indicate that lethal autophagy may be induced by increasing the reactive oxygen species (ROS) content and stimulating apoptosis <i>via</i> mitochondrial dysfunction in response to stress signals.<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19,20)</a> Excitingly, on the one hand, recent work has revealed that Au agents can not only generate excessive ROS but also induce cancer cell apoptosis <i>via</i> mitochondrial dysfunction.<a onclick="showRef(event, 'ref21 ref22 ref23 ref24 ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref21 ref22 ref23 ref24 ref25 ref26">(21−26)</a> On the other hand, Abram <i>et al</i>. reported that the anticancer activities of Au(III) thiosemicarbazone compounds are remarkably higher than that of thiosemicarbazone alone.<a onclick="showRef(event, 'ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref27 ref28">(27,28)</a> Considering that metal thiosemicarbazone compounds have shown great promise as next-generation metal anticancer drugs,<a onclick="showRef(event, 'ref29 ref30 ref31 ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref29 ref30 ref31 ref32 ref33">(29−33)</a> the development of a novel Au thiosemicarbazone compound is expected to significantly improve therapeutic efficiency due to the dual mode of action (dual-MOA) of glioma cells, inducing lethal autophagy as well as apoptosis.</div><div class="NLM_p">The design of metal-based drugs for glioma treatment is normally limited by three major obstacles. First, the metal agent is susceptible to destruction by endogenous ions/compounds and it may bind to other macromolecules, resulting in reduced efficiency and unexpected side effects <i>in vivo</i>. Second, the metal agent on its own cannot effectively cross the BBB. Finally, the bioavailability and targeting ability of metal agents <i>in vivo</i> are generally low. Previously, it was shown that nanoparticles (NPs) targeting endogenous receptor-mediated transport (RMT) systems can efficiently deliver drugs across the BBB.<a onclick="showRef(event, 'ref34 ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref34 ref35 ref36">(34−36)</a> For example, overexpressed transferrin receptor 1 (TfR1) in BBB endothelial cells (ECs) and glioma cells can deliver ferritin (frt) into the brain.<a onclick="showRef(event, 'ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref37 ref38">(37,38)</a> Frt is a natural spherical iron storage protein composed of a self-assembled 24 subunit protein shell. Interestingly, when iron is removed from frt, hollowed apoferritin (AFt) may be loaded with different kinds of drugs. Once the drug-loaded AFt binds to TfR1, the drug can penetrate the BBB to enter the brain.<a onclick="showRef(event, 'ref39 ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref39 ref40 ref41">(39−41)</a> In acidic environments (pH = 2), the AFt shell disassembles into subunits. However, when the pH increases to neutral, the subunits reassemble, thereby restoring the nanocage structure of AFt. Owing to its unique properties, AFt has been extensively studied as a nanocarrier that can deliver drugs across the BBB.<a onclick="showRef(event, 'ref42 ref43 ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref42 ref43 ref44 ref45">(42−45)</a></div><div class="NLM_p">Taking the above factors into account, we innovatively employed a combinatorial approach encompassing inorganic medicinal chemistry, biomaterials, and pharmaceutics to develop a Au agent to induce lethal autophagy and apoptosis in glioma cells and then constructed AFt-Au agent NPs to cross the BBB and target glioma (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). Herein, we designed and synthesized a series of Au(III) 3-(4-methylpiperidine)thiosemicarbazide agents (C1–C6) (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>), screened them for their cytotoxic activity, and investigated their structure–activity relationships against glioma cells <i>in vitro</i> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). C6, showing the highest cytotoxicity, was then used to prepare AFt-Au agent NPs. The ability of these NPs to deliver the Au agent across the BBB was assessed <i>in vitro</i> and <i>in vivo</i>. Finally, the <i>in vivo</i> therapeutic efficiencies of the AFt-C6 NPs and C6 were compared, and their dual-MOA mechanism was confirmed.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01257/20201120/images/medium/jm0c01257_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01257/20201120/images/large/jm0c01257_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Hypothesis of the development of an Au agent with a dual-MOA to treat glioma based on the unique properties of AFt NPs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01257/20201120/images/large/jm0c01257_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01257&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01257/20201120/images/medium/jm0c01257_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01257/20201120/images/large/jm0c01257_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Synthesis and structures of salicylaldehyde-3-(4-methylpiperidine)thiosemicarbazide ligands (L1–L6) and their corresponding Au compounds (C1–C6).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01257/20201120/images/large/jm0c01257_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01257&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. IC<sub>50</sub> Values of Ligands, Au Agents, and AFt-C6 NPs against Glioma (U87MG) and Normal (HL-7702) Cells within 48 h</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">U87MG (μM)</th><th class="colsep0 rowsep0" align="center">HL-7702 (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">L1</td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">>40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">L2</td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">>40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">L3</td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">>40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">L4</td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">>40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">L5</td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">>40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">L6</td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">>40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">C1</td><td class="colsep0 rowsep0" align="left">9.31 ± 0.51</td><td class="colsep0 rowsep0" align="left">18.49 ± 1.09</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">C2</td><td class="colsep0 rowsep0" align="left">3.51 ± 0.22</td><td class="colsep0 rowsep0" align="left">15.08 ± 0.80</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">C3</td><td class="colsep0 rowsep0" align="left">3.79 ± 0.37</td><td class="colsep0 rowsep0" align="left">15.56 ± 0.82</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">C4</td><td class="colsep0 rowsep0" align="left">3.64 ± 0.26</td><td class="colsep0 rowsep0" align="left">15.35 ± 0.65</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">C5</td><td class="colsep0 rowsep0" align="left">4.88 ± 0.33</td><td class="colsep0 rowsep0" align="left">17.22 ± 0.94</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">C6</td><td class="colsep0 rowsep0" align="left">0.66 ± 0.02</td><td class="colsep0 rowsep0" align="left">14.07 ± 0.53</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AFt-C6 NPs</td><td class="colsep0 rowsep0" align="left">0.31 ± 0.02</td><td class="colsep0 rowsep0" align="left">36.77 ± 1.38</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Na[AuCl<sub>4</sub>]·2H<sub>2</sub>O</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">temozolomide</td><td class="colsep0 rowsep0" align="left">35.9 ± 3.18</td><td class="colsep0 rowsep0" align="left">>40</td></tr></tbody></table></div></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33024" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33024" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Design and Structure of Au(III) 3-(4-Methylpiperidine)thiosemicarbazide Compounds</h3><div class="NLM_p last">Knowing that Au agents and thiosemicarbazones have separately demonstrated great potential as anticancer drugs, we designed novel Au thiosemicarbazone compounds by combining the advantages of both.<a onclick="showRef(event, 'ref27 ref46 ref47 ref48 ref49'); return false;" href="javascript:void(0);" class="ref ref27 ref46 ref47 ref48 ref49">(27,46−49)</a> Overall, six Au(III) 3-(4-methylpiperidine)thiosemicarbazide derivatives bearing different salicylaldehyde moieties (C1–C6) (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>) were synthesized. The structures of C1–C6 were verified by single-crystal X-ray diffraction analysis (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01257/suppl_file/jm0c01257_si_001.pdf" class="ext-link">Tables S1 and S2</a>). Based on the obtained results, the synthesized Au compounds are isomorphs, and they all have the same skeleton (one tridentate Schiff base ligand, one Au center, and one coordinated Cl atom). Moreover, all prepared compounds contain Au1, O1, N1, S1, and Cl1 in the same plane. This tridentate ligand structure is favorable for forming five- and six-membered closed loop rings, which enhances the stability of Au compounds.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Structure–Activity Relationships of Au(III) 3-(4-Methylpiperidine)thiosemicarbazide Compounds against Glioma Cells</h3><div class="NLM_p"><i>In vitro</i> cytotoxicity analyses of the ligands (L1–L6) and Au compounds (C1–C6) were conducted in glioma cells (U87MG) as well as in normal cells (HL-7702). As shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, the half maximal inhibitory concentration (IC<sub>50</sub>) values of the Au compounds (IC<sub>50</sub> = 0.66–9.31 μM) were significantly lower than those of the corresponding ligands (IC<sub>50</sub> ≥ 40 μM). These results suggest that the cytotoxicities of the Au thiosemicarbazide compounds are greater than those of the ligands used to prepare them. Among the investigated Au compounds, C1 with benzene rings at positions C-5 and C-6 showed the lowest cytotoxic activity (IC<sub>50</sub> = 9.31 μM ± 0.51 μM) and the Au compounds with methoxy, ethoxy, allyl, or chlorine groups at the C-3 or C-5 positions exhibited greater cytotoxicity (IC<sub>50</sub> = 3.51–4.88 μM). However, the most cytotoxic agent was C6 (without substitution at C-3, C-5, or C-6 of salicylaldehyde), which had an IC<sub>50</sub> value of 0.66 ± 0.02 μM. Importantly, all of the Au compounds presented greater cytotoxicity against glioma cells than against normal cells (IC<sub>50</sub> = 14.07–18.49 μM in human liver HL-7702 cells), which indicated that the Au compounds synthesized herein can selectively destroy cancer cells to some extent. As such, C6 was selected for further study by using AFt NPs.</div><div class="NLM_p last">To further determine whether the ability of the Au compound uptake by cancer cells was related to their cytotoxic activity against glioma cells, we measured the amount of Au compound uptake by glioma cells. The results showed that the uptake of C6 by glioma cells was greater than that of the other Au compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01257/suppl_file/jm0c01257_si_001.pdf" class="ext-link">Figure S1A</a>). Indeed, high hydrophilicity and lipophilicity can interfere with drug uptake by cancer cells. Thus, to confirm whether the lipophilicity (log <i>P</i><sub>o/w</sub>) of Au compounds plays an important role in the uptake of Au compounds by glioma cells, we measured hydrophilicity and lipophilicity of the Au compounds using the shake-flask technique. Our results demonstrated that the log <i>P</i><sub>o/w</sub> values of C1–C6 were 5.12, 4.38, 4.76, 4.54, 4.96, and 2.88, respectively (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01257/suppl_file/jm0c01257_si_001.pdf" class="ext-link">Figure S1B</a>). Based on Lipinski’s rule, C6 possesses rational lipophilicity and hydrophilicity values to facilitate its uptake by glioma cells because a log <i>P</i><sub>o/w</sub> value >3 does not improve the ability of an agent to be taken up by cancer cells, and there will be serious uptake problems when log <i>P</i><sub>o/w</sub> > 5 or < 0.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Feasibility of Developing a Au Agent Based on the Unique Properties of AFt NPs</h3><div id="sec2_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i8" class="anchor-spacer"></div><h4 class="article-section__title" id="_i8"> Preparation and Characterization of AFt-C6 NPs</h4><div class="NLM_p">The C6-loaded AFt NPs were prepared according to a previously published method (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A).<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> The integrity and size of these NPs were analyzed by dynamic light scattering (DLS), and their average diameter was found to be 13.17 nm (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01257/suppl_file/jm0c01257_si_001.pdf" class="ext-link">Figure S2A,B</a>). Their zeta potential was also determined, and it was used to assess the interactions between the NPs.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> The obtained results showed that a solution of 0.1 mg/mL AFt-C6 NPs and 0.1 M NaCl had a potential of −18.1 mV, which indicates that the electrostatic properties of the AFt surface before and after C6 loading are similar. The overlay of the AFt-C6 NPs and AFt circular dichroism (CD) spectra in the range of 190–250 nm suggested that the AFt conformation remains unchanged after C6 encapsulation (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01257/suppl_file/jm0c01257_si_001.pdf" class="ext-link">Figure S2C</a>). Scanning electron microscopy (SEM) analysis showed that the AFt-C6 NPs are monodispersed in solution and that they have a well-defined spherical morphology (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B,C).</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01257/20201120/images/medium/jm0c01257_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01257/20201120/images/large/jm0c01257_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Establishment of the AFt NP-based C6 delivery system. (A) Scheme of C6 loading into AFt. (B) SEM images of the AFt nanocage (left) and the AFt-C6 NPs (right). (C) Images of AFt (left) and AFt-C6 NPs (right) in a glass bottle. (D) <i>In vitro</i> release of C6 from the AFt-C6 NPs. (E) ICP-MS analysis of the ability of AFt-C6 NPs to target U87MG cells <i>in vitro</i>. (F) Confocal images of the intracellular uptake of Cy5.5-labeled AFt-C6 NPs by U87MG tumor cells. (G) Confocal images of the intracellular uptake of Cy5.5-labeled AFt-C6 NPs by HL-7702 cells. *<i>p</i> < 0.05.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01257/20201120/images/large/jm0c01257_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01257&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i9" class="anchor-spacer"></div><h4 class="article-section__title" id="_i9"> Release Behavior of C6 from AFt-C6 NPs</h4><div class="NLM_p last">Under acidic conditions, the AFt shell breaks down into subunits, thereby releasing the encapsulated C6. To verify the pH-dependent kinetics of C6 release from AFt-C6 NPs, the NPs were incubated for 48 h at pH 7.4, pH 4.7, and pH 2.0 at 37 °C. The release of C6 from these NPs was monitored using inductively coupled plasma mass spectrometry (ICP-MS). As shown in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>D, the AFt-C6 NPs were stable at pH 7.4, and only a minimal amount of free C6 was detected after 48 h of incubation. In contrast, at pH 4.7, the C6-loaded NPs had a half-life of 10 h, and C6 was released up to its maximum of 83% beyond 36 h. At pH = 2.0, C6 was released rapidly from AFt-C6 NPs, reaching a maximum of 95% beyond 5 h. These results suggested that AFt NP-based Au agent delivery systems may be controlled by an endo/lysosome-based drug release mechanism.</div></div><div id="sec2_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i10" class="anchor-spacer"></div><h4 class="article-section__title" id="_i10"> Targeting of the AFt-C6 NPs to Glioma Cells</h4><div class="NLM_p">Based on the IC<sub>50</sub> values listed in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, the AFt-C6 NPs (IC<sub>50</sub> ≤ 0.31 ± 0.02 μM) were approximately 2 times more cytotoxic than C6 alone (IC<sub>50</sub> ≤ 0.66 ± 0.02 μM) against U87MG cells. However, in human liver HL-7702 cells, the latter exhibited much higher cytotoxicity <i>in vitro</i> (IC<sub>50</sub> ≥ 14.07 ± 0.53 μM for C6 and IC<sub>50</sub> ≥ 36.77 ± 1.38 μM for AFt-C6 NPs). This indicates that the U87MG tumor-targeting ability of AFt-C6 NPs is greater than that of free C6.</div><div class="NLM_p last">To confirm the ability of AFt-C6 NPs to selectively target tumor cells, the NPs were incubated with HL-7702 (normal) and U87MG (tumor) cells. Free C6 was also incubated with these same cells for comparison purposes. After 48 h of incubation, the Au and AFt contents in the cells were determined by ICP-MS and western blotting, respectively. The results illustrated in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>E show that HL-7702 and U87MG cells treated with C6 display similar Au contents. However, U87MG cells incubated with AFt-C6 NPs showed significantly higher Au and AFt contents than their HL-7702 counterparts (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>E and <a href="/doi/suppl/10.1021/acs.jmedchem.0c01257/suppl_file/jm0c01257_si_001.pdf" class="ext-link">Figure S3</a>). The cells were also incubated with cyanine 5.5 (Cy5.5)-labeled AFt-C6 NPs and observed by confocal microscopy. Based on the images presented in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>F,G, the fluorescence intensity of the U87MG cells was much stronger than that in the HL-7702 cells.</div></div><div id="sec2_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i11" class="anchor-spacer"></div><h4 class="article-section__title" id="_i11"> Mechanism of AFt-C6 NP Uptake by Glioma Cells</h4><div class="NLM_p">According to previous studies, TfR1 mediates the uptake of AFt in U87MG cells <i>via</i> a mechanism driven by endosomes and lysosomes.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> To confirm this mechanism, the expression levels of TfR1 in U87MG and HL-7702 cells were assessed by western blotting. As shown in <a href="/doi/suppl/10.1021/acs.jmedchem.0c01257/suppl_file/jm0c01257_si_001.pdf" class="ext-link">Figure S3</a>, TfR1 is more highly expressed on the surface of U87MG cells than on the HL-7702 cell surface. Moreover, confocal microscopy analysis of U87MG cells incubated with Cy5.5-labeled AFt-C6 NPs and stained with the lysosomal marker Lamp1 showed that the NPs were located in the lysosomes (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>F). This suggests that U87MG cells may take up AFt-C6 NPs <i>via</i> lysosome-mediated endocytosis.</div><div class="NLM_p last">To further confirm the endocytosis mechanism of AFt-C6 NP uptake by glioma cells, we incubated U87MG cells with AFt-C6 NPs after the U87MG cells were pretreated with the endocytosis inhibitor chloroquine (CQ) or with carbonyl cyanide 3-chlorophenylhydrazone (CCCP, a potent mitochondrial oxidative phosphorylation uncoupler). U87MG cells pretreated with CQ (20 μM) exhibited cellular uptake blockage of AFt NPs, whereas U87MG cells pretreated with CCCP did not show a significant effect (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01257/suppl_file/jm0c01257_si_001.pdf" class="ext-link">Figure S4</a>). These results collectively indicated that AFt-C6 NPs are taken up by glioma cells <i>via</i> endocytic transport.</div></div><div id="sec2_3_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i12" class="anchor-spacer"></div><h4 class="article-section__title" id="_i12"> Models of the AFt-C6 NPs Crossing the BBB <i>In Vitro</i> and <i>In Vivo</i></h4><div class="NLM_p">To determine whether AFt-C6 NPs can cross the BBB, an <i>in vitro</i> BBB transcytosis model was established by culturing monolayer mouse brain ECs (bEnd.3) in Transwell plates. Based on ICP-MS analysis, the contents of AFt-C6 NPs in the lower compartment with U87MG cells was five to six times greater than the contents of C6 after 48 h of incubation (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A,B). This indicates that unlike C6, AFt-C6 NPs can effectively penetrate the BBB of mice <i>in vitro</i>.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01257/20201120/images/medium/jm0c01257_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01257/20201120/images/large/jm0c01257_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Models of AFt-C6 NPs crossing the BBB <i>in vitro</i> and <i>in vivo</i>. (A, B) ICP-MS analysis of NP uptake by lower chamber U87MG cells. <i>In vivo</i> imaging of the brains of (C) healthy and (D) tumor-bearing mice intravenously injected with Cy5.5-AFt-C6 NPs. Quantitative analysis of the fluorescence signals of Cy5.5-AFt-C6 NPs in the brain areas of (E) healthy and (F) tumor-bearing mice. *<i>p</i> < 0.05, **<i>p</i> < 0.02, ***<i>p</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01257/20201120/images/large/jm0c01257_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01257&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The ability of AFt-C6 NPs to cross the BBB and accumulate in glioma tumors was also investigated <i>in vivo.</i> Healthy mice and orthotopic mice bearing the luciferase-expressing U87MG human glioma tumors were administered Cy5.5-labeled AFt-C6 NPs. The microscopy images presented in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>C show no significant fluorescence in the brain areas of the healthy mice; however, the brains of tumor-bearing mice exhibited rapid accumulation of the fluorescence signal (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>D). This result clearly indicates that AFt-C6 NPs specifically target glioma tumor cells and are capable of traversing the BBB <i>in vivo</i>.</div><div class="NLM_p last">Furthermore, quantitative analysis of the fluorescence signals showed that the amount of accumulated Cy5.5-labeled AFt-C6 NPs in the brains of orthotropic U87MG tumor-bearing mice was five times greater than that of the accumulation of Cy5.5 (<i>p</i> < 0.001 at 6–12 h post-injection) and that maximum accumulation occurred 6 to 12 h after the injection (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>F). Similarly, AFt enrichment in the brain areas of healthy mice peaked at 6–12 h post-injection (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>E). Therefore, the ability of Cy5.5-labeled AFt-C6 NPs to cross the BBB was solely attributed to AFt.</div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Antitumor Behavior of C6 and AFt-C6 NPs <i>in vivo</i></h3><div id="sec2_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14"> Biosafety of C6 and the AFt-C6 NPs <i>in vivo</i></h4><div class="NLM_p last">To investigate the biosafety of C6 and the AFt-C6 NPs <i>in vivo</i>, Kunming (KM) mice were intravenously injected with NaCl and C6/AFt-C6 NPs. Three days after injection, blood samples were collected from the mice, and the serum levels of blood urea nitrogen (BUN), creatinine (CRE), alkaline phosphatase (ALT), aspartate aminotransferase (AST), and creatine kinase (CK) were analyzed. The obtained results show that the C6 and AFt-C6 NP treatments do not alter the blood levels of BUN, CK, and CRE in KM mice compared to the NaCl group. Therefore, C6 and AFt-C6 NPs have low nephrotoxicity and cardiotoxicity. Moreover, considering the similarity in the ALT and AST levels of C6-, AFt-C6 NPs-, and NaCl-treated mice (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01257/suppl_file/jm0c01257_si_001.pdf" class="ext-link">Table S3</a>), the C6 and AFt-C6 NPs did not damage the liver.</div></div><div id="sec2_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> Therapeutic Efficacy of C6 and AFt-C6 NPs <i>In Vivo</i></h4><div class="NLM_p">The effects of C6 and the AFt-C6 NPs on the growth of glioma tumors were examined using an orthotropic luciferase-expressing human glioma tumor-bearing (Luc-U87MG) mouse model. The mice were repeatedly injected with C6, AFt-C6 NPs, temozolomide (the first-line chemotherapeutic agent for glioma treatment), or 0.9% normal saline (control group), and the fluorescence signals in their tumors were recorded before treatment, after seven injections, and after the final injection. The <i>in vivo</i> images presented in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A show that at the end of treatment, the fluorescence intensity in the AFt-C6 NP-treated mice was lower than that detected in the C6-treated mice, and both signals were weaker than the control group signal. In addition, the tumor volumes in the AFt-C6 NP mice were much smaller than those observed in the temozolomide, control, and C6 groups (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B). After the last injection, the inhibition rates (IRTs) in the temozolomide, C6, and AFt-C6 NP groups were 45.6 ± 2, 22.8 ± 1, and 69.2 ± 3%, respectively (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>C–E). Overall, these results indicate that AFt-C6 NPs can efficiently suppress the growth of orthotopic glioma tumors in mice and that the therapeutic effects of these NPs are much greater than that of free C6 and temozolomide.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01257/20201120/images/medium/jm0c01257_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01257/20201120/images/large/jm0c01257_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Therapeutic efficiencies of C6 and AFt-C6 NPs <i>in vivo</i>. (A) <i>In vivo</i> fluorescence images of glioma tumor cells in orthotopic mice that were intravenously injected with vehicle control, C6, or AFt-C6 NPs for 28 days. (B) Images of the brains and tumor tissues recorded 2 days after the last treatment. (C) Quantitative analysis of the fluorescence signals in (A). (D) Tumor weights measured 2 days after the last treatment. (E) Tumor volumes measured 2 days after the last treatment. *<i>p</i> < 0.05, **<i>p</i> < 0.02.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01257/20201120/images/large/jm0c01257_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01257&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> Side Effects of C6 and AFt-C6 NPs <i>In Vivo</i></h4><div class="NLM_p">To assess the potential side effects of C6 and AFt-C6 NPs <i>in vivo</i>, the weights of the mice and their organs were recorded at the end of the treatment program, and tissue damage was evaluated <i>via</i> histological examination by hematoxylin and eosin (H&E) staining. The results demonstrated that the weights of mice treated with AFt-C6 NPs and C6 was higher than those of the mice administered normal saline (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A). We speculated that the normal control group of mice lost their appetite as the tumors grew, and the weights of the tumors might have caused the normal control mice to become anorexic; however, the groups of mice injected with C6 and the AFt-C6 NPs did not lose their appetite. Furthermore, the heart, liver, spleen, lung, and kidney tissues isolated from the mice in different groups showed no obvious histopathological abnormalities, lesions, or degenerations (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B). Similarly, there were no significant changes in the organ weights in the treated group compared to the untreated group (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>C). This confirms that both C6 and AFt-C6 NPs are biocompatible in mice.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01257/20201120/images/medium/jm0c01257_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01257/20201120/images/large/jm0c01257_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Side effects and bioavailability of C6 and the AFt-C6 NPs <i>in vivo</i>. (A) Average body weights of the mice (measured every 2 days for 28 days). (B) Histopathological analysis of the heart, liver, spleen, lung, and kidney tissues in mice (H&E staining at 400× two days after the last injection). (C) Average weights of the mouse organs recorded 2 days after the last injection. (D) Au content in the tumors and major organs of mice treated with C6/AFt-C6 NPs 2 days after the last injection. (E) <i>In vivo</i> imaging of the major organs harvested from mice. **<i>p</i> < 0.02.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01257/20201120/images/large/jm0c01257_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01257&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> Bioavailability of C6 and AFt-C6 NPs <i>In Vivo</i></h4><div class="NLM_p last">The Au content in the tumors and major organs of C6- and AFt-C6 NP-treated mice was determined using ICP-MS, which was performed 2 days after the last treatment. As shown in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>D, the tumors in the AFt-C6 NP-treated mice contained significantly more Au (<i>p</i> < 0.05) than the C6-treated mouse tumors. Moreover, reduced Au accumulation was detected in the major organs of the former group. This indicates that the AFt-C6 NPs selectively target and accumulate in tumors. To confirm this conclusion, <i>in vivo</i> tracking experiments of Cy5.5-labeled AFt-C6 NPs were conducted. The images presented in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>E show high fluorescence intensity in the brain tumor area, with minor fluorescence in the major organs.</div></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Confirming the Dual-MOA Anticancer Mechanism of C6</h3><div class="NLM_p">In general, cell death occurs through three pathways: apoptosis (type I), autophagy (type II), and necrosis (type III).<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> The former two pathways (apoptosis and autophagy) are triggered by stress signals, such as increased levels of ROS and mitochondrial dysfunction.</div><div id="sec2_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> Induction of U87MG Cell Apoptosis <i>In Vitro</i> and <i>In Vivo</i></h4><div class="NLM_p">Analysis of the TdT-mediated dUTP nick-end labeling (TUNEL)-stained brain tumor slices collected from different groups showed obvious variations in tumor tissue morphology between the treated groups and the untreated group. The apoptosis rates in the tumor tissues of U87MG-tumor-bearing mice treated with AFt-C6 NPs and C6 were 77.6 and 12.2%, respectively (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>A,B). In addition to their <i>in vivo</i> effects, C6 and AFt-C6 NPs induce U87MG cell apoptosis <i>in vitro</i>, as determined by the Annexin V-FITC/propidium iodide (PI) staining analysis illustrated in <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>C.</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01257/20201120/images/medium/jm0c01257_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01257/20201120/images/large/jm0c01257_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. <i>In vitro</i> and <i>in vivo</i> assessments of the apoptosis mechanism induced by C6 and AFt-C6 NPs. (A) Images of TUNEL-stained tumor tissues. (B) Quantitative analysis of (A). (C) Effects of C6/AFt-C6 NPs (0.3 μM) on U87MG cell apoptosis after 24 h of treatment. (D) Confocal microscopy images (JC-1 indicator, green) of the mitochondrial membrane after treatment with C6 and AFt-C6 NPs for 24 h. (E) Cellular ATP levels in U87MG cells incubated with AFt-C6 NPs for 24 h. (F) ROS (ROS indicator, green) and ER (red) levels in U87MG cells incubated with C6 and AFt-C6 NPs for 24 h. (G) Effects of mitochondria-targeted superoxide scavengers on AFt-C6 NP-induced cell death. (H) Western blot analysis of ER stress markers after incubation of U87MG cells with C6 and AFt-C6 NPs. (I) Expression levels of ER stress markers shown as percentages; the values are relative to the control. *<i>p</i> < 0.05, **<i>p</i> < 0.02, ***<i>p</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01257/20201120/images/large/jm0c01257_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01257&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">According to previous studies, apoptosis may be induced by mitochondrial dysfunction.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> To determine whether the apoptosis of C6 and AFt-C6 NP-treated U87MG cells is caused by mitochondrial dysfunction, accumulation of the administered Au in the mitochondria was monitored, and the mitochondrial membrane potential and adenosine triphosphate (ATP) levels were assessed. The images presented in <a href="/doi/suppl/10.1021/acs.jmedchem.0c01257/suppl_file/jm0c01257_si_001.pdf" class="ext-link">Figure S5</a> show an obvious accumulation of Au in the mitochondria of U87MG cells treated with AFt-C6 NPs. Moreover, the mitochondrial membrane potential and ATP levels clearly decreased after treatment with C6 and AFt-C6 NPs, indicating that mitochondrial dysfunction was underway (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>D,E).<a onclick="showRef(event, 'ref54 ref55 ref56'); return false;" href="javascript:void(0);" class="ref ref54 ref55 ref56">(54−56)</a></div><div class="NLM_p">High levels of ROS were also detected in C6- and AFt-C6 NP-treated tumor cells (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>F,G). To confirm whether the mechanism of C6 production of ROS in glioma cells occurred by a valence change in the Au agent, we used cyclic voltammetry to measure the Au<sup>I/III</sup> redox potentials of C6. The results showed that C6 lies within the range accessible to both cellular oxidants and reductants, and both the Au(I) and Au(III) forms are chemically stable (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01257/suppl_file/jm0c01257_si_001.pdf" class="ext-link">Figure S6</a>). Thus, C6 could redox cycle to generate intracellular ROS.</div><div class="NLM_p">The expression levels of C/EBP homologous protein (CHOP), phosphorylated RNA-dependent protein kinase-like endoplasmic reticulum kinase (PERK), and phosphorylated eukaryotic initiation factor 2a (eIF2a) in U87MG cells were determined by western blotting. U87MG cells were incubated with C6 and AFt-C6 NPs, and 48 h later, the protein levels were analyzed. Based on the results illustrated in <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>H,I, both treatments increased the expression levels of CHOP, PERK, and eIF2a, resulting in ER stress, which leads to apoptosis.</div><div class="NLM_p last">The mitochondrial-mediated apoptosis proteins were also evaluated, and the western blots presented in <a href="/doi/suppl/10.1021/acs.jmedchem.0c01257/suppl_file/jm0c01257_si_001.pdf" class="ext-link">Figure S7</a> indicate that C6 and AFt-C6 NPs suppressed the expression of the prosurvival protein Bcl-2 while enhancing the levels of proapoptotic proteins caspase-3, caspase-9, Bak, p53, and Cyt-c. Overall, the results suggest that C6 and AFt-C6 NPs can induce the death of U87MG cells <i>via</i> the mitochondrial-mediated apoptosis pathway.</div></div><div id="sec2_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> Inducing Lethal Autophagy in U87MG Cells <i>In Vitro</i> and <i>In Vivo</i></h4><div class="NLM_p">The increased ROS, ER stress, and mitochondrial dysfunction levels in C6- and AFt-C6 NP-treated tumor cells suggest that the cytotoxic effects of the Au agent may include autophagy. To confirm this hypothesis, autophagy markers were evaluated by monitoring the regulation of p62 and the transformation from LC3-I into LC3-II.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> The western blots and immunohistological staining images shown in <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>A–C demonstrate that the C6 and AFt-C6 NP treatments upregulated the expression of LC3-II relative to the untreated group while downregulating the expression of p62. We also investigated autophagy using red-green fluorescent protein (RFP-GFP)-fused LC3 (a specific label for autophagosome formation). As shown in <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>D, C6 and AFt-C6 NPs enhanced the accumulation of autophagosomes in U87MG tumor cells after 24 h of incubation. Moreover, transmission electron microscopy (TEM) analysis of autophagy in U87MG tumor xenograft mice treated with C6 and AFt-C6 NPs generated more autophagosomes than their untreated counterparts (assessment conducted 2 days after the last injection) (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>E).</div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01257/20201120/images/medium/jm0c01257_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01257/20201120/images/large/jm0c01257_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. <i>In vitro</i> and <i>in vivo</i> assessments of lethal autophagy in C6- and AFt-C6 NP-treated U87MG cells. (A) Western blots of key autophagy proteins in U87MG cells after treatment with C6 and AFt-C6 NPs. (B) Expression levels of the key autophagy proteins shown as percentages. (C) Immunohistochemistry analysis of the autophagy markers LC3-II and p62. (D) Immunofluorescence analysis of cells transiently transfected with RFP-GFP-LC3-II and treated with C6 and AFt-C6 NPs for 24 h. (E) TEM analysis of autophagic vesicles in U87MG cells treated with C6 and AFt-C6 NPs after the last injection. (F) Immunofluorescence analysis of cells transiently transfected with RFP-GFP-LC3-II, preincubated with 3-MA, and treated with AFt-C6 NPs for 24 h. (G) Western blot analysis of autophagy inhibition by 3-MA. (H) Expression levels of key autophagy proteins shown as percentages.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01257/20201120/images/large/jm0c01257_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01257&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">To confirm that autophagy is implicated in the death of U87MG cells treated with AFt-C6 NPs, the cells were incubated with 3-methyladenine (3-MA), a molecule that inhibits the initiation of autophagy and blocks autophagosome formation, for 1 h before treatment with the Aft-C6 NPs. The obtained results showed that in the AFt-C6 NP group, preincubation with 3-MA decreased the death rate of U87MG cells by ∼40%, with stronger death inhibition detected at higher concentrations of 3-MA (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01257/suppl_file/jm0c01257_si_001.pdf" class="ext-link">Figure S8</a>). In addition, the preincubated cells (2 mM 3-MA) presented reduced levels of autophagosome accumulation (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>F), upregulated expression of p62, and downregulated expression of LC3-II (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>G,H). This confirms that AFt-C6 NPs induce the death of U87MG cells by promoting lethal autophagy.</div></div><div id="sec2_5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> Relationship between Apoptosis and Autophagy in Glioma Cells</h4><div class="NLM_p">Apoptotic and autophagy pathways may interact, or they may proceed independently.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> To investigate the relationship between these two signaling pathways in AFt-C6 NP-induced U87MG cells, the expression level of the apoptotic executioner caspase-3 was analyzed in the presence and absence of 3-MA. The results illustrated in <a href="/doi/suppl/10.1021/acs.jmedchem.0c01257/suppl_file/jm0c01257_si_001.pdf" class="ext-link">Figure S9</a> show that after 48 h of treatment, similar levels of caspase-3 were detected in both groups of U87MG cells (with and without 3-MA preincubation). This indicates that the apoptotic and autophagy pathways induced by AFt-C6 NPs are independent of each other (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>).</div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01257/20201120/images/medium/jm0c01257_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01257/20201120/images/large/jm0c01257_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Relationship between apoptosis and lethal autophagy induced by AFt-C6 NPs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01257/20201120/images/large/jm0c01257_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01257&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76414" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76414" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The design of effective drugs for the treatment of brain tumors is difficult. Normally, drugs are limited by low tumor selectivity, low therapeutic efficiency, and/or <i>in vivo</i> side effects. To overcome these shortcomings, we developed novel dual-MOA agents based on metal/ligand complexation. In addition to their inhibitory effects on brain tumor growth (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>), the designed Au(III) salicylaldehyde-3-(4-methylpiperidine)thiosemicarbazide complexes are characterized by a few side effects and a dual-MOA mechanism (inducing lethal autophagy and apoptosis) (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a> and <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>). Therefore, it is worthwhile to develop C6 as a dual-MOA lead metal drug.</div><div class="NLM_p">However, similar to most commercially available brain tumor drugs, Au(III) salicylaldehyde-3-(4-methylpiperidine)thiosemicarbazides cannot efficiently penetrate the BBB on their own. To resolve this issue, we proposed to take advantage of the properties of AFt to construct nanocarriers to overcome this problem. Indeed, our results confirmed our hypothesis because AFt NPs facilitated more Au agents to cross the BBB (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a> and <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). Interestingly, release of the drug may be controlled simply by manipulating the pH conditions (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). At pH 7.4, only 5% of the Au agents are released from the AFt NPs, whereas at pH 4.7, 83% of these agents may be released. This shows that the AFt-Au agent NPs proposed herein are stable in circulating blood and that they disassemble only when they reach cancer cells, where the environment is acidic.</div><div class="NLM_p last"><i>In vivo</i> experiments conducted in Luc-U87MG model mice showed that AFt-C6 NPs can inhibit the rate of tumor growth by 69.2%, which is 3.0 times greater than the tumor inhibitory rate of free C6 (IRT = 22.8%) (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). Furthermore, the AFt NPs significantly enhanced the bioavailability of C6 <i>in vivo</i>, promoting the selective accumulation of this agent in tumor cells and decreasing C6 accumulation in the main organs (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). Notably, the use of AFt NPs to deliver Au therapeutic agents across the BBB and into glioma cells is an effective strategy for the development of brain cancer treatments.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48316" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48316" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">To effectively cause glioma regression, a Au agent was loaded into AFt NPs and delivered to tumor cells. The proposed AFt-Au agent NPs combined the advantages of the dual-MOA Au agent that kills glioma cells by inducing lethal autophagy and apoptosis with the ability of AFt to penetrate the BBB. Moreover, AFt NPs improved the bioavailability and targeting ability of the Au agent <i>in vivo</i>. Collectively, our results allow for the development of a novel dual-MOA metal agent that can effectively target glioma.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03602" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03602" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">All the chemical reagents were commercially purchased and used without further purification. The purities of all compounds used in the biophysical and biological experiments were routinely checked by HPLC and were found to be ≥95% (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01257/suppl_file/jm0c01257_si_001.pdf" class="ext-link">Figure S10</a>).</div><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Synthesis and Characterization of 3-(4-Methylpiperidine)thiosemicarbazide ligands</h3><div class="NLM_p">Ligands (L1–L6) were synthesized by the reaction of 3-(4-methylpiperidine)thiosemicarbazide with different aldehydes. 3-(4-Methylpiperidine)thiosemicarbazide (3 mmol) was dissolved in MeOH (10 mL), and the appropriate aldehyde (3 mmol) was added followed by stirring for 4 h at 65 °C. Ligands were purified as previously described,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> and their structures were characterized by <sup>1</sup>H NMR and ESI-MS spectra.</div><div id="sec5_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 2-Hydroxy-1-naphthaldehyde-3-(4-methylpiperidine)thiosemicarbazide (L1)</h4><div class="NLM_p last">Yield: 0.71 g, 72.5%. Elemental analysis: Calcd (%) for C<sub>18</sub>H<sub>21</sub>N<sub>3</sub>OS: C, 65.92; H, 6.46; N, 12.83; S, 9.79. Found: C, 65.93; H, 6.43; N, 12.84; S, 9.81. <sup>1</sup>H NMR (400 MHz, DMSO): δ 12.88 (s, 1 H, OH), 11.42 (s, 1 H, NH), 9.40 (s, 1 H, NCH), 8.08 (d, <i>J</i> = 8.5 Hz, 1 H), 7.90–7.88 (m, 2 H), 7.61–7.57 (m, 1 H), 7.41–7.37 (m, 1 H), 7.21–7.19 (m, 1 H), 4.74 (d, <i>J</i> = 13.1 Hz, 2 H), 3.18–3.11 (m, 2 H), 1.74–1.72 (m, 3 H), 1.26–1.08 (m, 2 H), 0.94 (d, <i>J</i> = 6.1 Hz, 3 H). ESI-MS: <i>m</i>/<i>z</i> 326.13 [M – H]<sup>−</sup>.</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 2-Hydroxy-5-chlorine-salicylaldehyde-3-(4-methylpiperidine)thiosemicarbazide (L2)</h4><div class="NLM_p last">Yield: 0.72 g, 77.1%. Elemental analysis: Calcd (%) for C<sub>14</sub>H<sub>18</sub>ClN<sub>3</sub>OS: C, 53.72; H, 5.82; N, 13.48; S, 10.28. Found: C, 53.71; H, 5.84; N, 13.52; S, 10.27. <sup>1</sup>H NMR (400 MHz, DMSO): δ 11.70 (s, 1 H), 11.50 (s, 1 H), 8.40 (s, 1 H), 7.52 (d, <i>J</i> = 2.7 Hz, 1 H), 7.27 (dd, <i>J</i> = 8.8, 2.7 Hz, 1 H), 6.91 (d, <i>J</i> = 8.8 Hz, 1 H), 4.69 (d, <i>J</i> = 13.1 Hz, 2 H), 3.22–2.93 (m, 2 H), 1.69 (d, <i>J</i> = 10.2 Hz, 3 H), 1.16–1.07 (m, 2 H), 0.92 (d, <i>J</i> = 6.1 Hz, 3 H). ESI-MS: <i>m</i>/<i>z</i> 310.08 [M – H]<sup>−</sup>.</div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 2-Hydroxy-3-ethoxy-salicylaldehyde-3-(4-methylpiperidine)thiosemicarbazide (L3)</h4><div class="NLM_p last">Yield: 0.74 g, 76.8%. Elemental analysis: Calcd (%) for C<sub>16</sub>H<sub>23</sub>N<sub>3</sub>O<sub>2</sub>S: C, 59.78; H, 7.21; N, 13.07; S, 9.98. Found: C, 59.74; H, 7.24; N, 13.11; S, 9.99. <sup>1</sup>H NMR (400 MHz, DMSO): δ 11.55 (s, 1 H, OH), 11.35 (s, 1 H, NH), 8.44 (s, 1 H, NCH), 6.98 (s, 1 H), 6.96 (s, 1 H), 6.83–6.79 (m, 1 H), 4.69 (d, <i>J</i> = 13.1 Hz, 2 H), 4.03 (q, <i>J</i> = 7.0 Hz, 2 H), 3.13–3.06 (m, 2 H), 1.73–1.66 (m, 3 H), 1.34 (t, <i>J</i> = 7.0 Hz, 3 H), 1.18–1.07 (m, 2 H), 0.92 (d, <i>J</i> = 6.1 Hz, 3 H). ESI-MS: <i>m</i>/<i>z</i> 322.16 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 2-Hydroxy-3-methoxy-salicylaldehyde-3-(4-methylpiperidine)thiosemicarbazide (L4)</h4><div class="NLM_p last">Yield: 0.69 g, 74.9%. Elemental analysis: Calcd (%) for C<sub>15</sub>H<sub>21</sub>N<sub>3</sub>O<sub>2</sub>S: C, 58.61; H, 6.89; N, 13.67; S, 10.43. Found: C, 58.65; H, 6.91; N, 13.65; S, 10.40. <sup>1</sup>H NMR (400 MHz, DMSO): δ 11.52 (s, 1 H, OH), 11.21 (s, 1 H, NH), 8.44 (s, 1 H, NCH), 7.00–6.97 (m, 2 H), 6.84–6.80 (m, 1 H), 4.69 (d, <i>J</i> = 11.9 Hz, 2 H), 3.79 (s, 3 H), 3.17–3.05 (m, 2 H), 1.71–1.67 (m, 3 H), 1.17–1.07 (m, 2 H), 0.92 (d, <i>J</i> = 6.1 Hz, 3 H). ESI-MS: <i>m</i>/<i>z</i> 308.14 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 2-Hydroxy-3-methoxy-5-allyl-salicylaldehyde-3-(4-methylpiperidine)thiosemicarbazide (L5)</h4><div class="NLM_p last">Yield: 0.79 g, 75.88%. Elemental analysis: Calcd (%) for C<sub>18</sub>H<sub>25</sub>N<sub>3</sub>O<sub>2</sub>S: C, 62.22; H, 7.25; N, 12.09; S, 9.23. Found: C, 62.21; H, 7.23; N, 12.10; S, 9.21. <sup>1</sup>H NMR (400 MHz, DMSO): δ 11.31 (s, 1 H), 11.23 (s, 1 H), 8.39 (s, 1 H), 6.87–6.76 (m, 2 H), 5.96 (d, <i>J</i> = 40.4 Hz, 1 H), 5.02 (s, 2 H), 4.68 (d, <i>J</i> = 15.8 Hz, 2 H), 3.78 (s, 3 H), 3.30 (d, <i>J</i> = 6.7 Hz, 2 H), 3.09 (td, <i>J</i> = 12.9, 2.3 Hz, 2 H), 1.70 (d, <i>J</i> = 17.8 Hz, 3 H), 1.13 (d, <i>J</i> = 41.3 Hz, 2 H), 0.93 (d, <i>J</i> = 6.1 Hz, 3 H). ESI-MS: <i>m</i>/<i>z</i> 348.78 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> Salicylaldehyde-3-(4-methylpiperidine)thiosemicarbazide (L6)</h4><div class="NLM_p last">Yield: 0.76 g, 91.4%. Elemental analysis: Calcd (%) for C<sub>14</sub>H<sub>19</sub>N<sub>3</sub>OS: C, 60.62; H, 6.90; N, 15.15; S, 11.56. Found: C, 60.58; H, 6.91; N, 15.19; S, 11.58. <sup>1</sup>H NMR (400 MHz, DMSO): δ 11.61 (s, 1 H, OH), 11.36 (s, 1 H, NH), 8.45 (s, 1 H, NCH), 7.38 (dd, <i>J</i> = 7.9, 1.7 Hz, 1 H), 7.28–7.24 (m, 1 H), 6.91–6.87 (m, 2 H), 4.69 (d, <i>J</i> = 13.2 Hz, 2 H), 3.13–3.06 (m, 2 H), 1.74–1.66 (m, 3 H), 1.17–1.07 (m, 2 H), 0.92 (d, <i>J</i> = 6.1 Hz, 3 H). ESI-MS: <i>m</i>/<i>z</i> 276.12 [M – H]<sup>−</sup>.</div></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Synthesis and Characterization of Au(III) 3-(4-Methylpiperidine)thiosemicarbazide Compounds</h3><div class="NLM_p">The Au-containing compounds (C1–C6) were synthesized by the reaction of the ligands with Na[AuCl<sub>4</sub>]·2H<sub>2</sub>O. Ligands (0.1 mmol) were dissolved in methanol (10 mL), and then Na[AuCl<sub>4</sub>]·2H<sub>2</sub>O (39.7 mg, 0.1 mmol) was added followed by stirring for 12 h at room temperature. The mixtures were filtered and vacuum dried to obtain a pale green solid. The solid was dissolved into dichloromethane (5 mL) and dropped into a test tube with a capacity of 20 mL and <i>n</i>-hexane (10 mL) was added slowly. The Au compound crystals (black) were acquired by diffusion and then evaporated at room temperature. Their structures were characterized by X-ray crystallography, <sup>1</sup>H NMR, and ESI-MS.</div><div id="sec5_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 2-Hydroxy-1-naphthaldehyde-3-(4-methylpiperidine)thiosemicarbazide Gold(III) Chloride (C1)</h4><div class="NLM_p last">Yield: 0.04 g, 71.5%. CCDC No. 1950024. Elemental analysis: Calcd (%) for C<sub>18</sub>H<sub>20</sub>ClAuN<sub>3</sub>OS: C, 38.68; H, 3.61; N, 7.52; S, 5.74. Found: C, 38.65; H, 3.64; N, 7.51; S, 5.78. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.52 (s, 1 H), 8.43 (d, <i>J</i> = 8.3 Hz, 1 H), 8.10 (d, <i>J</i> = 9.2 Hz, 1 H), 7.93–7.88 (m, 1 H), 7.64–7.60 (d, <i>J</i> = 16.9 Hz, 1 H), 7.45–7.41 (m, 1 H), 7.28 (d, <i>J</i> = 9.1 Hz, 1 H), 4.15 (d, <i>J</i> = 13.3 Hz, 2 H), 3.25–3.18 (m, 2 H), 2.03–1.96 (m, 1 H), 1.75–1.62 (m, 3 H), 1.23–1.14 (m, 2 H), 0.95 (d, <i>J</i> = 6.5 Hz, 3 H). ESI-MS: <i>m</i>/<i>z</i> 556.05 [M – H]<sup>−</sup>.</div></div><div id="sec5_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 2-Hydroxy-5-chlorine-salicylaldehyde-3-(4-methylpiperidine)thiosemicarbazide Gold(III) Chloride (C2)</h4><div class="NLM_p last">Yield: 0.038 g, 70.1%. CCDC No. 1950028. Elemental analysis: Calcd (%) for C<sub>14</sub>H<sub>17</sub>Cl<sub>2</sub>AuN<sub>3</sub>OS: C, 30.95; H, 3.15; N, 7.74; S, 5.90. Found: C, 30.93; H, 3.16; N, 7.78; S, 5.88. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.92 (s, 1 H), 7.84 (d, <i>J</i> = 2.8 Hz, 1 H), 7.57 (dd, <i>J</i> = 9.0, 2.8 Hz, 1 H), 7.05 (d, <i>J</i> = 9.0 Hz, 1 H), 4.07 (d, <i>J</i> = 13.3 Hz, 2 H), 3.21 (td, <i>J</i> = 12.6, 2.7 Hz, 2 H), 1.72–1.61 (m, 3 H), 1.22–1.13 (m, 2 H), 0.93 (d, <i>J</i> = 6.4 Hz, 3 H). ESI-MS: <i>m</i>/<i>z</i> 542.12 [M + H]<sup>+</sup>.</div></div><div id="sec5_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 2-Hydroxy-3-ethoxy-salicylaldehyde-3-(4-methylpiperidine)thiosemicarbazide Gold(III) Chloride (C3)</h4><div class="NLM_p last">Yield: 0.03 g, 55.6%. CCDC No. 1950025. Elemental analysis: Calcd (%) for C<sub>16</sub>H<sub>21</sub>ClAuN<sub>3</sub>O<sub>2</sub>S: C, 34.76; H, 4.01; N, 7.60; S, 5.80. Found: C, 34.73; H, 4.05; N, 7.62; S, 5.81. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.93 (s, 1 H), 7.31 (dd, <i>J</i> = 8.3, 1.4 Hz, 1 H), 7.21 (dd, <i>J</i> = 7.7, 1.4 Hz, 1 H), 6.78 (t, <i>J</i> = 7.9 Hz, 1 H), 4.10–4.05 (m, 4 H), 3.19 (td, <i>J</i> = 13.1, 2.3 Hz, 2 H), 1.73–1.60 (m, 3 H), 1.34 (t, <i>J</i> = 7.0 Hz, 3 H), 1.23–1.14 (m, 2 H), 0.93 (d, <i>J</i> = 6.5 Hz, 3 H). ESI-MS: <i>m</i>/<i>z</i> 550.06 [M – H]<sup>−</sup>.</div></div><div id="sec5_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 2-Hydroxy-3-methoxy-salicylaldehyde-3-(4-methylpiperidine)thiosemicarbazide Gold(III) Chloride (C4)</h4><div class="NLM_p last">Yield: 0.033 g, 59.6%. CCDC No. 1950027. Elemental analysis Calcd (%) for C<sub>15</sub>H<sub>19</sub>ClAuN<sub>3</sub>O<sub>2</sub>S: C, 33.44; H, 3.74; N, 7.80; S, 5.95. Found: C, 33.41; H, 3.75; N, 7.84; S, 5.97. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.94 (s, 1 H), 7.30 (dd, <i>J</i> = 8.3, 1.5 Hz, 1 H), 7.21 (dd, <i>J</i> = 7.8, 1.6 Hz, 1 H), 6.81 (t, <i>J</i> = 7.9 Hz, 1 H), 4.07 (d, <i>J</i> = 13.3 Hz, 2 H), 3.81 (s, 3 H), 3.19 (td, <i>J</i> = 12.9, 2.7 Hz, 2 H), 1.71–1.59 (s, 3 H), 1.20–1.16 (m, 2 H), 0.93 (d, <i>J</i> = 6.4 Hz, 3 H). ESI-MS: <i>m</i>/<i>z</i> 560.04 [M + Na]<sup>+</sup>.</div></div><div id="sec5_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 2-Hydroxy-3-methoxy-5-allyl-salicylaldehyde-3-(4-methylpiperidine)thiosemicarbazide Gold(III) Chloride (C5)</h4><div class="NLM_p last">Yield: 0.04 g, 69.32%. CCDC No. 1950029. Elemental analysis: Calcd (%) for C<sub>18</sub>H<sub>23</sub>ClAuN<sub>3</sub>O<sub>2</sub>S: C, 37.41; H, 4.01; N, 7.27; S, 5.55. Found: C, 37.40; H, 4.05; N, 7.26; S, 5.54. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.87 (s, 1 H), 7.08 (dd, <i>J</i> = 17.3, 2.1 Hz, 2 H), 6.02–5.92 (d, <i>J</i> = 40.4 Hz, 1 H), 5.15–5.01 (m, 2 H), 4.07 (d, <i>J</i> = 13.2 Hz, 2 H), 3.80 (s, 3 H), 3.35–3.14 (m, 4 H), 1.71–1.58 (m, 3 H), 1.24–1.15 (m, 2 H), 0.93 (d, <i>J</i> = 6.5 Hz, 3 H). ESI-MS: <i>m</i>/<i>z</i> 600.08 [M + Na]<sup>+</sup>.</div></div><div id="sec5_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> Salicylaldehyde-3-(4-methylpiperidine)thiosemicarbazide Gold(III) Chloride (C6)</h4><div class="NLM_p last">Yield: 0.035 g, 68.7%. CCDC No. 1950026. Elemental analysis: Calcd (%) for C<sub>14</sub>H<sub>18</sub>ClAuN<sub>3</sub>OS: C, 33.05; H, 3.57; N, 8.26; S, 6.30. Found: C, 33.02; H, 3.61; N, 8.28; S, 6.31. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.96 (s, 1 H), 7.74 (dd, <i>J</i> = 8.2, 1.8 Hz, 1 H), 7.61–7.56 (m, 1 H), 7.03 (d, <i>J</i> = 8.5 Hz, 1 H), 6.91–6.87 (m, 1 H), 4.07 (d, <i>J</i> = 13.3 Hz, 2 H), 3.23–3.15 (m, 2 H), 1.72–1.59 (s, 3 H), 1.20–1.16 (m, 2 H), 0.93 (d, <i>J</i> = 6.4 Hz, 3 H). ESI-MS: <i>m</i>/<i>z</i> 550.09 [M – Cl + DMSO]<sup>+</sup>.</div></div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> Synthesis and Characterization of AFt-C6 NPs</h3><div class="NLM_p">To synthesize the AFt–Au agent NPs, AFt was added to 1 mg/mL Au agent solutions, and the final protein concentration was adjusted to 1 mg/mL. Subsequently, 1 M HCl was added to decrease the pH and induce the dissociation of AFt. The acidic pH value of 2.0 was maintained for approximately 15 min, and then 1 M NaOH was added to restore the pH neutrality of the solution (pH of 7.5). The mixture stirred at 100 rpm and room temperature for 2 h and then dialyzed against saline water (NaCl, 0.15 M, renewed six times) for 48 h to eliminate excess Au agents. Thereafter, the solution was centrifuged three times at 10,000 rpm for 15 min each time. The precipitates were subsequently removed, and the NP solutions were concentrated using a Millipore spin filter (10,000 Da cutoff). A BCA protein assay kit (Beyotime Institute of Biotechnology, China) was used to determine the AFt concentration in each solution. The analyses were performed in triplicate, and bovine serum albumin was used as a standard. The Au content was determined using ICP-MS.</div><div class="NLM_p last">The AFt-C6 NPs were characterized by CD and field SEM (FEI Quanta 200). The CD spectra of samples loaded into a 0.1 cm quartz cell were recorded on a Jasco J-810 spectropolarimeter operating in the far-ultraviolet wavelength range of 200–250 nm. The analyzed samples had a protein concentration of 0.5 mg/mL (0.1 M NaCl), and the spectral data were averaged over three scans. The hydrodynamic diameters of the NPs were determined using a BI-200SM DLS system (Brookhaven Instruments Co., Holtsville, NY). NP solutions with a protein concentration of 0.1 mg/mL (0.1 M NaCl) were filtered through a 0.2 μm filter membrane before analysis, and the particle size measurements were performed in triplicate. Finally, the zeta potential of the AFt-C6 NPs was measured in NaCl solution (0.1 M) at a protein concentration of 0.1 mg/mL.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> <i>In Vivo</i> Animal Studies</h3><div id="sec5_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> Animal Subjects and Tumor Models</h4><div class="NLM_p last">All animal experiments performed in this study were approved by the Chinese Academy of Sciences Institutional Animal Care and Use Committee. The Institutional Animal Ethical Committee (IAEC) project number is SL-007-0. The animals included 15 6 week-old female BALB/c nude mice (Animal Center of the Chinese Academy of Medical Science) that were divided into three groups of five.</div></div><div id="sec5_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> Acute Toxicity Assay</h4><div class="NLM_p last">The acute toxicity of C6 and the AFt-C6 NPs was assessed in eighteen healthy Kunming mice (an equal number of male and female subjects, aged 3–4 weeks, weighing 18–22 g) divided into three groups of six. The mice were intravenously injected with C6 or AFt-C6 NPs at a dose of 2.5 mg/kg body weight, and NaCl was used as a control. Fourteen days later, serum samples were collected from each group, and the levels of BUN, CRE (renal function), CK, ALT, and AST were analyzed.</div></div><div id="sec5_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> <i>In Vivo</i> Antitumor Activity</h4><div class="NLM_p last">The orthotropic luciferase-expressing human glioma tumor model was prepared by introducing 5 × 10<sup>5</sup> Luc-U87MG cells into the left cerebral hemisphere of mice (15 mice in total) using stereotaxic apparatus. The growth of an orthotropic glioma was monitored by bioluminescence imaging (IVIS imaging system; Lumina LT Series III, PerkinElmer) of an intraperitoneally injected luciferin substrate (150 mg/kg). After approximately 10 days of preliminary testing, a fluorescence signal was observed, indicating that a brain tumor had been generated. The mice were then randomly divided into four groups and treated with intravenous injections of normal saline (vehicle), temozolomide, free C6, or AFt-C6 NPs at a dose of 2.5 mg/kg body weight. One injection was administered every 2 days. The body weights of the mice were measured before every injection. The growth of the orthotropic glioma (Luc-U87MG) was monitored by the <i>in vivo</i> imaging of luciferin. After the last injection, the mice were sacrificed, and their major organs and tumor tissues were collected for immunohistochemical analysis.</div></div><div id="sec5_4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> TUNEL Assay</h4><div class="NLM_p last">Paraffin-embedded glioma cancer tissue sections (5 μm) were warmed for 30 min (64 °C), deparaffinized, and then rehydrated. The apoptotic cells in these tissues were assayed using a TUNEL assay kit (A-23210; Molecular Probes, Eugene, OR) according to the manufacturer’s instructions. Images of the analyzed tissues were recorded using an Olympus BX43 fluorescence microscope (Japan).</div></div><div id="sec5_4_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> Selectivity of C6 and AFt-C6 NPs <i>In Vivo</i></h4><div class="NLM_p last">After the last injection of C6/AFt-C6 NPs, the tumor tissues and major organs of the mice were collected and homogenized. The samples were placed in a freeze-drying machine, and then 0.2 g of each sample was soaked in a solution of 3 mL of concentrated nitric acid and 1 mL of 30% H<sub>2</sub>O<sub>2</sub>. The Au contents in the tissue samples (tumors and major organs) were then determined by ICP-MS.</div></div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> Release of the Au Agent from AFt NPs</h3><div class="NLM_p last">The release of C6 from AFt-C6 NPs was analyzed <i>in vitro</i>. First, the cell matrix and interstitial space environment were stimulated using a buffer solution of pH 7.4, pH 4.7, or pH 2.0. Then, the NPs were dialyzed in a dialysis pocket, and 2 mL of the dialyzed solution was dispersed in a beaker containing 100 mL of buffer (pH 4.7 or pH 7.4). The amount of released Au agent was monitored as a function of time (seven time points at each pH condition) using ICP-MS.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> Statistical Analysis</h3><div class="NLM_p last">All of the experiments were repeated three to five times, and statistical analysis of the repeated measured values was performed using Student’s <i>t</i> test. Values were considered to be statistically significant at <i>p</i> values ≤0.05, and the results are expressed as the mean ± SD using SPSS 13.0.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i48"><a href="/doi/suppl/10.1021/acs.jmedchem.0c01257" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48268" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48268" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c01257?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01257</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Experimental methods; crystal data and detailed structural refinement for Au compounds C1–C6; DLS and CD spectra of AFt and AFt-C6 NPs; AFt uptake by HL-7702 and U87MG cells and expression of TfR1 on the surface of HL-7702 and U87MG cells; cellular uptake of C6 and AFt-C6 NPs and the accumulation of the Au agent in the nuclei and mitochondria; western blot analysis of mitochondria-mediated apoptosis markers; inhibition of the antitumor activity of AFt-C6 NPs by 3-MA; effects of autophagy inhibition on AFt-C6 NP-induced caspase-3 cleavage in U87MG cells; serological analysis of mice injected with NaCl; NMR spectra of L1–L6 and C1–C6; and ESI-MS spectra of L1-L6 and C1-C6 (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01257/suppl_file/jm0c01257_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01257/suppl_file/jm0c01257_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01257/suppl_file/jm0c01257_si_001.pdf">jm0c01257_si_001.pdf (1.6 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01257/suppl_file/jm0c01257_si_002.csv">jm0c01257_si_002.csv (0.88 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c01257" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42627" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42627" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Feng Yang</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory for the Chemistry and Molecular Engineering of Medicinal
Resources, Ministry of Science and Technology of China. Guangxi Normal University, Guilin, Guangxi 541003, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4201-1416" title="Orcid link">http://orcid.org/0000-0002-4201-1416</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#02647b636c65426f636b6e606d7a2c657a6c772c6766772c616c"><span class="__cf_email__" data-cfemail="482e3129262f08252921242a2730662f30263d662d2c3d662b26">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hong Liang</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory for the Chemistry and Molecular Engineering of Medicinal
Resources, Ministry of Science and Technology of China. Guangxi Normal University, Guilin, Guangxi 541003, China</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#b4dcd8ddd5dad3f4d9d5ddd8d6dbcc9ad3ccdac19ad1d0c19ad7da"><span class="__cf_email__" data-cfemail="721a1e1b131c15321f131b1e101d0a5c150a1c075c1716075c111c">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Juzheng Zhang</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory for the Chemistry and Molecular Engineering of Medicinal
Resources, Ministry of Science and Technology of China. Guangxi Normal University, Guilin, Guangxi 541003, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhenlei Zhang</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory for the Chemistry and Molecular Engineering of Medicinal
Resources, Ministry of Science and Technology of China. Guangxi Normal University, Guilin, Guangxi 541003, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ming Jiang</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory for the Chemistry and Molecular Engineering of Medicinal
Resources, Ministry of Science and Technology of China. Guangxi Normal University, Guilin, Guangxi 541003, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shanhe Li</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory for the Chemistry and Molecular Engineering of Medicinal
Resources, Ministry of Science and Technology of China. Guangxi Normal University, Guilin, Guangxi 541003, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Haoliang Yuan</span> - <span class="hlFld-Affiliation affiliation">Jiangsu
Key Laboratory of Drug Discovery for Metabolic Disease, China Pharmaceutical University, Nanjing, Jiangsu 210009, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hongbin Sun</span> - <span class="hlFld-Affiliation affiliation">Jiangsu
Key Laboratory of Drug Discovery for Metabolic Disease, China Pharmaceutical University, Nanjing, Jiangsu 210009, China</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>J.Z.Z. and Z.L.Z. contributed equally to this work.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i50">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72164" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72164" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work received financial support from the Natural Science Foundation of China (22077021), the Natural Science Foundation of Guangxi (2017GXNSFEA198002, AD17129007), the Guangxi “Bagui” scholar program to H.B.S., and the High-Level Innovation Team and Distinguished Scholar Program of Guangxi University to F.Y.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">ABBREVIATIONS</td></tr><tr><td class="NLM_term">AFt</td><td class="NLM_def"><p class="first last">apoferritin</p></td></tr><tr><td class="NLM_term">BBB</td><td class="NLM_def"><p class="first last">blood–brain barrier</p></td></tr><tr><td class="NLM_term">bEnd.3</td><td class="NLM_def"><p class="first last">brain endothelial cells</p></td></tr><tr><td class="NLM_term">Cy5.5</td><td class="NLM_def"><p class="first last">cyanine 5.5</p></td></tr><tr><td class="NLM_term">ROS</td><td class="NLM_def"><p class="first last">reactive oxygen species</p></td></tr><tr><td class="NLM_term">JC-1</td><td class="NLM_def"><p class="first last">5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethyl-imi-dacarbocyanine iodide</p></td></tr><tr><td class="NLM_term">SEM</td><td class="NLM_def"><p class="first last">scanning electron microscopy</p></td></tr><tr><td class="NLM_term">DLS</td><td class="NLM_def"><p class="first last">dynamic light scattering</p></td></tr><tr><td class="NLM_term">IRT</td><td class="NLM_def"><p class="first last">inhibition rate of tumor growth</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i52">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35778" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35778" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 57 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cloughesy, T. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavenee, W. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mischel, P. S.</span></span> <span> </span><span class="NLM_article-title">Glioblastoma: from molecular pathology to targeted treatment</span>. <i>Annu. Rev. Pathol.: Mech. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">25</span>, <span class="refDoi"> DOI: 10.1146/annurev-pathol-011110-130324</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.1146%2Fannurev-pathol-011110-130324" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=23937436" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlt1emsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=1-25&author=T.+F.+Cloughesyauthor=W.+K.+Caveneeauthor=P.+S.+Mischel&title=Glioblastoma%3A+from+molecular+pathology+to+targeted+treatment&doi=10.1146%2Fannurev-pathol-011110-130324"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Glioblastoma: from molecular pathology to targeted treatment</span></div><div class="casAuthors">Cloughesy, Timothy F.; Cavenee, Webster K.; Mischel, Paul S.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pathology: Mechanisms of Disease</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-25</span>CODEN:
                <span class="NLM_cas:coden">ARPMCU</span>;
        ISSN:<span class="NLM_cas:issn">1553-4006</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">A review.  Glioblastoma (GBM) is one of the most lethal human cancers.  Genomic analyses are defining the mol. architecture of GBM, uncovering relevant subsets of patients whose disease may require different treatments.  Many pharmacol. targets have been revealed, promising to transform patient care through targeted therapies.  However, for most patients, clin. responses to targeted inhibitors are either not apparent or not durable.  In this review, we address the challenge of developing more effective, molecularly guided approaches for the treatment of GBM patients.  We summarize the current state of knowledge regarding mol. classifiers and examine their benefit for stratifying patients for treatment.  We survey the mol. landscape of the disease, discussing the challenges raised by acquired drug resistance.  Furthermore, we analyze the biochem. features of GBM, suggesting a next generation of drug targets, and we examine the contribution of tumor heterogeneity and its implications.  We conclude with an anal. of the exptl. approaches and their potential benefit to patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooSONedmSmZrVg90H21EOLACvtfcHk0ljzQZxYW_kisg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlt1emsLc%253D&md5=517c62c78fcba4736d3bd30930611fc1</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1146%2Fannurev-pathol-011110-130324&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-pathol-011110-130324%26sid%3Dliteratum%253Aachs%26aulast%3DCloughesy%26aufirst%3DT.%2BF.%26aulast%3DCavenee%26aufirst%3DW.%2BK.%26aulast%3DMischel%26aufirst%3DP.%2BS.%26atitle%3DGlioblastoma%253A%2520from%2520molecular%2520pathology%2520to%2520targeted%2520treatment%26jtitle%3DAnnu.%2520Rev.%2520Pathol.%253A%2520Mech.%2520Dis.%26date%3D2014%26volume%3D9%26spage%3D1%26epage%3D25%26doi%3D10.1146%2Fannurev-pathol-011110-130324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yakisich, J.</span></span> <span> </span><span class="NLM_article-title">Overcoming the blood-brain barrier for chemotherapy: limitations, challenges and rising problems</span>. <i>Anti-Cancer Agents Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1085</span>– <span class="NLM_lpage">1093</span>, <span class="refDoi"> DOI: 10.2174/18715206113139990029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.2174%2F18715206113139990029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=23092271" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFCgtbfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2014&pages=1085-1093&author=Z.+Wangauthor=H.+Sunauthor=J.+Yakisich&title=Overcoming+the+blood-brain+barrier+for+chemotherapy%3A+limitations%2C+challenges+and+rising+problems&doi=10.2174%2F18715206113139990029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Overcoming the Blood-Brain Barrier for Chemotherapy: Limitations, Challenges and Rising Problems</span></div><div class="casAuthors">Wang, Zhaoye; Sun, Hui; Yakisich, Juan Sebastian</div><div class="citationInfo"><span class="NLM_cas:title">Anti-Cancer Agents in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1085-1093</span>CODEN:
                <span class="NLM_cas:coden">AAMCE4</span>;
        ISSN:<span class="NLM_cas:issn">1871-5206</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Treatment of brain tumors with chemotherapy is limited mostly because of delivery impediments related to the blood-brain barrier (BBB).  For gliomas, the most common and aggressive primary brain tumor, treatment includes surgery, radiotherapy, and chemotherapy usually administered orally or i.v.  These routes do not deliver effective concns.  To complicate matters, chemotherapy is usually a long treatment.  Therefore, transient disruption of the BBB is likely insufficient to deliver effective intratumoral concns. of anticancer drugs.  This review briefly updates current strategies for overcoming the BBB with emphasis on their limitations and challenges intrinsic to the biol. of cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoq32ZkkJBgIbVg90H21EOLACvtfcHk0ljzQZxYW_kisg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFCgtbfL&md5=3bfb1034f90a911bd646f81783ee2a7c</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.2174%2F18715206113139990029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F18715206113139990029%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DYakisich%26aufirst%3DJ.%26atitle%3DOvercoming%2520the%2520blood-brain%2520barrier%2520for%2520chemotherapy%253A%2520limitations%252C%2520challenges%2520and%2520rising%2520problems%26jtitle%3DAnti-Cancer%2520Agents%2520Med.%2520Chem.%26date%3D2014%26volume%3D14%26spage%3D1085%26epage%3D1093%26doi%3D10.2174%2F18715206113139990029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fadzen, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolfe, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, C.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Spreckelsen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutchinson, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiocca, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawler, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yilmaz, O. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lippard, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pentelute, B. L.</span></span> <span> </span><span class="NLM_article-title">A platinum(IV) prodrug–perfluoroaryl macrocyclic peptide conjugate enhances platinum uptake in the brain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">6741</span>– <span class="NLM_lpage">6747</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.0c00022</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.0c00022" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BB3cXpsVCqt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=6741-6747&author=C.+M.+Fadzenauthor=J.+M.+Wolfeauthor=W.+Zhouauthor=C.-F.+Choauthor=N.+von+Spreckelsenauthor=K.+T.+Hutchinsonauthor=Y.+C.+Leeauthor=E.+A.+Chioccaauthor=S.+E.+Lawlerauthor=O.+H.+Yilmazauthor=S.+J.+Lippardauthor=B.+L.+Pentelute&title=A+platinum%28IV%29+prodrug%E2%80%93perfluoroaryl+macrocyclic+peptide+conjugate+enhances+platinum+uptake+in+the+brain&doi=10.1021%2Facs.jmedchem.0c00022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">A Platinum(IV) Prodrug-Perfluoroaryl Macrocyclic Peptide Conjugate Enhances Platinum Uptake in the Brain</span></div><div class="casAuthors">Fadzen, Colin M.; Wolfe, Justin M.; Zhou, Wen; Cho, Choi-Fong; von Spreckelsen, Niklas; Hutchinson, Kathryn T.; Lee, Yen-Chun; Chiocca, E. Antonio; Lawler, Sean E.; Yilmaz, Omer H.; Lippard, Stephen J.; Pentelute, Bradley L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">6741-6747</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Effective delivery to the brain limits the development of novel glioblastoma therapies.  Here, we introduce conjugation between platinum(IV) prodrugs of cisplatin and perfluoroaryl peptide macrocycles to increase brain uptake.  We demonstrate that one such conjugate shows efficacy against glioma stem-like cells.  We investigate the pharmacokinetics of this conjugate in mice and show that the amt. of platinum in the brain after treatment with the conjugate is 15-fold greater than with cisplatin after 5 h.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXQ96IXBOnIbVg90H21EOLACvtfcHk0lg0rSFuyDcOYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXpsVCqt70%253D&md5=751d7a15a4061bb1ae3e7a31aaecee11</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.0c00022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.0c00022%26sid%3Dliteratum%253Aachs%26aulast%3DFadzen%26aufirst%3DC.%2BM.%26aulast%3DWolfe%26aufirst%3DJ.%2BM.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DCho%26aufirst%3DC.-F.%26aulast%3Dvon%2BSpreckelsen%26aufirst%3DN.%26aulast%3DHutchinson%26aufirst%3DK.%2BT.%26aulast%3DLee%26aufirst%3DY.%2BC.%26aulast%3DChiocca%26aufirst%3DE.%2BA.%26aulast%3DLawler%26aufirst%3DS.%2BE.%26aulast%3DYilmaz%26aufirst%3DO.%2BH.%26aulast%3DLippard%26aufirst%3DS.%2BJ.%26aulast%3DPentelute%26aufirst%3DB.%2BL.%26atitle%3DA%2520platinum%2528IV%2529%2520prodrug%25E2%2580%2593perfluoroaryl%2520macrocyclic%2520peptide%2520conjugate%2520enhances%2520platinum%2520uptake%2520in%2520the%2520brain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D6741%26epage%3D6747%26doi%3D10.1021%2Facs.jmedchem.0c00022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zanotto-Filho, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braganhol, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klafke, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Figueiró, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terra, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paludo, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrone, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bristot, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Battastini, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forcelini, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bishop, A. J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gelain, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreira, J. C. F.</span></span> <span> </span><span class="NLM_article-title">Autophagy inhibition improves the efficacy of curcumin/temozolomide combination therapy in glioblastomas</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>358</i></span>,  <span class="NLM_fpage">220</span>– <span class="NLM_lpage">231</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2014.12.044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.1016%2Fj.canlet.2014.12.044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=25542083" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmslOlsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=358&publication_year=2015&pages=220-231&author=A.+Zanotto-Filhoauthor=E.+Braganholauthor=K.+Klafkeauthor=F.+Figueir%C3%B3author=S.+R.+Terraauthor=F.+J.+Paludoauthor=M.+Morroneauthor=I.+J.+Bristotauthor=A.+M.+Battastiniauthor=C.+M.+Forceliniauthor=A.+J.+R.+Bishopauthor=D.+P.+Gelainauthor=J.+C.+F.+Moreira&title=Autophagy+inhibition+improves+the+efficacy+of+curcumin%2Ftemozolomide+combination+therapy+in+glioblastomas&doi=10.1016%2Fj.canlet.2014.12.044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Autophagy inhibition improves the efficacy of curcumin/temozolomide combination therapy in glioblastomas</span></div><div class="casAuthors">Zanotto-Filho, Alfeu; Braganhol, Elizandra; Klafke, Karina; Figueiro, Fabricio; Terra, Silvia Resende; Paludo, Francis Jackson; Morrone, Maurilio; Bristot, Ivi Juliana; Battastini, Ana Maria; Forcelini, Cassiano Mateus; Bishop, Alexander James Roy; Gelain, Daniel Pens; Moreira, Jose Claudio Fonseca</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">358</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">220-231</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Glioblastoma is a devastating primary brain tumor resistant to conventional therapies.  In this study, we tested the efficacy of combining temozolomide with curcumin, a phytochem. known to inhibit glioblastoma growth, and investigated the mechanisms involved.  The data showed that synergy between curcumin and temozolomide was not achieved due to redundant mechanisms that lead to activating protective autophagy both in vitro and in vivo.  Autophagy preceded apoptosis, and blocking this response with autophagy inhibitors (3-methyl-adenine, ATG7 siRNA and chloroquine) rendered cells susceptible to temozolomide and curcumin alone or combinations by increasing apoptosis.  While curcumin inhibited STAT3, NFκB and PI3K/Akt to affect survival, temozolomide-induced autophagy relied on the DNA damage response and repair components ATM and MSH6, as well as p38 and JNK1/2.  However, the most interesting observation was that both temozolomide and curcumin required ERK1/2 to induce autophagy.  Blocking this ERK1/2-mediated temozolomide and curcumin induced autophagy with resveratrol, a blood-brain barrier permeable drug, improved temozolomide/curcumin efficacy in brain-implanted tumors.  Overall, the data presented demonstrate that autophagy impairs the efficacy of temozolomide/curcumin, and inhibiting this phenomenon could provide novel opportunities to improve brain tumor treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptyYWeuXaIxrVg90H21EOLACvtfcHk0liOfXHwA743mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmslOlsA%253D%253D&md5=cf864787d0cfb802be7f4146615dae1f</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2014.12.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2014.12.044%26sid%3Dliteratum%253Aachs%26aulast%3DZanotto-Filho%26aufirst%3DA.%26aulast%3DBraganhol%26aufirst%3DE.%26aulast%3DKlafke%26aufirst%3DK.%26aulast%3DFigueir%25C3%25B3%26aufirst%3DF.%26aulast%3DTerra%26aufirst%3DS.%2BR.%26aulast%3DPaludo%26aufirst%3DF.%2BJ.%26aulast%3DMorrone%26aufirst%3DM.%26aulast%3DBristot%26aufirst%3DI.%2BJ.%26aulast%3DBattastini%26aufirst%3DA.%2BM.%26aulast%3DForcelini%26aufirst%3DC.%2BM.%26aulast%3DBishop%26aufirst%3DA.%2BJ.%2BR.%26aulast%3DGelain%26aufirst%3DD.%2BP.%26aulast%3DMoreira%26aufirst%3DJ.%2BC.%2BF.%26atitle%3DAutophagy%2520inhibition%2520improves%2520the%2520efficacy%2520of%2520curcumin%252Ftemozolomide%2520combination%2520therapy%2520in%2520glioblastomas%26jtitle%3DCancer%2520Lett.%26date%3D2015%26volume%3D358%26spage%3D220%26epage%3D231%26doi%3D10.1016%2Fj.canlet.2014.12.044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Geng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klocke, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, K. A.</span></span> <span> </span><span class="NLM_article-title">Chloroquine-induced autophagy vacuole accumulation and cell death in glioma cells is p53 independent</span>. <i>Neuro. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">473</span>– <span class="NLM_lpage">481</span>, <span class="refDoi"> DOI: 10.1093/neuonc/nop048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.1093%2Fneuonc%2Fnop048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=20406898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BC3cXotVWmsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=473-481&author=Y.+Gengauthor=L.+Kohliauthor=B.+J.+Klockeauthor=K.+A.+Roth&title=Chloroquine-induced+autophagy+vacuole+accumulation+and+cell+death+in+glioma+cells+is+p53+independent&doi=10.1093%2Fneuonc%2Fnop048"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Chloroquine-induced autophagic vacuole accumulation and cell death in glioma cells is p53 independent</span></div><div class="casAuthors">Geng, Ying; Kohli, Latika; Klocke, Barbara J.; Roth, Kevin A.</div><div class="citationInfo"><span class="NLM_cas:title">Neuro-Oncology (Cary, NC, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">473-481</span>CODEN:
                <span class="NLM_cas:coden">NEURJR</span>;
        ISSN:<span class="NLM_cas:issn">1522-8517</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Glioblastoma (GBM) is a high-grade central nervous system malignancy and despite aggressive treatment strategies, GBM patients have a median survival time of just 1 yr.  Chloroquine (CQ), an antimalarial lysosomotropic agent, has been identified as a potential adjuvant in the treatment regimen of GBMs.  However, the mechanism of CQ-induced tumor cell death is poorly defined.  We and others have shown that CQ-mediated cell death may be p53-dependent and at least in part due to the intrinsic apoptotic death pathway.  Here, we investigated the effects of CQ on 5 established human GBM lines, differing in their p53 gene status.  CQ was found to induce a concn.-dependent death in each of these cell lines.  Although CQ treatment increased caspase-3-like enzymic activity in all 5 cell lines, a broad-spectrum caspase inhibitor did not significantly attenuate death.  Moreover, CQ caused an accumulation of autophagic vacuoles in all cell lines and was found to affect the levels and subcellular distribution of cathepsin D, suggesting that altered lysosomal function may also play a role in CQ-induced cell death.  Thus, CQ can induce p53-independent death in gliomas that do not require caspase-mediated apoptosis.  To potentially identify more potent chemotherapeutics, various CQ derivs. and lysosomotropic compds. were tested on the GBM cells.  Quinacrine and mefloquine were found to be more potent than CQ in killing GBM cells in vitro and given their superior blood-brain barrier penetration compared with CQ may prove more efficacious as chemotherapeutic agents for GBM patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhZFAIX1dz47Vg90H21EOLACvtfcHk0liOfXHwA743mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXotVWmsbc%253D&md5=c43a7a9c4469dafc27b95859d8169efe</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1093%2Fneuonc%2Fnop048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fneuonc%252Fnop048%26sid%3Dliteratum%253Aachs%26aulast%3DGeng%26aufirst%3DY.%26aulast%3DKohli%26aufirst%3DL.%26aulast%3DKlocke%26aufirst%3DB.%2BJ.%26aulast%3DRoth%26aufirst%3DK.%2BA.%26atitle%3DChloroquine-induced%2520autophagy%2520vacuole%2520accumulation%2520and%2520cell%2520death%2520in%2520glioma%2520cells%2520is%2520p53%2520independent%26jtitle%3DNeuro.%2520Oncol.%26date%3D2010%26volume%3D12%26spage%3D473%26epage%3D481%26doi%3D10.1093%2Fneuonc%2Fnop048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, N.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, H.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, S.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, Y.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joe, Y. A.</span></span> <span> </span><span class="NLM_article-title">The synergistic effect of combination temozolomide and chloroquine treatment is dependent on autophagy formation and p53 status in glioma cells</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>360</i></span>,  <span class="NLM_fpage">195</span>– <span class="NLM_lpage">204</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2015.02.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.1016%2Fj.canlet.2015.02.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=25681668" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BC2MXivFWrtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=360&publication_year=2015&pages=195-204&author=S.+W.+Leeauthor=H.-K.+Kimauthor=N.-H.+Leeauthor=H.-Y.+Yiauthor=H.-S.+Kimauthor=S.-H.+Hongauthor=Y.-K.+Hongauthor=Y.+A.+Joe&title=The+synergistic+effect+of+combination+temozolomide+and+chloroquine+treatment+is+dependent+on+autophagy+formation+and+p53+status+in+glioma+cells&doi=10.1016%2Fj.canlet.2015.02.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The synergistic effect of combination temozolomide and chloroquine treatment is dependent on autophagy formation and p53 status in glioma cells</span></div><div class="casAuthors">Lee, Seung Woo; Kim, Hyun-Kyung; Lee, Na-Hyeon; Yi, Hee-Yeon; Kim, Hong-Sug; Hong, Sung Hee; Hong, Yong-Kil; Joe, Young Ae</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">360</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">195-204</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Temozolomide (TMZ) is an alkylating agent used for the treatment of glioblastoma.  The late autophagy inhibitor chloroquine (CQ) inhibits glioblastoma tumors in a p53-independent and p53-dependent manner.  We addressed a possible beneficial effect of combination treatment with TMZ and CQ by examg. the mol. and cellular mechanism of co-treatment.  Combination treatment of U87 cell (wild type p53) with TMZ and CQ synergistically reduced cell proliferation and enhanced apoptosis, with increased sub-G1 hypodiploid cells and caspase activation.  This effect was abolished by a pan-caspase inhibitor, Z-VAD-FMK.  TMZ induced autophagy, and the addn. of CQ further increased autophagic vacuoles.  Inhibition of early stages of autophagy by Beclin 1 knockdown and 3-methyladenine pretreatment prevented the enhanced effect of the combination treatment.  The combination treatment also upregulated p53 and phospho-p53 levels, whereas p53 knockdown or overexpression of mutant p53 abolished the combination effect.  In contrast, combination therapy had no enhanced effect on U373 cell (mutant p53) proliferation and apoptosis within 3 d, although TMZ induced autophagy and co-treatment with CQ increased autophagic vacuole accumulation.  However, long term combination treatment for 9-10 d effectively decreased clonal and cellular growth with increased G2-M arrest.  This effect was also abolished by Beclin 1 knockdown.  Our data support the beneficial effect of combination treatment with TMZ and CQ in glioma via differential autophagy-assocd. mechanisms, depending on p53 status.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7TI7E98qL-bVg90H21EOLACvtfcHk0lgFIhC8tCw_eA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXivFWrtrk%253D&md5=c92fb6c5d58f9b202304760a84aebd65</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2015.02.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2015.02.012%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DS.%2BW.%26aulast%3DKim%26aufirst%3DH.-K.%26aulast%3DLee%26aufirst%3DN.-H.%26aulast%3DYi%26aufirst%3DH.-Y.%26aulast%3DKim%26aufirst%3DH.-S.%26aulast%3DHong%26aufirst%3DS.-H.%26aulast%3DHong%26aufirst%3DY.-K.%26aulast%3DJoe%26aufirst%3DY.%2BA.%26atitle%3DThe%2520synergistic%2520effect%2520of%2520combination%2520temozolomide%2520and%2520chloroquine%2520treatment%2520is%2520dependent%2520on%2520autophagy%2520formation%2520and%2520p53%2520status%2520in%2520glioma%2520cells%26jtitle%3DCancer%2520Lett.%26date%3D2015%26volume%3D360%26spage%3D195%26epage%3D204%26doi%3D10.1016%2Fj.canlet.2015.02.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nassour, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radford, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Correia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fusté, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoell, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jauch, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlseder, J.</span></span> <span> </span><span class="NLM_article-title">Autophagic cell death restricts chromosomal instability during replicative crisis</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>565</i></span>,  <span class="NLM_fpage">659</span>– <span class="NLM_lpage">663</span>, <span class="refDoi"> DOI: 10.1038/s41586-019-0885-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.1038%2Fs41586-019-0885-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=30675059" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BC1MXmtVyjtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=565&publication_year=2019&pages=659-663&author=J.+Nassourauthor=R.+Radfordauthor=A.+Correiaauthor=J.+M.+Fust%C3%A9author=B.+Schoellauthor=A.+Jauchauthor=R.+J.+Shawauthor=J.+Karlseder&title=Autophagic+cell+death+restricts+chromosomal+instability+during+replicative+crisis&doi=10.1038%2Fs41586-019-0885-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Autophagic cell death restricts chromosomal instability during replicative crisis</span></div><div class="casAuthors">Nassour, Joe; Radford, Robert; Correia, Adriana; Fuste, Javier Miralles; Schoell, Brigitte; Jauch, Anna; Shaw, Reuben J.; Karlseder, Jan</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">565</span>
        (<span class="NLM_cas:issue">7741</span>),
    <span class="NLM_cas:pages">659-663</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Replicative crisis is a senescence-independent process that acts as a final barrier against oncogenic transformation by eliminating pre-cancerous cells with disrupted cell cycle checkpoints1.  It functions as a potent tumor suppressor and culminates in extensive cell death.  Cells rarely evade elimination and evolve towards malignancy, but the mechanisms that underlie cell death in crisis are not well understood.  Here we show that macroautophagy has a dominant role in the death of fibroblasts and epithelial cells during crisis.  Activation of autophagy is crit. for cell death, as its suppression promoted bypass of crisis, continued proliferation and accumulation of genome instability.  Telomere dysfunction specifically triggers autophagy, implicating a telomere-driven autophagy pathway that is not induced by intrachromosomal breaks.  Telomeric DNA damage generates cytosolic DNA species with fragile nuclear envelopes that undergo spontaneous disruption.  The cytosolic chromatin fragments activate the cGAS-STING (cGMP-AMP synthase-stimulator of interferon genes) pathway and engage the autophagy machinery.  Our data suggest that autophagy is an integral component of the tumor suppressive crisis mechanism and that loss of autophagy function is required for the initiation of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnN8n5rUFsorVg90H21EOLACvtfcHk0lgFIhC8tCw_eA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXmtVyjtLw%253D&md5=a1f28b16bbb361c2269cbc63fc22f6d5</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fs41586-019-0885-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41586-019-0885-0%26sid%3Dliteratum%253Aachs%26aulast%3DNassour%26aufirst%3DJ.%26aulast%3DRadford%26aufirst%3DR.%26aulast%3DCorreia%26aufirst%3DA.%26aulast%3DFust%25C3%25A9%26aufirst%3DJ.%2BM.%26aulast%3DSchoell%26aufirst%3DB.%26aulast%3DJauch%26aufirst%3DA.%26aulast%3DShaw%26aufirst%3DR.%2BJ.%26aulast%3DKarlseder%26aufirst%3DJ.%26atitle%3DAutophagic%2520cell%2520death%2520restricts%2520chromosomal%2520instability%2520during%2520replicative%2520crisis%26jtitle%3DNature%26date%3D2019%26volume%3D565%26spage%3D659%26epage%3D663%26doi%3D10.1038%2Fs41586-019-0885-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dou, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nice, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C.</span></span> <span> </span><span class="NLM_article-title">Ivermectin induces cytostatic autophagy by blocking the PAK1/Akt axis in breast cancer</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">4457</span>– <span class="NLM_lpage">4469</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-15-2887</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.1158%2F0008-5472.CAN-15-2887" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=27302166" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1Gmt7nK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2016&pages=4457-4469&author=Q.+Douauthor=H.+N.+Chenauthor=K.+Wangauthor=K.+Yuanauthor=Y.+Leiauthor=K.+Liauthor=J.+Lanauthor=Y.+Chenauthor=Z.+Huangauthor=N.+Xieauthor=L.+Zhangauthor=R.+Xiangauthor=E.+C.+Niceauthor=Y.+Weiauthor=C.+Huang&title=Ivermectin+induces+cytostatic+autophagy+by+blocking+the+PAK1%2FAkt+axis+in+breast+cancer&doi=10.1158%2F0008-5472.CAN-15-2887"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Ivermectin Induces Cytostatic Autophagy by Blocking the PAK1/Akt Axis in Breast Cancer</span></div><div class="casAuthors">Dou, Qianhui; Chen, Hai-Ning; Wang, Kui; Yuan, Kefei; Lei, Yunlong; Li, Kai; Lan, Jiang; Chen, Yan; Huang, Zhao; Xie, Na; Zhang, Lu; Xiang, Rong; Nice, Edouard C.; Wei, Yuquan; Huang, Canhua</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4457-4469</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Breast cancer is the most common cancer among women worldwide, yet successful treatment remains a clin. challenge.  Ivermectin, a broad-spectrum antiparasitic drug, has recently been characterized as a potential anticancer agent due to obsd. antitumor effects.  However, the mol. mechanisms involved remain poorly understood.  Here, we report a role for ivermectin in breast cancer suppression by activating cytostatic autophagy both in vitro and in vivo.  Mechanistically, ivermectin-induced autophagy in breast cancer cells is assocd. with decreased P21-activated kinase 1 (PAK1) expression via the ubiquitination-mediated degrdn. pathway.  The inhibition of PAK1 decreases the phosphorylation level of Akt, resulting in the blockade of the Akt/mTOR signaling pathway.  In breast cancer xenografts, the ivermectin-induced cytostatic autophagy leads to suppression of tumor growth.  Together, our results provide a mol. basis for the use of ivermectin to inhibit the proliferation of breast cancer cells and indicate that ivermectin is a potential option for the treatment of breast cancer.  Cancer Res; 76(15); 4457-69.2016 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZKWcGfsuUE7Vg90H21EOLACvtfcHk0linDc3-DA953g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1Gmt7nK&md5=b1475e60805d04efee9040e91d6aaf4f</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-15-2887&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-15-2887%26sid%3Dliteratum%253Aachs%26aulast%3DDou%26aufirst%3DQ.%26aulast%3DChen%26aufirst%3DH.%2BN.%26aulast%3DWang%26aufirst%3DK.%26aulast%3DYuan%26aufirst%3DK.%26aulast%3DLei%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DK.%26aulast%3DLan%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DXie%26aufirst%3DN.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DXiang%26aufirst%3DR.%26aulast%3DNice%26aufirst%3DE.%2BC.%26aulast%3DWei%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DC.%26atitle%3DIvermectin%2520induces%2520cytostatic%2520autophagy%2520by%2520blocking%2520the%2520PAK1%252FAkt%2520axis%2520in%2520breast%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2016%26volume%3D76%26spage%3D4457%26epage%3D4469%26doi%3D10.1158%2F0008-5472.CAN-15-2887" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Latorraca, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feitosa, W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mariano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moura, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fontes, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nogueira, M. F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paula-Lopes, F. F.</span></span> <span> </span><span class="NLM_article-title">Autophagy is a pro-survival adaptive response to heat shock in bovine cumulus-oocyte complexes</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">13711</span>, <span class="refDoi"> DOI: 10.1038/s41598-020-69939-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.1038%2Fs41598-020-69939-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=32792582" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhs1Cktb7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2020&pages=13711&author=L.+B.+Latorracaauthor=W.+B.+Feitosaauthor=C.+Marianoauthor=M.+T.+Mouraauthor=P.+K.+Fontesauthor=M.+F.+G.+Nogueiraauthor=F.+F.+Paula-Lopes&title=Autophagy+is+a+pro-survival+adaptive+response+to+heat+shock+in+bovine+cumulus-oocyte+complexes&doi=10.1038%2Fs41598-020-69939-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Autophagy is a pro-survival adaptive response to heat shock in bovine cumulus-oocyte complexes</span></div><div class="casAuthors">Latorraca, Lais B.; Feitosa, Weber B.; Mariano, Camila; Moura, Marcelo T.; Fontes, Patricia K.; Nogueira, Marcelo F. G.; Paula-Lopes, Fabiola F.</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">13711</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Autophagy is a physiol. mechanism that can be activated under stress conditions.  However, the role of autophagy during oocyte maturation has been poorly investigated.  Therefore, this study characterized the role of autophagy on developmental competence and gene expression of bovine oocytes exposed to heat shock (HS).  Cumulus-oocyte-complexes (COCs) were matured at Control (38.5°C) and HS (41°C) temps. in the presence of 0 and 10 mM 3-methyladenine (3MA; autophagy inhibitor).  Western blotting anal. revealed that HS increased autophagy marker LC3-II/LC3-I ratio in oocytes.  However, there was no effect of temp. for oocytes matured with 3MA.  On cumulus cells, 3MA reduced LC3-II/LC3-I ratio regardless of temp.  Inhibition of autophagy during IVM of heat-shocked oocytes (3MA-41°C) reduced cleavage and blastocyst rates compared to std. in vitro matured heat-shocked oocytes (IVM-41°C).  Therefore, the magnitude of HS detrimental effects was greater in the presence of autophagy inhibitor.  Oocyte maturation under 3MA-41°C reduced mRNA abundance for genes related to energy metab. (MTIF3), heat shock response (HSF1), and oocyte maturation (HAS2 and GREM1).  In conclusion, autophagy is a stress response induced on heat shocked oocytes.  Inhibition of autophagy modulated key functional processes rendering the oocyte more susceptible to the deleterious effects of heat shock.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4bQNzuZ7YnrVg90H21EOLACvtfcHk0linDc3-DA953g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhs1Cktb7L&md5=efd87478ee79856cb1efe247c2d0a1ec</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fs41598-020-69939-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-020-69939-3%26sid%3Dliteratum%253Aachs%26aulast%3DLatorraca%26aufirst%3DL.%2BB.%26aulast%3DFeitosa%26aufirst%3DW.%2BB.%26aulast%3DMariano%26aufirst%3DC.%26aulast%3DMoura%26aufirst%3DM.%2BT.%26aulast%3DFontes%26aufirst%3DP.%2BK.%26aulast%3DNogueira%26aufirst%3DM.%2BF.%2BG.%26aulast%3DPaula-Lopes%26aufirst%3DF.%2BF.%26atitle%3DAutophagy%2520is%2520a%2520pro-survival%2520adaptive%2520response%2520to%2520heat%2520shock%2520in%2520bovine%2520cumulus-oocyte%2520complexes%26jtitle%3DSci.%2520Rep.%26date%3D2020%26volume%3D10%26spage%3D13711%26doi%3D10.1038%2Fs41598-020-69939-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nice, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C.</span></span> <span> </span><span class="NLM_article-title">Regorafenib induces lethal autophagy arrest by stabilizing PSAT1 in glioblastoma</span>. <i>Autophagy</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">106</span>– <span class="NLM_lpage">122</span>, <span class="refDoi"> DOI: 10.1080/15548627.2019.1598752</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.1080%2F15548627.2019.1598752" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=30909789" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BC1MXnt1Cit7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2020&pages=106-122&author=J.+Jiangauthor=L.+Zhangauthor=H.+Chenauthor=Y.+Leiauthor=T.+Zhangauthor=Y.+Wangauthor=P.+Jinauthor=J.+Lanauthor=L.+Zhouauthor=Z.+Huangauthor=B.+Liauthor=Y.+Liuauthor=W.+Gaoauthor=K.+Xieauthor=L.+Zhouauthor=E.+C.+Niceauthor=Y.+Pengauthor=Y.+Caoauthor=Y.+Weiauthor=K.+Wangauthor=C.+Huang&title=Regorafenib+induces+lethal+autophagy+arrest+by+stabilizing+PSAT1+in+glioblastoma&doi=10.1080%2F15548627.2019.1598752"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Regorafenib induces lethal autophagy arrest by stabilizing PSAT1 in glioblastoma</span></div><div class="casAuthors">Jiang, Jingwen; Zhang, Lu; Chen, Haining; Lei, Yunlong; Zhang, Tao; Wang, Yuelong; Jin, Ping; Lan, Jiang; Zhou, Li; Huang, Zhao; Li, Bowen; Liu, Yuan; Gao, Wei; Xie, Ke; Zhou, Liangxue; Nice, Edouard C.; Peng, Yong; Cao, Yihai; Wei, Yuquan; Wang, Kui; Huang, Canhua</div><div class="citationInfo"><span class="NLM_cas:title">Autophagy</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">106-122</span>CODEN:
                <span class="NLM_cas:coden">AUTOC9</span>;
        ISSN:<span class="NLM_cas:issn">1554-8635</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">GBM (glioblastoma multiforme) is the most common and aggressive brain tumor with no curative options available.  Therefore, it is imperative to develop novel potent therapeutic drugs for GBM treatment.  Here, we show that regorafenib, an oral multi-kinase inhibitor, exhibits superior therapeutic efficacy over temozolomide, the first-line chemotherapeutic agent for GBM treatment both in vitro and in vivo.  Mechanistically, regorafenib directly stabilizes PSAT1 (phosphoserine aminotransferase 1), a crit. enzyme for serine synthesis, to trigger PRKAA-dependent autophagy initiation and inhibit RAB11A-mediated autophagosome-lysosome fusion, resulting in lethal autophagy arrest in GBM cells.  Maintenance of PSAT1 at a high level is essential for regorafenib-induced GBM suppression.  Together, our data provide novel mechanistic insights of regorafenib-induced autophagy arrest and suggest a new paradigm for effective treatment of GBM. 3-MA: 3-methyladenine; ACACA: acetyl CoA carboxylase alpha; ACTB/β-actin: actin, beta; AMPK: adenosine monophosphate-activated protein kinase; ATG5: autophagy related 5; CTSD: cathepsin D; DN-: dominant-neg.; GBM: glioblastoma multiforme; LAMP1: lysosomal-assocd. membrane protein 1; MAP1LC3B/LC3B: microtubule assocd. protein 1 light chain 3 beta; PIK3C3/VPS34: phosphatidylinositol 3-kinase catalytic subunit type 3; PRKAA/AMPKα: protein kinase AMP-activated catalytic subunit alpha; PSAT1: phosphoserine aminotransferase 1; SQSTM1/p62: sequestosome 1; TKIs: tyrosine kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjYimekOwQ8rVg90H21EOLACvtfcHk0ljo1PsVwU6Vmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXnt1Cit7w%253D&md5=069e5e8a379732797be4ea1a6970c562</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1080%2F15548627.2019.1598752&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F15548627.2019.1598752%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DLei%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DJin%26aufirst%3DP.%26aulast%3DLan%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DGao%26aufirst%3DW.%26aulast%3DXie%26aufirst%3DK.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DNice%26aufirst%3DE.%2BC.%26aulast%3DPeng%26aufirst%3DY.%26aulast%3DCao%26aufirst%3DY.%26aulast%3DWei%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DK.%26aulast%3DHuang%26aufirst%3DC.%26atitle%3DRegorafenib%2520induces%2520lethal%2520autophagy%2520arrest%2520by%2520stabilizing%2520PSAT1%2520in%2520glioblastoma%26jtitle%3DAutophagy%26date%3D2020%26volume%3D16%26spage%3D106%26epage%3D122%26doi%3D10.1080%2F15548627.2019.1598752" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Golden, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, H.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jahanian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofman, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Louie, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schönthal, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T. C.</span></span> <span> </span><span class="NLM_article-title">Chloroquine enhances temozolomide cytotoxicity in malignant gliomas by blocking autophagy</span>. <i>Neurosurg. Focus.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">E12</span>, <span class="refDoi"> DOI: 10.3171/2014.9.FOCUS14504</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.3171%2F2014.9.FOCUS14504" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=25434381" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2014&pages=E12&author=E.+B.+Goldenauthor=H.-Y.+Choauthor=A.+Jahanianauthor=F.+M.+Hofmanauthor=S.+G.+Louieauthor=A.+H.+Sch%C3%B6nthalauthor=T.+C.+Chen&title=Chloroquine+enhances+temozolomide+cytotoxicity+in+malignant+gliomas+by+blocking+autophagy&doi=10.3171%2F2014.9.FOCUS14504"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.3171%2F2014.9.FOCUS14504&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3171%252F2014.9.FOCUS14504%26sid%3Dliteratum%253Aachs%26aulast%3DGolden%26aufirst%3DE.%2BB.%26aulast%3DCho%26aufirst%3DH.-Y.%26aulast%3DJahanian%26aufirst%3DA.%26aulast%3DHofman%26aufirst%3DF.%2BM.%26aulast%3DLouie%26aufirst%3DS.%2BG.%26aulast%3DSch%25C3%25B6nthal%26aufirst%3DA.%2BH.%26aulast%3DChen%26aufirst%3DT.%2BC.%26atitle%3DChloroquine%2520enhances%2520temozolomide%2520cytotoxicity%2520in%2520malignant%2520gliomas%2520by%2520blocking%2520autophagy%26jtitle%3DNeurosurg.%2520Focus.%26date%3D2014%26volume%3D37%26spage%3DE12%26doi%3D10.3171%2F2014.9.FOCUS14504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, Z.</span></span> <span> </span><span class="NLM_article-title">Targeting autophagy to sensitive glioma to temozolomide treatment</span>. <i>J. Exp. Clin Cancer. Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">23</span>, <span class="refDoi"> DOI: 10.1186/s13046-016-0303-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.1186%2Fs13046-016-0303-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=26830677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlKqtbvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2016&pages=23&author=Y.+Yanauthor=Z.+Xuauthor=S.+Daiauthor=L.+Qianauthor=L.+Sunauthor=Z.+Gong&title=Targeting+autophagy+to+sensitive+glioma+to+temozolomide+treatment&doi=10.1186%2Fs13046-016-0303-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting autophagy to sensitive glioma to temozolomide treatment</span></div><div class="casAuthors">Yan, Yuanliang; Xu, Zhijie; Dai, Shuang; Qian, Long; Sun, Lunquan; Gong, Zhicheng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental & Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">23/1-23/14</span>CODEN:
                <span class="NLM_cas:coden">JECRDN</span>;
        ISSN:<span class="NLM_cas:issn">1756-9966</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Temozolomide (TMZ), an alkylating agent, is widely used for treating primary and recurrent high-grade gliomas.  However, the efficacy of TMZ is often limited by the development of resistance.  Recently, studies have found that TMZ treatment could induce autophagy, which contributes to therapy resistance in glioma.  To enhance the benefit of TMZ in the treatment of glioblastomas, effective combination strategies are needed to sensitize glioblastoma cells to TMZ.  In this regard, as autophagy could promote cell survival or autophagic cell death, modulating autophagy using a pharmacol. inhibitor, such as chloroquine, or an inducer, such as rapamycin, has received considerably more attention.  To understand the effectiveness of regulating autophagy in glioblastoma treatment, this review summarizes reports on glioblastoma treatments with TMZ and autophagic modulators from in vitro and in vivo studies, as well as clin. trials.  Addnl., we discuss the possibility of using autophagy regulatory compds. that can sensitive TMZ treatment as a chemotherapy for glioma treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptB6HcZCkR4rVg90H21EOLACvtfcHk0ljo1PsVwU6Vmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlKqtbvJ&md5=673d5324b7d3b62dee45f1d03ef87d0d</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1186%2Fs13046-016-0303-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13046-016-0303-5%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DDai%26aufirst%3DS.%26aulast%3DQian%26aufirst%3DL.%26aulast%3DSun%26aufirst%3DL.%26aulast%3DGong%26aufirst%3DZ.%26atitle%3DTargeting%2520autophagy%2520to%2520sensitive%2520glioma%2520to%2520temozolomide%2520treatment%26jtitle%3DJ.%2520Exp.%2520Clin%2520Cancer.%2520Res.%26date%3D2016%26volume%3D35%26spage%3D23%26doi%3D10.1186%2Fs13046-016-0303-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Galluzzi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bravo-San Pedro, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levine, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kroemer, G.</span></span> <span> </span><span class="NLM_article-title">Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">487</span>– <span class="NLM_lpage">511</span>, <span class="refDoi"> DOI: 10.1038/nrd.2017.22</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.1038%2Fnrd.2017.22" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=28529316" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BC2sXotVKntr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=487-511&author=L.+Galluzziauthor=J.+M.+Bravo-San+Pedroauthor=B.+Levineauthor=D.+R.+Greenauthor=G.+Kroemer&title=Pharmacological+modulation+of+autophagy%3A+therapeutic+potential+and+persisting+obstacles&doi=10.1038%2Fnrd.2017.22"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles</span></div><div class="casAuthors">Galluzzi, Lorenzo; Bravo-San Pedro, Jose Manuel; Levine, Beth; Green, Douglas R.; Kroemer, Guido</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">487-511</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Autophagy is central to the maintenance of organismal homeostasis in both physiol. and pathol. situations.  Accordingly, alterations in autophagy have been linked to clin. relevant conditions as diverse as cancer, neurodegeneration and cardiac disorders.  Throughout the past decade, autophagy has attracted considerable attention as a target for the development of novel therapeutics.  However, such efforts have not yet generated clin. viable interventions.  In this review, we discuss the therapeutic potential of autophagy modulators, analyze the obstacles that have limited their development and propose strategies that may unlock the full therapeutic potential of autophagy modulation in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1YAuK4nNrTbVg90H21EOLACvtfcHk0lijveZ7bM3Brg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXotVKntr4%253D&md5=0cf36178d5fd9b4d2493649d44aa1051</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2017.22&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2017.22%26sid%3Dliteratum%253Aachs%26aulast%3DGalluzzi%26aufirst%3DL.%26aulast%3DBravo-San%2BPedro%26aufirst%3DJ.%2BM.%26aulast%3DLevine%26aufirst%3DB.%26aulast%3DGreen%26aufirst%3DD.%2BR.%26aulast%3DKroemer%26aufirst%3DG.%26atitle%3DPharmacological%2520modulation%2520of%2520autophagy%253A%2520therapeutic%2520potential%2520and%2520persisting%2520obstacles%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2017%26volume%3D16%26spage%3D487%26epage%3D511%26doi%3D10.1038%2Fnrd.2017.22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, F.</span></span> <span> </span><span class="NLM_article-title">Discovery of new fluorescent thiazole–pyrazoline derivatives as autophagy inducers by inhibiting mTOR activity in A549 human lung cancer cells</span>. <i>Cell Death & Disease.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">551</span>, <span class="refDoi"> DOI: 10.1038/s41419-020-02746-w</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.1038%2Fs41419-020-02746-w" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=32686662" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhsVWqsrzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2020&pages=551&author=Z.+Linauthor=Z.+Wangauthor=X.+Zhouauthor=M.+Zhangauthor=D.+Gaoauthor=L.+Zhangauthor=P.+Wangauthor=Y.+Chenauthor=Y.+Linauthor=B.+Zhaoauthor=J.+Miaoauthor=F.+Kong&title=Discovery+of+new+fluorescent+thiazole%E2%80%93pyrazoline+derivatives+as+autophagy+inducers+by+inhibiting+mTOR+activity+in+A549+human+lung+cancer+cells&doi=10.1038%2Fs41419-020-02746-w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of new fluorescent thiazole-pyrazoline derivatives as autophagy inducers by inhibiting mTOR activity in A549 human lung cancer cells</span></div><div class="casAuthors">Lin, Zhao Min; Wang, Zhao Yang; Zhou, Xue Wen; Zhang, Ming; Gao, Dong Fang; Zhang, Lu; Wang, Peng; Chen, Yuan; Lin, Yu Xing; Zhao, Bao Xiang; Miao, Jun Ying; Kong, Feng</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">551</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">A series of fluorescent thiazole-pyrazoline derivs. was synthesized and their structures were characterized by 1H NMR, 13C NMR, and HRMS.  Biol. evaluation demonstrated that these compds. could effectively inhibit the growth of human non-small cell lung cancer (NSCLC) A549 cells in a dose- and time-dependent manner in vitro and inhibit tumor growth in vivo.  The structure-activity relationship (SAR) of the compds. was analyzed.  Further mechanism research revealed they could induce autophagy and cell cycle arrest while had no influence on cell necrosis.  Compd. 5e inhibited the activity of mTOR via FKBP12, which could be reversed by 3BDO, an mTOR activator and autophagy inhibitor.  Compd. I (R = 4-Cl, Ar = 4-MeOPh) inhibited growth, promoted autophagy of A549 cells in vivo.  Moreover, compd. I (R = 4-Cl, Ar = 4-MeOPh) showed good selectivity with no influence on normal vascular endothelial cell growth and the normal chick embryo chorioallantoic membrane (CAM) capillary formation.  Therefore, our research provides potential lead compds. for the development of new anticancer drugs against human lung cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDzCYT4H8CBbVg90H21EOLACvtfcHk0lijveZ7bM3Brg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhsVWqsrzJ&md5=a97dcd92db2c1f5aca3d562d3421baa7</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fs41419-020-02746-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41419-020-02746-w%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DGao%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DLin%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DB.%26aulast%3DMiao%26aufirst%3DJ.%26aulast%3DKong%26aufirst%3DF.%26atitle%3DDiscovery%2520of%2520new%2520fluorescent%2520thiazole%25E2%2580%2593pyrazoline%2520derivatives%2520as%2520autophagy%2520inducers%2520by%2520inhibiting%2520mTOR%2520activity%2520in%2520A549%2520human%2520lung%2520cancer%2520cells%26jtitle%3DCell%2520Death%2520%2526%2520Disease.%26date%3D2020%26volume%3D11%26spage%3D551%26doi%3D10.1038%2Fs41419-020-02746-w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cho, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koh, J. Y.</span></span> <span> </span><span class="NLM_article-title">A role of metallothionein-3 in radiation-induced autophagy in glioma cells</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">2015</span>, <span class="refDoi"> DOI: 10.1038/s41598-020-58237-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.1038%2Fs41598-020-58237-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=32029749" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BB3cXntlSguro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2020&pages=2015&author=Y.+H.+Choauthor=S.+H.+Leeauthor=S.+J.+Leeauthor=H.+N.+Kimauthor=J.+Y.+Koh&title=A+role+of+metallothionein-3+in+radiation-induced+autophagy+in+glioma+cells&doi=10.1038%2Fs41598-020-58237-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">A role of metallothionein-3 in radiation-induced autophagy in glioma cells</span></div><div class="casAuthors">Cho, Young Hyun; Lee, Seung-Hwan; Lee, Sook-Jeong; Kim, Ha Na; Koh, Jae-Young</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">2015</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Abstr.: Although metallothionein-3 (MT3), a brain-enriched form of metallothioneins, has been linked to Alzheimer's disease, little is known regarding the role of MT3 in glioma.  As MT3 plays a role in autophagy in astrocytes, here, we investigated its role in irradiated glioma cells.  Irradn. increased autophagy flux in GL261 glioma cells as evidenced by increased levels of LC3-II but decreased levels of p62 (SQSTM1).  Indicating that autophagy plays a cytoprotective role in glioma cell survival following irradn., measures inhibiting autophagy flux at various steps decreased their clonogenic survival of irradiated GL261 as well as SF295 and U251 glioma cells.  Knockdown of MT3 with siRNA in irradiated glioma cells induced arrested autophagy, and decreased cell survival.  At the same time, the accumulation of labile zinc in lysosomes was markedly attenuated by MT3 knockdown.  Indicating that such zinc accumulation was important in autophagy flux, chelation of zinc with tetrakis-(2-pyridylmethyl)ethylenediamine (TPEN), induced arrested autophagy in and reduced survival of GL261 cells following irradn.  Suggesting a possible mechanism for arrested autophagy, MT3 knockdown and zinc chelation were found to impair lysosomal acidification.  Since autophagy flux plays a cytoprotective role in irradiated glioma cells, present results suggest that MT3 and zinc may be regarded as possible therapeutic targets to sensitize glioma cells to ionizing radiation therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1xplWEHnYEbVg90H21EOLACvtfcHk0lggLnYe1WKbLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXntlSguro%253D&md5=092cfd477bbbfdf4fb7cc7eb7beb3d31</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fs41598-020-58237-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-020-58237-7%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DY.%2BH.%26aulast%3DLee%26aufirst%3DS.%2BH.%26aulast%3DLee%26aufirst%3DS.%2BJ.%26aulast%3DKim%26aufirst%3DH.%2BN.%26aulast%3DKoh%26aufirst%3DJ.%2BY.%26atitle%3DA%2520role%2520of%2520metallothionein-3%2520in%2520radiation-induced%2520autophagy%2520in%2520glioma%2520cells%26jtitle%3DSci.%2520Rep.%26date%3D2020%26volume%3D10%26spage%3D2015%26doi%3D10.1038%2Fs41598-020-58237-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, G. J.</span></span> <span> </span><span class="NLM_article-title">Therapeutic strategies of drug repositioning targeting autophagy to induce cancer cell death: from pathophysiology to treatment</span>. <i>J. Hematol. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">67</span>, <span class="refDoi"> DOI: 10.1186/s13045-017-0436-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.1186%2Fs13045-017-0436-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=28279189" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BC1cXksl2msr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2017&pages=67&author=G.+J.+Yoshida&title=Therapeutic+strategies+of+drug+repositioning+targeting+autophagy+to+induce+cancer+cell+death%3A+from+pathophysiology+to+treatment&doi=10.1186%2Fs13045-017-0436-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic strategies of drug repositioning targeting autophagy to induce cancer cell death: from pathophysiology to treatment</span></div><div class="casAuthors">Yoshida, Go J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hematology & Oncology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">67/1-67/14</span>CODEN:
                <span class="NLM_cas:coden">JHOOAO</span>;
        ISSN:<span class="NLM_cas:issn">1756-8722</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">The 2016 Nobel Prize in Physiol. or Medicine was awarded to the researcher that discovered autophagy, which is an evolutionally conserved catabolic process which degrades cytoplasmic constituents and organelles in the lysosome.  Autophagy plays a crucial role in both normal tissue homeostasis and tumor development and is necessary for cancer cells to adapt efficiently to an unfavorable tumor microenvironment characterized by hypo-nutrient conditions.  This protein degrdn. process leads to amino acid recycling, which provides sufficient amino acid substrates for cellular survival and proliferation.  Autophagy is constitutively activated in cancer cells due to the deregulation of PI3K/Akt/mTOR signaling pathway, which enables them to adapt to hypo-nutrient microenvironment and exhibit the robust proliferation at the pre-metastatic niche.  That is why just the activation of autophagy with mTOR inhibitor often fails in vain.  In contrast, disturbance of autophagy-lysosome flux leads to endoplasmic reticulum (ER) stress and an unfolded protein response (UPR), which finally leads to increased apoptotic cell death in the tumor tissue.  Accumulating evidence suggests that autophagy has a close relationship with programmed cell death, while uncontrolled autophagy itself often induces autophagic cell death in tumor cells.  Autophagic cell death was originally defined as cell death accompanied by large-scale autophagic vacuolization of the cytoplasm.  However, autophagy is a "double-edged sword" for cancer cells as it can either promote or suppress the survival and proliferation in the tumor microenvironment.  Furthermore, several studies of drug re-positioning suggest that "conventional" agents used to treat diseases other than cancer can have antitumor therapeutic effects by activating/suppressing autophagy.  Because of ever increasing failure rates and high cost assocd. with anticancer drug development, this therapeutic development strategy has attracted increasing attention because the safety profiles of these medicines are well known.  Antimalarial agents such as artemisinin and disease-modifying antirheumatic drug (DMARD) are the typical examples of drug re-positioning which affect the autophagy regulation for the therapeutic use.  This review article focuses on recent advances in some of the novel therapeutic strategies that target autophagy with a view to treating/preventing malignant neoplasms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrByPEabuGYjbVg90H21EOLACvtfcHk0lggLnYe1WKbLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXksl2msr4%253D&md5=da231073d7fd84da91eb848455e2b59f</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1186%2Fs13045-017-0436-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13045-017-0436-9%26sid%3Dliteratum%253Aachs%26aulast%3DYoshida%26aufirst%3DG.%2BJ.%26atitle%3DTherapeutic%2520strategies%2520of%2520drug%2520repositioning%2520targeting%2520autophagy%2520to%2520induce%2520cancer%2520cell%2520death%253A%2520from%2520pathophysiology%2520to%2520treatment%26jtitle%3DJ.%2520Hematol.%2520Oncol.%26date%3D2017%26volume%3D10%26spage%3D67%26doi%3D10.1186%2Fs13045-017-0436-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ozben, T.</span></span> <span> </span><span class="NLM_article-title">Oxidative stress and apoptosis: impact on cancer therapy</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">2181</span>– <span class="NLM_lpage">2196</span>, <span class="refDoi"> DOI: 10.1002/jps.20874</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.1002%2Fjps.20874" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=17593552" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVWntLnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2007&pages=2181-2196&author=T.+Ozben&title=Oxidative+stress+and+apoptosis%3A+impact+on+cancer+therapy&doi=10.1002%2Fjps.20874"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative stress and apoptosis: impact on cancer therapy</span></div><div class="casAuthors">Ozben, Tomris</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2181-2196</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  It is well established that some chemotherapeutic agents and radiation therapy generate reactive oxygen species (ROS) in patients during cancer therapy.  Free radicals, particularly ROS have been proposed as common mediators for apoptosis.  Recent studies have demonstrated that the mode of cell death depends on the severity of the oxidative damage.  This review will address some of the current paradigms of oxidative stress, and antioxidants on apoptosis, and discuss the potential mechanisms by which oxidants can regulate apoptotic pathways.  It will also review new developments in eliminating cancer cells by selectively inducing apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWwZ5lgHXtJbVg90H21EOLACvtfcHk0lggLnYe1WKbLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVWntLnI&md5=a87205dc90c12a711cf432e1877d16ed</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2Fjps.20874&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.20874%26sid%3Dliteratum%253Aachs%26aulast%3DOzben%26aufirst%3DT.%26atitle%3DOxidative%2520stress%2520and%2520apoptosis%253A%2520impact%2520on%2520cancer%2520therapy%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2007%26volume%3D96%26spage%3D2181%26epage%3D2196%26doi%3D10.1002%2Fjps.20874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ostrom, Q. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gittleman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farah, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ondracek, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolinsky, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stroup, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruchko, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnholtz-Sloan, J. S.</span></span> <span> </span><span class="NLM_article-title">CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2006–2010</span>. <i>Neuro. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">ii1</span>– <span class="NLM_lpage">ii56</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2013&pages=ii1-ii56&author=Q.+T.+Ostromauthor=H.+Gittlemanauthor=P.+Farahauthor=A.+Ondracekauthor=Y.+Chenauthor=Y.+L.+Wolinskyauthor=N.+E.+Stroupauthor=C.+Kruchkoauthor=J.+S.+Barnholtz-Sloan&title=CBTRUS+statistical+report%3A+primary+brain+and+central+nervous+system+tumors+diagnosed+in+the+United+States+in+2006%E2%80%932010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOstrom%26aufirst%3DQ.%2BT.%26aulast%3DGittleman%26aufirst%3DH.%26aulast%3DFarah%26aufirst%3DP.%26aulast%3DOndracek%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DWolinsky%26aufirst%3DY.%2BL.%26aulast%3DStroup%26aufirst%3DN.%2BE.%26aulast%3DKruchko%26aufirst%3DC.%26aulast%3DBarnholtz-Sloan%26aufirst%3DJ.%2BS.%26atitle%3DCBTRUS%2520statistical%2520report%253A%2520primary%2520brain%2520and%2520central%2520nervous%2520system%2520tumors%2520diagnosed%2520in%2520the%2520United%2520States%2520in%25202006%25E2%2580%25932010%26jtitle%3DNeuro.%2520Oncol.%26date%3D2013%26volume%3D2%26spage%3Dii1%26epage%3Dii56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, K.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, X.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, H.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.-N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, H.</span></span> <span> </span><span class="NLM_article-title">Organometallic gold(III) complexes similar to tetrahydroisoquinoline induce ER-stress-mediated apoptosis and pro-death autophagy in A549 cancer cells</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">3478</span>– <span class="NLM_lpage">3490</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01694</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01694" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmslGqsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=3478-3490&author=K.-B.+Huangauthor=F.-Y.+Wangauthor=X.-M.+Tangauthor=H.-W.+Fengauthor=Z.-F.+Chenauthor=Y.-C.+Liuauthor=Y.-N.+Liuauthor=H.+Liang&title=Organometallic+gold%28III%29+complexes+similar+to+tetrahydroisoquinoline+induce+ER-stress-mediated+apoptosis+and+pro-death+autophagy+in+A549+cancer+cells&doi=10.1021%2Facs.jmedchem.7b01694"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Organometallic Gold(III) complexes similar to tetrahydroisoquinoline induce ER-stress-mediated apoptosis and pro-death autophagy in A549 cancer cells</span></div><div class="casAuthors">Huang, Ke-Bin; Wang, Feng-Yang; Tang, Xiao-Ming; Feng, Hai-Wen; Chen, Zhen-Feng; Liu, Yan-Cheng; Liu, You-Nian; Liang, Hong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3478-3490</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Gold(III) cyclometalated benzeneethanamine chelate complexes exhibit high cytotoxic activity towards lung cancer cells, causing ER-controlled apoptosis and autophagy, exhibiting less toxicity compared to cisplatin.  Agents inducing both apoptosis and autophagic death can be effective chemotherapeutic drugs.  In our present work, we synthesized two organometallic gold(III) complexes harboring C-N ligands that structurally resemble tetrahydroisoquinoline (THIQ): Cyc-Au-1 (AuL1Cl2, HL1 = 3,4-dimethoxyphenethylamine) and Cyc-Au-2 (AuL2Cl2, HL2 = 1,3-benzodioxole-5-ethanamine).  In screening their in vitro activity, we found both gold complexes exhibited lower toxicity, lower resistance factors, and better anticancer activity than those of cisplatin.  The organometallic gold(III) complexes accumulate in mitochondria and induce elevated ROS and an ER stress response through mitochondrial dysfunction.  These effects ultimately result in simultaneous apoptosis and autophagy.  Importantly, compared to cisplatin, Cyc-Au-2 exhibits lower toxicity and better anticancer activity in a murine tumor model.  To the best of our knowledge, Cyc-Au-2 is the first organometallic Au(III) compd. that induces apoptosis and autophagic death.  On the basis of our results, we believe Cyc-Au-2 to be a promising anticancer agent or lead compd. for further anticancer drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIcN1K09UUe7Vg90H21EOLACvtfcHk0lhEvjq8vY3vmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmslGqsLo%253D&md5=08921b2a076c3cf07260611ab629fe93</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01694&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01694%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DK.-B.%26aulast%3DWang%26aufirst%3DF.-Y.%26aulast%3DTang%26aufirst%3DX.-M.%26aulast%3DFeng%26aufirst%3DH.-W.%26aulast%3DChen%26aufirst%3DZ.-F.%26aulast%3DLiu%26aufirst%3DY.-C.%26aulast%3DLiu%26aufirst%3DY.-N.%26aulast%3DLiang%26aufirst%3DH.%26atitle%3DOrganometallic%2520gold%2528III%2529%2520complexes%2520similar%2520to%2520tetrahydroisoquinoline%2520induce%2520ER-stress-mediated%2520apoptosis%2520and%2520pro-death%2520autophagy%2520in%2520A549%2520cancer%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D3478%26epage%3D3490%26doi%3D10.1021%2Facs.jmedchem.7b01694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, R. W. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, C. M.</span></span> <span> </span><span class="NLM_article-title">A dual cytotoxic and antiangiogenic water-soluble gold(III) complex induces endoplasmic reticulum damage in HeLa cells</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">3388</span>– <span class="NLM_lpage">3390</span>, <span class="refDoi"> DOI: 10.1039/c2cc00029f</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.1039%2Fc2cc00029f" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=22373586" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtlKrsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2012&pages=3388-3390&author=J.+J.+Zhangauthor=R.+W.+Y.+Sunauthor=C.+M.+Che&title=A+dual+cytotoxic+and+antiangiogenic+water-soluble+gold%28III%29+complex+induces+endoplasmic+reticulum+damage+in+HeLa+cells&doi=10.1039%2Fc2cc00029f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">A dual cytotoxic and anti-angiogenic water-soluble gold(III) complex induces endoplasmic reticulum damage in HeLa cells</span></div><div class="casAuthors">Zhang, Jing-Jing; Sun, Raymond Wai-Yin; Che, Chi-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">3388-3390</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The water-sol. gold(iii) complex [AuIII(butyl-CN)biguanide]Cl (butyl-HCN = 2-(4-n-butylphenyl)pyridine, BCN) displays cytotoxicity through S-phase cell cycle arrest and endoplasmic reticulum (ER) damage in HeLa cells, and shows a promising anti-angiogenic effect at sub-cytotoxic concns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZ_dgUe-g6E7Vg90H21EOLACvtfcHk0lhEvjq8vY3vmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtlKrsb8%253D&md5=42f78e8cebbf5d4520da1bf09dd60dc9</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1039%2Fc2cc00029f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2cc00029f%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%2BJ.%26aulast%3DSun%26aufirst%3DR.%2BW.%2BY.%26aulast%3DChe%26aufirst%3DC.%2BM.%26atitle%3DA%2520dual%2520cytotoxic%2520and%2520antiangiogenic%2520water-soluble%2520gold%2528III%2529%2520complex%2520induces%2520endoplasmic%2520reticulum%2520damage%2520in%2520HeLa%2520cells%26jtitle%3DChem.%2520Commun.%26date%3D2012%26volume%3D48%26spage%3D3388%26epage%3D3390%26doi%3D10.1039%2Fc2cc00029f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, R. W. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lok, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fong, T. T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C. K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siu, A. F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, C. M.</span></span> <span> </span><span class="NLM_article-title">A dinuclear cyclometalated gold(III)-phosphine complex targeting thioredoxin reductase inhibits hepatocellular carcinoma in vivo</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1979</span>– <span class="NLM_lpage">1988</span>, <span class="refDoi"> DOI: 10.1039/c3sc21972k</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.1039%2Fc3sc21972k" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BC3sXltVOltLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1979-1988&author=R.+W.+Y.+Sunauthor=C.+N.+Lokauthor=T.+T.+H.+Fongauthor=C.+K.+L.+Liauthor=Z.+F.+Yangauthor=T.+Zouauthor=A.+F.+M.+Siuauthor=C.+M.+Che&title=A+dinuclear+cyclometalated+gold%28III%29-phosphine+complex+targeting+thioredoxin+reductase+inhibits+hepatocellular+carcinoma+in+vivo&doi=10.1039%2Fc3sc21972k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">A dinuclear cyclometalated gold(iii)-phosphine complex targeting thioredoxin reductase inhibits hepatocellular carcinoma in vivo</span></div><div class="casAuthors">Sun, Raymond Wai-Yin; Lok, Chun-Nam; Fong, Tommy Tsz-Him; Li, Carrie Ka-Lei; Yang, Zhen Fan; Zou, Taotao; Siu, Annie Fung-Ming; Che, Chi-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1979-1988</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A stable gold(iii)-phosphine complex [(CNC)2Au2(μ-dppp)](CF3SO3)2 [Au3, HCNCH = 2,6-diphenylpyridine; dppp = bis(diphenylphosphino)propane] displays potent in vitro cytotoxicity towards various cancers with sub-micromolar range cytotoxic IC50 values, and is significantly more potent than its structural and iso-electronic platinum(ii) analog [(CNN)2Pt2(μ-dppp)](CF3SO3)2 (HCNN = 6-phenyl-2,2'-bipyridine) and gold(iii)-carbene complexes.  Complex Au3 displays promising inhibition on tumor growth in animal models, and its acute and sub-chronic toxicities have been examd. in mice and beagle dogs.  Transcriptomic and connectivity map analyses have revealed that the transcriptional profile of Au3 is similar to those of inhibitors of thioredoxin reductase (TrxR) and inducers of endoplasmic reticulum (ER) stress.  As we found that Au3 is also a nanomolar inhibitor of TrxR, a model of ER stress-induced cell death mediated by inhibition of TrxR is proposed.  The transcriptomic anal. also leads to the identification of TRAIL, a ligand for death receptor 5 (DR5), as a synergistic agent of the anti-tumor activity of Au3.  Collectively, our results demonstrate that the gold(iii) complex Au3 effectively inhibits tumor growth in vivo, and displays promising cytotoxicity towards cancer cells in assocn. with the inhibition of TrxR, induction of ER stress and also a death-receptor-dependent apoptotic pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4mMzz5l_pV7Vg90H21EOLACvtfcHk0lglwSWTc3MT7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXltVOltLg%253D&md5=b176ca64a02b28686c3b6c448bbc634d</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1039%2Fc3sc21972k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3sc21972k%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DR.%2BW.%2BY.%26aulast%3DLok%26aufirst%3DC.%2BN.%26aulast%3DFong%26aufirst%3DT.%2BT.%2BH.%26aulast%3DLi%26aufirst%3DC.%2BK.%2BL.%26aulast%3DYang%26aufirst%3DZ.%2BF.%26aulast%3DZou%26aufirst%3DT.%26aulast%3DSiu%26aufirst%3DA.%2BF.%2BM.%26aulast%3DChe%26aufirst%3DC.%2BM.%26atitle%3DA%2520dinuclear%2520cyclometalated%2520gold%2528III%2529-phosphine%2520complex%2520targeting%2520thioredoxin%2520reductase%2520inhibits%2520hepatocellular%2520carcinoma%2520in%2520vivo%26jtitle%3DChem.%2520Sci.%26date%3D2013%26volume%3D4%26spage%3D1979%26epage%3D1988%26doi%3D10.1039%2Fc3sc21972k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lum, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lok, C.-N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, C.-M.</span></span> <span> </span><span class="NLM_article-title">Chemical biology of anticancer gold(iii) and gold(i) complexes</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">8786</span>– <span class="NLM_lpage">8801</span>, <span class="refDoi"> DOI: 10.1039/C5CS00132C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.1039%2FC5CS00132C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=25868756" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmsVChurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2015&pages=8786-8801&author=T.+Zouauthor=C.+T.+Lumauthor=C.-N.+Lokauthor=J.-J.+Zhangauthor=C.-M.+Che&title=Chemical+biology+of+anticancer+gold%28iii%29+and+gold%28i%29+complexes&doi=10.1039%2FC5CS00132C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical biology of anticancer gold(III) and gold(I) complexes</span></div><div class="casAuthors">Zou, Taotao; Lum, Ching Tung; Lok, Chun-Nam; Zhang, Jing-Jing; Che, Chi-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8786-8801</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Gold complexes have recently gained increasing attention in the design of new metal-based anticancer therapeutics.  Gold(III) complexes are generally reactive/unstable under physiol. conditions via intracellular redox reactions, and the intracellular AuIII to AuI redn. reaction has recently been "traced" by the introduction of appropriate fluorescent ligands.  Similar to most Au(I) complexes, Au(III) complexes can inhibit the activities of thiol-contg. enzymes, including thioredoxin reductase, via ligand exchange reactions to form Au-S(Se) bonds.  Nonetheless, there are examples of physiol. stable Au(III) and Au(I) complexes, such as [Au(TPP)]Cl (H2TPP = 5,10,15,20-tetraphenylporphyrin) and [Au(dppe)2]Cl (dppe = 1,2-bis(diphenylphosphanyl)ethane), which are known to display highly potent in vitro and in vivo anticancer activities.  In this review, we summarize our current understanding of anticancer gold complexes, including their mechanisms of action and the approaches adopted to improve their anticancer efficiency.  Some recent examples of gold anticancer chemotherapeutics are highlighted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraSf5EPIPo8rVg90H21EOLACvtfcHk0lglwSWTc3MT7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmsVChurg%253D&md5=6e546124df776ce9612fb8a4fdbcad37</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1039%2FC5CS00132C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5CS00132C%26sid%3Dliteratum%253Aachs%26aulast%3DZou%26aufirst%3DT.%26aulast%3DLum%26aufirst%3DC.%2BT.%26aulast%3DLok%26aufirst%3DC.-N.%26aulast%3DZhang%26aufirst%3DJ.-J.%26aulast%3DChe%26aufirst%3DC.-M.%26atitle%3DChemical%2520biology%2520of%2520anticancer%2520gold%2528iii%2529%2520and%2520gold%2528i%2529%2520complexes%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2015%26volume%3D44%26spage%3D8786%26epage%3D8801%26doi%3D10.1039%2FC5CS00132C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bazzicalupi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferraroni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Massai, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertrand, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messori, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gratteri, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casini, A.</span></span> <span> </span><span class="NLM_article-title">Determinants for tight and selective binding of a medicinal dicarbene gold(I) complex to a telomeric DNA G–quadruplex: a joint ESI MS and XRD investigation</span>. <i>Am. Ethnol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>128</i></span>,  <span class="NLM_fpage">4328</span>– <span class="NLM_lpage">4331</span>, <span class="refDoi"> DOI: 10.1002/ange.201511999</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.1002%2Fange.201511999" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2016&pages=4328-4331&author=C.+Bazzicalupiauthor=M.+Ferraroniauthor=F.+Papiauthor=L.+Massaiauthor=B.+Bertrandauthor=L.+Messoriauthor=P.+Gratteriauthor=A.+Casini&title=Determinants+for+tight+and+selective+binding+of+a+medicinal+dicarbene+gold%28I%29+complex+to+a+telomeric+DNA+G%E2%80%93quadruplex%3A+a+joint+ESI+MS+and+XRD+investigation&doi=10.1002%2Fange.201511999"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1002%2Fange.201511999&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fange.201511999%26sid%3Dliteratum%253Aachs%26aulast%3DBazzicalupi%26aufirst%3DC.%26aulast%3DFerraroni%26aufirst%3DM.%26aulast%3DPapi%26aufirst%3DF.%26aulast%3DMassai%26aufirst%3DL.%26aulast%3DBertrand%26aufirst%3DB.%26aulast%3DMessori%26aufirst%3DL.%26aulast%3DGratteri%26aufirst%3DP.%26aulast%3DCasini%26aufirst%3DA.%26atitle%3DDeterminants%2520for%2520tight%2520and%2520selective%2520binding%2520of%2520a%2520medicinal%2520dicarbene%2520gold%2528I%2529%2520complex%2520to%2520a%2520telomeric%2520DNA%2520G%25E2%2580%2593quadruplex%253A%2520a%2520joint%2520ESI%2520MS%2520and%2520XRD%2520investigation%26jtitle%3DAm.%2520Ethnol.%26date%3D2016%26volume%3D128%26spage%3D4328%26epage%3D4331%26doi%3D10.1002%2Fange.201511999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ali, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dondaine, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adolle, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sampaio, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chotard, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richard, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denat, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bettaieb, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Gendre, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laurens, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goze, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paul, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bodio, E.</span></span> <span> </span><span class="NLM_article-title">Anticancer agents: does a phosphonium behave like a gold(I) phosphine complex? let a “smart” probe answer</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">4521</span>– <span class="NLM_lpage">4528</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00480</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00480" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BC2MXotlChs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=4521-4528&author=M.+Aliauthor=L.+Dondaineauthor=A.+Adolleauthor=C.+Sampaioauthor=F.+Chotardauthor=P.+Richardauthor=F.+Denatauthor=A.+Bettaiebauthor=P.+Le+Gendreauthor=V.+Laurensauthor=C.+Gozeauthor=C.+Paulauthor=E.+Bodio&title=Anticancer+agents%3A+does+a+phosphonium+behave+like+a+gold%28I%29+phosphine+complex%3F+let+a+%E2%80%9Csmart%E2%80%9D+probe+answer&doi=10.1021%2Facs.jmedchem.5b00480"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Anticancer Agents: Does a Phosphonium Behave Like a Gold(I) Phosphine Complex? Let a "Smart" Probe Answer!</span></div><div class="casAuthors">Ali, Moussa; Dondaine, Lucile; Adolle, Anais; Sampaio, Carla; Chotard, Florian; Richard, Philippe; Denat, Franck; Bettaieb, Ali; Le Gendre, Pierre; Laurens, Veronique; Goze, Christine; Paul, Catherine; Bodio, Ewen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4521-4528</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Gold phosphine complexes, such as auranofin, have been recognized for decades as antirheumatic agents.  Clin. trials are now underway to validate their use in anticancer or anti-HIV treatments.  However, their mechanisms of action remain unclear.  A challenging question is whether the gold phosphine complex is a prodrug that is administered in an inactive precursor form or rather that the gold atom remains attached to the phosphine ligand during treatment.  In this study, we present two novel gold complexes, which we compared to auranofin and to their phosphonium analog.  The chosen ligand is a phosphine-based smart probe, whose strong fluorescence depends on the presence of the gold atom.  The in vitro biol. action of the gold complexes and the phosphonium deriv. were investigated, and a preliminary in vivo study in healthy zebrafish larvae allowed us to evaluate gold complex biodistribution and toxicity.  The different analyses carried out showed that these gold complexes were stable and behaved differently from phosphonium and auranofin, both in vitro and in vivo.  Two-photon microscopy expts. demonstrated that the cellular targets of these gold complexes are not the same as those of the phosphonium analog.  Moreover, despite similar IC50 values in some cancer cell lines, gold complexes displayed a low toxicity in vivo, in contrast to the phosphonium salt.  They are therefore suitable for future in vivo investigations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbXqkJmQP-ULVg90H21EOLACvtfcHk0lhdq_CYd1ReOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXotlChs74%253D&md5=0dd0066fff3d6f4b4ce5ed8f8577535a</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00480&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00480%26sid%3Dliteratum%253Aachs%26aulast%3DAli%26aufirst%3DM.%26aulast%3DDondaine%26aufirst%3DL.%26aulast%3DAdolle%26aufirst%3DA.%26aulast%3DSampaio%26aufirst%3DC.%26aulast%3DChotard%26aufirst%3DF.%26aulast%3DRichard%26aufirst%3DP.%26aulast%3DDenat%26aufirst%3DF.%26aulast%3DBettaieb%26aufirst%3DA.%26aulast%3DLe%2BGendre%26aufirst%3DP.%26aulast%3DLaurens%26aufirst%3DV.%26aulast%3DGoze%26aufirst%3DC.%26aulast%3DPaul%26aufirst%3DC.%26aulast%3DBodio%26aufirst%3DE.%26atitle%3DAnticancer%2520agents%253A%2520does%2520a%2520phosphonium%2520behave%2520like%2520a%2520gold%2528I%2529%2520phosphine%2520complex%253F%2520let%2520a%2520%25E2%2580%259Csmart%25E2%2580%259D%2520probe%2520answer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D4521%26epage%3D4528%26doi%3D10.1021%2Facs.jmedchem.5b00480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernández-Gallardo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalo, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mangas-Sanjuan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">González-Alvarez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serrano del Valle, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">González-Alvarez, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bermejo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marzo, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Contel, M.</span></span> <span> </span><span class="NLM_article-title">Cyclometalated iminophosphorane gold(III) and platinum(II) complexes. a highly permeable cationic platinum(II) compound with promising anticancer properties</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">5825</span>– <span class="NLM_lpage">5841</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00427</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00427" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFejt7fL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=5825-5841&author=M.+Frikauthor=J.+Fern%C3%A1ndez-Gallardoauthor=O.+Gonzaloauthor=V.+Mangas-Sanjuanauthor=M.+Gonz%C3%A1lez-Alvarezauthor=A.+Serrano+del+Valleauthor=C.+Huauthor=I.+Gonz%C3%A1lez-Alvarezauthor=M.+Bermejoauthor=I.+Marzoauthor=M.+Contel&title=Cyclometalated+iminophosphorane+gold%28III%29+and+platinum%28II%29+complexes.+a+highly+permeable+cationic+platinum%28II%29+compound+with+promising+anticancer+properties&doi=10.1021%2Facs.jmedchem.5b00427"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclometalated Iminophosphorane Gold(III) and Platinum(II) Complexes. A Highly Permeable Cationic Platinum(II) Compound with Promising Anticancer Properties</span></div><div class="casAuthors">Frik, Malgorzata; Fernandez-Gallardo, Jacob; Gonzalo, Oscar; Mangas-Sanjuan, Victor; Gonzalez-Alvarez, Marta; Serrano del Valle, Alfonso; Hu, Chunhua; Gonzalez-Alvarez, Isabel; Bermejo, Marival; Marzo, Isabel; Contel, Maria</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5825-5841</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">New organometallic gold(III) and platinum(II) complexes contg. iminophosphorane ligands are described.  Most of them are more cytotoxic to a no. of human cancer cell lines than cisplatin.  Cationic Pt(II) derivs. I and II, which differ only in the anion, Hg2Cl62- or PF6- resp., display almost identical IC50 values in the sub-micromolar range (25-335-fold more active than cisplatin on these cell lines).  The gold compds. induced mainly caspase-independent cell death, as previously reported for related cycloaurated compds. contg. IM ligands.  Cycloplatinated compds. III, I, and II can also activate alternative caspase-independent mechanisms of death.  However, at short incubation times cell death seems to be mainly caspase dependent, suggesting that the main mechanism of cell death for these compds. is apoptosis.  Mercury-free compd. II does not interact with plasmid (pBR322) DNA or with calf thymus DNA.  Permeability studies of II by two different assays, in vitro Caco-2 monolayers and a rat perfusion model, have revealed a high permeability profile for this compd. (comparable to that of metoprolol or caffeine) and an estd. oral fraction absorbed of 100%, which potentially makes it a good candidate for oral administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCVbeOCYU7r7Vg90H21EOLACvtfcHk0lhdq_CYd1ReOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFejt7fL&md5=4be8e3445fe1696438d76b582f363380</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00427&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00427%26sid%3Dliteratum%253Aachs%26aulast%3DFrik%26aufirst%3DM.%26aulast%3DFern%25C3%25A1ndez-Gallardo%26aufirst%3DJ.%26aulast%3DGonzalo%26aufirst%3DO.%26aulast%3DMangas-Sanjuan%26aufirst%3DV.%26aulast%3DGonz%25C3%25A1lez-Alvarez%26aufirst%3DM.%26aulast%3DSerrano%2Bdel%2BValle%26aufirst%3DA.%26aulast%3DHu%26aufirst%3DC.%26aulast%3DGonz%25C3%25A1lez-Alvarez%26aufirst%3DI.%26aulast%3DBermejo%26aufirst%3DM.%26aulast%3DMarzo%26aufirst%3DI.%26aulast%3DContel%26aufirst%3DM.%26atitle%3DCyclometalated%2520iminophosphorane%2520gold%2528III%2529%2520and%2520platinum%2528II%2529%2520complexes.%2520a%2520highly%2520permeable%2520cationic%2520platinum%2528II%2529%2520compound%2520with%2520promising%2520anticancer%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D5825%26epage%3D5841%26doi%3D10.1021%2Facs.jmedchem.5b00427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hickey, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruhayel, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnard, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berners-Price, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filipovska, A.</span></span> <span> </span><span class="NLM_article-title">Mitochondria-targeted chemotherapeutics: the rational design of gold(I) N-heterocyclic carbene complexes that are selectively toxic to cancer cells and target protein selenols in preference to thiols</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>130</i></span>,  <span class="NLM_fpage">12570</span>– <span class="NLM_lpage">12571</span>, <span class="refDoi"> DOI: 10.1021/ja804027j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja804027j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVCmsrvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2008&pages=12570-12571&author=J.+L.+Hickeyauthor=R.+A.+Ruhayelauthor=P.+J.+Barnardauthor=M.+V.+Bakerauthor=S.+J.+Berners-Priceauthor=A.+Filipovska&title=Mitochondria-targeted+chemotherapeutics%3A+the+rational+design+of+gold%28I%29+N-heterocyclic+carbene+complexes+that+are+selectively+toxic+to+cancer+cells+and+target+protein+selenols+in+preference+to+thiols&doi=10.1021%2Fja804027j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondria-Targeted Chemotherapeutics: The Rational Design of Gold(I) N-Heterocyclic Carbene Complexes That Are Selectively Toxic to Cancer Cells and Target Protein Selenols in Preference to Thiols</span></div><div class="casAuthors">Hickey, James L.; Ruhayel, Rasha A.; Barnard, Peter J.; Baker, Murray V.; Berners-Price, Susan J.; Filipovska, Aleksandra</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">12570-12571</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A family of lipophilic, cationic Au(I) complexes of N-heterocyclic carbenes (NHCs) have been designed as new mitochondria-targeted antitumor agents that combine both selective mitochondrial accumulation and selective thioredoxin reductase inhibition properties within a single mol.  Two-step ligand exchange reactions with cysteine (Cys) and selenocysteine (Sec) occur with release of the NHC ligands.  At physiol. pH the rate consts. for the reactions with Sec are 20- to 80-fold higher than those with Cys.  The complexes are selectively toxic to two highly tumorigenic breast cancer cell lines and not to normal breast cells, and the degree of selectivity and potency are optimized by modification of the substituent on the simple imidazolium salt precursor.  The lead compd. is shown to accumulate in mitochondria of cancer cells, to cause cell death through a mitochondrial apoptotic pathway and to inhibit the activity of thioredoxin reductase (TrxR) but not the closely related and Se-free enzyme glutathione reductase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMjYB2SW6pI7Vg90H21EOLACvtfcHk0lgDQdLpPhafKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVCmsrvK&md5=f30a5a95527abef38383b68181b68708</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fja804027j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja804027j%26sid%3Dliteratum%253Aachs%26aulast%3DHickey%26aufirst%3DJ.%2BL.%26aulast%3DRuhayel%26aufirst%3DR.%2BA.%26aulast%3DBarnard%26aufirst%3DP.%2BJ.%26aulast%3DBaker%26aufirst%3DM.%2BV.%26aulast%3DBerners-Price%26aufirst%3DS.%2BJ.%26aulast%3DFilipovska%26aufirst%3DA.%26atitle%3DMitochondria-targeted%2520chemotherapeutics%253A%2520the%2520rational%2520design%2520of%2520gold%2528I%2529%2520N-heterocyclic%2520carbene%2520complexes%2520that%2520are%2520selectively%2520toxic%2520to%2520cancer%2520cells%2520and%2520target%2520protein%2520selenols%2520in%2520preference%2520to%2520thiols%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2008%26volume%3D130%26spage%3D12570%26epage%3D12571%26doi%3D10.1021%2Fja804027j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">da
S. Maia, P. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ponader, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagenbach, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergemann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gust, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deflon, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abram, U.</span></span> <span> </span><span class="NLM_article-title">Neutral gold complexes with tridentate SNS thiosemicarbazide ligands</span>. <i>Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">1604</span>– <span class="NLM_lpage">1613</span>, <span class="refDoi"> DOI: 10.1021/ic201905t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ic201905t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=1604-1613&author=P.+I.+da%0AS.+Maiaauthor=H.+H.+Nguyenauthor=D.+Ponaderauthor=A.+Hagenbachauthor=S.+Bergemannauthor=R.+Gustauthor=V.+M.+Deflonauthor=U.+Abram&title=Neutral+gold+complexes+with+tridentate+SNS+thiosemicarbazide+ligands&doi=10.1021%2Fic201905t"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fic201905t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fic201905t%26sid%3Dliteratum%253Aachs%26aulast%3Dda%2BS.%2BMaia%26aufirst%3DP.%2BI.%26aulast%3DNguyen%26aufirst%3DH.%2BH.%26aulast%3DPonader%26aufirst%3DD.%26aulast%3DHagenbach%26aufirst%3DA.%26aulast%3DBergemann%26aufirst%3DS.%26aulast%3DGust%26aufirst%3DR.%26aulast%3DDeflon%26aufirst%3DV.%2BM.%26aulast%3DAbram%26aufirst%3DU.%26atitle%3DNeutral%2520gold%2520complexes%2520with%2520tridentate%2520SNS%2520thiosemicarbazide%2520ligands%26jtitle%3DInorg.%2520Chem.%26date%3D2012%26volume%3D51%26spage%3D1604%26epage%3D1613%26doi%3D10.1021%2Fic201905t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Casas, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castaño, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cifuentes, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Monteagudo, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sánchez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sordo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abram, U.</span></span> <span> </span><span class="NLM_article-title">Complexes of dichloro[2-(dimethylaminomethyl)phenyl-<i>C</i><sup>1</sup>,<i>N</i>]gold(III),[Au(damp-<i>C</i><sup>1</sup>,N)Cl<sub>2</sub>], with formylferrocene thiosemicarbazone: synthesis, structure and cytotoxicity</span>. <i>J. Inorg. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">1009</span>– <span class="NLM_lpage">1016</span>, <span class="refDoi"> DOI: 10.1016/j.jinorgbio.2004.02.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.1016%2Fj.jinorgbio.2004.02.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=15149809" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BD2cXktVCmtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2004&pages=1009-1016&author=J.+S.+Casasauthor=M.+V.+Casta%C3%B1oauthor=M.+C.+Cifuentesauthor=J.+C.+Garc%C3%ADa-Monteagudoauthor=A.+S%C3%A1nchezauthor=J.+Sordoauthor=U.+Abram&title=Complexes+of+dichloro%5B2-%28dimethylaminomethyl%29phenyl-C1%2CN%5Dgold%28III%29%2C%5BAu%28damp-C1%2CN%29Cl2%5D%2C+with+formylferrocene+thiosemicarbazone%3A+synthesis%2C+structure+and+cytotoxicity&doi=10.1016%2Fj.jinorgbio.2004.02.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Complexes of dichloro[2-(dimethylaminomethyl)phenyl-C1,N]gold(III), [Au(damp-C1,N)Cl2], with formylferrocene thiosemicarbazones: synthesis, structure and cytotoxicity</span></div><div class="casAuthors">Casas, Jose S.; Castano, Maria V.; Cifuentes, Maria C.; Garcia-Monteagudo, Juan C.; Sanchez, Agustin; Sordo, Jose; Abram, Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Inorganic Biochemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1009-1016</span>CODEN:
                <span class="NLM_cas:coden">JIBIDJ</span>;
        ISSN:<span class="NLM_cas:issn">0162-0134</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Dichloro[2-(dimethylaminomethyl)phenyl-C1,N]gold(III), [Au(damp-C1,N)Cl2], reacts with the formylferrocene thiosemicarbazones derived from 4-methyl-, 4-phenyl-, 4-ethyl- and 4,4-dimethyl-3-thiosemicarbazides, HFcTSC, to give complexes of general formula [Au(Hdamp-1C)Cl(FcTSC)]Cl.  These complexes were isolated and characterized by elemental anal., mass spectrometry and IR, 1H NMR and 13C NMR spectroscopy.  In some cases, cyclic voltammetric studies were carried out and these showed that the complexation of gold affects the redox behavior of the ferrocene unit.  The in vitro antitumor activity against the HeLa cell line was also detd. for the more sol. complexes.  The IC50 values were found to be higher than that of cisplatin but the max. antiproliferative activity was similar.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoM3jcic_Jm17Vg90H21EOLACvtfcHk0liApaPu9wvEZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXktVCmtr8%253D&md5=45bd62162d8aaaa90e57dcc824b5c46e</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.jinorgbio.2004.02.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jinorgbio.2004.02.019%26sid%3Dliteratum%253Aachs%26aulast%3DCasas%26aufirst%3DJ.%2BS.%26aulast%3DCasta%25C3%25B1o%26aufirst%3DM.%2BV.%26aulast%3DCifuentes%26aufirst%3DM.%2BC.%26aulast%3DGarc%25C3%25ADa-Monteagudo%26aufirst%3DJ.%2BC.%26aulast%3DS%25C3%25A1nchez%26aufirst%3DA.%26aulast%3DSordo%26aufirst%3DJ.%26aulast%3DAbram%26aufirst%3DU.%26atitle%3DComplexes%2520of%2520dichloro%255B2-%2528dimethylaminomethyl%2529phenyl-C1%252CN%255Dgold%2528III%2529%252C%255BAu%2528damp-C1%252CN%2529Cl2%255D%252C%2520with%2520formylferrocene%2520thiosemicarbazone%253A%2520synthesis%252C%2520structure%2520and%2520cytotoxicity%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D2004%26volume%3D98%26spage%3D1009%26epage%3D1016%26doi%3D10.1016%2Fj.jinorgbio.2004.02.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kowol, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eichinger, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roller, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakupec, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arion, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keppler, B. K.</span></span> <span> </span><span class="NLM_article-title">Gallium(III) and iron(III) complexes of α-N-heterocyclic thiosemicarbazone: synthesis, characterization, cytotoxicity, and interaction with ribonucleotide reductase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">1254</span>– <span class="NLM_lpage">1265</span>, <span class="refDoi"> DOI: 10.1021/jm0612618</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0612618" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhvFags7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=1254-1265&author=C.+R.+Kowolauthor=R.+Bergerauthor=R.+Eichingerauthor=A.+Rollerauthor=M.+A.+Jakupecauthor=P.+P.+Schmidtauthor=V.+B.+Arionauthor=B.+K.+Keppler&title=Gallium%28III%29+and+iron%28III%29+complexes+of+%CE%B1-N-heterocyclic+thiosemicarbazone%3A+synthesis%2C+characterization%2C+cytotoxicity%2C+and+interaction+with+ribonucleotide+reductase&doi=10.1021%2Fjm0612618"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Gallium(III) and Iron(III) Complexes of α-N-Heterocyclic Thiosemicarbazones: Synthesis, Characterization, Cytotoxicity, and Interaction with Ribonucleotide Reductase</span></div><div class="casAuthors">Kowol, Christian R.; Berger, Roland; Eichinger, Rene; Roller, Alexander; Jakupec, Michael A.; Schmidt, Peter P.; Arion, Vladimir B.; Keppler, Bernhard K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1254-1265</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Ga(III) and Fe(III) complexes with five different 4N-substituted α-N-heterocyclic thiosemicarbazones, viz., 2-acetylpyridine N,N-dimethylthiosemicarbazone (1), 2-acetylpyridine N-pyrrolidinylthiosemicarbazone (2), acetylpyrazine N,N-dimethylthiosemicarbazone (3), acetylpyrazine N-pyrrolidinylthiosemicarbazone (4), and acetylpyrazine N-piperidinylthiosemicarbazone (5), [GaLCl2] (HL = 1 and 2) and [ML2][Y] (M = Ga, HL = 1-5, Y = PF6; M = Fe, HL = 1-5, Y = FeCl4 and PF6) were synthesized and characterized by elemental anal., a no. of spectroscopic methods (NMR, IR, UV-visible), mass spectrometry, and x-ray crystallog.  In vitro antitumor potency was studied in human cancer cell lines (41M and SK-BR-3).  The central metal ions exert pronounced effects in a divergent manner: Ga(III) enhances, whereas Fe(III) weakens the cytotoxicity of the ligands.  The capacity of ligand 1 and its Ga(III) and Fe(III) complexes to destroy the tyrosyl radical of the presumed target ribonucleotide reductase is reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrK0rY8cgonJLVg90H21EOLACvtfcHk0liApaPu9wvEZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhvFags7g%253D&md5=18ea78354426cd88f574be43934eee27</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm0612618&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0612618%26sid%3Dliteratum%253Aachs%26aulast%3DKowol%26aufirst%3DC.%2BR.%26aulast%3DBerger%26aufirst%3DR.%26aulast%3DEichinger%26aufirst%3DR.%26aulast%3DRoller%26aufirst%3DA.%26aulast%3DJakupec%26aufirst%3DM.%2BA.%26aulast%3DSchmidt%26aufirst%3DP.%2BP.%26aulast%3DArion%26aufirst%3DV.%2BB.%26aulast%3DKeppler%26aufirst%3DB.%2BK.%26atitle%3DGallium%2528III%2529%2520and%2520iron%2528III%2529%2520complexes%2520of%2520%25CE%25B1-N-heterocyclic%2520thiosemicarbazone%253A%2520synthesis%252C%2520characterization%252C%2520cytotoxicity%252C%2520and%2520interaction%2520with%2520ribonucleotide%2520reductase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D1254%26epage%3D1265%26doi%3D10.1021%2Fjm0612618" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lovejoy, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharp, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seebacher, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obeidy, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prichard, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefani, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basha, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharpe, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jansson, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalinowski, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernhardt, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, D. R.</span></span> <span> </span><span class="NLM_article-title">Novel second-generation di-2-pyridylketone thiosemicarbazones show synergism with standard chemotherapeutics and demonstrate potent activity against lung cancer xenogrAFts after oral and intravenous administration <i>in vivo</i></span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">7230</span>– <span class="NLM_lpage">7244</span>, <span class="refDoi"> DOI: 10.1021/jm300768u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300768u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFClurbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=7230-7244&author=D.+B.+Lovejoyauthor=D.+M.+Sharpauthor=N.+Seebacherauthor=P.+Obeidyauthor=T.+Prichardauthor=C.+Stefaniauthor=M.+T.+Bashaauthor=P.+C.+Sharpeauthor=P.+J.+Janssonauthor=D.+S.+Kalinowskiauthor=P.+V.+Bernhardtauthor=D.+R.+Richardson&title=Novel+second-generation+di-2-pyridylketone+thiosemicarbazones+show+synergism+with+standard+chemotherapeutics+and+demonstrate+potent+activity+against+lung+cancer+xenogrAFts+after+oral+and+intravenous+administration+in+vivo&doi=10.1021%2Fjm300768u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Second-Generation Di-2-Pyridylketone Thiosemicarbazones Show Synergism with Standard Chemotherapeutics and Demonstrate Potent Activity against Lung Cancer Xenografts after Oral and Intravenous Administration in Vivo</span></div><div class="casAuthors">Lovejoy, David B.; Sharp, Danae M.; Seebacher, Nicole; Obeidy, Peyman; Prichard, Thomas; Stefani, Christian; Basha, Maram T.; Sharpe, Philip C.; Jansson, Patric J.; Kalinowski, Danuta S.; Bernhardt, Paul V.; Richardson, Des R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7230-7244</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We developed a series of second-generation di-2-pyridyl ketone thiosemicarbazone (DpT) and 2-benzoylpyridine thiosemicarbazone (BpT) ligands to improve the efficacy and safety profile of these potential antitumor agents.  Two novel DpT analogs, Dp4e4mT and DpC, exhibited pronounced and selective activity against human lung cancer xenografts in vivo via the i.v. and oral routes.  Importantly, these analogs did not induce the cardiotoxicity obsd. at high nonoptimal doses of the first-generation DpT analog, Dp44mT.  The Cu(II) complexes of these ligands exhibited potent antiproliferative activity having redox potentials in a range accessible to biol. reductants.  The activity of the copper complexes of Dp4e4mT and DpC against lung cancer cells was synergistic in combination with gemcitabine or cisplatin.  It was demonstrated by EPR spectroscopy that dimeric copper compds. of the type [CuLCl]2, identified crystallog., dissoc. in soln. to give monomeric 1:1 Cu:ligand complexes.  These monomers represent the biol. active form of the complex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo75KAO0Ooc6bVg90H21EOLACvtfcHk0lgt6weZTt7XJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFClurbK&md5=ce94f696851fc28cde48fc91bb38d132</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm300768u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300768u%26sid%3Dliteratum%253Aachs%26aulast%3DLovejoy%26aufirst%3DD.%2BB.%26aulast%3DSharp%26aufirst%3DD.%2BM.%26aulast%3DSeebacher%26aufirst%3DN.%26aulast%3DObeidy%26aufirst%3DP.%26aulast%3DPrichard%26aufirst%3DT.%26aulast%3DStefani%26aufirst%3DC.%26aulast%3DBasha%26aufirst%3DM.%2BT.%26aulast%3DSharpe%26aufirst%3DP.%2BC.%26aulast%3DJansson%26aufirst%3DP.%2BJ.%26aulast%3DKalinowski%26aufirst%3DD.%2BS.%26aulast%3DBernhardt%26aufirst%3DP.%2BV.%26aulast%3DRichardson%26aufirst%3DD.%2BR.%26atitle%3DNovel%2520second-generation%2520di-2-pyridylketone%2520thiosemicarbazones%2520show%2520synergism%2520with%2520standard%2520chemotherapeutics%2520and%2520demonstrate%2520potent%2520activity%2520against%2520lung%2520cancer%2520xenogrAFts%2520after%2520oral%2520and%2520intravenous%2520administration%2520in%2520vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D7230%26epage%3D7244%26doi%3D10.1021%2Fjm300768u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, F.</span></span> <span> </span><span class="NLM_article-title">Developing anticancer ferric prodrugs based on the N-Donor residues of human serum albumin carrier IIA subdomain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">7497</span>– <span class="NLM_lpage">7511</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00509</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00509" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1SktLrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=7497-7511&author=J.+Qiauthor=Y.+Gouauthor=Y.+Zhangauthor=K.+Yangauthor=S.+Chenauthor=L.+Liuauthor=X.+Wuauthor=T.+Wangauthor=W.+Zhangauthor=F.+Yang&title=Developing+anticancer+ferric+prodrugs+based+on+the+N-Donor+residues+of+human+serum+albumin+carrier+IIA+subdomain&doi=10.1021%2Facs.jmedchem.6b00509"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Developing Anticancer Ferric Prodrugs Based on the N-Donor Residues of Human Serum Albumin Carrier IIA Subdomain</span></div><div class="casAuthors">Qi, Jinxu; Gou, Yi; Zhang, Yao; Yang, Kun; Chen, Shifang; Liu, Li; Wu, Xiaoyang; Wang, Tao; Zhang, Wei; Yang, Feng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7497-7511</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To improve the selectivity, delivery, and activity of ferric (Fe) anticancer agents, the authors design prodrugs based on N-donor residues of the human serum albumin (HSA) carrier IIA subdomain.  The authors synthesized six Fe(III) compds. derived from 2-hydroxy-1-naphthaldehyde thiosemicarbazone (7-12).  HSA complex structure revealed that Fe compd. binds to the hydrophobic cavity in the HSA IIA subdomain.  Lys199 and His242 of HSA replace the two Cl atoms of Fe compd., coordinating with Fe3+.  In vivo data revealed that compd. 12 and HSA-12 complex inhibit the growth of the liver tumor and that the HSA-12 complex has stronger targeting ability and therapeutic efficacy than compd. 12 alone.  The authors' results showed that compd. 12 and HSA-12 complex induce Bel-7402 cell death possible by several mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgWEKbMYrXyrVg90H21EOLACvtfcHk0lg3zfttWCtuQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1SktLrM&md5=6b9d962c4272056886c3525f2e7fcd1c</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00509&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00509%26sid%3Dliteratum%253Aachs%26aulast%3DQi%26aufirst%3DJ.%26aulast%3DGou%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DF.%26atitle%3DDeveloping%2520anticancer%2520ferric%2520prodrugs%2520based%2520on%2520the%2520N-Donor%2520residues%2520of%2520human%2520serum%2520albumin%2520carrier%2520IIA%2520subdomain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D7497%26epage%3D7511%26doi%3D10.1021%2Facs.jmedchem.6b00509" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muhammad, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Z.</span></span> <span> </span><span class="NLM_article-title">Metal-based anticancer chemo-therapeutic agents</span>. <i>Curr. Opin. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">144</span>– <span class="NLM_lpage">153</span>, <span class="refDoi"> DOI: 10.1016/j.cbpa.2014.02.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.1016%2Fj.cbpa.2014.02.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=24608084" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BC2cXntFymtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=144-153&author=N.+Muhammadauthor=Z.+Guo&title=Metal-based+anticancer+chemo-therapeutic+agents&doi=10.1016%2Fj.cbpa.2014.02.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Metal-based anticancer chemotherapeutic agents</span></div><div class="casAuthors">Muhammad, Nafees; Guo, Zijian</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">144-153</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Since the discovery of the cisplatin antitumor activity, great efforts have focused on the rational design of metal-based anticancer agents that can be potentially used in cancer chemotherapy.  Over the last four decades, a large no. of metal complexes have been extensively investigated and evaluated in vitro and in vivo, and some of them were at different stages of clin. studies.  Amongst these complexes, platinum (PtII and PtIV), ruthenium (RuII and RuIII), gold (AuI and AuIII) and titanium (TiIV) complexes are the most studied metals.  We describe here some most recent progresses on PtIV prodrugs which can be activated once enter tumor cells, polynuclear PtII complexes which have unique DNA binding ability and mode, anti-metastatic RuII/RuIII complexes, and AuI/AuIII and TiIV antitumor active complexes.  The key focuses of these studies lie in finding novel metal complexes which could potentially overcome the hurdles of current clin. drugs including toxicity, resistance and other pharmacol. deficiencies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqitR6wQhcA-LVg90H21EOLACvtfcHk0lg3zfttWCtuQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXntFymtbk%253D&md5=f082fcbe7c5069a5606a3b0ede09122d</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2014.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2014.02.003%26sid%3Dliteratum%253Aachs%26aulast%3DMuhammad%26aufirst%3DN.%26aulast%3DGuo%26aufirst%3DZ.%26atitle%3DMetal-based%2520anticancer%2520chemo-therapeutic%2520agents%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2014%26volume%3D19%26spage%3D144%26epage%3D153%26doi%3D10.1016%2Fj.cbpa.2014.02.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jansson, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharpe, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernhardt, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, D. R.</span></span> <span> </span><span class="NLM_article-title">Novel thiosemicarbazones of the ApT and DpT series and their copper complexes: identification of pronounced redox activity and characterization of their antitumor activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">5759</span>– <span class="NLM_lpage">5769</span>, <span class="refDoi"> DOI: 10.1021/jm100561b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100561b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BC3cXotlSnsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5759-5769&author=P.+J.+Janssonauthor=P.+C.+Sharpeauthor=P.+V.+Bernhardtauthor=D.+R.+Richardson&title=Novel+thiosemicarbazones+of+the+ApT+and+DpT+series+and+their+copper+complexes%3A+identification+of+pronounced+redox+activity+and+characterization+of+their+antitumor+activity&doi=10.1021%2Fjm100561b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Thiosemicarbazones of the ApT and DpT Series and Their Copper Complexes: Identification of Pronounced Redox Activity and Characterization of Their Antitumor Activity</span></div><div class="casAuthors">Jansson, Patric J.; Sharpe, Philip C.; Bernhardt, Paul V.; Richardson, Des R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5759-5769</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The novel chelators 2-acetylpyridine-4,4-dimethyl-3-thiosemicarbazone (HAp44mT) and di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone (HDp44mT) have been examd. to elucidate the structure-activity relationships necessary to form copper (Cu) complexes with pronounced antitumor activity.  Electrochem. studies demonstrated that the Cu complexes of these ligands had lower redox potentials than their iron complexes.  Moreover, the Cu complexes where the ligand/metal ratio was 1:1 rather than 2:1 had significantly higher intracellular oxidative properties and antitumor efficacy.  Interestingly, the 2:1 complex was shown to dissoc. to give significant amts. of the 1:1 complex that could be the major cytotoxic effector.  Both types of Cu complex showed significantly more antiproliferative activity than the ligand alone.  We also demonstrate the importance of the inductive effects of substituents on the carbonyl group of the parent ketone, which influence the CuII/I redox potentials because of their proximity to the metal center.  The structure-activity relationships described are important for the design of potent thiosemicarbazone Cu complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhryQ9dAB5CLVg90H21EOLACvtfcHk0lg3zfttWCtuQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXotlSnsr4%253D&md5=7417f8c18eed7edddd542da369ecb5ab</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm100561b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100561b%26sid%3Dliteratum%253Aachs%26aulast%3DJansson%26aufirst%3DP.%2BJ.%26aulast%3DSharpe%26aufirst%3DP.%2BC.%26aulast%3DBernhardt%26aufirst%3DP.%2BV.%26aulast%3DRichardson%26aufirst%3DD.%2BR.%26atitle%3DNovel%2520thiosemicarbazones%2520of%2520the%2520ApT%2520and%2520DpT%2520series%2520and%2520their%2520copper%2520complexes%253A%2520identification%2520of%2520pronounced%2520redox%2520activity%2520and%2520characterization%2520of%2520their%2520antitumor%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D5759%26epage%3D5769%26doi%3D10.1021%2Fjm100561b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conde, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, X.</span></span> <span> </span><span class="NLM_article-title">Ferritin nanocarrier traverses the blood brain barrier and kills glioma</span>. <i>ACS Nano</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">4105</span>– <span class="NLM_lpage">4115</span>, <span class="refDoi"> DOI: 10.1021/acsnano.7b06969</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsnano.7b06969" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmvVaktLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2018&pages=4105-4115&author=K.+Fanauthor=X.+Jiaauthor=M.+Zhouauthor=K.+Wangauthor=J.+Condeauthor=J.+Heauthor=J.+Tianauthor=X.+Yan&title=Ferritin+nanocarrier+traverses+the+blood+brain+barrier+and+kills+glioma&doi=10.1021%2Facsnano.7b06969"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Ferritin nanocarrier traverses the blood brain barrier and kills glioma</span></div><div class="casAuthors">Fan, Kelong; Jia, Xiaohua; Zhou, Meng; Wang, Kun; Conde, Joao; He, Jiuyang; Tian, Jie; Yan, Xiyun</div><div class="citationInfo"><span class="NLM_cas:title">ACS Nano</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">4105-4115</span>CODEN:
                <span class="NLM_cas:coden">ANCAC3</span>;
        ISSN:<span class="NLM_cas:issn">1936-0851</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Over the last decades, considerable efforts have been put into developing active nanocarrier systems that cross the blood brain barrier (BBB) to treat brain-related diseases such as glioma tumors.  However, to date none have been approved for clin. usage.  Here, we show that a human H-ferritin (HFn) nanocarrier both successfully crosses the BBB and kills glioma tumor cells.  Its principle point of entry is the HFn receptor (transferrin receptor 1), which is overexpressed in both BBB endothelial cells (ECs) and glioma cells.  Importantly, we found that HFn enters and exits the BBB via the endosome compartment.  In contrast, upon specifically targeting and entering glioma cells, nearly all of the HFn accumulated in the lysosomal compartment, resulting in the killing of glioma tumor cells, with no HFn accumulation in the surrounding healthy brain tissue.  Thus, HFn is an ideal nanocarrier for glioma therapy and possesses the potential to serve as a therapeutic approach against a broad range of central nervous system diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrh1GasvY-QyLVg90H21EOLACvtfcHk0li83p28K5So0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmvVaktLo%253D&md5=b5aacd421d7304f1043701926200437a</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Facsnano.7b06969&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsnano.7b06969%26sid%3Dliteratum%253Aachs%26aulast%3DFan%26aufirst%3DK.%26aulast%3DJia%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DK.%26aulast%3DConde%26aufirst%3DJ.%26aulast%3DHe%26aufirst%3DJ.%26aulast%3DTian%26aufirst%3DJ.%26aulast%3DYan%26aufirst%3DX.%26atitle%3DFerritin%2520nanocarrier%2520traverses%2520the%2520blood%2520brain%2520barrier%2520and%2520kills%2520glioma%26jtitle%3DACS%2520Nano%26date%3D2018%26volume%3D12%26spage%3D4105%26epage%3D4115%26doi%3D10.1021%2Facsnano.7b06969" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pelaz, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexiou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez-Puebla, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alves, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashraf, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balogh, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballerini, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bestetti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brendel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carril, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, W. C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dullin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escudero, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feliu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">George, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gogotsi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grünweller, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halas, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hampp, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hersam, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunziker, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jungebluth, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kadhiresan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kataoka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khademhosseini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kopeček, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotov, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krug, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehr, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leong, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ling, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liz-Marzán, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macchiarini, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Möhwald, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mulvaney, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nel, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nordlander, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okano, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliveira, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penner, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prato, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puntes, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rotello, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samarakoon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaak, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sjöqvist, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skirtach, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soliman, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sung, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, B. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tietze, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Udugama, B. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">VanEpps, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weil, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willner, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yue, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parak, W. J.</span></span> <span> </span><span class="NLM_article-title">Diverse applications of nanomedicine</span>. <i>ACS Nano</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">2313</span>– <span class="NLM_lpage">2381</span>, <span class="refDoi"> DOI: 10.1021/acsnano.6b06040</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsnano.6b06040" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BC2sXktV2isLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2017&pages=2313-2381&author=B.+Pelazauthor=C.+Alexiouauthor=R.+A.+Alvarez-Pueblaauthor=F.+Alvesauthor=A.+M.+Andrewsauthor=S.+Ashrafauthor=L.+P.+Baloghauthor=L.+Balleriniauthor=A.+Bestettiauthor=C.+Brendelauthor=S.+Bosiauthor=M.+Carrilauthor=W.+C.+W.+Chanauthor=C.+Chenauthor=X.+Chenauthor=X.+Chenauthor=Z.+Chengauthor=D.+Cuiauthor=J.+Duauthor=C.+Dullinauthor=A.+Escuderoauthor=N.+Feliuauthor=M.+Gaoauthor=M.+Georgeauthor=Y.+Gogotsiauthor=A.+Gr%C3%BCnwellerauthor=Z.+Guauthor=N.+J.+Halasauthor=N.+Hamppauthor=R.+K.+Hartmannauthor=M.+C.+Hersamauthor=P.+Hunzikerauthor=J.+Jianauthor=X.+Jiangauthor=P.+Jungebluthauthor=P.+Kadhiresanauthor=K.+Kataokaauthor=A.+Khademhosseiniauthor=J.+Kope%C4%8Dekauthor=N.+A.+Kotovauthor=H.+F.+Krugauthor=D.+S.+Leeauthor=C.+M.+Lehrauthor=K.+W.+Leongauthor=X.+J.+Liangauthor=L.+M.+Lingauthor=L.+M.+Liz-Marz%C3%A1nauthor=X.+Maauthor=P.+Macchiariniauthor=H.+Mengauthor=H.+M%C3%B6hwaldauthor=P.+Mulvaneyauthor=A.+E.+Nelauthor=S.+Nieauthor=P.+Nordlanderauthor=T.+Okanoauthor=J.+Oliveiraauthor=T.+H.+Parkauthor=R.+M.+Pennerauthor=M.+Pratoauthor=V.+Puntesauthor=V.+M.+Rotelloauthor=A.+Samarakoonauthor=R.+E.+Schaakauthor=Y.+Shenauthor=S.+Sj%C3%B6qvistauthor=A.+G.+Skirtachauthor=M.+G.+Solimanauthor=M.+M.+Stevensauthor=H.+W.+Sungauthor=B.+Z.+Tangauthor=R.+Tietzeauthor=B.+N.+Udugamaauthor=J.+S.+VanEppsauthor=T.+Weilauthor=P.+S.+Weissauthor=I.+Willnerauthor=Y.+Wuauthor=L.+Yangauthor=Z.+Yueauthor=Q.+Zhangauthor=Q.+Zhangauthor=X.+E.+Zhangauthor=Y.+Zhaoauthor=X.+Zhouauthor=W.+J.+Parak&title=Diverse+applications+of+nanomedicine&doi=10.1021%2Facsnano.6b06040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Diverse Applications of Nanomedicine</span></div><div class="casAuthors">Pelaz, Beatriz; Alexiou, Christoph; Alvarez-Puebla, Ramon A.; Alves, Frauke; Andrews, Anne M.; Ashraf, Sumaira; Balogh, Lajos P.; Ballerini, Laura; Bestetti, Alessandra; Brendel, Cornelia; Bosi, Susanna; Carril, Monica; Chan, Warren C. W.; Chen, Chunying; Chen, Xiaodong; Chen, Xiaoyuan; Cheng, Zhen; Cui, Daxiang; Du, Jianzhong; Dullin, Christian; Escudero, Alberto; Feliu, Neus; Gao, Mingyuan; George, Michael; Gogotsi, Yury; Gruenweller, Arnold; Gu, Zhongwei; Halas, Naomi J.; Hampp, Norbert; Hartmann, Roland K.; Hersam, Mark C.; Hunziker, Patrick; Jian, Ji; Jiang, Xingyu; Jungebluth, Philipp; Kadhiresan, Pranav; Kataoka, Kazunori; Khademhosseini, Ali; Kopecek, Jindrich; Kotov, Nicholas A.; Krug, Harald F.; Lee, Dong Soo; Lehr, Claus-Michael; Leong, Kam W.; Liang, Xing-Jie; Ling Lim, Mei; Liz-Marzan, Luis M.; Ma, Xiaowei; Macchiarini, Paolo; Meng, Huan; Moehwald, Helmuth; Mulvaney, Paul; Nel, Andre E.; Nie, Shuming; Nordlander, Peter; Okano, Teruo; Oliveira, Jose; Park, Tai Hyun; Penner, Reginald M.; Prato, Maurizio; Puntes, Victor; Rotello, Vincent M.; Samarakoon, Amila; Schaak, Raymond E.; Shen, Youqing; Sjoeqvist, Sebastian; Skirtach, Andre G.; Soliman, Mahmoud G.; Stevens, Molly M.; Sung, Hsing-Wen; Tang, Ben Zhong; Tietze, Rainer; Udugama, Buddhisha N.; VanEpps, J. Scott; Weil, Tanja; Weiss, Paul S.; Willner, Itamar; Wu, Yuzhou; Yang, Lily; Yue, Zhao; Zhang, Qian; Zhang, Qiang; Zhang, Xian-En; Zhao, Yuliang; Zhou, Xin; Parak, Wolfgang J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Nano</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">2313-2381</span>CODEN:
                <span class="NLM_cas:coden">ANCAC3</span>;
        ISSN:<span class="NLM_cas:issn">1936-0851</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The design and use of materials in the nanoscale size range for addressing medical and health-related issues continues to receive increasing interest.  Research in nanomedicine spans a multitude of areas, including drug delivery, vaccine development, antibacterial, diagnosis and imaging tools, wearable devices, implants, high-throughput screening platforms, etc. using biol., nonbiol., biomimetic, or hybrid materials.  Many of these developments are starting to be translated into viable clin. products.  Here, we provide an overview of recent developments in nanomedicine and highlight the current challenges and upcoming opportunities for the field and translation to the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWUllaG7Ak6LVg90H21EOLACvtfcHk0ljp74fdj7H0sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXktV2isLg%253D&md5=3441feba35a8ea371b661906e1d0813b</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Facsnano.6b06040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsnano.6b06040%26sid%3Dliteratum%253Aachs%26aulast%3DPelaz%26aufirst%3DB.%26aulast%3DAlexiou%26aufirst%3DC.%26aulast%3DAlvarez-Puebla%26aufirst%3DR.%2BA.%26aulast%3DAlves%26aufirst%3DF.%26aulast%3DAndrews%26aufirst%3DA.%2BM.%26aulast%3DAshraf%26aufirst%3DS.%26aulast%3DBalogh%26aufirst%3DL.%2BP.%26aulast%3DBallerini%26aufirst%3DL.%26aulast%3DBestetti%26aufirst%3DA.%26aulast%3DBrendel%26aufirst%3DC.%26aulast%3DBosi%26aufirst%3DS.%26aulast%3DCarril%26aufirst%3DM.%26aulast%3DChan%26aufirst%3DW.%2BC.%2BW.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DCheng%26aufirst%3DZ.%26aulast%3DCui%26aufirst%3DD.%26aulast%3DDu%26aufirst%3DJ.%26aulast%3DDullin%26aufirst%3DC.%26aulast%3DEscudero%26aufirst%3DA.%26aulast%3DFeliu%26aufirst%3DN.%26aulast%3DGao%26aufirst%3DM.%26aulast%3DGeorge%26aufirst%3DM.%26aulast%3DGogotsi%26aufirst%3DY.%26aulast%3DGr%25C3%25BCnweller%26aufirst%3DA.%26aulast%3DGu%26aufirst%3DZ.%26aulast%3DHalas%26aufirst%3DN.%2BJ.%26aulast%3DHampp%26aufirst%3DN.%26aulast%3DHartmann%26aufirst%3DR.%2BK.%26aulast%3DHersam%26aufirst%3DM.%2BC.%26aulast%3DHunziker%26aufirst%3DP.%26aulast%3DJian%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DJungebluth%26aufirst%3DP.%26aulast%3DKadhiresan%26aufirst%3DP.%26aulast%3DKataoka%26aufirst%3DK.%26aulast%3DKhademhosseini%26aufirst%3DA.%26aulast%3DKope%25C4%258Dek%26aufirst%3DJ.%26aulast%3DKotov%26aufirst%3DN.%2BA.%26aulast%3DKrug%26aufirst%3DH.%2BF.%26aulast%3DLee%26aufirst%3DD.%2BS.%26aulast%3DLehr%26aufirst%3DC.%2BM.%26aulast%3DLeong%26aufirst%3DK.%2BW.%26aulast%3DLiang%26aufirst%3DX.%2BJ.%26aulast%3DLing%26aufirst%3DL.%2BM.%26aulast%3DLiz-Marz%25C3%25A1n%26aufirst%3DL.%2BM.%26aulast%3DMa%26aufirst%3DX.%26aulast%3DMacchiarini%26aufirst%3DP.%26aulast%3DMeng%26aufirst%3DH.%26aulast%3DM%25C3%25B6hwald%26aufirst%3DH.%26aulast%3DMulvaney%26aufirst%3DP.%26aulast%3DNel%26aufirst%3DA.%2BE.%26aulast%3DNie%26aufirst%3DS.%26aulast%3DNordlander%26aufirst%3DP.%26aulast%3DOkano%26aufirst%3DT.%26aulast%3DOliveira%26aufirst%3DJ.%26aulast%3DPark%26aufirst%3DT.%2BH.%26aulast%3DPenner%26aufirst%3DR.%2BM.%26aulast%3DPrato%26aufirst%3DM.%26aulast%3DPuntes%26aufirst%3DV.%26aulast%3DRotello%26aufirst%3DV.%2BM.%26aulast%3DSamarakoon%26aufirst%3DA.%26aulast%3DSchaak%26aufirst%3DR.%2BE.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DSj%25C3%25B6qvist%26aufirst%3DS.%26aulast%3DSkirtach%26aufirst%3DA.%2BG.%26aulast%3DSoliman%26aufirst%3DM.%2BG.%26aulast%3DStevens%26aufirst%3DM.%2BM.%26aulast%3DSung%26aufirst%3DH.%2BW.%26aulast%3DTang%26aufirst%3DB.%2BZ.%26aulast%3DTietze%26aufirst%3DR.%26aulast%3DUdugama%26aufirst%3DB.%2BN.%26aulast%3DVanEpps%26aufirst%3DJ.%2BS.%26aulast%3DWeil%26aufirst%3DT.%26aulast%3DWeiss%26aufirst%3DP.%2BS.%26aulast%3DWillner%26aufirst%3DI.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DYue%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DX.%2BE.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DParak%26aufirst%3DW.%2BJ.%26atitle%3DDiverse%2520applications%2520of%2520nanomedicine%26jtitle%3DACS%2520Nano%26date%3D2017%26volume%3D11%26spage%3D2313%26epage%3D2381%26doi%3D10.1021%2Facsnano.6b06040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cerna, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stiborova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adam, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kizek, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckschlager, T.</span></span> <span> </span><span class="NLM_article-title">Nanocarrier drugs in the treatment of brain tumors</span>. <i>J. Cancer Metastasis Treat.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">407</span>– <span class="NLM_lpage">416</span>, <span class="refDoi"> DOI: 10.20517/2394-4722.2015.95</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.20517%2F2394-4722.2015.95" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlShu7rE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2016&pages=407-416&author=T.+Cernaauthor=M.+Stiborovaauthor=V.+Adamauthor=R.+Kizekauthor=T.+Eckschlager&title=Nanocarrier+drugs+in+the+treatment+of+brain+tumors&doi=10.20517%2F2394-4722.2015.95"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Nanocarrier drugs in the treatment of brain tumors</span></div><div class="casAuthors">Cerna, Tereza; Stiborova, Marie; Adam, Vojtech; Kizek, Rene; Eckschlager, Tomas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cancer Metastasis and Treatment</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">407-416</span>CODEN:
                <span class="NLM_cas:coden">JCMTCU</span>;
        ISSN:<span class="NLM_cas:issn">2454-2857</span>.
    
            (<span class="NLM_cas:orgname">OAE Publishing Inc.</span>)
        </div><div class="casAbstract">Nanoparticle-mediated targeted delivery of drugs might significantly reduce the dosage and optimize their release properties, increase specificity and bioavailability, improve shelf life, and reduce toxicity.  Some nanodrugs are able to overcome the blood-brain barrier that is an obstacle to treatment of brain tumors.  Vessels in tumors have abnormal architecture and are highly permeable; moreover, tumors also have poor lymphatic drainage, allowing for accumulation of macromols. greater than approx. 40 kDa within the tumor microenvironment.  Nanoparticles exploit this feature, known as the enhanced permeability and retention effect, to target solid tumors.  Active targeting, i.e. surface modification of nanoparticles, is a way to decrease uptake in normal tissue and increase accumulation in a tumor, and it usually involves targeting surface membrane proteins that are upregulated in cancer cells.  The targeting mols. are typically antibodies or their fragments; aptamers; oligopeptides or small mols.  There are currently several FDA-approved nanomedicines, but none approved for brain tumor therapy.  This review, based both on the study of literature and on the authors own exptl. work describes a comprehensive overview of preclin. and clin. research of nanodrugs in therapy of brain tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9AoNrO2ls_7Vg90H21EOLACvtfcHk0ljp74fdj7H0sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlShu7rE&md5=4aab07bc604698875a344a0b0877f32f</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.20517%2F2394-4722.2015.95&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.20517%252F2394-4722.2015.95%26sid%3Dliteratum%253Aachs%26aulast%3DCerna%26aufirst%3DT.%26aulast%3DStiborova%26aufirst%3DM.%26aulast%3DAdam%26aufirst%3DV.%26aulast%3DKizek%26aufirst%3DR.%26aulast%3DEckschlager%26aufirst%3DT.%26atitle%3DNanocarrier%2520drugs%2520in%2520the%2520treatment%2520of%2520brain%2520tumors%26jtitle%3DJ.%2520Cancer%2520Metastasis%2520Treat.%26date%3D2016%26volume%3D2%26spage%3D407%26epage%3D416%26doi%3D10.20517%2F2394-4722.2015.95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moos, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, E. H.</span></span> <span> </span><span class="NLM_article-title">Transferrin and transferrin receptor function in brain barrier systems</span>. <i>Cell Mol. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">77</span>– <span class="NLM_lpage">95</span>, <span class="refDoi"> DOI: 10.1023/A:1006948027674</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.1023%2FA%3A1006948027674" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10690503" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhtV2ltL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2000&pages=77-95&author=T.+Moosauthor=E.+H.+Morgan&title=Transferrin+and+transferrin+receptor+function+in+brain+barrier+systems&doi=10.1023%2FA%3A1006948027674"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Transferrin and transferrin receptor function in brain barrier systems</span></div><div class="casAuthors">Moos, Torben; Morgan, Evan H.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Neurobiology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">77-95</span>CODEN:
                <span class="NLM_cas:coden">CMNEDI</span>;
        ISSN:<span class="NLM_cas:issn">0272-4340</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic/Plenum Publishers</span>)
        </div><div class="casAbstract">A review with many refs.  Iron (Fe) is an essential component of virtually all types of cells and organisms.  In plasma and interstitial fluids, Fe is carried by transferrin.  Iron-contg. transferrin has a high affinity for the transferrin receptor, which is present on all cells with a requirement for Fe.  The degree of expression of transferrin receptors on most types of cells is detd. by the level of Fe supply and their rate of proliferation.  The brain, like other organs, requires Fe for metabolic processes and suffers from disturbed function when a Fe deficiency or excess occurs.  Hence, the transport of Fe across brain barrier systems must be regulated.  The interaction between transferrin and transferrin receptor appears to serve this function in the blood-brain, blood-CSF, and cellular-plasmalemma barriers.  Transferrin is present in blood plasma and brain extracellular fluids, and the transferrin receptor is present on brain capillary endothelial cells, choroid plexus epithelial cells, neurons, and probably also glial cells.  The rate of Fe transport from plasma to brain is developmentally regulated, peaking in the first few weeks of postnatal life in the rat, after which it decreases rapidly to low values.  Two mechanisms for Fe transport across the blood-brain barrier have been proposed.  One is that the Fe-transferrin complex is transported intact across the capillary wall by receptor-mediated transcytosis.  In the second, Fe transport is the result of receptor-mediated endocytosis of Fe-transferrin by capillary endothelial cells, followed by release of Fe from transferrin within the cell, recycling of transferrin to the blood, and transport of Fe into the brain.  Current evidence indicates that although some transcytosis of transferrin does occur, the amt. is quant. insufficient to account for the rate of Fe transport, and the majority of Fe transport probably occurs by the second of the above mechanisms.  An addnl. route of Fe and transferrin transport from the blood to the brain is via the blood-CSF barrier and from the CSF into the brain.  Iron-contg. transferrin is transported through the blood-CSF barrier by a mechanism that appears to be regulated by developmental stage and iron status.  The transfer of transferrin from blood to CSF is higher than that of albumin, which may be due to the presence of transferrin receptors on choroid plexus epithelial cells so that transferrin can be transported across the cells by a receptor-mediated process as well as by nonselective mechanisms.  Transferrin receptors have been detected in neurons in vivo and in cultured glial cells.  Transferrin is present in the brain interstitial fluid, and it is generally assumed that Fe which transverses the blood-brain barrier is rapidly bound by brain transferrin and can then be taken up by receptor-mediated endocytosis in brain cells.  The uptake of transferrin-bound Fe by neurons and glial cells is probably regulated by the no. of transferrin receptors present on cells, which changes during development and in conditions with an altered iron status.  This review focuses on the information available on the functions of transferrin and transferrin receptor with respect to Fe transport across the blood-brain and blood-CSF barriers and the cell membranes of neurons and glial cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMFzsMZ67jibVg90H21EOLACvtfcHk0ljfS9mtWTGDKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhtV2ltL8%253D&md5=7e5d711f88eeb29cc1b7b074bda8a367</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1023%2FA%3A1006948027674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1006948027674%26sid%3Dliteratum%253Aachs%26aulast%3DMoos%26aufirst%3DT.%26aulast%3DMorgan%26aufirst%3DE.%2BH.%26atitle%3DTransferrin%2520and%2520transferrin%2520receptor%2520function%2520in%2520brain%2520barrier%2520systems%26jtitle%3DCell%2520Mol.%2520Neurobiol.%26date%3D2000%26volume%3D20%26spage%3D77%26epage%3D95%26doi%3D10.1023%2FA%3A1006948027674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bien-Ly, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bumbaca, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elstrott, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boswell, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luk, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dennis, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weimer, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watts, R. J.</span></span> <span> </span><span class="NLM_article-title">Transferrin receptor (TfR) trafficking determines brain uptake of TfR antibody affinity variants</span>. <i>J. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>211</i></span>,  <span class="NLM_fpage">233</span>– <span class="NLM_lpage">244</span>, <span class="refDoi"> DOI: 10.1084/jem.20131660</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.1084%2Fjem.20131660" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=24470444" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisFarurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=211&publication_year=2014&pages=233-244&author=N.+Bien-Lyauthor=Y.+J.+Yuauthor=D.+Bumbacaauthor=J.+Elstrottauthor=C.+A.+Boswellauthor=Y.+Zhangauthor=W.+Lukauthor=Y.+Luauthor=M.+S.+Dennisauthor=R.+M.+Weimerauthor=I.+Chungauthor=R.+J.+Watts&title=Transferrin+receptor+%28TfR%29+trafficking+determines+brain+uptake+of+TfR+antibody+affinity+variants&doi=10.1084%2Fjem.20131660"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Transferrin receptor (TfR) trafficking determines brain uptake of TfR antibody affinity variants</span></div><div class="casAuthors">Bien-Ly, Nga; Yu, Y. Joy; Bumbaca, Daniela; Elstrott, Justin; Boswell, C. Andrew; Zhang, Yin; Luk, Wilman; Lu, Yanmei; Dennis, Mark S.; Weimer, Robby M.; Chung, Inhee; Watts, Ryan J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">211</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">233-244</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-1007</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Antibodies to transferrin receptor (TfR) have potential use for therapeutic entry into the brain.  We have shown that bispecific antibodies against TfR and β-secretase (BACE1 [β-amyloid cleaving enzyme-1]) traverse the blood-brain barrier (BBB) and effectively reduce brain amyloid β levels.  We found that optimizing anti-TfR affinity improves brain exposure and BACE1 inhibition.  Here we probe the cellular basis of this improvement and explore whether TfR antibody affinity alters the intracellular trafficking of TfR.  Comparing high- and low-affinity TfR bispecific antibodies in vivo, we found that high-affinity binding to TfR caused a dose-dependent redn. of brain TfR levels.  In vitro live imaging and colocalization expts. revealed that high-affinity TfR bispecific antibodies facilitated the trafficking of TfR to lysosomes and thus induced the degrdn. of TfR, an observation which was further confirmed in vivo.  Importantly, high-affinity anti-TfR dosing induced redns. in brain TfR levels, which significantly decreased brain exposure to a second dose of low-affinity anti-TfR bispecific.  Thus, high-affinity anti-TfR alters TfR trafficking, which dramatically impacts the capacity for TfR to mediate BBB transcytosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNIVuFjhPwUbVg90H21EOLACvtfcHk0ljfS9mtWTGDKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisFarurY%253D&md5=9f8de8cec4986bf07515425a44b79db9</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1084%2Fjem.20131660&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20131660%26sid%3Dliteratum%253Aachs%26aulast%3DBien-Ly%26aufirst%3DN.%26aulast%3DYu%26aufirst%3DY.%2BJ.%26aulast%3DBumbaca%26aufirst%3DD.%26aulast%3DElstrott%26aufirst%3DJ.%26aulast%3DBoswell%26aufirst%3DC.%2BA.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLuk%26aufirst%3DW.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DDennis%26aufirst%3DM.%2BS.%26aulast%3DWeimer%26aufirst%3DR.%2BM.%26aulast%3DChung%26aufirst%3DI.%26aulast%3DWatts%26aufirst%3DR.%2BJ.%26atitle%3DTransferrin%2520receptor%2520%2528TfR%2529%2520trafficking%2520determines%2520brain%2520uptake%2520of%2520TfR%2520antibody%2520affinity%2520variants%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2014%26volume%3D211%26spage%3D233%26epage%3D244%26doi%3D10.1084%2Fjem.20131660" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Saraiva, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Praça, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferreira, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferreira, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernardino, L.</span></span> <span> </span><span class="NLM_article-title">Nanoparticle-mediated brain drug delivery: overcoming blood–brain barrier to treat neurodegenerative diseases</span>. <i>J. Controlled Release</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>235</i></span>,  <span class="NLM_fpage">34</span>– <span class="NLM_lpage">47</span>, <span class="refDoi"> DOI: 10.1016/j.jconrel.2016.05.044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.1016%2Fj.jconrel.2016.05.044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=27208862" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BC28XovV2hsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=235&publication_year=2016&pages=34-47&author=C.+Saraivaauthor=C.+Pra%C3%A7aauthor=R.+Ferreiraauthor=T.+Santosauthor=L.+Ferreiraauthor=L.+Bernardino&title=Nanoparticle-mediated+brain+drug+delivery%3A+overcoming+blood%E2%80%93brain+barrier+to+treat+neurodegenerative+diseases&doi=10.1016%2Fj.jconrel.2016.05.044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Nanoparticle-mediated brain drug delivery: Overcoming blood-brain barrier to treat neurodegenerative diseases</span></div><div class="casAuthors">Saraiva, Claudia; Praca, Catarina; Ferreira, Raquel; Santos, Tiago; Ferreira, Lino; Bernardino, Liliana</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Controlled Release</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">235</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">34-47</span>CODEN:
                <span class="NLM_cas:coden">JCREEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-3659</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The blood-brain barrier (BBB) is a vital boundary between neural tissue and circulating blood.  The BBB's unique and protective features control brain homeostasis as well as ion and mol. movement.  Failure in maintaining any of these components results in the breakdown of this specialized multicellular structure and consequently promotes neuro inflammation and neurodegeneration.  In several high incidence pathologies such as stroke, Alzheimer's (AD) and Parkinson's disease (PD) the BBB is impaired.  However, even a damaged and more permeable BBB can pose serious challenges to drug delivery into the brain.  The use of nanoparticle (NP) formulations able to encapsulate mols. with therapeutic value, while targeting specific transport processes in the brain vasculature, may enhance drug transport through the BBB in neurodegenerative/ischemic disorders and target relevant regions in the brain for regenerative processes.  In this review, we will discuss BBB compn. and characteristics and how these features are altered in pathol., namely in stroke, AD and PD.  Addnl., factors influencing an efficient i.v. delivery of polymeric and inorg. NPs into the brain as well as NP-related delivery systems with the most promising functional outcomes will also be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaTfl3mFXDRLVg90H21EOLACvtfcHk0liI9dUFJTB--g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XovV2hsbY%253D&md5=9a656f4dfad25bb41b0d8e4996822031</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.jconrel.2016.05.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jconrel.2016.05.044%26sid%3Dliteratum%253Aachs%26aulast%3DSaraiva%26aufirst%3DC.%26aulast%3DPra%25C3%25A7a%26aufirst%3DC.%26aulast%3DFerreira%26aufirst%3DR.%26aulast%3DSantos%26aufirst%3DT.%26aulast%3DFerreira%26aufirst%3DL.%26aulast%3DBernardino%26aufirst%3DL.%26atitle%3DNanoparticle-mediated%2520brain%2520drug%2520delivery%253A%2520overcoming%2520blood%25E2%2580%2593brain%2520barrier%2520to%2520treat%2520neurodegenerative%2520diseases%26jtitle%3DJ.%2520Controlled%2520Release%26date%3D2016%26volume%3D235%26spage%3D34%26epage%3D47%26doi%3D10.1016%2Fj.jconrel.2016.05.044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bell, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ehlers, M. D.</span></span> <span> </span><span class="NLM_article-title">Breaching the blood-brain barrier for drug delivery</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">3</span>, <span class="refDoi"> DOI: 10.1016/j.neuron.2013.12.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.1016%2Fj.neuron.2013.12.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=24411725" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlt1enuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2014&pages=1-3&author=R.+D.+Bellauthor=M.+D.+Ehlers&title=Breaching+the+blood-brain+barrier+for+drug+delivery&doi=10.1016%2Fj.neuron.2013.12.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Breaching the Blood-Brain Barrier for Drug Delivery</span></div><div class="casAuthors">Bell, Robert D.; Ehlers, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-3</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Mol. "hitchhiking" through receptor-mediated transcytosis at the blood-brain barrier is a CNS drug delivery strategy.  In this issue of Neuron, Niewoehner et al. (2014) describe a modular anti-transferrin receptor Fab approach for shuttling therapeutic antibodies into the brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplP2Mq1NP0g7Vg90H21EOLACvtfcHk0liI9dUFJTB--g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlt1enuw%253D%253D&md5=63d7326c8e49166317e8ca757461e608</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2013.12.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2013.12.023%26sid%3Dliteratum%253Aachs%26aulast%3DBell%26aufirst%3DR.%2BD.%26aulast%3DEhlers%26aufirst%3DM.%2BD.%26atitle%3DBreaching%2520the%2520blood-brain%2520barrier%2520for%2520drug%2520delivery%26jtitle%3DNeuron%26date%3D2014%26volume%3D81%26spage%3D1%26epage%3D3%26doi%3D10.1016%2Fj.neuron.2013.12.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Niewoehner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohrmann, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urich, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sade, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maier, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rueger, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stracke, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lau, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tissot, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loetscher, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freskgard, P.-O.</span></span> <span> </span><span class="NLM_article-title">Increased brain penetration and potency of a therapeutic antibody using a monovalent molecular shuttle</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">49</span>– <span class="NLM_lpage">60</span>, <span class="refDoi"> DOI: 10.1016/j.neuron.2013.10.061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.1016%2Fj.neuron.2013.10.061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=24411731" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlt1CmtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2014&pages=49-60&author=J.+Niewoehnerauthor=B.+Bohrmannauthor=L.+Collinauthor=E.+Urichauthor=H.+Sadeauthor=P.+Maierauthor=P.+Ruegerauthor=J.+O.+Strackeauthor=W.+Lauauthor=A.+C.+Tissotauthor=H.+Loetscherauthor=A.+Ghoshauthor=P.-O.+Freskgard&title=Increased+brain+penetration+and+potency+of+a+therapeutic+antibody+using+a+monovalent+molecular+shuttle&doi=10.1016%2Fj.neuron.2013.10.061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Increased Brain Penetration and Potency of a Therapeutic Antibody Using a Monovalent Molecular Shuttle</span></div><div class="casAuthors">Niewoehner, Jens; Bohrmann, Bernd; Collin, Ludovic; Urich, Eduard; Sade, Hadassah; Maier, Peter; Rueger, Petra; Stracke, Jan Olaf; Lau, Wilma; Tissot, Alain C.; Loetscher, Hansruedi; Ghosh, Anirvan; Freskgard, Per-Ola</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">49-60</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Although biotherapeutics have vast potential for treating brain disorders, their use has been limited due to low exposure across the blood-brain barrier (BBB).  We report that by manipulating the binding mode of an antibody fragment to the transferrin receptor (TfR), we have developed a Brain Shuttle module, which can be engineered into a std. therapeutic antibody for successful BBB transcytosis.  Brain Shuttle version of an anti-Aβ antibody, which uses a monovalent binding mode to the TfR, increases β-Amyloid target engagement in a mouse model of Alzheimer's disease by 55-fold compared to the parent antibody.  We provide in vitro and in vivo evidence that the monovalent binding mode facilitates transcellular transport, whereas a bivalent binding mode leads to lysosome sorting.  Enhanced target engagement of the Brain Shuttle module translates into a significant improvement in amyloid redn.  These findings have major implications for the development of biologics-based treatment of brain disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOzgePXqpPLrVg90H21EOLACvtfcHk0liI9dUFJTB--g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlt1CmtQ%253D%253D&md5=61f31b943fb6b90c28bae76bef4ba5ce</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2013.10.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2013.10.061%26sid%3Dliteratum%253Aachs%26aulast%3DNiewoehner%26aufirst%3DJ.%26aulast%3DBohrmann%26aufirst%3DB.%26aulast%3DCollin%26aufirst%3DL.%26aulast%3DUrich%26aufirst%3DE.%26aulast%3DSade%26aufirst%3DH.%26aulast%3DMaier%26aufirst%3DP.%26aulast%3DRueger%26aufirst%3DP.%26aulast%3DStracke%26aufirst%3DJ.%2BO.%26aulast%3DLau%26aufirst%3DW.%26aulast%3DTissot%26aufirst%3DA.%2BC.%26aulast%3DLoetscher%26aufirst%3DH.%26aulast%3DGhosh%26aufirst%3DA.%26aulast%3DFreskgard%26aufirst%3DP.-O.%26atitle%3DIncreased%2520brain%2520penetration%2520and%2520potency%2520of%2520a%2520therapeutic%2520antibody%2520using%2520a%2520monovalent%2520molecular%2520shuttle%26jtitle%3DNeuron%26date%3D2014%26volume%3D81%26spage%3D49%26epage%3D60%26doi%3D10.1016%2Fj.neuron.2013.10.061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Watts, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dennis, M. S.</span></span> <span> </span><span class="NLM_article-title">Bispecific antibodies for delivery into the brain</span>. <i>Curr. Opin. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">393</span>– <span class="NLM_lpage">399</span>, <span class="refDoi"> DOI: 10.1016/j.cbpa.2013.03.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.1016%2Fj.cbpa.2013.03.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=23570979" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlsFejurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2013&pages=393-399&author=R.+J.+Wattsauthor=M.+S.+Dennis&title=Bispecific+antibodies+for+delivery+into+the+brain&doi=10.1016%2Fj.cbpa.2013.03.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Bispecific antibodies for delivery into the brain</span></div><div class="casAuthors">Watts, Ryan J.; Dennis, Mark S.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">393-399</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The blood-brain barrier (BBB) is a formidable obstacle preventing drug delivery to the brain, particularly for large protein therapeutics.  The utilization of endogenous brain endothelial transport pathways, however, represents a promising approach to cross the cellular barrier through receptor-mediated transcytosis.  Therapeutics designed to take advantage of this approach require at least 2 functionalities, one that facilitates transport and the other to provide therapeutic benefit, and bispecific antibodies are ideally suited for this task.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPiQMZjB0QArVg90H21EOLACvtfcHk0lh3TGCINvd99g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlsFejurs%253D&md5=6f5758b62bff2edcc30213f89e807523</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2013.03.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2013.03.023%26sid%3Dliteratum%253Aachs%26aulast%3DWatts%26aufirst%3DR.%2BJ.%26aulast%3DDennis%26aufirst%3DM.%2BS.%26atitle%3DBispecific%2520antibodies%2520for%2520delivery%2520into%2520the%2520brain%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2013%26volume%3D17%26spage%3D393%26epage%3D399%26doi%3D10.1016%2Fj.cbpa.2013.03.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prior, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reifenberger, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wechsler, W.</span></span> <span> </span><span class="NLM_article-title">Transferrin receptor expression in tumors of the human nervous-system-relation to tumor type, grading and tumor-growth fraction</span>. <i>Virchows. Arch. A. Pathol Anat. Histopathol.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>416</i></span>,  <span class="NLM_fpage">491</span>– <span class="NLM_lpage">496</span>, <span class="refDoi"> DOI: 10.1007/BF01600299</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.1007%2FBF01600299" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=2110696" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A280%3ADyaK3c3ks1Oisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=416&publication_year=1990&pages=491-496&author=R.+Priorauthor=G.+Reifenbergerauthor=W.+Wechsler&title=Transferrin+receptor+expression+in+tumors+of+the+human+nervous-system-relation+to+tumor+type%2C+grading+and+tumor-growth+fraction&doi=10.1007%2FBF01600299"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Transferrin receptor expression in tumours of the human nervous system: relation to tumour type, grading and tumour growth fraction</span></div><div class="casAuthors">Prior R; Reifenberger G; Wechsler W</div><div class="citationInfo"><span class="NLM_cas:title">Virchows Archiv. A, Pathological anatomy and histopathology</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">416</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">491-6</span>
        ISSN:<span class="NLM_cas:issn">0174-7398</span>.
    </div><div class="casAbstract">The expression of transferrin receptor (Tr) was investigated by means of immunohistochemistry in 101 tumours of the human central and peripheral nervous system.  The results were compared with the proliferative activity of the tumours, determined by immunostaining for the proliferation-associated antigen Ki-67.  In addition to immunostaining of normal and proliferated blood vessel endothelium and of a fraction of tumour infiltrating lymphocytes, we observed staining for Tr in a variable fraction of neoplastic cells of all histological tumour types.  Immunoreactivity in the majority of tumour cells was found only in anaplastic tumours such as glioblastomas.  Furthermore, a positive correlation between Tr expression and the Ki-67 growth fraction was established for gliomas.  Non-glial tumours strongly expressing Tr included one metastatic rhabdomyosarcoma, one intracerebral malignant lymphoma, two of four plasmocytomas and seven of nine metastatic carcinomas.  Our results indicate that immunohistochemistry for Tr and Ki-67 can provide additional information about the biological behaviour of nervous system tumours, thus complementing conventional histopathological criteria for anaplasia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQqPOygotjA4cSzjBFCN0BJfW6udTcc2eavYN3heh_1YLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3c3ks1Oisw%253D%253D&md5=32d96b9a1425ef21d6097bd5f75aa456</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1007%2FBF01600299&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF01600299%26sid%3Dliteratum%253Aachs%26aulast%3DPrior%26aufirst%3DR.%26aulast%3DReifenberger%26aufirst%3DG.%26aulast%3DWechsler%26aufirst%3DW.%26atitle%3DTransferrin%2520receptor%2520expression%2520in%2520tumors%2520of%2520the%2520human%2520nervous-system-relation%2520to%2520tumor%2520type%252C%2520grading%2520and%2520tumor-growth%2520fraction%26jtitle%3DVirchows.%2520Arch.%2520A.%2520Pathol%2520Anat.%2520Histopathol.%26date%3D1990%26volume%3D416%26spage%3D491%26epage%3D496%26doi%3D10.1007%2FBF01600299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Recht, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torres, C. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raso, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, T. W.</span></span> <span> </span><span class="NLM_article-title">Transferrin receptor in normal and neoplastic brain-tissue-implications for brain-tumor immunotherapy</span>. <i>J. Neurosurg.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">941</span>– <span class="NLM_lpage">945</span>, <span class="refDoi"> DOI: 10.3171/jns.1990.72.6.0941</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.3171%2Fjns.1990.72.6.0941" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=2159987" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A280%3ADyaK3c3ltVCruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=1990&pages=941-945&author=L.+Rechtauthor=C.+O.+Torresauthor=T.+W.+Smithauthor=V.+Rasoauthor=T.+W.+Griffin&title=Transferrin+receptor+in+normal+and+neoplastic+brain-tissue-implications+for+brain-tumor+immunotherapy&doi=10.3171%2Fjns.1990.72.6.0941"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Transferrin receptor in normal and neoplastic brain tissue: implications for brain-tumor immunotherapy</span></div><div class="casAuthors">Recht L; Torres C O; Smith T W; Raso V; Griffin T W</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neurosurgery</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">941-5</span>
        ISSN:<span class="NLM_cas:issn">0022-3085</span>.
    </div><div class="casAbstract">The distribution of transferrin receptor (TfR) in normal human brain-tissue obtained at autopsy and in brain-tumor biopsy specimens from 27 patients was determined by immunohistochemistry using two specific murine monoclonal antibodies against human TfR.  The tumors studied included 10 glioblastomas multiforme (GBM's), nine other glial tumors, and eight meningiomas.  In normal brain, TfR was detected primarily in endothelial cells; rare glial cells also contained immunoreactive product.  All tumors contained TfR-positive cells, although the intensity (number of cells stained) and pattern (focal vs. diffuse) of staining varied with the histopathological type of the tumor.  Among gliomas, the most intense staining was seen in GBM's, especially in areas of pseudopalisading where virtually all cells were stained.  A rough correlation between tumor grade, number of positively stained cells, and staining pattern was seen in the other astrocytic tumors.  By contrast, all meningiomas demonstrated an identical and characteristic focal staining pattern.  Considering the differential immunostaining for TfR between normal and neoplastic tissue, the authors conclude that TfR may be an appropriate target for monoclonal antibody-directed brain-tumor immunotherapy, especially in more malignant tumors such as GBM's.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT6LX_O25TE_iXXDYhVZBdlfW6udTcc2eavYN3heh_1YLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3c3ltVCruw%253D%253D&md5=1c79831a095480e2f8665c5f3ce19ac9</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.3171%2Fjns.1990.72.6.0941&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3171%252Fjns.1990.72.6.0941%26sid%3Dliteratum%253Aachs%26aulast%3DRecht%26aufirst%3DL.%26aulast%3DTorres%26aufirst%3DC.%2BO.%26aulast%3DSmith%26aufirst%3DT.%2BW.%26aulast%3DRaso%26aufirst%3DV.%26aulast%3DGriffin%26aufirst%3DT.%2BW.%26atitle%3DTransferrin%2520receptor%2520in%2520normal%2520and%2520neoplastic%2520brain-tissue-implications%2520for%2520brain-tumor%2520immunotherapy%26jtitle%3DJ.%2520Neurosurg.%26date%3D1990%26volume%3D72%26spage%3D941%26epage%3D945%26doi%3D10.3171%2Fjns.1990.72.6.0941" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Todd, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowger, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, J.</span></span> <span> </span><span class="NLM_article-title">RGD-modified apoferritin NPs for efficient drug delivery to tumors</span>. <i>ACS Nano</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">4830</span>– <span class="NLM_lpage">4837</span>, <span class="refDoi"> DOI: 10.1021/nn305791q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/nn305791q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BC3sXosVejtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2013&pages=4830-4837&author=Z.+Zhenauthor=W.+Tangauthor=H.+Chenauthor=X.+Linauthor=T.+Toddauthor=G.+Wangauthor=T.+Cowgerauthor=X.+Chenauthor=J.+Xie&title=RGD-modified+apoferritin+NPs+for+efficient+drug+delivery+to+tumors&doi=10.1021%2Fnn305791q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">RGD-Modified Apoferritin Nanoparticles for Efficient Drug Delivery to Tumors</span></div><div class="casAuthors">Zhen, Zipeng; Tang, Wei; Chen, Hongmin; Lin, Xin; Todd, Trever; Wang, Geoffrey; Cowger, Taku; Chen, Xiaoyuan; Xie, Jin</div><div class="citationInfo"><span class="NLM_cas:title">ACS Nano</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">4830-4837</span>CODEN:
                <span class="NLM_cas:coden">ANCAC3</span>;
        ISSN:<span class="NLM_cas:issn">1936-0851</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Ferritin (FRT) is a major iron storage protein found in humans and most living organisms.  Each ferritin is composed of 24 subunits, which self-assemble to form a cage-like nanostructure.  FRT nanocages can be genetically modified to present a peptide sequence on the surface.  Recently, we demonstrated that Cys-Asp-Cys-Arg-Gly-Asp-Cys-Phe-Cys (RGD4C)-modified ferritin can efficiently home to tumors through RGD-integrin αvβ3 interaction.  Though promising, studies on evaluating surface modified ferritin nanocages as drug delivery vehicles have seldom been reported.  Herein, we showed that after being precomplexed with Cu(II), doxorubicin can be loaded onto RGD modified apoferritin nanocages with high efficiency (up to 73.49 wt %).  When studied on U87MG s.c. tumor models, these doxorubicin-loaded ferritin nanocages showed a longer circulation half-life, higher tumor uptake, better tumor growth inhibition, and less cardiotoxicity than free doxorubicin.  Such a technol. might be extended to load a broad range of therapeutics and holds great potential in clin. translation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvD-JvyIxsHrVg90H21EOLACvtfcHk0ljJgJkrRTSi6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXosVejtbY%253D&md5=1db3611654b22ee0f93f2697ed92bfd3</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fnn305791q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnn305791q%26sid%3Dliteratum%253Aachs%26aulast%3DZhen%26aufirst%3DZ.%26aulast%3DTang%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DTodd%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DCowger%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DXie%26aufirst%3DJ.%26atitle%3DRGD-modified%2520apoferritin%2520NPs%2520for%2520efficient%2520drug%2520delivery%2520to%2520tumors%26jtitle%3DACS%2520Nano%26date%3D2013%26volume%3D7%26spage%3D4830%26epage%3D4837%26doi%3D10.1021%2Fnn305791q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tong, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lok, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fung, Y. M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, C. M.</span></span> <span> </span><span class="NLM_article-title">An anticancer gold(III)-activated porphyrin scaffold that covalently modifies protein cysteine thiols</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">1321</span>– <span class="NLM_lpage">1329</span>, <span class="refDoi"> DOI: 10.1073/pnas.1915202117</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.1073%2Fpnas.1915202117" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=31896586" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhsFKktL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2020&pages=1321-1329&author=K.+C.+Tongauthor=C.+N.+Lokauthor=P.+K.+Wanauthor=D.+Huauthor=Y.+M.+E.+Fungauthor=X.+Y.+Changauthor=S.+Huangauthor=H.+Jiangauthor=C.+M.+Che&title=An+anticancer+gold%28III%29-activated+porphyrin+scaffold+that+covalently+modifies+protein+cysteine+thiols&doi=10.1073%2Fpnas.1915202117"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">An anticancer gold(III)-activated porphyrin scaffold that covalently modifies protein cysteine thiols</span></div><div class="casAuthors">Tong, Ka-Chung; Lok, Chun-Nam; Wan, Pui-Ki; Hu, Di; Eva Fung, Yi Man; Chang, Xiao-Yong; Huang, Song; Jiang, Haibo; Che, Chi-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1321-1329</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Cysteine thiols of many cancer-assocd. proteins are attractive targets of anticancer agents.  Herein, we unequivocally demonstrate a distinct thiol-targeting property of gold(III) mesoporphyrin IX di-Me ester (AuMesoIX) and its anticancer activities.  While the binding of cysteine thiols with metal complexes usually occurs via M-S bond formation, AuMesoIX is unique in that the meso-carbon atom of the porphyrin ring is activated by the gold(III) ion to undergo nucleophilic arom. substitution with thiols.  AuMesoIX was shown to modify reactive cysteine residues and inhibit the activities of anticancer protein targets including thioredoxin, peroxiredoxin, and deubiquitinases.  Treatment of cancer cells with AuMesoIX resulted in the formation of gold-bound sulfur-rich protein aggregates, oxidative stress-mediated cytotoxicity, and accumulation of ubiquitinated proteins.  Importantly, AuMesoIX exhibited effective antitumor activity in mice.  Our study has uncovered a gold(III)-induced ligand scaffold reactivity for thiol targeting that can be exploited for anticancer applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJuhQj8AqhG7Vg90H21EOLACvtfcHk0ljJgJkrRTSi6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhsFKktL4%253D&md5=58f9fb7cbcbb4da43df2f07f97b7d311</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1915202117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1915202117%26sid%3Dliteratum%253Aachs%26aulast%3DTong%26aufirst%3DK.%2BC.%26aulast%3DLok%26aufirst%3DC.%2BN.%26aulast%3DWan%26aufirst%3DP.%2BK.%26aulast%3DHu%26aufirst%3DD.%26aulast%3DFung%26aufirst%3DY.%2BM.%2BE.%26aulast%3DChang%26aufirst%3DX.%2BY.%26aulast%3DHuang%26aufirst%3DS.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DChe%26aufirst%3DC.%2BM.%26atitle%3DAn%2520anticancer%2520gold%2528III%2529-activated%2520porphyrin%2520scaffold%2520that%2520covalently%2520modifies%2520protein%2520cysteine%2520thiols%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2020%26volume%3D117%26spage%3D1321%26epage%3D1329%26doi%3D10.1073%2Fpnas.1915202117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mertens, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parkin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awuah, S. G.</span></span> <span> </span><span class="NLM_article-title">Cancer cell-selective modulation of mitochondrial respiration and metabolism by potent organogold(iii) dithiocarbamates</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">10465</span>– <span class="NLM_lpage">10482</span>, <span class="refDoi"> DOI: 10.1039/D0SC03628E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.1039%2FD0SC03628E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhvVGgs7zL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2020&pages=10465-10482&author=R.+T.+Mertensauthor=S.+Parkinauthor=S.+G.+Awuah&title=Cancer+cell-selective+modulation+of+mitochondrial+respiration+and+metabolism+by+potent+organogold%28iii%29+dithiocarbamates&doi=10.1039%2FD0SC03628E"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer cell-selective modulation of mitochondrial respiration and metabolism by potent organogold(III) dithiocarbamates</span></div><div class="casAuthors">Mertens, Randall T.; Parkin, Sean; Awuah, Samuel G.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">10465-10482</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Metabolic reprogramming is a key cancer hallmark that has led to the therapeutic targeting of glycolysis.  However, agents that target dysfunctional mitochondrial respiration for targeted therapy remains underexplored.  We report the synthesis and characterization of ten (10) novel, highly potent organometallic gold(III) complexes supported by dithiocarbamate ligands as selective inhibitors of mitochondrial respiration.  The structure of dithiocarbamates employed dictates the biol. stability and cellular cytotoxicity.  Most of the compds. exhibit 50% inhibitory concn. (IC50) in the low-micromolar (0.50-2.9 μM) range when tested in a panel of aggressive cancer types with significant selectivity for cancer cells over normal cells.  Consequently, there is great interest in the mechanism of action of gold chemotherapeutics, particularly, considering that DNA is not the major target of most gold complexes.  We investigate the mechanism of action of representative complexes, 1a and 2a in the recalcitrant triple neg. breast cancer (TNBC) cell line, MDA-MB-231.  Whole-cell transcriptomics sequencing revealed genes related to three major pathways, namely: cell cycle, organelle fission, and oxidative phosphorylation. 2a irreversibly and rapidly inhibits maximal respiration in TNBC with no effect on normal epithelial cells, implicating mitochondrial OXPHOS as a potential target.  Furthermore, the modulation of cyclin dependent kinases and G1 cell cycle arrest induced by these compds. is promising for the treatment of cancer.  This work contributes to the need for mitochondrial respiration modulators in biomedical research and outlines a systematic approach to study the mechanism of action of metal-based agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqy7PCLc_HGgrVg90H21EOLACvtfcHk0lg4SKldjEBy2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhvVGgs7zL&md5=bb3f230316d8b08686829a5b6fcc540d</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1039%2FD0SC03628E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FD0SC03628E%26sid%3Dliteratum%253Aachs%26aulast%3DMertens%26aufirst%3DR.%2BT.%26aulast%3DParkin%26aufirst%3DS.%26aulast%3DAwuah%26aufirst%3DS.%2BG.%26atitle%3DCancer%2520cell-selective%2520modulation%2520of%2520mitochondrial%2520respiration%2520and%2520metabolism%2520by%2520potent%2520organogold%2528iii%2529%2520dithiocarbamates%26jtitle%3DChem.%2520Sci.%26date%3D2020%26volume%3D11%26spage%3D10465%26epage%3D10482%26doi%3D10.1039%2FD0SC03628E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reeder, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parkin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awuah, S. G.</span></span> <span> </span><span class="NLM_article-title">Gold(I/III)-phosphine complexes as potent antiproliferative agents</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">12335</span>, <span class="refDoi"> DOI: 10.1038/s41598-019-48584-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.1038%2Fs41598-019-48584-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=31451718" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A280%3ADC%252BB3MrhvVGrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2019&pages=12335&author=J.+H.+Kimauthor=E.+Reederauthor=S.+Parkinauthor=S.+G.+Awuah&title=Gold%28I%2FIII%29-phosphine+complexes+as+potent+antiproliferative+agents&doi=10.1038%2Fs41598-019-48584-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Gold(I/III)-Phosphine Complexes as Potent Antiproliferative Agents</span></div><div class="casAuthors">Kim Jong Hyun; Reeder Evan; Parkin Sean; Awuah Samuel G</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">12335</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The reaction of gold reagents [HAuCl4•3H2O], [AuCl(tht)], or cyclometalated gold(III) precursor, [C NAuCl2] with chiral ((R,R)-(-)-2,3-bis(t-butylmethylphosphino) quinoxaline) and non-chiral phosphine (1,2-Bis(diphenylphosphino)ethane, dppe) ligands lead to distorted Au(I), (1, 2, 4, 5) and novel cyclometalated Au(III) complexes (3, 6).  These gold compounds were characterized by multinuclear NMR, microanalysis, mass spectrometry, and X-ray crystallography.  The inherent electrochemical properties of the gold complexes were also studied by cyclic voltammetry and theoretical insight of the complexes was gained by density functional theory and TD-DFT calculations.  The complexes effectively kill cancer cells with IC50 in the range of ~0.10-2.53 μΜ across K562, H460, and OVCAR8 cell lines.  In addition, the retinal pigment epithelial cell line, RPE-Neo was used as a healthy cell line for comparison.  Differential cellular uptake in cancer cells was observed for the compounds by measuring the intracellular accumulation of gold using ICP-OES.  Furthermore, the compounds trigger early - late stage apoptosis through potential disruption of redox homeostasis.  Complexes 1 and 3 induce predominant G1 cell cycle arrest.  Results presented in this report suggest that stable gold-phosphine complexes with variable oxidation states hold promise in anticancer drug discovery and need further development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS__ehwZ0OhMh0LsK7uFuY7fW6udTcc2eb51wLgYd9xWLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MrhvVGrsw%253D%253D&md5=1d0a70644aa1bd4626a76bb96bda8c47</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1038%2Fs41598-019-48584-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-019-48584-5%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DReeder%26aufirst%3DE.%26aulast%3DParkin%26aufirst%3DS.%26aulast%3DAwuah%26aufirst%3DS.%2BG.%26atitle%3DGold%2528I%252FIII%2529-phosphine%2520complexes%2520as%2520potent%2520antiproliferative%2520agents%26jtitle%3DSci.%2520Rep.%26date%3D2019%26volume%3D9%26spage%3D12335%26doi%3D10.1038%2Fs41598-019-48584-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gukathasan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parkin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awuah, S. G.</span></span> <span> </span><span class="NLM_article-title">Cyclometalated gold(III) complexes bearing DACH ligands</span>. <i>Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">9326</span>– <span class="NLM_lpage">9340</span>, <span class="refDoi"> DOI: 10.1021/acs.inorgchem.9b01031</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.inorgchem.9b01031" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BC1MXht1eru7jM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2019&pages=9326-9340&author=S.+Gukathasanauthor=S.+Parkinauthor=S.+G.+Awuah&title=Cyclometalated+gold%28III%29+complexes+bearing+DACH+ligands&doi=10.1021%2Facs.inorgchem.9b01031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclometalated Gold(III) Complexes Bearing DACH Ligands</span></div><div class="casAuthors">Gukathasan, Sailajah; Parkin, Sean; Awuah, Samuel G.</div><div class="citationInfo"><span class="NLM_cas:title">Inorganic Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">9326-9340</span>CODEN:
                <span class="NLM_cas:coden">INOCAJ</span>;
        ISSN:<span class="NLM_cas:issn">0020-1669</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis of a novel class of cyclometalated gold(III) complexes supported by benzoylpyridine, benzylpyridine, and (1R,2R)-(+)-1,2-diaminocyclohexane (DACH) ligands, along with their crystal structures, is reported.  These compds. provide a new scaffold to investigate biol. properties of gold(III) complexes.  The six complexes were prepd. and characterized, following reactions of (C,N) cyclometalated gold(III) scaffolds, [Au(C N)Cl2] with DACH, which yielded a new series of cyclometaled gold(III), 3-5, of the type [Au(C NH)(DACH)2]+ and the nitrogen-substituted cyclometalated Au(III), 6-8, of the type [Au(C N)(DACH)]2+.  Antiproliferative activity of these complexes in a panel of cancer cells showed promising results with IC50 in the micromolar range and selectivity over normal epithelial cells, MRC5.  Whereas 8 shows minimal interaction with superhelical DNA except at high gold concns. of 500μM, complex 5 does not show interaction even at 1000μM.  The complexes display significant uptake in OVCAR8 cancer cells within 200-1200 pmol/million cells with the exception of complex 4.  Differential cellular uptake was obsd. for the complexes; for example, while 3 and 8 display significant uptake, 4 showed minimal uptake.  The compds. proved to be stable under physiol. conditions and were minimally affected by either glutathione or sodium ascorbate.  Cell cycle studies reveal a G1 arrest induced by representative complexes.  The results reveal that enhanced Au(III) stabilization promoted by combined cyclometalated and DACH ligands may offer ligand tuning insights for novel anticancer drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxUSNZnA3_YLVg90H21EOLACvtfcHk0lg4SKldjEBy2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXht1eru7jM&md5=2653b7cab5e02eca231c79b09061c995</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Facs.inorgchem.9b01031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.inorgchem.9b01031%26sid%3Dliteratum%253Aachs%26aulast%3DGukathasan%26aufirst%3DS.%26aulast%3DParkin%26aufirst%3DS.%26aulast%3DAwuah%26aufirst%3DS.%2BG.%26atitle%3DCyclometalated%2520gold%2528III%2529%2520complexes%2520bearing%2520DACH%2520ligands%26jtitle%3DInorg.%2520Chem.%26date%3D2019%26volume%3D58%26spage%3D9326%26epage%3D9340%26doi%3D10.1021%2Facs.inorgchem.9b01031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Z.</span></span> <span> </span><span class="NLM_article-title">Encapsulation of platinum anticancer drugs by apoferritin</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">3453</span>– <span class="NLM_lpage">3455</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.1039%2Fb705326f" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2007&pages=3453-3455&author=Z.+Yangauthor=X.+Wangauthor=H.+Diaoauthor=J.+Zhangauthor=H.+Liauthor=H.+Sunauthor=Z.+Guo&title=Encapsulation+of+platinum+anticancer+drugs+by+apoferritin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1039%2Fb705326f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb705326f%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DDiao%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DGuo%26aufirst%3DZ.%26atitle%3DEncapsulation%2520of%2520platinum%2520anticancer%2520drugs%2520by%2520apoferritin%26jtitle%3DChem.%2520Commun.%26date%3D2007%26volume%3D103%26spage%3D3453%26epage%3D3455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xing, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Z.</span></span> <span> </span><span class="NLM_article-title">Characterization and cellular uptake of platinum anticancer drugs encapsulated in apoferritin</span>. <i>J. Inorg. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">1039</span>– <span class="NLM_lpage">1044</span>, <span class="refDoi"> DOI: 10.1016/j.jinorgbio.2009.05.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.1016%2Fj.jinorgbio.2009.05.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=19501911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnvVWltr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2009&pages=1039-1044&author=R.+Xingauthor=X.+Wangauthor=C.+Zhangauthor=Y.+Zhangauthor=Q.+Wangauthor=Z.+Yangauthor=Z.+Guo&title=Characterization+and+cellular+uptake+of+platinum+anticancer+drugs+encapsulated+in+apoferritin&doi=10.1016%2Fj.jinorgbio.2009.05.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization and cellular uptake of platinum anticancer drugs encapsulated in apoferritin</span></div><div class="casAuthors">Xing, Ruimin; Wang, Xiaoyong; Zhang, Changli; Zhang, Yangmiao; Wang, Qi; Yang, Zhen; Guo, Zijian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Inorganic Biochemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1039-1044</span>CODEN:
                <span class="NLM_cas:coden">JIBIDJ</span>;
        ISSN:<span class="NLM_cas:issn">0162-0134</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Clin. application of platinum-based anticancer drugs is largely limited by severe general toxicity and drug resistance.  Drug delivery systems with tumor-targeting potential are highly desired for improving the efficacy and applicability of these drugs.  This study describes an alternative strategy for the delivery of platinum drugs (cisplatin, carboplatin and oxaliplatin) by encapsulating each of them in the cavity of apoferritin (AFt).  The encapsulation was achieved through manipulating the pH-dependent unfolding-refolding process of AFt at pH 2.0 and 7.4, resp., in satd. drug soln.  UV-vis spectrometry, CD spectrometry, dynamic light scattering, and inductively coupled plasma mass spectrometry were used to characterize the AFt-drug complexes.  The loading capacity of AFt varies with resp. drugs and the structural integrity of the protein shell remains intact after encapsulation.  In vitro assays on the rat pheochromocytoma cell line (PC12) show that AFt-cisplatin inhibits the cells in a slow but sustaining mode and the cellular uptake of platinum is enhanced by AFt.  AFt-carboplatin and AFt-oxaliplatin complexes only exhibit a marginal cytotoxicity towards this cell line under similar concns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoi1Rq7ZN9k0LVg90H21EOLACvtfcHk0lh38RUK35cwvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnvVWltr0%253D&md5=5b333de0d4b8dc737865a7377596b4da</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.jinorgbio.2009.05.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jinorgbio.2009.05.001%26sid%3Dliteratum%253Aachs%26aulast%3DXing%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DGuo%26aufirst%3DZ.%26atitle%3DCharacterization%2520and%2520cellular%2520uptake%2520of%2520platinum%2520anticancer%2520drugs%2520encapsulated%2520in%2520apoferritin%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D2009%26volume%3D103%26spage%3D1039%26epage%3D1044%26doi%3D10.1016%2Fj.jinorgbio.2009.05.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hotchkiss, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strasser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDunn, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swanson, P. E.</span></span> <span> </span><span class="NLM_article-title">Cell death</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>361</i></span>,  <span class="NLM_fpage">1570</span>– <span class="NLM_lpage">1583</span>, <span class="refDoi"> DOI: 10.1056/NEJMra0901217</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.1056%2FNEJMra0901217" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=19828534" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1OrurzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=361&publication_year=2009&pages=1570-1583&author=R.+S.+Hotchkissauthor=A.+Strasserauthor=J.+E.+McDunnauthor=P.+E.+Swanson&title=Cell+death&doi=10.1056%2FNEJMra0901217"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of disease: cell death</span></div><div class="casAuthors">Hotchkiss, Richard S.; Strasser, Andreas; McDunn, Jonathan E.; Swanson, Paul E.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">361</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1570-1583</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review, discussing classifications of cell death and mechanisms in health and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxQNrCODaf3rVg90H21EOLACvtfcHk0lh38RUK35cwvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1OrurzP&md5=a0a119908df325aa6a008c7654fccf43</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1056%2FNEJMra0901217&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra0901217%26sid%3Dliteratum%253Aachs%26aulast%3DHotchkiss%26aufirst%3DR.%2BS.%26aulast%3DStrasser%26aufirst%3DA.%26aulast%3DMcDunn%26aufirst%3DJ.%2BE.%26aulast%3DSwanson%26aufirst%3DP.%2BE.%26atitle%3DCell%2520death%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2009%26volume%3D361%26spage%3D1570%26epage%3D1583%26doi%3D10.1056%2FNEJMra0901217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Simon, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haj-Yehia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levi-Schaffer, F.</span></span> <span> </span><span class="NLM_article-title">Role of reactive oxygen species (ROS) in apoptosis Induces</span>. <i>Apoptosis.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">415</span>– <span class="NLM_lpage">418</span>, <span class="refDoi"> DOI: 10.1023/A:1009616228304</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.1023%2FA%3A1009616228304" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=11256882" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitV2ru7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2000&pages=415-418&author=H.+U.+Simonauthor=A.+Haj-Yehiaauthor=F.+Levi-Schaffer&title=Role+of+reactive+oxygen+species+%28ROS%29+in+apoptosis+Induces&doi=10.1023%2FA%3A1009616228304"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Role of reactive oxygen species (ROS) in apoptosis induction</span></div><div class="casAuthors">Simon, H.-U.; Haj-Yehia, A.; Levi-Schaffer, F.</div><div class="citationInfo"><span class="NLM_cas:title">Apoptosis</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">415-418</span>CODEN:
                <span class="NLM_cas:coden">APOPFN</span>;
        ISSN:<span class="NLM_cas:issn">1360-8185</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">A review with 49 refs.  Reactive O species (ROS) and mitochondria play an important role in apoptosis induction under both physiol. and pathol. conditions.  Interestingly, mitochondria are both source and target of ROS.  Cytochrome c release from mitochondria, that triggers caspase activation, appears to be largely mediated by direct or indirect ROS action.  On the other hand, ROS have also anti-apoptotic effects.  This review focuses on the role of ROS in the regulation of apoptosis, esp. in inflammatory cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPu13B3_9rGLVg90H21EOLACvtfcHk0ljW3-yKPosVjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitV2ru7k%253D&md5=752558ae104d1b8446ab51c6a63c8331</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1023%2FA%3A1009616228304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1009616228304%26sid%3Dliteratum%253Aachs%26aulast%3DSimon%26aufirst%3DH.%2BU.%26aulast%3DHaj-Yehia%26aufirst%3DA.%26aulast%3DLevi-Schaffer%26aufirst%3DF.%26atitle%3DRole%2520of%2520reactive%2520oxygen%2520species%2520%2528ROS%2529%2520in%2520apoptosis%2520Induces%26jtitle%3DApoptosis.%26date%3D2000%26volume%3D5%26spage%3D415%26epage%3D418%26doi%3D10.1023%2FA%3A1009616228304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, C.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, L.-N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, Z.-W.</span></span> <span> </span><span class="NLM_article-title">Phosphorescent iridium(III)-bis-N-heterocyclic carbene complexes as mitochondria-targeted theranostic and photodynamic anticancer agents</span>. <i>Biomaterials</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">95</span>– <span class="NLM_lpage">104</span>, <span class="refDoi"> DOI: 10.1016/j.biomaterials.2014.10.070</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.1016%2Fj.biomaterials.2014.10.070" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=25477176" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVyhsrjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2015&pages=95-104&author=Y.+Liauthor=C.-P.+Tanauthor=W.+Zhangauthor=L.+Heauthor=L.-N.+Jiauthor=Z.-W.+Mao&title=Phosphorescent+iridium%28III%29-bis-N-heterocyclic+carbene+complexes+as+mitochondria-targeted+theranostic+and+photodynamic+anticancer+agents&doi=10.1016%2Fj.biomaterials.2014.10.070"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphorescent iridium(III)-bis-N-heterocyclic carbene complexes as mitochondria-targeted theranostic and photodynamic anticancer agents</span></div><div class="casAuthors">Li, Yi; Tan, Cai-Ping; Zhang, Wei; He, Liang; Ji, Liang-Nian; Mao, Zong-Wan</div><div class="citationInfo"><span class="NLM_cas:title">Biomaterials</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">95-104</span>CODEN:
                <span class="NLM_cas:coden">BIMADU</span>;
        ISSN:<span class="NLM_cas:issn">0142-9612</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Mitochondria-targeted compds. represent a promising approach to target tumors selectively and overcome resistance to current anticancer therapies.  In this work, 3 cyclometalated iridium(III) complexes (1-3) contg. bis-N-heterocyclic carbene (NHC) ligands were explored as theranostic and photodynamic agents targeting mitochondria.  These complexes display rich photophys. properties, which greatly facilitates the study of their intracellular fate.  All 3 complexes are more cytotoxic than cisplatin against the cancer cells screened. 1-3 can penetrate into human cervical carcinoma (HeLa) cells quickly and efficiently, and they can carry out theranostic functions by simultaneously inducing and monitoring the morphol. changes in mitochondria.  Mechanism studies show that these complexes exert their anticancer efficacy by initiating a cascade of events related to mitochondrial dysfunction.  Addnl., they display up to 3 orders of magnitude higher cytotoxicity upon irradn. at 365 nm, which is so far the highest photocytotoxic responses reported for iridium complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqD_Mn-JAwZeLVg90H21EOLACvtfcHk0ljW3-yKPosVjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVyhsrjM&md5=cd8df6801aa88858a2a63a39d6727384</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.biomaterials.2014.10.070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biomaterials.2014.10.070%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%26aulast%3DTan%26aufirst%3DC.-P.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DHe%26aufirst%3DL.%26aulast%3DJi%26aufirst%3DL.-N.%26aulast%3DMao%26aufirst%3DZ.-W.%26atitle%3DPhosphorescent%2520iridium%2528III%2529-bis-N-heterocyclic%2520carbene%2520complexes%2520as%2520mitochondria-targeted%2520theranostic%2520and%2520photodynamic%2520anticancer%2520agents%26jtitle%3DBiomaterials%26date%3D2015%26volume%3D39%26spage%3D95%26epage%3D104%26doi%3D10.1016%2Fj.biomaterials.2014.10.070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stock, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leslie, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, J. E.</span></span> <span> </span><span class="NLM_article-title">Molecular architecture of the rotary motor in ATP synthase</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>286</i></span>,  <span class="NLM_fpage">1700</span>– <span class="NLM_lpage">1705</span>, <span class="refDoi"> DOI: 10.1126/science.286.5445.1700</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.1126%2Fscience.286.5445.1700" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10576729" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADyaK1MXnslKntr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=1999&pages=1700-1705&author=D.+Stockauthor=A.+G.+Leslieauthor=J.+E.+Walker&title=Molecular+architecture+of+the+rotary+motor+in+ATP+synthase&doi=10.1126%2Fscience.286.5445.1700"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular architecture of the rotary motor in ATP synthase</span></div><div class="casAuthors">Stock, Daniela; Leslie, Andrew G. W.; Walker, John E.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">5445</span>),
    <span class="NLM_cas:pages">1700-1705</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">ATP synthase contains a rotary motor involved in biol. energy conversion.  Its membrane-embedded F0 sector has a rotation generator fueled by protonmotive force, which provides the energy required for the synthesis of ATP by the F1 domain.  An electron d. map obtained from crystals of a subcomplex of yeast mitochondrial ATP synthase shows a ring of 10 c subunits.  Each c subunit forms an α-helical hairpin.  The interhelical loops of 6-7 of the c subunits are in close contact with the γ and δ subunits of the central stalk.  The extensive contact between the c ring and the stalk suggests that they may rotate as an ensemble during catalysis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojmVflzjYsVbVg90H21EOLACvtfcHk0ljW3-yKPosVjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnslKntr8%253D&md5=7ba1357b50d872513b7f0c4c3823019a</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1126%2Fscience.286.5445.1700&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.286.5445.1700%26sid%3Dliteratum%253Aachs%26aulast%3DStock%26aufirst%3DD.%26aulast%3DLeslie%26aufirst%3DA.%2BG.%26aulast%3DWalker%26aufirst%3DJ.%2BE.%26atitle%3DMolecular%2520architecture%2520of%2520the%2520rotary%2520motor%2520in%2520ATP%2520synthase%26jtitle%3DScience%26date%3D1999%26volume%3D286%26spage%3D1700%26epage%3D1705%26doi%3D10.1126%2Fscience.286.5445.1700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weinberg, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandel, N. S.</span></span> <span> </span><span class="NLM_article-title">Targeting mitochondria metabolism for cancer therapy</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">9</span>– <span class="NLM_lpage">15</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1712</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.1038%2Fnchembio.1712" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=25517383" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFCqsr%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=9-15&author=S.+E.+Weinbergauthor=N.+S.+Chandel&title=Targeting+mitochondria+metabolism+for+cancer+therapy&doi=10.1038%2Fnchembio.1712"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting mitochondria metabolism for cancer therapy</span></div><div class="casAuthors">Weinberg, Samuel E.; Chandel, Navdeep S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-15</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Mitochondria have a well-recognized role in the prodn. of ATP and the intermediates needed for macromol. biosynthesis, such as nucleotides.  Mitochondria also participate in the activation of signaling pathways.  Overall, accumulating evidence now suggests that mitochondrial bioenergetics, biosynthesis and signaling are required for tumorigenesis.  Thus, emerging studies have begun to demonstrate that mitochondrial metab. is potentially a fruitful arena for cancer therapy.  In this Perspective, we highlight recent developments in targeting mitochondrial metab. for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXSbrOBwYo37Vg90H21EOLACvtfcHk0lh89iY7_32htg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFCqsr%252FN&md5=5774621d8403ea5749b4f27e0e2a0b48</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1712&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1712%26sid%3Dliteratum%253Aachs%26aulast%3DWeinberg%26aufirst%3DS.%2BE.%26aulast%3DChandel%26aufirst%3DN.%2BS.%26atitle%3DTargeting%2520mitochondria%2520metabolism%2520for%2520cancer%2520therapy%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2015%26volume%3D11%26spage%3D9%26epage%3D15%26doi%3D10.1038%2Fnchembio.1712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Klionsky, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuervo, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seglen, P. O.</span></span> <span> </span><span class="NLM_article-title">Methods for monitoring autophagy from yeast to human</span>. <i>Autophagy</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">181</span>– <span class="NLM_lpage">206</span>, <span class="refDoi"> DOI: 10.4161/auto.3678</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.4161%2Fauto.3678" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=17224625" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVGrtLvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2007&pages=181-206&author=D.+J.+Klionskyauthor=A.+M.+Cuervoauthor=P.+O.+Seglen&title=Methods+for+monitoring+autophagy+from+yeast+to+human&doi=10.4161%2Fauto.3678"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Methods for monitoring autophagy from yeast to human</span></div><div class="casAuthors">Klionsky, Daniel J.; Cuervo, Ana Maria; Seglen, Per O.</div><div class="citationInfo"><span class="NLM_cas:title">Autophagy</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">181-206</span>CODEN:
                <span class="NLM_cas:coden">AUTOC9</span>;
        ISSN:<span class="NLM_cas:issn">1554-8627</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">A review.  The increasing interest in autophagy in a wide range of organisms, accompanied by an ever-growing influx of researchers into this field, necessitates a good understanding of the methodologies available to monitor this process.  In this review we discuss current approaches that can be used to follow the overall process of autophagy, as well as individual steps, from yeast to human.  The majority of the review considers methods that apply to macroautophagy; however, we also consider alternative types of degrdn. including chaperone-mediated autophagy and microautophagy.  This information is meant to provide a resource for newcomers as well as a stimulus for experienced researchers who may be prompted to develop addnl. assays to examine autophagy-related pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNrp8-VBeLWbVg90H21EOLACvtfcHk0lh89iY7_32htg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVGrtLvF&md5=38362110dcbfcc852eb2680e455ada1d</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.4161%2Fauto.3678&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fauto.3678%26sid%3Dliteratum%253Aachs%26aulast%3DKlionsky%26aufirst%3DD.%2BJ.%26aulast%3DCuervo%26aufirst%3DA.%2BM.%26aulast%3DSeglen%26aufirst%3DP.%2BO.%26atitle%3DMethods%2520for%2520monitoring%2520autophagy%2520from%2520yeast%2520to%2520human%26jtitle%3DAutophagy%26date%3D2007%26volume%3D3%26spage%3D181%26epage%3D206%26doi%3D10.4161%2Fauto.3678" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 4 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Juzheng Zhang, Ming Jiang, Shanhe Li, Zhenlei Zhang, Hongbin Sun, Feng Yang, <span class="NLM_string-name hlFld-ContribAuthor">Hong Liang</span>. </span><span class="cited-content_cbyCitation_article-title">Developing a Novel Anticancer Gold(III) Agent to Integrate Chemotherapy and Immunotherapy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (10)
                                     , 6777-6791. <a href="https://doi.org/10.1021/acs.jmedchem.1c00050" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00050</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00050%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDeveloping%252Ba%252BNovel%252BAnticancer%252BGold%252528III%252529%252BAgent%252Bto%252BIntegrate%252BChemotherapy%252Band%252BImmunotherapy%26aulast%3DZhang%26aufirst%3DJuzheng%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D12012021%26date%3D17052021%26volume%3D64%26issue%3D10%26spage%3D6777%26epage%3D6791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhe  Cheng</span>, <span class="hlFld-ContribAuthor ">Maoyu  Li</span>, <span class="hlFld-ContribAuthor ">Raja  Dey</span>, <span class="hlFld-ContribAuthor ">Yongheng  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Nanomaterials for cancer therapy: current progress and perspectives. </span><span class="cited-content_cbyCitation_journal-name">Journal of Hematology & Oncology</span><span> <strong>2021,</strong> <em>14 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13045-021-01096-0" title="DOI URL">https://doi.org/10.1186/s13045-021-01096-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13045-021-01096-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13045-021-01096-0%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Hematology%2520%2526%2520Oncology%26atitle%3DNanomaterials%252Bfor%252Bcancer%252Btherapy%25253A%252Bcurrent%252Bprogress%252Band%252Bperspectives%26aulast%3DCheng%26aufirst%3DZhe%26date%3D2021%26date%3D2021%26volume%3D14%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jong  Hyun Kim</span>, <span class="hlFld-ContribAuthor ">Samuel  Ofori</span>, <span class="hlFld-ContribAuthor ">R. Tyler  Mertens</span>, <span class="hlFld-ContribAuthor ">Sean  Parkin</span>, <span class="hlFld-ContribAuthor ">Samuel G.  Awuah</span>. </span><span class="cited-content_cbyCitation_article-title">Water‐Soluble Gold(III)–Metformin Complex Alters Mitochondrial Bioenergetics in Breast Cancer Cells. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2021,</strong> <em>35 </em><a href="https://doi.org/10.1002/cmdc.202100233" title="DOI URL">https://doi.org/10.1002/cmdc.202100233</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202100233&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202100233%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DWater%2525E2%252580%252590Soluble%252BGold%252528III%252529%2525E2%252580%252593Metformin%252BComplex%252BAlters%252BMitochondrial%252BBioenergetics%252Bin%252BBreast%252BCancer%252BCells%26aulast%3DHyun%2BKim%26aufirst%3DJong%26date%3D2021%26date%3D2021%26volume%3D35" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ying  Sun</span>, <span class="hlFld-ContribAuthor ">Yunlong  Lu</span>, <span class="hlFld-ContribAuthor ">Mianli  Bian</span>, <span class="hlFld-ContribAuthor ">Zhibin  Yang</span>, <span class="hlFld-ContribAuthor ">Xiaoyan  Ma</span>, <span class="hlFld-ContribAuthor ">Wukun  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Pt(II) and Au(III) complexes containing Schiff-base ligands: A promising source for antitumor treatment. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>211 </em>, 113098. <a href="https://doi.org/10.1016/j.ejmech.2020.113098" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.113098</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.113098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.113098%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPt%252528II%252529%252Band%252BAu%252528III%252529%252Bcomplexes%252Bcontaining%252BSchiff-base%252Bligands%25253A%252BA%252Bpromising%252Bsource%252Bfor%252Bantitumor%252Btreatment%26aulast%3DSun%26aufirst%3DYing%26date%3D2021%26volume%3D211%26spage%3D113098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01257/20201120/images/medium/jm0c01257_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01257/20201120/images/large/jm0c01257_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01257&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01257/20201120/images/medium/jm0c01257_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01257/20201120/images/large/jm0c01257_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Hypothesis of the development of an Au agent with a dual-MOA to treat glioma based on the unique properties of AFt NPs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01257/20201120/images/large/jm0c01257_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01257&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01257/20201120/images/medium/jm0c01257_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01257/20201120/images/large/jm0c01257_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Synthesis and structures of salicylaldehyde-3-(4-methylpiperidine)thiosemicarbazide ligands (L1–L6) and their corresponding Au compounds (C1–C6).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01257/20201120/images/large/jm0c01257_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01257&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01257/20201120/images/medium/jm0c01257_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01257/20201120/images/large/jm0c01257_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Establishment of the AFt NP-based C6 delivery system. (A) Scheme of C6 loading into AFt. (B) SEM images of the AFt nanocage (left) and the AFt-C6 NPs (right). (C) Images of AFt (left) and AFt-C6 NPs (right) in a glass bottle. (D) <i>In vitro</i> release of C6 from the AFt-C6 NPs. (E) ICP-MS analysis of the ability of AFt-C6 NPs to target U87MG cells <i>in vitro</i>. (F) Confocal images of the intracellular uptake of Cy5.5-labeled AFt-C6 NPs by U87MG tumor cells. (G) Confocal images of the intracellular uptake of Cy5.5-labeled AFt-C6 NPs by HL-7702 cells. *<i>p</i> < 0.05.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01257/20201120/images/large/jm0c01257_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01257&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01257/20201120/images/medium/jm0c01257_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01257/20201120/images/large/jm0c01257_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Models of AFt-C6 NPs crossing the BBB <i>in vitro</i> and <i>in vivo</i>. (A, B) ICP-MS analysis of NP uptake by lower chamber U87MG cells. <i>In vivo</i> imaging of the brains of (C) healthy and (D) tumor-bearing mice intravenously injected with Cy5.5-AFt-C6 NPs. Quantitative analysis of the fluorescence signals of Cy5.5-AFt-C6 NPs in the brain areas of (E) healthy and (F) tumor-bearing mice. *<i>p</i> < 0.05, **<i>p</i> < 0.02, ***<i>p</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01257/20201120/images/large/jm0c01257_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01257&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01257/20201120/images/medium/jm0c01257_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01257/20201120/images/large/jm0c01257_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Therapeutic efficiencies of C6 and AFt-C6 NPs <i>in vivo</i>. (A) <i>In vivo</i> fluorescence images of glioma tumor cells in orthotopic mice that were intravenously injected with vehicle control, C6, or AFt-C6 NPs for 28 days. (B) Images of the brains and tumor tissues recorded 2 days after the last treatment. (C) Quantitative analysis of the fluorescence signals in (A). (D) Tumor weights measured 2 days after the last treatment. (E) Tumor volumes measured 2 days after the last treatment. *<i>p</i> < 0.05, **<i>p</i> < 0.02.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01257/20201120/images/large/jm0c01257_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01257&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01257/20201120/images/medium/jm0c01257_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01257/20201120/images/large/jm0c01257_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Side effects and bioavailability of C6 and the AFt-C6 NPs <i>in vivo</i>. (A) Average body weights of the mice (measured every 2 days for 28 days). (B) Histopathological analysis of the heart, liver, spleen, lung, and kidney tissues in mice (H&E staining at 400× two days after the last injection). (C) Average weights of the mouse organs recorded 2 days after the last injection. (D) Au content in the tumors and major organs of mice treated with C6/AFt-C6 NPs 2 days after the last injection. (E) <i>In vivo</i> imaging of the major organs harvested from mice. **<i>p</i> < 0.02.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01257/20201120/images/large/jm0c01257_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01257&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01257/20201120/images/medium/jm0c01257_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01257/20201120/images/large/jm0c01257_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. <i>In vitro</i> and <i>in vivo</i> assessments of the apoptosis mechanism induced by C6 and AFt-C6 NPs. (A) Images of TUNEL-stained tumor tissues. (B) Quantitative analysis of (A). (C) Effects of C6/AFt-C6 NPs (0.3 μM) on U87MG cell apoptosis after 24 h of treatment. (D) Confocal microscopy images (JC-1 indicator, green) of the mitochondrial membrane after treatment with C6 and AFt-C6 NPs for 24 h. (E) Cellular ATP levels in U87MG cells incubated with AFt-C6 NPs for 24 h. (F) ROS (ROS indicator, green) and ER (red) levels in U87MG cells incubated with C6 and AFt-C6 NPs for 24 h. (G) Effects of mitochondria-targeted superoxide scavengers on AFt-C6 NP-induced cell death. (H) Western blot analysis of ER stress markers after incubation of U87MG cells with C6 and AFt-C6 NPs. (I) Expression levels of ER stress markers shown as percentages; the values are relative to the control. *<i>p</i> < 0.05, **<i>p</i> < 0.02, ***<i>p</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01257/20201120/images/large/jm0c01257_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01257&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01257/20201120/images/medium/jm0c01257_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01257/20201120/images/large/jm0c01257_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. <i>In vitro</i> and <i>in vivo</i> assessments of lethal autophagy in C6- and AFt-C6 NP-treated U87MG cells. (A) Western blots of key autophagy proteins in U87MG cells after treatment with C6 and AFt-C6 NPs. (B) Expression levels of the key autophagy proteins shown as percentages. (C) Immunohistochemistry analysis of the autophagy markers LC3-II and p62. (D) Immunofluorescence analysis of cells transiently transfected with RFP-GFP-LC3-II and treated with C6 and AFt-C6 NPs for 24 h. (E) TEM analysis of autophagic vesicles in U87MG cells treated with C6 and AFt-C6 NPs after the last injection. (F) Immunofluorescence analysis of cells transiently transfected with RFP-GFP-LC3-II, preincubated with 3-MA, and treated with AFt-C6 NPs for 24 h. (G) Western blot analysis of autophagy inhibition by 3-MA. (H) Expression levels of key autophagy proteins shown as percentages.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01257/20201120/images/large/jm0c01257_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01257&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01257/20201120/images/medium/jm0c01257_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01257/20201120/images/large/jm0c01257_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Relationship between apoptosis and lethal autophagy induced by AFt-C6 NPs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c01257/20201120/images/large/jm0c01257_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01257&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i52">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36777" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36777" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 57 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cloughesy, T. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavenee, W. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mischel, P. S.</span></span> <span> </span><span class="NLM_article-title">Glioblastoma: from molecular pathology to targeted treatment</span>. <i>Annu. Rev. Pathol.: Mech. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">25</span>, <span class="refDoi"> DOI: 10.1146/annurev-pathol-011110-130324</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.1146%2Fannurev-pathol-011110-130324" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=23937436" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlt1emsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=1-25&author=T.+F.+Cloughesyauthor=W.+K.+Caveneeauthor=P.+S.+Mischel&title=Glioblastoma%3A+from+molecular+pathology+to+targeted+treatment&doi=10.1146%2Fannurev-pathol-011110-130324"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Glioblastoma: from molecular pathology to targeted treatment</span></div><div class="casAuthors">Cloughesy, Timothy F.; Cavenee, Webster K.; Mischel, Paul S.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pathology: Mechanisms of Disease</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-25</span>CODEN:
                <span class="NLM_cas:coden">ARPMCU</span>;
        ISSN:<span class="NLM_cas:issn">1553-4006</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">A review.  Glioblastoma (GBM) is one of the most lethal human cancers.  Genomic analyses are defining the mol. architecture of GBM, uncovering relevant subsets of patients whose disease may require different treatments.  Many pharmacol. targets have been revealed, promising to transform patient care through targeted therapies.  However, for most patients, clin. responses to targeted inhibitors are either not apparent or not durable.  In this review, we address the challenge of developing more effective, molecularly guided approaches for the treatment of GBM patients.  We summarize the current state of knowledge regarding mol. classifiers and examine their benefit for stratifying patients for treatment.  We survey the mol. landscape of the disease, discussing the challenges raised by acquired drug resistance.  Furthermore, we analyze the biochem. features of GBM, suggesting a next generation of drug targets, and we examine the contribution of tumor heterogeneity and its implications.  We conclude with an anal. of the exptl. approaches and their potential benefit to patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooSONedmSmZrVg90H21EOLACvtfcHk0lhUw57ksd3ZDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlt1emsLc%253D&md5=517c62c78fcba4736d3bd30930611fc1</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1146%2Fannurev-pathol-011110-130324&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-pathol-011110-130324%26sid%3Dliteratum%253Aachs%26aulast%3DCloughesy%26aufirst%3DT.%2BF.%26aulast%3DCavenee%26aufirst%3DW.%2BK.%26aulast%3DMischel%26aufirst%3DP.%2BS.%26atitle%3DGlioblastoma%253A%2520from%2520molecular%2520pathology%2520to%2520targeted%2520treatment%26jtitle%3DAnnu.%2520Rev.%2520Pathol.%253A%2520Mech.%2520Dis.%26date%3D2014%26volume%3D9%26spage%3D1%26epage%3D25%26doi%3D10.1146%2Fannurev-pathol-011110-130324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yakisich, J.</span></span> <span> </span><span class="NLM_article-title">Overcoming the blood-brain barrier for chemotherapy: limitations, challenges and rising problems</span>. <i>Anti-Cancer Agents Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1085</span>– <span class="NLM_lpage">1093</span>, <span class="refDoi"> DOI: 10.2174/18715206113139990029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.2174%2F18715206113139990029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=23092271" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFCgtbfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2014&pages=1085-1093&author=Z.+Wangauthor=H.+Sunauthor=J.+Yakisich&title=Overcoming+the+blood-brain+barrier+for+chemotherapy%3A+limitations%2C+challenges+and+rising+problems&doi=10.2174%2F18715206113139990029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Overcoming the Blood-Brain Barrier for Chemotherapy: Limitations, Challenges and Rising Problems</span></div><div class="casAuthors">Wang, Zhaoye; Sun, Hui; Yakisich, Juan Sebastian</div><div class="citationInfo"><span class="NLM_cas:title">Anti-Cancer Agents in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1085-1093</span>CODEN:
                <span class="NLM_cas:coden">AAMCE4</span>;
        ISSN:<span class="NLM_cas:issn">1871-5206</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Treatment of brain tumors with chemotherapy is limited mostly because of delivery impediments related to the blood-brain barrier (BBB).  For gliomas, the most common and aggressive primary brain tumor, treatment includes surgery, radiotherapy, and chemotherapy usually administered orally or i.v.  These routes do not deliver effective concns.  To complicate matters, chemotherapy is usually a long treatment.  Therefore, transient disruption of the BBB is likely insufficient to deliver effective intratumoral concns. of anticancer drugs.  This review briefly updates current strategies for overcoming the BBB with emphasis on their limitations and challenges intrinsic to the biol. of cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoq32ZkkJBgIbVg90H21EOLACvtfcHk0ljR3VtG54UIzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFCgtbfL&md5=3bfb1034f90a911bd646f81783ee2a7c</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.2174%2F18715206113139990029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F18715206113139990029%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DYakisich%26aufirst%3DJ.%26atitle%3DOvercoming%2520the%2520blood-brain%2520barrier%2520for%2520chemotherapy%253A%2520limitations%252C%2520challenges%2520and%2520rising%2520problems%26jtitle%3DAnti-Cancer%2520Agents%2520Med.%2520Chem.%26date%3D2014%26volume%3D14%26spage%3D1085%26epage%3D1093%26doi%3D10.2174%2F18715206113139990029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fadzen, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolfe, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, C.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Spreckelsen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutchinson, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiocca, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawler, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yilmaz, O. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lippard, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pentelute, B. L.</span></span> <span> </span><span class="NLM_article-title">A platinum(IV) prodrug–perfluoroaryl macrocyclic peptide conjugate enhances platinum uptake in the brain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">6741</span>– <span class="NLM_lpage">6747</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.0c00022</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.0c00022" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BB3cXpsVCqt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=6741-6747&author=C.+M.+Fadzenauthor=J.+M.+Wolfeauthor=W.+Zhouauthor=C.-F.+Choauthor=N.+von+Spreckelsenauthor=K.+T.+Hutchinsonauthor=Y.+C.+Leeauthor=E.+A.+Chioccaauthor=S.+E.+Lawlerauthor=O.+H.+Yilmazauthor=S.+J.+Lippardauthor=B.+L.+Pentelute&title=A+platinum%28IV%29+prodrug%E2%80%93perfluoroaryl+macrocyclic+peptide+conjugate+enhances+platinum+uptake+in+the+brain&doi=10.1021%2Facs.jmedchem.0c00022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">A Platinum(IV) Prodrug-Perfluoroaryl Macrocyclic Peptide Conjugate Enhances Platinum Uptake in the Brain</span></div><div class="casAuthors">Fadzen, Colin M.; Wolfe, Justin M.; Zhou, Wen; Cho, Choi-Fong; von Spreckelsen, Niklas; Hutchinson, Kathryn T.; Lee, Yen-Chun; Chiocca, E. Antonio; Lawler, Sean E.; Yilmaz, Omer H.; Lippard, Stephen J.; Pentelute, Bradley L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">6741-6747</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Effective delivery to the brain limits the development of novel glioblastoma therapies.  Here, we introduce conjugation between platinum(IV) prodrugs of cisplatin and perfluoroaryl peptide macrocycles to increase brain uptake.  We demonstrate that one such conjugate shows efficacy against glioma stem-like cells.  We investigate the pharmacokinetics of this conjugate in mice and show that the amt. of platinum in the brain after treatment with the conjugate is 15-fold greater than with cisplatin after 5 h.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXQ96IXBOnIbVg90H21EOLACvtfcHk0ljR3VtG54UIzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXpsVCqt70%253D&md5=751d7a15a4061bb1ae3e7a31aaecee11</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.0c00022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.0c00022%26sid%3Dliteratum%253Aachs%26aulast%3DFadzen%26aufirst%3DC.%2BM.%26aulast%3DWolfe%26aufirst%3DJ.%2BM.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DCho%26aufirst%3DC.-F.%26aulast%3Dvon%2BSpreckelsen%26aufirst%3DN.%26aulast%3DHutchinson%26aufirst%3DK.%2BT.%26aulast%3DLee%26aufirst%3DY.%2BC.%26aulast%3DChiocca%26aufirst%3DE.%2BA.%26aulast%3DLawler%26aufirst%3DS.%2BE.%26aulast%3DYilmaz%26aufirst%3DO.%2BH.%26aulast%3DLippard%26aufirst%3DS.%2BJ.%26aulast%3DPentelute%26aufirst%3DB.%2BL.%26atitle%3DA%2520platinum%2528IV%2529%2520prodrug%25E2%2580%2593perfluoroaryl%2520macrocyclic%2520peptide%2520conjugate%2520enhances%2520platinum%2520uptake%2520in%2520the%2520brain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D6741%26epage%3D6747%26doi%3D10.1021%2Facs.jmedchem.0c00022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zanotto-Filho, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braganhol, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klafke, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Figueiró, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terra, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paludo, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrone, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bristot, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Battastini, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forcelini, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bishop, A. J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gelain, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreira, J. C. F.</span></span> <span> </span><span class="NLM_article-title">Autophagy inhibition improves the efficacy of curcumin/temozolomide combination therapy in glioblastomas</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>358</i></span>,  <span class="NLM_fpage">220</span>– <span class="NLM_lpage">231</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2014.12.044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.1016%2Fj.canlet.2014.12.044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=25542083" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmslOlsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=358&publication_year=2015&pages=220-231&author=A.+Zanotto-Filhoauthor=E.+Braganholauthor=K.+Klafkeauthor=F.+Figueir%C3%B3author=S.+R.+Terraauthor=F.+J.+Paludoauthor=M.+Morroneauthor=I.+J.+Bristotauthor=A.+M.+Battastiniauthor=C.+M.+Forceliniauthor=A.+J.+R.+Bishopauthor=D.+P.+Gelainauthor=J.+C.+F.+Moreira&title=Autophagy+inhibition+improves+the+efficacy+of+curcumin%2Ftemozolomide+combination+therapy+in+glioblastomas&doi=10.1016%2Fj.canlet.2014.12.044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Autophagy inhibition improves the efficacy of curcumin/temozolomide combination therapy in glioblastomas</span></div><div class="casAuthors">Zanotto-Filho, Alfeu; Braganhol, Elizandra; Klafke, Karina; Figueiro, Fabricio; Terra, Silvia Resende; Paludo, Francis Jackson; Morrone, Maurilio; Bristot, Ivi Juliana; Battastini, Ana Maria; Forcelini, Cassiano Mateus; Bishop, Alexander James Roy; Gelain, Daniel Pens; Moreira, Jose Claudio Fonseca</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">358</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">220-231</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Glioblastoma is a devastating primary brain tumor resistant to conventional therapies.  In this study, we tested the efficacy of combining temozolomide with curcumin, a phytochem. known to inhibit glioblastoma growth, and investigated the mechanisms involved.  The data showed that synergy between curcumin and temozolomide was not achieved due to redundant mechanisms that lead to activating protective autophagy both in vitro and in vivo.  Autophagy preceded apoptosis, and blocking this response with autophagy inhibitors (3-methyl-adenine, ATG7 siRNA and chloroquine) rendered cells susceptible to temozolomide and curcumin alone or combinations by increasing apoptosis.  While curcumin inhibited STAT3, NFκB and PI3K/Akt to affect survival, temozolomide-induced autophagy relied on the DNA damage response and repair components ATM and MSH6, as well as p38 and JNK1/2.  However, the most interesting observation was that both temozolomide and curcumin required ERK1/2 to induce autophagy.  Blocking this ERK1/2-mediated temozolomide and curcumin induced autophagy with resveratrol, a blood-brain barrier permeable drug, improved temozolomide/curcumin efficacy in brain-implanted tumors.  Overall, the data presented demonstrate that autophagy impairs the efficacy of temozolomide/curcumin, and inhibiting this phenomenon could provide novel opportunities to improve brain tumor treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptyYWeuXaIxrVg90H21EOLACvtfcHk0lhLTPbCsyuRnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmslOlsA%253D%253D&md5=cf864787d0cfb802be7f4146615dae1f</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2014.12.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2014.12.044%26sid%3Dliteratum%253Aachs%26aulast%3DZanotto-Filho%26aufirst%3DA.%26aulast%3DBraganhol%26aufirst%3DE.%26aulast%3DKlafke%26aufirst%3DK.%26aulast%3DFigueir%25C3%25B3%26aufirst%3DF.%26aulast%3DTerra%26aufirst%3DS.%2BR.%26aulast%3DPaludo%26aufirst%3DF.%2BJ.%26aulast%3DMorrone%26aufirst%3DM.%26aulast%3DBristot%26aufirst%3DI.%2BJ.%26aulast%3DBattastini%26aufirst%3DA.%2BM.%26aulast%3DForcelini%26aufirst%3DC.%2BM.%26aulast%3DBishop%26aufirst%3DA.%2BJ.%2BR.%26aulast%3DGelain%26aufirst%3DD.%2BP.%26aulast%3DMoreira%26aufirst%3DJ.%2BC.%2BF.%26atitle%3DAutophagy%2520inhibition%2520improves%2520the%2520efficacy%2520of%2520curcumin%252Ftemozolomide%2520combination%2520therapy%2520in%2520glioblastomas%26jtitle%3DCancer%2520Lett.%26date%3D2015%26volume%3D358%26spage%3D220%26epage%3D231%26doi%3D10.1016%2Fj.canlet.2014.12.044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Geng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klocke, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, K. A.</span></span> <span> </span><span class="NLM_article-title">Chloroquine-induced autophagy vacuole accumulation and cell death in glioma cells is p53 independent</span>. <i>Neuro. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">473</span>– <span class="NLM_lpage">481</span>, <span class="refDoi"> DOI: 10.1093/neuonc/nop048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.1093%2Fneuonc%2Fnop048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=20406898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BC3cXotVWmsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=473-481&author=Y.+Gengauthor=L.+Kohliauthor=B.+J.+Klockeauthor=K.+A.+Roth&title=Chloroquine-induced+autophagy+vacuole+accumulation+and+cell+death+in+glioma+cells+is+p53+independent&doi=10.1093%2Fneuonc%2Fnop048"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Chloroquine-induced autophagic vacuole accumulation and cell death in glioma cells is p53 independent</span></div><div class="casAuthors">Geng, Ying; Kohli, Latika; Klocke, Barbara J.; Roth, Kevin A.</div><div class="citationInfo"><span class="NLM_cas:title">Neuro-Oncology (Cary, NC, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">473-481</span>CODEN:
                <span class="NLM_cas:coden">NEURJR</span>;
        ISSN:<span class="NLM_cas:issn">1522-8517</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Glioblastoma (GBM) is a high-grade central nervous system malignancy and despite aggressive treatment strategies, GBM patients have a median survival time of just 1 yr.  Chloroquine (CQ), an antimalarial lysosomotropic agent, has been identified as a potential adjuvant in the treatment regimen of GBMs.  However, the mechanism of CQ-induced tumor cell death is poorly defined.  We and others have shown that CQ-mediated cell death may be p53-dependent and at least in part due to the intrinsic apoptotic death pathway.  Here, we investigated the effects of CQ on 5 established human GBM lines, differing in their p53 gene status.  CQ was found to induce a concn.-dependent death in each of these cell lines.  Although CQ treatment increased caspase-3-like enzymic activity in all 5 cell lines, a broad-spectrum caspase inhibitor did not significantly attenuate death.  Moreover, CQ caused an accumulation of autophagic vacuoles in all cell lines and was found to affect the levels and subcellular distribution of cathepsin D, suggesting that altered lysosomal function may also play a role in CQ-induced cell death.  Thus, CQ can induce p53-independent death in gliomas that do not require caspase-mediated apoptosis.  To potentially identify more potent chemotherapeutics, various CQ derivs. and lysosomotropic compds. were tested on the GBM cells.  Quinacrine and mefloquine were found to be more potent than CQ in killing GBM cells in vitro and given their superior blood-brain barrier penetration compared with CQ may prove more efficacious as chemotherapeutic agents for GBM patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhZFAIX1dz47Vg90H21EOLACvtfcHk0lhLTPbCsyuRnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXotVWmsbc%253D&md5=c43a7a9c4469dafc27b95859d8169efe</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1093%2Fneuonc%2Fnop048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fneuonc%252Fnop048%26sid%3Dliteratum%253Aachs%26aulast%3DGeng%26aufirst%3DY.%26aulast%3DKohli%26aufirst%3DL.%26aulast%3DKlocke%26aufirst%3DB.%2BJ.%26aulast%3DRoth%26aufirst%3DK.%2BA.%26atitle%3DChloroquine-induced%2520autophagy%2520vacuole%2520accumulation%2520and%2520cell%2520death%2520in%2520glioma%2520cells%2520is%2520p53%2520independent%26jtitle%3DNeuro.%2520Oncol.%26date%3D2010%26volume%3D12%26spage%3D473%26epage%3D481%26doi%3D10.1093%2Fneuonc%2Fnop048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, N.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, H.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, S.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, Y.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joe, Y. A.</span></span> <span> </span><span class="NLM_article-title">The synergistic effect of combination temozolomide and chloroquine treatment is dependent on autophagy formation and p53 status in glioma cells</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>360</i></span>,  <span class="NLM_fpage">195</span>– <span class="NLM_lpage">204</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2015.02.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.1016%2Fj.canlet.2015.02.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=25681668" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BC2MXivFWrtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=360&publication_year=2015&pages=195-204&author=S.+W.+Leeauthor=H.-K.+Kimauthor=N.-H.+Leeauthor=H.-Y.+Yiauthor=H.-S.+Kimauthor=S.-H.+Hongauthor=Y.-K.+Hongauthor=Y.+A.+Joe&title=The+synergistic+effect+of+combination+temozolomide+and+chloroquine+treatment+is+dependent+on+autophagy+formation+and+p53+status+in+glioma+cells&doi=10.1016%2Fj.canlet.2015.02.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The synergistic effect of combination temozolomide and chloroquine treatment is dependent on autophagy formation and p53 status in glioma cells</span></div><div class="casAuthors">Lee, Seung Woo; Kim, Hyun-Kyung; Lee, Na-Hyeon; Yi, Hee-Yeon; Kim, Hong-Sug; Hong, Sung Hee; Hong, Yong-Kil; Joe, Young Ae</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">360</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">195-204</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Temozolomide (TMZ) is an alkylating agent used for the treatment of glioblastoma.  The late autophagy inhibitor chloroquine (CQ) inhibits glioblastoma tumors in a p53-independent and p53-dependent manner.  We addressed a possible beneficial effect of combination treatment with TMZ and CQ by examg. the mol. and cellular mechanism of co-treatment.  Combination treatment of U87 cell (wild type p53) with TMZ and CQ synergistically reduced cell proliferation and enhanced apoptosis, with increased sub-G1 hypodiploid cells and caspase activation.  This effect was abolished by a pan-caspase inhibitor, Z-VAD-FMK.  TMZ induced autophagy, and the addn. of CQ further increased autophagic vacuoles.  Inhibition of early stages of autophagy by Beclin 1 knockdown and 3-methyladenine pretreatment prevented the enhanced effect of the combination treatment.  The combination treatment also upregulated p53 and phospho-p53 levels, whereas p53 knockdown or overexpression of mutant p53 abolished the combination effect.  In contrast, combination therapy had no enhanced effect on U373 cell (mutant p53) proliferation and apoptosis within 3 d, although TMZ induced autophagy and co-treatment with CQ increased autophagic vacuole accumulation.  However, long term combination treatment for 9-10 d effectively decreased clonal and cellular growth with increased G2-M arrest.  This effect was also abolished by Beclin 1 knockdown.  Our data support the beneficial effect of combination treatment with TMZ and CQ in glioma via differential autophagy-assocd. mechanisms, depending on p53 status.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7TI7E98qL-bVg90H21EOLACvtfcHk0lhLTPbCsyuRnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXivFWrtrk%253D&md5=c92fb6c5d58f9b202304760a84aebd65</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2015.02.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2015.02.012%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DS.%2BW.%26aulast%3DKim%26aufirst%3DH.-K.%26aulast%3DLee%26aufirst%3DN.-H.%26aulast%3DYi%26aufirst%3DH.-Y.%26aulast%3DKim%26aufirst%3DH.-S.%26aulast%3DHong%26aufirst%3DS.-H.%26aulast%3DHong%26aufirst%3DY.-K.%26aulast%3DJoe%26aufirst%3DY.%2BA.%26atitle%3DThe%2520synergistic%2520effect%2520of%2520combination%2520temozolomide%2520and%2520chloroquine%2520treatment%2520is%2520dependent%2520on%2520autophagy%2520formation%2520and%2520p53%2520status%2520in%2520glioma%2520cells%26jtitle%3DCancer%2520Lett.%26date%3D2015%26volume%3D360%26spage%3D195%26epage%3D204%26doi%3D10.1016%2Fj.canlet.2015.02.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nassour, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radford, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Correia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fusté, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoell, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jauch, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlseder, J.</span></span> <span> </span><span class="NLM_article-title">Autophagic cell death restricts chromosomal instability during replicative crisis</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>565</i></span>,  <span class="NLM_fpage">659</span>– <span class="NLM_lpage">663</span>, <span class="refDoi"> DOI: 10.1038/s41586-019-0885-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.1038%2Fs41586-019-0885-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=30675059" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BC1MXmtVyjtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=565&publication_year=2019&pages=659-663&author=J.+Nassourauthor=R.+Radfordauthor=A.+Correiaauthor=J.+M.+Fust%C3%A9author=B.+Schoellauthor=A.+Jauchauthor=R.+J.+Shawauthor=J.+Karlseder&title=Autophagic+cell+death+restricts+chromosomal+instability+during+replicative+crisis&doi=10.1038%2Fs41586-019-0885-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Autophagic cell death restricts chromosomal instability during replicative crisis</span></div><div class="casAuthors">Nassour, Joe; Radford, Robert; Correia, Adriana; Fuste, Javier Miralles; Schoell, Brigitte; Jauch, Anna; Shaw, Reuben J.; Karlseder, Jan</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">565</span>
        (<span class="NLM_cas:issue">7741</span>),
    <span class="NLM_cas:pages">659-663</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Replicative crisis is a senescence-independent process that acts as a final barrier against oncogenic transformation by eliminating pre-cancerous cells with disrupted cell cycle checkpoints1.  It functions as a potent tumor suppressor and culminates in extensive cell death.  Cells rarely evade elimination and evolve towards malignancy, but the mechanisms that underlie cell death in crisis are not well understood.  Here we show that macroautophagy has a dominant role in the death of fibroblasts and epithelial cells during crisis.  Activation of autophagy is crit. for cell death, as its suppression promoted bypass of crisis, continued proliferation and accumulation of genome instability.  Telomere dysfunction specifically triggers autophagy, implicating a telomere-driven autophagy pathway that is not induced by intrachromosomal breaks.  Telomeric DNA damage generates cytosolic DNA species with fragile nuclear envelopes that undergo spontaneous disruption.  The cytosolic chromatin fragments activate the cGAS-STING (cGMP-AMP synthase-stimulator of interferon genes) pathway and engage the autophagy machinery.  Our data suggest that autophagy is an integral component of the tumor suppressive crisis mechanism and that loss of autophagy function is required for the initiation of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnN8n5rUFsorVg90H21EOLACvtfcHk0lhq8hvy09EVkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXmtVyjtLw%253D&md5=a1f28b16bbb361c2269cbc63fc22f6d5</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fs41586-019-0885-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41586-019-0885-0%26sid%3Dliteratum%253Aachs%26aulast%3DNassour%26aufirst%3DJ.%26aulast%3DRadford%26aufirst%3DR.%26aulast%3DCorreia%26aufirst%3DA.%26aulast%3DFust%25C3%25A9%26aufirst%3DJ.%2BM.%26aulast%3DSchoell%26aufirst%3DB.%26aulast%3DJauch%26aufirst%3DA.%26aulast%3DShaw%26aufirst%3DR.%2BJ.%26aulast%3DKarlseder%26aufirst%3DJ.%26atitle%3DAutophagic%2520cell%2520death%2520restricts%2520chromosomal%2520instability%2520during%2520replicative%2520crisis%26jtitle%3DNature%26date%3D2019%26volume%3D565%26spage%3D659%26epage%3D663%26doi%3D10.1038%2Fs41586-019-0885-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dou, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nice, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C.</span></span> <span> </span><span class="NLM_article-title">Ivermectin induces cytostatic autophagy by blocking the PAK1/Akt axis in breast cancer</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">4457</span>– <span class="NLM_lpage">4469</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-15-2887</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.1158%2F0008-5472.CAN-15-2887" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=27302166" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1Gmt7nK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2016&pages=4457-4469&author=Q.+Douauthor=H.+N.+Chenauthor=K.+Wangauthor=K.+Yuanauthor=Y.+Leiauthor=K.+Liauthor=J.+Lanauthor=Y.+Chenauthor=Z.+Huangauthor=N.+Xieauthor=L.+Zhangauthor=R.+Xiangauthor=E.+C.+Niceauthor=Y.+Weiauthor=C.+Huang&title=Ivermectin+induces+cytostatic+autophagy+by+blocking+the+PAK1%2FAkt+axis+in+breast+cancer&doi=10.1158%2F0008-5472.CAN-15-2887"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Ivermectin Induces Cytostatic Autophagy by Blocking the PAK1/Akt Axis in Breast Cancer</span></div><div class="casAuthors">Dou, Qianhui; Chen, Hai-Ning; Wang, Kui; Yuan, Kefei; Lei, Yunlong; Li, Kai; Lan, Jiang; Chen, Yan; Huang, Zhao; Xie, Na; Zhang, Lu; Xiang, Rong; Nice, Edouard C.; Wei, Yuquan; Huang, Canhua</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4457-4469</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Breast cancer is the most common cancer among women worldwide, yet successful treatment remains a clin. challenge.  Ivermectin, a broad-spectrum antiparasitic drug, has recently been characterized as a potential anticancer agent due to obsd. antitumor effects.  However, the mol. mechanisms involved remain poorly understood.  Here, we report a role for ivermectin in breast cancer suppression by activating cytostatic autophagy both in vitro and in vivo.  Mechanistically, ivermectin-induced autophagy in breast cancer cells is assocd. with decreased P21-activated kinase 1 (PAK1) expression via the ubiquitination-mediated degrdn. pathway.  The inhibition of PAK1 decreases the phosphorylation level of Akt, resulting in the blockade of the Akt/mTOR signaling pathway.  In breast cancer xenografts, the ivermectin-induced cytostatic autophagy leads to suppression of tumor growth.  Together, our results provide a mol. basis for the use of ivermectin to inhibit the proliferation of breast cancer cells and indicate that ivermectin is a potential option for the treatment of breast cancer.  Cancer Res; 76(15); 4457-69.2016 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZKWcGfsuUE7Vg90H21EOLACvtfcHk0lhq8hvy09EVkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1Gmt7nK&md5=b1475e60805d04efee9040e91d6aaf4f</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-15-2887&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-15-2887%26sid%3Dliteratum%253Aachs%26aulast%3DDou%26aufirst%3DQ.%26aulast%3DChen%26aufirst%3DH.%2BN.%26aulast%3DWang%26aufirst%3DK.%26aulast%3DYuan%26aufirst%3DK.%26aulast%3DLei%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DK.%26aulast%3DLan%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DXie%26aufirst%3DN.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DXiang%26aufirst%3DR.%26aulast%3DNice%26aufirst%3DE.%2BC.%26aulast%3DWei%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DC.%26atitle%3DIvermectin%2520induces%2520cytostatic%2520autophagy%2520by%2520blocking%2520the%2520PAK1%252FAkt%2520axis%2520in%2520breast%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2016%26volume%3D76%26spage%3D4457%26epage%3D4469%26doi%3D10.1158%2F0008-5472.CAN-15-2887" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Latorraca, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feitosa, W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mariano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moura, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fontes, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nogueira, M. F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paula-Lopes, F. F.</span></span> <span> </span><span class="NLM_article-title">Autophagy is a pro-survival adaptive response to heat shock in bovine cumulus-oocyte complexes</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">13711</span>, <span class="refDoi"> DOI: 10.1038/s41598-020-69939-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.1038%2Fs41598-020-69939-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=32792582" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhs1Cktb7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2020&pages=13711&author=L.+B.+Latorracaauthor=W.+B.+Feitosaauthor=C.+Marianoauthor=M.+T.+Mouraauthor=P.+K.+Fontesauthor=M.+F.+G.+Nogueiraauthor=F.+F.+Paula-Lopes&title=Autophagy+is+a+pro-survival+adaptive+response+to+heat+shock+in+bovine+cumulus-oocyte+complexes&doi=10.1038%2Fs41598-020-69939-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Autophagy is a pro-survival adaptive response to heat shock in bovine cumulus-oocyte complexes</span></div><div class="casAuthors">Latorraca, Lais B.; Feitosa, Weber B.; Mariano, Camila; Moura, Marcelo T.; Fontes, Patricia K.; Nogueira, Marcelo F. G.; Paula-Lopes, Fabiola F.</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">13711</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Autophagy is a physiol. mechanism that can be activated under stress conditions.  However, the role of autophagy during oocyte maturation has been poorly investigated.  Therefore, this study characterized the role of autophagy on developmental competence and gene expression of bovine oocytes exposed to heat shock (HS).  Cumulus-oocyte-complexes (COCs) were matured at Control (38.5°C) and HS (41°C) temps. in the presence of 0 and 10 mM 3-methyladenine (3MA; autophagy inhibitor).  Western blotting anal. revealed that HS increased autophagy marker LC3-II/LC3-I ratio in oocytes.  However, there was no effect of temp. for oocytes matured with 3MA.  On cumulus cells, 3MA reduced LC3-II/LC3-I ratio regardless of temp.  Inhibition of autophagy during IVM of heat-shocked oocytes (3MA-41°C) reduced cleavage and blastocyst rates compared to std. in vitro matured heat-shocked oocytes (IVM-41°C).  Therefore, the magnitude of HS detrimental effects was greater in the presence of autophagy inhibitor.  Oocyte maturation under 3MA-41°C reduced mRNA abundance for genes related to energy metab. (MTIF3), heat shock response (HSF1), and oocyte maturation (HAS2 and GREM1).  In conclusion, autophagy is a stress response induced on heat shocked oocytes.  Inhibition of autophagy modulated key functional processes rendering the oocyte more susceptible to the deleterious effects of heat shock.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4bQNzuZ7YnrVg90H21EOLACvtfcHk0lgJ49iijdoLvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhs1Cktb7L&md5=efd87478ee79856cb1efe247c2d0a1ec</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fs41598-020-69939-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-020-69939-3%26sid%3Dliteratum%253Aachs%26aulast%3DLatorraca%26aufirst%3DL.%2BB.%26aulast%3DFeitosa%26aufirst%3DW.%2BB.%26aulast%3DMariano%26aufirst%3DC.%26aulast%3DMoura%26aufirst%3DM.%2BT.%26aulast%3DFontes%26aufirst%3DP.%2BK.%26aulast%3DNogueira%26aufirst%3DM.%2BF.%2BG.%26aulast%3DPaula-Lopes%26aufirst%3DF.%2BF.%26atitle%3DAutophagy%2520is%2520a%2520pro-survival%2520adaptive%2520response%2520to%2520heat%2520shock%2520in%2520bovine%2520cumulus-oocyte%2520complexes%26jtitle%3DSci.%2520Rep.%26date%3D2020%26volume%3D10%26spage%3D13711%26doi%3D10.1038%2Fs41598-020-69939-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nice, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C.</span></span> <span> </span><span class="NLM_article-title">Regorafenib induces lethal autophagy arrest by stabilizing PSAT1 in glioblastoma</span>. <i>Autophagy</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">106</span>– <span class="NLM_lpage">122</span>, <span class="refDoi"> DOI: 10.1080/15548627.2019.1598752</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.1080%2F15548627.2019.1598752" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=30909789" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BC1MXnt1Cit7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2020&pages=106-122&author=J.+Jiangauthor=L.+Zhangauthor=H.+Chenauthor=Y.+Leiauthor=T.+Zhangauthor=Y.+Wangauthor=P.+Jinauthor=J.+Lanauthor=L.+Zhouauthor=Z.+Huangauthor=B.+Liauthor=Y.+Liuauthor=W.+Gaoauthor=K.+Xieauthor=L.+Zhouauthor=E.+C.+Niceauthor=Y.+Pengauthor=Y.+Caoauthor=Y.+Weiauthor=K.+Wangauthor=C.+Huang&title=Regorafenib+induces+lethal+autophagy+arrest+by+stabilizing+PSAT1+in+glioblastoma&doi=10.1080%2F15548627.2019.1598752"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Regorafenib induces lethal autophagy arrest by stabilizing PSAT1 in glioblastoma</span></div><div class="casAuthors">Jiang, Jingwen; Zhang, Lu; Chen, Haining; Lei, Yunlong; Zhang, Tao; Wang, Yuelong; Jin, Ping; Lan, Jiang; Zhou, Li; Huang, Zhao; Li, Bowen; Liu, Yuan; Gao, Wei; Xie, Ke; Zhou, Liangxue; Nice, Edouard C.; Peng, Yong; Cao, Yihai; Wei, Yuquan; Wang, Kui; Huang, Canhua</div><div class="citationInfo"><span class="NLM_cas:title">Autophagy</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">106-122</span>CODEN:
                <span class="NLM_cas:coden">AUTOC9</span>;
        ISSN:<span class="NLM_cas:issn">1554-8635</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">GBM (glioblastoma multiforme) is the most common and aggressive brain tumor with no curative options available.  Therefore, it is imperative to develop novel potent therapeutic drugs for GBM treatment.  Here, we show that regorafenib, an oral multi-kinase inhibitor, exhibits superior therapeutic efficacy over temozolomide, the first-line chemotherapeutic agent for GBM treatment both in vitro and in vivo.  Mechanistically, regorafenib directly stabilizes PSAT1 (phosphoserine aminotransferase 1), a crit. enzyme for serine synthesis, to trigger PRKAA-dependent autophagy initiation and inhibit RAB11A-mediated autophagosome-lysosome fusion, resulting in lethal autophagy arrest in GBM cells.  Maintenance of PSAT1 at a high level is essential for regorafenib-induced GBM suppression.  Together, our data provide novel mechanistic insights of regorafenib-induced autophagy arrest and suggest a new paradigm for effective treatment of GBM. 3-MA: 3-methyladenine; ACACA: acetyl CoA carboxylase alpha; ACTB/β-actin: actin, beta; AMPK: adenosine monophosphate-activated protein kinase; ATG5: autophagy related 5; CTSD: cathepsin D; DN-: dominant-neg.; GBM: glioblastoma multiforme; LAMP1: lysosomal-assocd. membrane protein 1; MAP1LC3B/LC3B: microtubule assocd. protein 1 light chain 3 beta; PIK3C3/VPS34: phosphatidylinositol 3-kinase catalytic subunit type 3; PRKAA/AMPKα: protein kinase AMP-activated catalytic subunit alpha; PSAT1: phosphoserine aminotransferase 1; SQSTM1/p62: sequestosome 1; TKIs: tyrosine kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjYimekOwQ8rVg90H21EOLACvtfcHk0lgJ49iijdoLvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXnt1Cit7w%253D&md5=069e5e8a379732797be4ea1a6970c562</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1080%2F15548627.2019.1598752&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F15548627.2019.1598752%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DLei%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DJin%26aufirst%3DP.%26aulast%3DLan%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DGao%26aufirst%3DW.%26aulast%3DXie%26aufirst%3DK.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DNice%26aufirst%3DE.%2BC.%26aulast%3DPeng%26aufirst%3DY.%26aulast%3DCao%26aufirst%3DY.%26aulast%3DWei%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DK.%26aulast%3DHuang%26aufirst%3DC.%26atitle%3DRegorafenib%2520induces%2520lethal%2520autophagy%2520arrest%2520by%2520stabilizing%2520PSAT1%2520in%2520glioblastoma%26jtitle%3DAutophagy%26date%3D2020%26volume%3D16%26spage%3D106%26epage%3D122%26doi%3D10.1080%2F15548627.2019.1598752" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Golden, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, H.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jahanian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofman, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Louie, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schönthal, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T. C.</span></span> <span> </span><span class="NLM_article-title">Chloroquine enhances temozolomide cytotoxicity in malignant gliomas by blocking autophagy</span>. <i>Neurosurg. Focus.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">E12</span>, <span class="refDoi"> DOI: 10.3171/2014.9.FOCUS14504</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.3171%2F2014.9.FOCUS14504" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=25434381" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2014&pages=E12&author=E.+B.+Goldenauthor=H.-Y.+Choauthor=A.+Jahanianauthor=F.+M.+Hofmanauthor=S.+G.+Louieauthor=A.+H.+Sch%C3%B6nthalauthor=T.+C.+Chen&title=Chloroquine+enhances+temozolomide+cytotoxicity+in+malignant+gliomas+by+blocking+autophagy&doi=10.3171%2F2014.9.FOCUS14504"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.3171%2F2014.9.FOCUS14504&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3171%252F2014.9.FOCUS14504%26sid%3Dliteratum%253Aachs%26aulast%3DGolden%26aufirst%3DE.%2BB.%26aulast%3DCho%26aufirst%3DH.-Y.%26aulast%3DJahanian%26aufirst%3DA.%26aulast%3DHofman%26aufirst%3DF.%2BM.%26aulast%3DLouie%26aufirst%3DS.%2BG.%26aulast%3DSch%25C3%25B6nthal%26aufirst%3DA.%2BH.%26aulast%3DChen%26aufirst%3DT.%2BC.%26atitle%3DChloroquine%2520enhances%2520temozolomide%2520cytotoxicity%2520in%2520malignant%2520gliomas%2520by%2520blocking%2520autophagy%26jtitle%3DNeurosurg.%2520Focus.%26date%3D2014%26volume%3D37%26spage%3DE12%26doi%3D10.3171%2F2014.9.FOCUS14504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, Z.</span></span> <span> </span><span class="NLM_article-title">Targeting autophagy to sensitive glioma to temozolomide treatment</span>. <i>J. Exp. Clin Cancer. Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">23</span>, <span class="refDoi"> DOI: 10.1186/s13046-016-0303-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.1186%2Fs13046-016-0303-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=26830677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlKqtbvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2016&pages=23&author=Y.+Yanauthor=Z.+Xuauthor=S.+Daiauthor=L.+Qianauthor=L.+Sunauthor=Z.+Gong&title=Targeting+autophagy+to+sensitive+glioma+to+temozolomide+treatment&doi=10.1186%2Fs13046-016-0303-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting autophagy to sensitive glioma to temozolomide treatment</span></div><div class="casAuthors">Yan, Yuanliang; Xu, Zhijie; Dai, Shuang; Qian, Long; Sun, Lunquan; Gong, Zhicheng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental & Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">23/1-23/14</span>CODEN:
                <span class="NLM_cas:coden">JECRDN</span>;
        ISSN:<span class="NLM_cas:issn">1756-9966</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Temozolomide (TMZ), an alkylating agent, is widely used for treating primary and recurrent high-grade gliomas.  However, the efficacy of TMZ is often limited by the development of resistance.  Recently, studies have found that TMZ treatment could induce autophagy, which contributes to therapy resistance in glioma.  To enhance the benefit of TMZ in the treatment of glioblastomas, effective combination strategies are needed to sensitize glioblastoma cells to TMZ.  In this regard, as autophagy could promote cell survival or autophagic cell death, modulating autophagy using a pharmacol. inhibitor, such as chloroquine, or an inducer, such as rapamycin, has received considerably more attention.  To understand the effectiveness of regulating autophagy in glioblastoma treatment, this review summarizes reports on glioblastoma treatments with TMZ and autophagic modulators from in vitro and in vivo studies, as well as clin. trials.  Addnl., we discuss the possibility of using autophagy regulatory compds. that can sensitive TMZ treatment as a chemotherapy for glioma treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptB6HcZCkR4rVg90H21EOLACvtfcHk0lhSnhNhnh_oog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlKqtbvJ&md5=673d5324b7d3b62dee45f1d03ef87d0d</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1186%2Fs13046-016-0303-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13046-016-0303-5%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DDai%26aufirst%3DS.%26aulast%3DQian%26aufirst%3DL.%26aulast%3DSun%26aufirst%3DL.%26aulast%3DGong%26aufirst%3DZ.%26atitle%3DTargeting%2520autophagy%2520to%2520sensitive%2520glioma%2520to%2520temozolomide%2520treatment%26jtitle%3DJ.%2520Exp.%2520Clin%2520Cancer.%2520Res.%26date%3D2016%26volume%3D35%26spage%3D23%26doi%3D10.1186%2Fs13046-016-0303-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Galluzzi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bravo-San Pedro, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levine, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kroemer, G.</span></span> <span> </span><span class="NLM_article-title">Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">487</span>– <span class="NLM_lpage">511</span>, <span class="refDoi"> DOI: 10.1038/nrd.2017.22</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.1038%2Fnrd.2017.22" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=28529316" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BC2sXotVKntr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=487-511&author=L.+Galluzziauthor=J.+M.+Bravo-San+Pedroauthor=B.+Levineauthor=D.+R.+Greenauthor=G.+Kroemer&title=Pharmacological+modulation+of+autophagy%3A+therapeutic+potential+and+persisting+obstacles&doi=10.1038%2Fnrd.2017.22"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles</span></div><div class="casAuthors">Galluzzi, Lorenzo; Bravo-San Pedro, Jose Manuel; Levine, Beth; Green, Douglas R.; Kroemer, Guido</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">487-511</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Autophagy is central to the maintenance of organismal homeostasis in both physiol. and pathol. situations.  Accordingly, alterations in autophagy have been linked to clin. relevant conditions as diverse as cancer, neurodegeneration and cardiac disorders.  Throughout the past decade, autophagy has attracted considerable attention as a target for the development of novel therapeutics.  However, such efforts have not yet generated clin. viable interventions.  In this review, we discuss the therapeutic potential of autophagy modulators, analyze the obstacles that have limited their development and propose strategies that may unlock the full therapeutic potential of autophagy modulation in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1YAuK4nNrTbVg90H21EOLACvtfcHk0lhSnhNhnh_oog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXotVKntr4%253D&md5=0cf36178d5fd9b4d2493649d44aa1051</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2017.22&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2017.22%26sid%3Dliteratum%253Aachs%26aulast%3DGalluzzi%26aufirst%3DL.%26aulast%3DBravo-San%2BPedro%26aufirst%3DJ.%2BM.%26aulast%3DLevine%26aufirst%3DB.%26aulast%3DGreen%26aufirst%3DD.%2BR.%26aulast%3DKroemer%26aufirst%3DG.%26atitle%3DPharmacological%2520modulation%2520of%2520autophagy%253A%2520therapeutic%2520potential%2520and%2520persisting%2520obstacles%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2017%26volume%3D16%26spage%3D487%26epage%3D511%26doi%3D10.1038%2Fnrd.2017.22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, F.</span></span> <span> </span><span class="NLM_article-title">Discovery of new fluorescent thiazole–pyrazoline derivatives as autophagy inducers by inhibiting mTOR activity in A549 human lung cancer cells</span>. <i>Cell Death & Disease.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">551</span>, <span class="refDoi"> DOI: 10.1038/s41419-020-02746-w</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.1038%2Fs41419-020-02746-w" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=32686662" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhsVWqsrzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2020&pages=551&author=Z.+Linauthor=Z.+Wangauthor=X.+Zhouauthor=M.+Zhangauthor=D.+Gaoauthor=L.+Zhangauthor=P.+Wangauthor=Y.+Chenauthor=Y.+Linauthor=B.+Zhaoauthor=J.+Miaoauthor=F.+Kong&title=Discovery+of+new+fluorescent+thiazole%E2%80%93pyrazoline+derivatives+as+autophagy+inducers+by+inhibiting+mTOR+activity+in+A549+human+lung+cancer+cells&doi=10.1038%2Fs41419-020-02746-w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of new fluorescent thiazole-pyrazoline derivatives as autophagy inducers by inhibiting mTOR activity in A549 human lung cancer cells</span></div><div class="casAuthors">Lin, Zhao Min; Wang, Zhao Yang; Zhou, Xue Wen; Zhang, Ming; Gao, Dong Fang; Zhang, Lu; Wang, Peng; Chen, Yuan; Lin, Yu Xing; Zhao, Bao Xiang; Miao, Jun Ying; Kong, Feng</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">551</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">A series of fluorescent thiazole-pyrazoline derivs. was synthesized and their structures were characterized by 1H NMR, 13C NMR, and HRMS.  Biol. evaluation demonstrated that these compds. could effectively inhibit the growth of human non-small cell lung cancer (NSCLC) A549 cells in a dose- and time-dependent manner in vitro and inhibit tumor growth in vivo.  The structure-activity relationship (SAR) of the compds. was analyzed.  Further mechanism research revealed they could induce autophagy and cell cycle arrest while had no influence on cell necrosis.  Compd. 5e inhibited the activity of mTOR via FKBP12, which could be reversed by 3BDO, an mTOR activator and autophagy inhibitor.  Compd. I (R = 4-Cl, Ar = 4-MeOPh) inhibited growth, promoted autophagy of A549 cells in vivo.  Moreover, compd. I (R = 4-Cl, Ar = 4-MeOPh) showed good selectivity with no influence on normal vascular endothelial cell growth and the normal chick embryo chorioallantoic membrane (CAM) capillary formation.  Therefore, our research provides potential lead compds. for the development of new anticancer drugs against human lung cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDzCYT4H8CBbVg90H21EOLACvtfcHk0lhSnhNhnh_oog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhsVWqsrzJ&md5=a97dcd92db2c1f5aca3d562d3421baa7</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fs41419-020-02746-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41419-020-02746-w%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DGao%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DLin%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DB.%26aulast%3DMiao%26aufirst%3DJ.%26aulast%3DKong%26aufirst%3DF.%26atitle%3DDiscovery%2520of%2520new%2520fluorescent%2520thiazole%25E2%2580%2593pyrazoline%2520derivatives%2520as%2520autophagy%2520inducers%2520by%2520inhibiting%2520mTOR%2520activity%2520in%2520A549%2520human%2520lung%2520cancer%2520cells%26jtitle%3DCell%2520Death%2520%2526%2520Disease.%26date%3D2020%26volume%3D11%26spage%3D551%26doi%3D10.1038%2Fs41419-020-02746-w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cho, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koh, J. Y.</span></span> <span> </span><span class="NLM_article-title">A role of metallothionein-3 in radiation-induced autophagy in glioma cells</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">2015</span>, <span class="refDoi"> DOI: 10.1038/s41598-020-58237-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.1038%2Fs41598-020-58237-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=32029749" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BB3cXntlSguro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2020&pages=2015&author=Y.+H.+Choauthor=S.+H.+Leeauthor=S.+J.+Leeauthor=H.+N.+Kimauthor=J.+Y.+Koh&title=A+role+of+metallothionein-3+in+radiation-induced+autophagy+in+glioma+cells&doi=10.1038%2Fs41598-020-58237-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">A role of metallothionein-3 in radiation-induced autophagy in glioma cells</span></div><div class="casAuthors">Cho, Young Hyun; Lee, Seung-Hwan; Lee, Sook-Jeong; Kim, Ha Na; Koh, Jae-Young</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">2015</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Abstr.: Although metallothionein-3 (MT3), a brain-enriched form of metallothioneins, has been linked to Alzheimer's disease, little is known regarding the role of MT3 in glioma.  As MT3 plays a role in autophagy in astrocytes, here, we investigated its role in irradiated glioma cells.  Irradn. increased autophagy flux in GL261 glioma cells as evidenced by increased levels of LC3-II but decreased levels of p62 (SQSTM1).  Indicating that autophagy plays a cytoprotective role in glioma cell survival following irradn., measures inhibiting autophagy flux at various steps decreased their clonogenic survival of irradiated GL261 as well as SF295 and U251 glioma cells.  Knockdown of MT3 with siRNA in irradiated glioma cells induced arrested autophagy, and decreased cell survival.  At the same time, the accumulation of labile zinc in lysosomes was markedly attenuated by MT3 knockdown.  Indicating that such zinc accumulation was important in autophagy flux, chelation of zinc with tetrakis-(2-pyridylmethyl)ethylenediamine (TPEN), induced arrested autophagy in and reduced survival of GL261 cells following irradn.  Suggesting a possible mechanism for arrested autophagy, MT3 knockdown and zinc chelation were found to impair lysosomal acidification.  Since autophagy flux plays a cytoprotective role in irradiated glioma cells, present results suggest that MT3 and zinc may be regarded as possible therapeutic targets to sensitize glioma cells to ionizing radiation therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1xplWEHnYEbVg90H21EOLACvtfcHk0liwPS9p0ZYhgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXntlSguro%253D&md5=092cfd477bbbfdf4fb7cc7eb7beb3d31</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fs41598-020-58237-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-020-58237-7%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DY.%2BH.%26aulast%3DLee%26aufirst%3DS.%2BH.%26aulast%3DLee%26aufirst%3DS.%2BJ.%26aulast%3DKim%26aufirst%3DH.%2BN.%26aulast%3DKoh%26aufirst%3DJ.%2BY.%26atitle%3DA%2520role%2520of%2520metallothionein-3%2520in%2520radiation-induced%2520autophagy%2520in%2520glioma%2520cells%26jtitle%3DSci.%2520Rep.%26date%3D2020%26volume%3D10%26spage%3D2015%26doi%3D10.1038%2Fs41598-020-58237-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, G. J.</span></span> <span> </span><span class="NLM_article-title">Therapeutic strategies of drug repositioning targeting autophagy to induce cancer cell death: from pathophysiology to treatment</span>. <i>J. Hematol. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">67</span>, <span class="refDoi"> DOI: 10.1186/s13045-017-0436-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.1186%2Fs13045-017-0436-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=28279189" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BC1cXksl2msr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2017&pages=67&author=G.+J.+Yoshida&title=Therapeutic+strategies+of+drug+repositioning+targeting+autophagy+to+induce+cancer+cell+death%3A+from+pathophysiology+to+treatment&doi=10.1186%2Fs13045-017-0436-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic strategies of drug repositioning targeting autophagy to induce cancer cell death: from pathophysiology to treatment</span></div><div class="casAuthors">Yoshida, Go J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hematology & Oncology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">67/1-67/14</span>CODEN:
                <span class="NLM_cas:coden">JHOOAO</span>;
        ISSN:<span class="NLM_cas:issn">1756-8722</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">The 2016 Nobel Prize in Physiol. or Medicine was awarded to the researcher that discovered autophagy, which is an evolutionally conserved catabolic process which degrades cytoplasmic constituents and organelles in the lysosome.  Autophagy plays a crucial role in both normal tissue homeostasis and tumor development and is necessary for cancer cells to adapt efficiently to an unfavorable tumor microenvironment characterized by hypo-nutrient conditions.  This protein degrdn. process leads to amino acid recycling, which provides sufficient amino acid substrates for cellular survival and proliferation.  Autophagy is constitutively activated in cancer cells due to the deregulation of PI3K/Akt/mTOR signaling pathway, which enables them to adapt to hypo-nutrient microenvironment and exhibit the robust proliferation at the pre-metastatic niche.  That is why just the activation of autophagy with mTOR inhibitor often fails in vain.  In contrast, disturbance of autophagy-lysosome flux leads to endoplasmic reticulum (ER) stress and an unfolded protein response (UPR), which finally leads to increased apoptotic cell death in the tumor tissue.  Accumulating evidence suggests that autophagy has a close relationship with programmed cell death, while uncontrolled autophagy itself often induces autophagic cell death in tumor cells.  Autophagic cell death was originally defined as cell death accompanied by large-scale autophagic vacuolization of the cytoplasm.  However, autophagy is a "double-edged sword" for cancer cells as it can either promote or suppress the survival and proliferation in the tumor microenvironment.  Furthermore, several studies of drug re-positioning suggest that "conventional" agents used to treat diseases other than cancer can have antitumor therapeutic effects by activating/suppressing autophagy.  Because of ever increasing failure rates and high cost assocd. with anticancer drug development, this therapeutic development strategy has attracted increasing attention because the safety profiles of these medicines are well known.  Antimalarial agents such as artemisinin and disease-modifying antirheumatic drug (DMARD) are the typical examples of drug re-positioning which affect the autophagy regulation for the therapeutic use.  This review article focuses on recent advances in some of the novel therapeutic strategies that target autophagy with a view to treating/preventing malignant neoplasms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrByPEabuGYjbVg90H21EOLACvtfcHk0li7SzmeD0nXXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXksl2msr4%253D&md5=da231073d7fd84da91eb848455e2b59f</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1186%2Fs13045-017-0436-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13045-017-0436-9%26sid%3Dliteratum%253Aachs%26aulast%3DYoshida%26aufirst%3DG.%2BJ.%26atitle%3DTherapeutic%2520strategies%2520of%2520drug%2520repositioning%2520targeting%2520autophagy%2520to%2520induce%2520cancer%2520cell%2520death%253A%2520from%2520pathophysiology%2520to%2520treatment%26jtitle%3DJ.%2520Hematol.%2520Oncol.%26date%3D2017%26volume%3D10%26spage%3D67%26doi%3D10.1186%2Fs13045-017-0436-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ozben, T.</span></span> <span> </span><span class="NLM_article-title">Oxidative stress and apoptosis: impact on cancer therapy</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">2181</span>– <span class="NLM_lpage">2196</span>, <span class="refDoi"> DOI: 10.1002/jps.20874</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.1002%2Fjps.20874" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=17593552" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVWntLnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2007&pages=2181-2196&author=T.+Ozben&title=Oxidative+stress+and+apoptosis%3A+impact+on+cancer+therapy&doi=10.1002%2Fjps.20874"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative stress and apoptosis: impact on cancer therapy</span></div><div class="casAuthors">Ozben, Tomris</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2181-2196</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  It is well established that some chemotherapeutic agents and radiation therapy generate reactive oxygen species (ROS) in patients during cancer therapy.  Free radicals, particularly ROS have been proposed as common mediators for apoptosis.  Recent studies have demonstrated that the mode of cell death depends on the severity of the oxidative damage.  This review will address some of the current paradigms of oxidative stress, and antioxidants on apoptosis, and discuss the potential mechanisms by which oxidants can regulate apoptotic pathways.  It will also review new developments in eliminating cancer cells by selectively inducing apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWwZ5lgHXtJbVg90H21EOLACvtfcHk0li7SzmeD0nXXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVWntLnI&md5=a87205dc90c12a711cf432e1877d16ed</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2Fjps.20874&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.20874%26sid%3Dliteratum%253Aachs%26aulast%3DOzben%26aufirst%3DT.%26atitle%3DOxidative%2520stress%2520and%2520apoptosis%253A%2520impact%2520on%2520cancer%2520therapy%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2007%26volume%3D96%26spage%3D2181%26epage%3D2196%26doi%3D10.1002%2Fjps.20874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ostrom, Q. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gittleman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farah, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ondracek, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolinsky, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stroup, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruchko, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnholtz-Sloan, J. S.</span></span> <span> </span><span class="NLM_article-title">CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2006–2010</span>. <i>Neuro. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">ii1</span>– <span class="NLM_lpage">ii56</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2013&pages=ii1-ii56&author=Q.+T.+Ostromauthor=H.+Gittlemanauthor=P.+Farahauthor=A.+Ondracekauthor=Y.+Chenauthor=Y.+L.+Wolinskyauthor=N.+E.+Stroupauthor=C.+Kruchkoauthor=J.+S.+Barnholtz-Sloan&title=CBTRUS+statistical+report%3A+primary+brain+and+central+nervous+system+tumors+diagnosed+in+the+United+States+in+2006%E2%80%932010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOstrom%26aufirst%3DQ.%2BT.%26aulast%3DGittleman%26aufirst%3DH.%26aulast%3DFarah%26aufirst%3DP.%26aulast%3DOndracek%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DWolinsky%26aufirst%3DY.%2BL.%26aulast%3DStroup%26aufirst%3DN.%2BE.%26aulast%3DKruchko%26aufirst%3DC.%26aulast%3DBarnholtz-Sloan%26aufirst%3DJ.%2BS.%26atitle%3DCBTRUS%2520statistical%2520report%253A%2520primary%2520brain%2520and%2520central%2520nervous%2520system%2520tumors%2520diagnosed%2520in%2520the%2520United%2520States%2520in%25202006%25E2%2580%25932010%26jtitle%3DNeuro.%2520Oncol.%26date%3D2013%26volume%3D2%26spage%3Dii1%26epage%3Dii56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, K.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, X.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, H.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.-N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, H.</span></span> <span> </span><span class="NLM_article-title">Organometallic gold(III) complexes similar to tetrahydroisoquinoline induce ER-stress-mediated apoptosis and pro-death autophagy in A549 cancer cells</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">3478</span>– <span class="NLM_lpage">3490</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01694</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01694" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmslGqsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=3478-3490&author=K.-B.+Huangauthor=F.-Y.+Wangauthor=X.-M.+Tangauthor=H.-W.+Fengauthor=Z.-F.+Chenauthor=Y.-C.+Liuauthor=Y.-N.+Liuauthor=H.+Liang&title=Organometallic+gold%28III%29+complexes+similar+to+tetrahydroisoquinoline+induce+ER-stress-mediated+apoptosis+and+pro-death+autophagy+in+A549+cancer+cells&doi=10.1021%2Facs.jmedchem.7b01694"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Organometallic Gold(III) complexes similar to tetrahydroisoquinoline induce ER-stress-mediated apoptosis and pro-death autophagy in A549 cancer cells</span></div><div class="casAuthors">Huang, Ke-Bin; Wang, Feng-Yang; Tang, Xiao-Ming; Feng, Hai-Wen; Chen, Zhen-Feng; Liu, Yan-Cheng; Liu, You-Nian; Liang, Hong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3478-3490</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Gold(III) cyclometalated benzeneethanamine chelate complexes exhibit high cytotoxic activity towards lung cancer cells, causing ER-controlled apoptosis and autophagy, exhibiting less toxicity compared to cisplatin.  Agents inducing both apoptosis and autophagic death can be effective chemotherapeutic drugs.  In our present work, we synthesized two organometallic gold(III) complexes harboring C-N ligands that structurally resemble tetrahydroisoquinoline (THIQ): Cyc-Au-1 (AuL1Cl2, HL1 = 3,4-dimethoxyphenethylamine) and Cyc-Au-2 (AuL2Cl2, HL2 = 1,3-benzodioxole-5-ethanamine).  In screening their in vitro activity, we found both gold complexes exhibited lower toxicity, lower resistance factors, and better anticancer activity than those of cisplatin.  The organometallic gold(III) complexes accumulate in mitochondria and induce elevated ROS and an ER stress response through mitochondrial dysfunction.  These effects ultimately result in simultaneous apoptosis and autophagy.  Importantly, compared to cisplatin, Cyc-Au-2 exhibits lower toxicity and better anticancer activity in a murine tumor model.  To the best of our knowledge, Cyc-Au-2 is the first organometallic Au(III) compd. that induces apoptosis and autophagic death.  On the basis of our results, we believe Cyc-Au-2 to be a promising anticancer agent or lead compd. for further anticancer drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIcN1K09UUe7Vg90H21EOLACvtfcHk0lhlJwOGM2hvbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmslGqsLo%253D&md5=08921b2a076c3cf07260611ab629fe93</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01694&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01694%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DK.-B.%26aulast%3DWang%26aufirst%3DF.-Y.%26aulast%3DTang%26aufirst%3DX.-M.%26aulast%3DFeng%26aufirst%3DH.-W.%26aulast%3DChen%26aufirst%3DZ.-F.%26aulast%3DLiu%26aufirst%3DY.-C.%26aulast%3DLiu%26aufirst%3DY.-N.%26aulast%3DLiang%26aufirst%3DH.%26atitle%3DOrganometallic%2520gold%2528III%2529%2520complexes%2520similar%2520to%2520tetrahydroisoquinoline%2520induce%2520ER-stress-mediated%2520apoptosis%2520and%2520pro-death%2520autophagy%2520in%2520A549%2520cancer%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D3478%26epage%3D3490%26doi%3D10.1021%2Facs.jmedchem.7b01694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, R. W. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, C. M.</span></span> <span> </span><span class="NLM_article-title">A dual cytotoxic and antiangiogenic water-soluble gold(III) complex induces endoplasmic reticulum damage in HeLa cells</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">3388</span>– <span class="NLM_lpage">3390</span>, <span class="refDoi"> DOI: 10.1039/c2cc00029f</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.1039%2Fc2cc00029f" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=22373586" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtlKrsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2012&pages=3388-3390&author=J.+J.+Zhangauthor=R.+W.+Y.+Sunauthor=C.+M.+Che&title=A+dual+cytotoxic+and+antiangiogenic+water-soluble+gold%28III%29+complex+induces+endoplasmic+reticulum+damage+in+HeLa+cells&doi=10.1039%2Fc2cc00029f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">A dual cytotoxic and anti-angiogenic water-soluble gold(III) complex induces endoplasmic reticulum damage in HeLa cells</span></div><div class="casAuthors">Zhang, Jing-Jing; Sun, Raymond Wai-Yin; Che, Chi-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">3388-3390</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The water-sol. gold(iii) complex [AuIII(butyl-CN)biguanide]Cl (butyl-HCN = 2-(4-n-butylphenyl)pyridine, BCN) displays cytotoxicity through S-phase cell cycle arrest and endoplasmic reticulum (ER) damage in HeLa cells, and shows a promising anti-angiogenic effect at sub-cytotoxic concns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZ_dgUe-g6E7Vg90H21EOLACvtfcHk0lhlJwOGM2hvbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtlKrsb8%253D&md5=42f78e8cebbf5d4520da1bf09dd60dc9</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1039%2Fc2cc00029f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2cc00029f%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%2BJ.%26aulast%3DSun%26aufirst%3DR.%2BW.%2BY.%26aulast%3DChe%26aufirst%3DC.%2BM.%26atitle%3DA%2520dual%2520cytotoxic%2520and%2520antiangiogenic%2520water-soluble%2520gold%2528III%2529%2520complex%2520induces%2520endoplasmic%2520reticulum%2520damage%2520in%2520HeLa%2520cells%26jtitle%3DChem.%2520Commun.%26date%3D2012%26volume%3D48%26spage%3D3388%26epage%3D3390%26doi%3D10.1039%2Fc2cc00029f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, R. W. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lok, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fong, T. T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C. K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siu, A. F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, C. M.</span></span> <span> </span><span class="NLM_article-title">A dinuclear cyclometalated gold(III)-phosphine complex targeting thioredoxin reductase inhibits hepatocellular carcinoma in vivo</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1979</span>– <span class="NLM_lpage">1988</span>, <span class="refDoi"> DOI: 10.1039/c3sc21972k</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.1039%2Fc3sc21972k" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BC3sXltVOltLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1979-1988&author=R.+W.+Y.+Sunauthor=C.+N.+Lokauthor=T.+T.+H.+Fongauthor=C.+K.+L.+Liauthor=Z.+F.+Yangauthor=T.+Zouauthor=A.+F.+M.+Siuauthor=C.+M.+Che&title=A+dinuclear+cyclometalated+gold%28III%29-phosphine+complex+targeting+thioredoxin+reductase+inhibits+hepatocellular+carcinoma+in+vivo&doi=10.1039%2Fc3sc21972k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">A dinuclear cyclometalated gold(iii)-phosphine complex targeting thioredoxin reductase inhibits hepatocellular carcinoma in vivo</span></div><div class="casAuthors">Sun, Raymond Wai-Yin; Lok, Chun-Nam; Fong, Tommy Tsz-Him; Li, Carrie Ka-Lei; Yang, Zhen Fan; Zou, Taotao; Siu, Annie Fung-Ming; Che, Chi-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1979-1988</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A stable gold(iii)-phosphine complex [(CNC)2Au2(μ-dppp)](CF3SO3)2 [Au3, HCNCH = 2,6-diphenylpyridine; dppp = bis(diphenylphosphino)propane] displays potent in vitro cytotoxicity towards various cancers with sub-micromolar range cytotoxic IC50 values, and is significantly more potent than its structural and iso-electronic platinum(ii) analog [(CNN)2Pt2(μ-dppp)](CF3SO3)2 (HCNN = 6-phenyl-2,2'-bipyridine) and gold(iii)-carbene complexes.  Complex Au3 displays promising inhibition on tumor growth in animal models, and its acute and sub-chronic toxicities have been examd. in mice and beagle dogs.  Transcriptomic and connectivity map analyses have revealed that the transcriptional profile of Au3 is similar to those of inhibitors of thioredoxin reductase (TrxR) and inducers of endoplasmic reticulum (ER) stress.  As we found that Au3 is also a nanomolar inhibitor of TrxR, a model of ER stress-induced cell death mediated by inhibition of TrxR is proposed.  The transcriptomic anal. also leads to the identification of TRAIL, a ligand for death receptor 5 (DR5), as a synergistic agent of the anti-tumor activity of Au3.  Collectively, our results demonstrate that the gold(iii) complex Au3 effectively inhibits tumor growth in vivo, and displays promising cytotoxicity towards cancer cells in assocn. with the inhibition of TrxR, induction of ER stress and also a death-receptor-dependent apoptotic pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4mMzz5l_pV7Vg90H21EOLACvtfcHk0liqTgzu8XvzJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXltVOltLg%253D&md5=b176ca64a02b28686c3b6c448bbc634d</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1039%2Fc3sc21972k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3sc21972k%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DR.%2BW.%2BY.%26aulast%3DLok%26aufirst%3DC.%2BN.%26aulast%3DFong%26aufirst%3DT.%2BT.%2BH.%26aulast%3DLi%26aufirst%3DC.%2BK.%2BL.%26aulast%3DYang%26aufirst%3DZ.%2BF.%26aulast%3DZou%26aufirst%3DT.%26aulast%3DSiu%26aufirst%3DA.%2BF.%2BM.%26aulast%3DChe%26aufirst%3DC.%2BM.%26atitle%3DA%2520dinuclear%2520cyclometalated%2520gold%2528III%2529-phosphine%2520complex%2520targeting%2520thioredoxin%2520reductase%2520inhibits%2520hepatocellular%2520carcinoma%2520in%2520vivo%26jtitle%3DChem.%2520Sci.%26date%3D2013%26volume%3D4%26spage%3D1979%26epage%3D1988%26doi%3D10.1039%2Fc3sc21972k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lum, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lok, C.-N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, C.-M.</span></span> <span> </span><span class="NLM_article-title">Chemical biology of anticancer gold(iii) and gold(i) complexes</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">8786</span>– <span class="NLM_lpage">8801</span>, <span class="refDoi"> DOI: 10.1039/C5CS00132C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.1039%2FC5CS00132C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=25868756" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmsVChurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2015&pages=8786-8801&author=T.+Zouauthor=C.+T.+Lumauthor=C.-N.+Lokauthor=J.-J.+Zhangauthor=C.-M.+Che&title=Chemical+biology+of+anticancer+gold%28iii%29+and+gold%28i%29+complexes&doi=10.1039%2FC5CS00132C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical biology of anticancer gold(III) and gold(I) complexes</span></div><div class="casAuthors">Zou, Taotao; Lum, Ching Tung; Lok, Chun-Nam; Zhang, Jing-Jing; Che, Chi-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8786-8801</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Gold complexes have recently gained increasing attention in the design of new metal-based anticancer therapeutics.  Gold(III) complexes are generally reactive/unstable under physiol. conditions via intracellular redox reactions, and the intracellular AuIII to AuI redn. reaction has recently been "traced" by the introduction of appropriate fluorescent ligands.  Similar to most Au(I) complexes, Au(III) complexes can inhibit the activities of thiol-contg. enzymes, including thioredoxin reductase, via ligand exchange reactions to form Au-S(Se) bonds.  Nonetheless, there are examples of physiol. stable Au(III) and Au(I) complexes, such as [Au(TPP)]Cl (H2TPP = 5,10,15,20-tetraphenylporphyrin) and [Au(dppe)2]Cl (dppe = 1,2-bis(diphenylphosphanyl)ethane), which are known to display highly potent in vitro and in vivo anticancer activities.  In this review, we summarize our current understanding of anticancer gold complexes, including their mechanisms of action and the approaches adopted to improve their anticancer efficiency.  Some recent examples of gold anticancer chemotherapeutics are highlighted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraSf5EPIPo8rVg90H21EOLACvtfcHk0liqTgzu8XvzJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmsVChurg%253D&md5=6e546124df776ce9612fb8a4fdbcad37</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1039%2FC5CS00132C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5CS00132C%26sid%3Dliteratum%253Aachs%26aulast%3DZou%26aufirst%3DT.%26aulast%3DLum%26aufirst%3DC.%2BT.%26aulast%3DLok%26aufirst%3DC.-N.%26aulast%3DZhang%26aufirst%3DJ.-J.%26aulast%3DChe%26aufirst%3DC.-M.%26atitle%3DChemical%2520biology%2520of%2520anticancer%2520gold%2528iii%2529%2520and%2520gold%2528i%2529%2520complexes%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2015%26volume%3D44%26spage%3D8786%26epage%3D8801%26doi%3D10.1039%2FC5CS00132C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bazzicalupi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferraroni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Massai, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertrand, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messori, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gratteri, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casini, A.</span></span> <span> </span><span class="NLM_article-title">Determinants for tight and selective binding of a medicinal dicarbene gold(I) complex to a telomeric DNA G–quadruplex: a joint ESI MS and XRD investigation</span>. <i>Am. Ethnol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>128</i></span>,  <span class="NLM_fpage">4328</span>– <span class="NLM_lpage">4331</span>, <span class="refDoi"> DOI: 10.1002/ange.201511999</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.1002%2Fange.201511999" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2016&pages=4328-4331&author=C.+Bazzicalupiauthor=M.+Ferraroniauthor=F.+Papiauthor=L.+Massaiauthor=B.+Bertrandauthor=L.+Messoriauthor=P.+Gratteriauthor=A.+Casini&title=Determinants+for+tight+and+selective+binding+of+a+medicinal+dicarbene+gold%28I%29+complex+to+a+telomeric+DNA+G%E2%80%93quadruplex%3A+a+joint+ESI+MS+and+XRD+investigation&doi=10.1002%2Fange.201511999"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1002%2Fange.201511999&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fange.201511999%26sid%3Dliteratum%253Aachs%26aulast%3DBazzicalupi%26aufirst%3DC.%26aulast%3DFerraroni%26aufirst%3DM.%26aulast%3DPapi%26aufirst%3DF.%26aulast%3DMassai%26aufirst%3DL.%26aulast%3DBertrand%26aufirst%3DB.%26aulast%3DMessori%26aufirst%3DL.%26aulast%3DGratteri%26aufirst%3DP.%26aulast%3DCasini%26aufirst%3DA.%26atitle%3DDeterminants%2520for%2520tight%2520and%2520selective%2520binding%2520of%2520a%2520medicinal%2520dicarbene%2520gold%2528I%2529%2520complex%2520to%2520a%2520telomeric%2520DNA%2520G%25E2%2580%2593quadruplex%253A%2520a%2520joint%2520ESI%2520MS%2520and%2520XRD%2520investigation%26jtitle%3DAm.%2520Ethnol.%26date%3D2016%26volume%3D128%26spage%3D4328%26epage%3D4331%26doi%3D10.1002%2Fange.201511999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ali, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dondaine, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adolle, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sampaio, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chotard, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richard, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denat, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bettaieb, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Gendre, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laurens, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goze, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paul, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bodio, E.</span></span> <span> </span><span class="NLM_article-title">Anticancer agents: does a phosphonium behave like a gold(I) phosphine complex? let a “smart” probe answer</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">4521</span>– <span class="NLM_lpage">4528</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00480</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00480" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BC2MXotlChs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=4521-4528&author=M.+Aliauthor=L.+Dondaineauthor=A.+Adolleauthor=C.+Sampaioauthor=F.+Chotardauthor=P.+Richardauthor=F.+Denatauthor=A.+Bettaiebauthor=P.+Le+Gendreauthor=V.+Laurensauthor=C.+Gozeauthor=C.+Paulauthor=E.+Bodio&title=Anticancer+agents%3A+does+a+phosphonium+behave+like+a+gold%28I%29+phosphine+complex%3F+let+a+%E2%80%9Csmart%E2%80%9D+probe+answer&doi=10.1021%2Facs.jmedchem.5b00480"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Anticancer Agents: Does a Phosphonium Behave Like a Gold(I) Phosphine Complex? Let a "Smart" Probe Answer!</span></div><div class="casAuthors">Ali, Moussa; Dondaine, Lucile; Adolle, Anais; Sampaio, Carla; Chotard, Florian; Richard, Philippe; Denat, Franck; Bettaieb, Ali; Le Gendre, Pierre; Laurens, Veronique; Goze, Christine; Paul, Catherine; Bodio, Ewen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4521-4528</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Gold phosphine complexes, such as auranofin, have been recognized for decades as antirheumatic agents.  Clin. trials are now underway to validate their use in anticancer or anti-HIV treatments.  However, their mechanisms of action remain unclear.  A challenging question is whether the gold phosphine complex is a prodrug that is administered in an inactive precursor form or rather that the gold atom remains attached to the phosphine ligand during treatment.  In this study, we present two novel gold complexes, which we compared to auranofin and to their phosphonium analog.  The chosen ligand is a phosphine-based smart probe, whose strong fluorescence depends on the presence of the gold atom.  The in vitro biol. action of the gold complexes and the phosphonium deriv. were investigated, and a preliminary in vivo study in healthy zebrafish larvae allowed us to evaluate gold complex biodistribution and toxicity.  The different analyses carried out showed that these gold complexes were stable and behaved differently from phosphonium and auranofin, both in vitro and in vivo.  Two-photon microscopy expts. demonstrated that the cellular targets of these gold complexes are not the same as those of the phosphonium analog.  Moreover, despite similar IC50 values in some cancer cell lines, gold complexes displayed a low toxicity in vivo, in contrast to the phosphonium salt.  They are therefore suitable for future in vivo investigations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbXqkJmQP-ULVg90H21EOLACvtfcHk0liqTgzu8XvzJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXotlChs74%253D&md5=0dd0066fff3d6f4b4ce5ed8f8577535a</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00480&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00480%26sid%3Dliteratum%253Aachs%26aulast%3DAli%26aufirst%3DM.%26aulast%3DDondaine%26aufirst%3DL.%26aulast%3DAdolle%26aufirst%3DA.%26aulast%3DSampaio%26aufirst%3DC.%26aulast%3DChotard%26aufirst%3DF.%26aulast%3DRichard%26aufirst%3DP.%26aulast%3DDenat%26aufirst%3DF.%26aulast%3DBettaieb%26aufirst%3DA.%26aulast%3DLe%2BGendre%26aufirst%3DP.%26aulast%3DLaurens%26aufirst%3DV.%26aulast%3DGoze%26aufirst%3DC.%26aulast%3DPaul%26aufirst%3DC.%26aulast%3DBodio%26aufirst%3DE.%26atitle%3DAnticancer%2520agents%253A%2520does%2520a%2520phosphonium%2520behave%2520like%2520a%2520gold%2528I%2529%2520phosphine%2520complex%253F%2520let%2520a%2520%25E2%2580%259Csmart%25E2%2580%259D%2520probe%2520answer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D4521%26epage%3D4528%26doi%3D10.1021%2Facs.jmedchem.5b00480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernández-Gallardo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalo, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mangas-Sanjuan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">González-Alvarez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serrano del Valle, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">González-Alvarez, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bermejo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marzo, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Contel, M.</span></span> <span> </span><span class="NLM_article-title">Cyclometalated iminophosphorane gold(III) and platinum(II) complexes. a highly permeable cationic platinum(II) compound with promising anticancer properties</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">5825</span>– <span class="NLM_lpage">5841</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00427</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00427" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFejt7fL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=5825-5841&author=M.+Frikauthor=J.+Fern%C3%A1ndez-Gallardoauthor=O.+Gonzaloauthor=V.+Mangas-Sanjuanauthor=M.+Gonz%C3%A1lez-Alvarezauthor=A.+Serrano+del+Valleauthor=C.+Huauthor=I.+Gonz%C3%A1lez-Alvarezauthor=M.+Bermejoauthor=I.+Marzoauthor=M.+Contel&title=Cyclometalated+iminophosphorane+gold%28III%29+and+platinum%28II%29+complexes.+a+highly+permeable+cationic+platinum%28II%29+compound+with+promising+anticancer+properties&doi=10.1021%2Facs.jmedchem.5b00427"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclometalated Iminophosphorane Gold(III) and Platinum(II) Complexes. A Highly Permeable Cationic Platinum(II) Compound with Promising Anticancer Properties</span></div><div class="casAuthors">Frik, Malgorzata; Fernandez-Gallardo, Jacob; Gonzalo, Oscar; Mangas-Sanjuan, Victor; Gonzalez-Alvarez, Marta; Serrano del Valle, Alfonso; Hu, Chunhua; Gonzalez-Alvarez, Isabel; Bermejo, Marival; Marzo, Isabel; Contel, Maria</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5825-5841</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">New organometallic gold(III) and platinum(II) complexes contg. iminophosphorane ligands are described.  Most of them are more cytotoxic to a no. of human cancer cell lines than cisplatin.  Cationic Pt(II) derivs. I and II, which differ only in the anion, Hg2Cl62- or PF6- resp., display almost identical IC50 values in the sub-micromolar range (25-335-fold more active than cisplatin on these cell lines).  The gold compds. induced mainly caspase-independent cell death, as previously reported for related cycloaurated compds. contg. IM ligands.  Cycloplatinated compds. III, I, and II can also activate alternative caspase-independent mechanisms of death.  However, at short incubation times cell death seems to be mainly caspase dependent, suggesting that the main mechanism of cell death for these compds. is apoptosis.  Mercury-free compd. II does not interact with plasmid (pBR322) DNA or with calf thymus DNA.  Permeability studies of II by two different assays, in vitro Caco-2 monolayers and a rat perfusion model, have revealed a high permeability profile for this compd. (comparable to that of metoprolol or caffeine) and an estd. oral fraction absorbed of 100%, which potentially makes it a good candidate for oral administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCVbeOCYU7r7Vg90H21EOLACvtfcHk0lihPjjUVgvz3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFejt7fL&md5=4be8e3445fe1696438d76b582f363380</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00427&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00427%26sid%3Dliteratum%253Aachs%26aulast%3DFrik%26aufirst%3DM.%26aulast%3DFern%25C3%25A1ndez-Gallardo%26aufirst%3DJ.%26aulast%3DGonzalo%26aufirst%3DO.%26aulast%3DMangas-Sanjuan%26aufirst%3DV.%26aulast%3DGonz%25C3%25A1lez-Alvarez%26aufirst%3DM.%26aulast%3DSerrano%2Bdel%2BValle%26aufirst%3DA.%26aulast%3DHu%26aufirst%3DC.%26aulast%3DGonz%25C3%25A1lez-Alvarez%26aufirst%3DI.%26aulast%3DBermejo%26aufirst%3DM.%26aulast%3DMarzo%26aufirst%3DI.%26aulast%3DContel%26aufirst%3DM.%26atitle%3DCyclometalated%2520iminophosphorane%2520gold%2528III%2529%2520and%2520platinum%2528II%2529%2520complexes.%2520a%2520highly%2520permeable%2520cationic%2520platinum%2528II%2529%2520compound%2520with%2520promising%2520anticancer%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D5825%26epage%3D5841%26doi%3D10.1021%2Facs.jmedchem.5b00427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hickey, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruhayel, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnard, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berners-Price, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filipovska, A.</span></span> <span> </span><span class="NLM_article-title">Mitochondria-targeted chemotherapeutics: the rational design of gold(I) N-heterocyclic carbene complexes that are selectively toxic to cancer cells and target protein selenols in preference to thiols</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>130</i></span>,  <span class="NLM_fpage">12570</span>– <span class="NLM_lpage">12571</span>, <span class="refDoi"> DOI: 10.1021/ja804027j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja804027j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVCmsrvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2008&pages=12570-12571&author=J.+L.+Hickeyauthor=R.+A.+Ruhayelauthor=P.+J.+Barnardauthor=M.+V.+Bakerauthor=S.+J.+Berners-Priceauthor=A.+Filipovska&title=Mitochondria-targeted+chemotherapeutics%3A+the+rational+design+of+gold%28I%29+N-heterocyclic+carbene+complexes+that+are+selectively+toxic+to+cancer+cells+and+target+protein+selenols+in+preference+to+thiols&doi=10.1021%2Fja804027j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondria-Targeted Chemotherapeutics: The Rational Design of Gold(I) N-Heterocyclic Carbene Complexes That Are Selectively Toxic to Cancer Cells and Target Protein Selenols in Preference to Thiols</span></div><div class="casAuthors">Hickey, James L.; Ruhayel, Rasha A.; Barnard, Peter J.; Baker, Murray V.; Berners-Price, Susan J.; Filipovska, Aleksandra</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">12570-12571</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A family of lipophilic, cationic Au(I) complexes of N-heterocyclic carbenes (NHCs) have been designed as new mitochondria-targeted antitumor agents that combine both selective mitochondrial accumulation and selective thioredoxin reductase inhibition properties within a single mol.  Two-step ligand exchange reactions with cysteine (Cys) and selenocysteine (Sec) occur with release of the NHC ligands.  At physiol. pH the rate consts. for the reactions with Sec are 20- to 80-fold higher than those with Cys.  The complexes are selectively toxic to two highly tumorigenic breast cancer cell lines and not to normal breast cells, and the degree of selectivity and potency are optimized by modification of the substituent on the simple imidazolium salt precursor.  The lead compd. is shown to accumulate in mitochondria of cancer cells, to cause cell death through a mitochondrial apoptotic pathway and to inhibit the activity of thioredoxin reductase (TrxR) but not the closely related and Se-free enzyme glutathione reductase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMjYB2SW6pI7Vg90H21EOLACvtfcHk0lihPjjUVgvz3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVCmsrvK&md5=f30a5a95527abef38383b68181b68708</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fja804027j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja804027j%26sid%3Dliteratum%253Aachs%26aulast%3DHickey%26aufirst%3DJ.%2BL.%26aulast%3DRuhayel%26aufirst%3DR.%2BA.%26aulast%3DBarnard%26aufirst%3DP.%2BJ.%26aulast%3DBaker%26aufirst%3DM.%2BV.%26aulast%3DBerners-Price%26aufirst%3DS.%2BJ.%26aulast%3DFilipovska%26aufirst%3DA.%26atitle%3DMitochondria-targeted%2520chemotherapeutics%253A%2520the%2520rational%2520design%2520of%2520gold%2528I%2529%2520N-heterocyclic%2520carbene%2520complexes%2520that%2520are%2520selectively%2520toxic%2520to%2520cancer%2520cells%2520and%2520target%2520protein%2520selenols%2520in%2520preference%2520to%2520thiols%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2008%26volume%3D130%26spage%3D12570%26epage%3D12571%26doi%3D10.1021%2Fja804027j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">da
S. Maia, P. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ponader, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagenbach, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergemann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gust, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deflon, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abram, U.</span></span> <span> </span><span class="NLM_article-title">Neutral gold complexes with tridentate SNS thiosemicarbazide ligands</span>. <i>Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">1604</span>– <span class="NLM_lpage">1613</span>, <span class="refDoi"> DOI: 10.1021/ic201905t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ic201905t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=1604-1613&author=P.+I.+da%0AS.+Maiaauthor=H.+H.+Nguyenauthor=D.+Ponaderauthor=A.+Hagenbachauthor=S.+Bergemannauthor=R.+Gustauthor=V.+M.+Deflonauthor=U.+Abram&title=Neutral+gold+complexes+with+tridentate+SNS+thiosemicarbazide+ligands&doi=10.1021%2Fic201905t"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fic201905t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fic201905t%26sid%3Dliteratum%253Aachs%26aulast%3Dda%2BS.%2BMaia%26aufirst%3DP.%2BI.%26aulast%3DNguyen%26aufirst%3DH.%2BH.%26aulast%3DPonader%26aufirst%3DD.%26aulast%3DHagenbach%26aufirst%3DA.%26aulast%3DBergemann%26aufirst%3DS.%26aulast%3DGust%26aufirst%3DR.%26aulast%3DDeflon%26aufirst%3DV.%2BM.%26aulast%3DAbram%26aufirst%3DU.%26atitle%3DNeutral%2520gold%2520complexes%2520with%2520tridentate%2520SNS%2520thiosemicarbazide%2520ligands%26jtitle%3DInorg.%2520Chem.%26date%3D2012%26volume%3D51%26spage%3D1604%26epage%3D1613%26doi%3D10.1021%2Fic201905t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Casas, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castaño, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cifuentes, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Monteagudo, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sánchez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sordo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abram, U.</span></span> <span> </span><span class="NLM_article-title">Complexes of dichloro[2-(dimethylaminomethyl)phenyl-<i>C</i><sup>1</sup>,<i>N</i>]gold(III),[Au(damp-<i>C</i><sup>1</sup>,N)Cl<sub>2</sub>], with formylferrocene thiosemicarbazone: synthesis, structure and cytotoxicity</span>. <i>J. Inorg. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">1009</span>– <span class="NLM_lpage">1016</span>, <span class="refDoi"> DOI: 10.1016/j.jinorgbio.2004.02.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.1016%2Fj.jinorgbio.2004.02.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=15149809" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BD2cXktVCmtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2004&pages=1009-1016&author=J.+S.+Casasauthor=M.+V.+Casta%C3%B1oauthor=M.+C.+Cifuentesauthor=J.+C.+Garc%C3%ADa-Monteagudoauthor=A.+S%C3%A1nchezauthor=J.+Sordoauthor=U.+Abram&title=Complexes+of+dichloro%5B2-%28dimethylaminomethyl%29phenyl-C1%2CN%5Dgold%28III%29%2C%5BAu%28damp-C1%2CN%29Cl2%5D%2C+with+formylferrocene+thiosemicarbazone%3A+synthesis%2C+structure+and+cytotoxicity&doi=10.1016%2Fj.jinorgbio.2004.02.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Complexes of dichloro[2-(dimethylaminomethyl)phenyl-C1,N]gold(III), [Au(damp-C1,N)Cl2], with formylferrocene thiosemicarbazones: synthesis, structure and cytotoxicity</span></div><div class="casAuthors">Casas, Jose S.; Castano, Maria V.; Cifuentes, Maria C.; Garcia-Monteagudo, Juan C.; Sanchez, Agustin; Sordo, Jose; Abram, Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Inorganic Biochemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1009-1016</span>CODEN:
                <span class="NLM_cas:coden">JIBIDJ</span>;
        ISSN:<span class="NLM_cas:issn">0162-0134</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Dichloro[2-(dimethylaminomethyl)phenyl-C1,N]gold(III), [Au(damp-C1,N)Cl2], reacts with the formylferrocene thiosemicarbazones derived from 4-methyl-, 4-phenyl-, 4-ethyl- and 4,4-dimethyl-3-thiosemicarbazides, HFcTSC, to give complexes of general formula [Au(Hdamp-1C)Cl(FcTSC)]Cl.  These complexes were isolated and characterized by elemental anal., mass spectrometry and IR, 1H NMR and 13C NMR spectroscopy.  In some cases, cyclic voltammetric studies were carried out and these showed that the complexation of gold affects the redox behavior of the ferrocene unit.  The in vitro antitumor activity against the HeLa cell line was also detd. for the more sol. complexes.  The IC50 values were found to be higher than that of cisplatin but the max. antiproliferative activity was similar.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoM3jcic_Jm17Vg90H21EOLACvtfcHk0lj8KVl3UxCvBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXktVCmtr8%253D&md5=45bd62162d8aaaa90e57dcc824b5c46e</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.jinorgbio.2004.02.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jinorgbio.2004.02.019%26sid%3Dliteratum%253Aachs%26aulast%3DCasas%26aufirst%3DJ.%2BS.%26aulast%3DCasta%25C3%25B1o%26aufirst%3DM.%2BV.%26aulast%3DCifuentes%26aufirst%3DM.%2BC.%26aulast%3DGarc%25C3%25ADa-Monteagudo%26aufirst%3DJ.%2BC.%26aulast%3DS%25C3%25A1nchez%26aufirst%3DA.%26aulast%3DSordo%26aufirst%3DJ.%26aulast%3DAbram%26aufirst%3DU.%26atitle%3DComplexes%2520of%2520dichloro%255B2-%2528dimethylaminomethyl%2529phenyl-C1%252CN%255Dgold%2528III%2529%252C%255BAu%2528damp-C1%252CN%2529Cl2%255D%252C%2520with%2520formylferrocene%2520thiosemicarbazone%253A%2520synthesis%252C%2520structure%2520and%2520cytotoxicity%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D2004%26volume%3D98%26spage%3D1009%26epage%3D1016%26doi%3D10.1016%2Fj.jinorgbio.2004.02.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kowol, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eichinger, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roller, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakupec, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arion, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keppler, B. K.</span></span> <span> </span><span class="NLM_article-title">Gallium(III) and iron(III) complexes of α-N-heterocyclic thiosemicarbazone: synthesis, characterization, cytotoxicity, and interaction with ribonucleotide reductase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">1254</span>– <span class="NLM_lpage">1265</span>, <span class="refDoi"> DOI: 10.1021/jm0612618</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0612618" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhvFags7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=1254-1265&author=C.+R.+Kowolauthor=R.+Bergerauthor=R.+Eichingerauthor=A.+Rollerauthor=M.+A.+Jakupecauthor=P.+P.+Schmidtauthor=V.+B.+Arionauthor=B.+K.+Keppler&title=Gallium%28III%29+and+iron%28III%29+complexes+of+%CE%B1-N-heterocyclic+thiosemicarbazone%3A+synthesis%2C+characterization%2C+cytotoxicity%2C+and+interaction+with+ribonucleotide+reductase&doi=10.1021%2Fjm0612618"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Gallium(III) and Iron(III) Complexes of α-N-Heterocyclic Thiosemicarbazones: Synthesis, Characterization, Cytotoxicity, and Interaction with Ribonucleotide Reductase</span></div><div class="casAuthors">Kowol, Christian R.; Berger, Roland; Eichinger, Rene; Roller, Alexander; Jakupec, Michael A.; Schmidt, Peter P.; Arion, Vladimir B.; Keppler, Bernhard K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1254-1265</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Ga(III) and Fe(III) complexes with five different 4N-substituted α-N-heterocyclic thiosemicarbazones, viz., 2-acetylpyridine N,N-dimethylthiosemicarbazone (1), 2-acetylpyridine N-pyrrolidinylthiosemicarbazone (2), acetylpyrazine N,N-dimethylthiosemicarbazone (3), acetylpyrazine N-pyrrolidinylthiosemicarbazone (4), and acetylpyrazine N-piperidinylthiosemicarbazone (5), [GaLCl2] (HL = 1 and 2) and [ML2][Y] (M = Ga, HL = 1-5, Y = PF6; M = Fe, HL = 1-5, Y = FeCl4 and PF6) were synthesized and characterized by elemental anal., a no. of spectroscopic methods (NMR, IR, UV-visible), mass spectrometry, and x-ray crystallog.  In vitro antitumor potency was studied in human cancer cell lines (41M and SK-BR-3).  The central metal ions exert pronounced effects in a divergent manner: Ga(III) enhances, whereas Fe(III) weakens the cytotoxicity of the ligands.  The capacity of ligand 1 and its Ga(III) and Fe(III) complexes to destroy the tyrosyl radical of the presumed target ribonucleotide reductase is reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrK0rY8cgonJLVg90H21EOLACvtfcHk0lj8KVl3UxCvBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhvFags7g%253D&md5=18ea78354426cd88f574be43934eee27</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm0612618&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0612618%26sid%3Dliteratum%253Aachs%26aulast%3DKowol%26aufirst%3DC.%2BR.%26aulast%3DBerger%26aufirst%3DR.%26aulast%3DEichinger%26aufirst%3DR.%26aulast%3DRoller%26aufirst%3DA.%26aulast%3DJakupec%26aufirst%3DM.%2BA.%26aulast%3DSchmidt%26aufirst%3DP.%2BP.%26aulast%3DArion%26aufirst%3DV.%2BB.%26aulast%3DKeppler%26aufirst%3DB.%2BK.%26atitle%3DGallium%2528III%2529%2520and%2520iron%2528III%2529%2520complexes%2520of%2520%25CE%25B1-N-heterocyclic%2520thiosemicarbazone%253A%2520synthesis%252C%2520characterization%252C%2520cytotoxicity%252C%2520and%2520interaction%2520with%2520ribonucleotide%2520reductase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D1254%26epage%3D1265%26doi%3D10.1021%2Fjm0612618" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lovejoy, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharp, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seebacher, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obeidy, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prichard, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefani, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basha, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharpe, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jansson, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalinowski, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernhardt, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, D. R.</span></span> <span> </span><span class="NLM_article-title">Novel second-generation di-2-pyridylketone thiosemicarbazones show synergism with standard chemotherapeutics and demonstrate potent activity against lung cancer xenogrAFts after oral and intravenous administration <i>in vivo</i></span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">7230</span>– <span class="NLM_lpage">7244</span>, <span class="refDoi"> DOI: 10.1021/jm300768u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300768u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFClurbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=7230-7244&author=D.+B.+Lovejoyauthor=D.+M.+Sharpauthor=N.+Seebacherauthor=P.+Obeidyauthor=T.+Prichardauthor=C.+Stefaniauthor=M.+T.+Bashaauthor=P.+C.+Sharpeauthor=P.+J.+Janssonauthor=D.+S.+Kalinowskiauthor=P.+V.+Bernhardtauthor=D.+R.+Richardson&title=Novel+second-generation+di-2-pyridylketone+thiosemicarbazones+show+synergism+with+standard+chemotherapeutics+and+demonstrate+potent+activity+against+lung+cancer+xenogrAFts+after+oral+and+intravenous+administration+in+vivo&doi=10.1021%2Fjm300768u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Second-Generation Di-2-Pyridylketone Thiosemicarbazones Show Synergism with Standard Chemotherapeutics and Demonstrate Potent Activity against Lung Cancer Xenografts after Oral and Intravenous Administration in Vivo</span></div><div class="casAuthors">Lovejoy, David B.; Sharp, Danae M.; Seebacher, Nicole; Obeidy, Peyman; Prichard, Thomas; Stefani, Christian; Basha, Maram T.; Sharpe, Philip C.; Jansson, Patric J.; Kalinowski, Danuta S.; Bernhardt, Paul V.; Richardson, Des R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7230-7244</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We developed a series of second-generation di-2-pyridyl ketone thiosemicarbazone (DpT) and 2-benzoylpyridine thiosemicarbazone (BpT) ligands to improve the efficacy and safety profile of these potential antitumor agents.  Two novel DpT analogs, Dp4e4mT and DpC, exhibited pronounced and selective activity against human lung cancer xenografts in vivo via the i.v. and oral routes.  Importantly, these analogs did not induce the cardiotoxicity obsd. at high nonoptimal doses of the first-generation DpT analog, Dp44mT.  The Cu(II) complexes of these ligands exhibited potent antiproliferative activity having redox potentials in a range accessible to biol. reductants.  The activity of the copper complexes of Dp4e4mT and DpC against lung cancer cells was synergistic in combination with gemcitabine or cisplatin.  It was demonstrated by EPR spectroscopy that dimeric copper compds. of the type [CuLCl]2, identified crystallog., dissoc. in soln. to give monomeric 1:1 Cu:ligand complexes.  These monomers represent the biol. active form of the complex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo75KAO0Ooc6bVg90H21EOLACvtfcHk0ljWlFH_RLhp7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFClurbK&md5=ce94f696851fc28cde48fc91bb38d132</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm300768u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300768u%26sid%3Dliteratum%253Aachs%26aulast%3DLovejoy%26aufirst%3DD.%2BB.%26aulast%3DSharp%26aufirst%3DD.%2BM.%26aulast%3DSeebacher%26aufirst%3DN.%26aulast%3DObeidy%26aufirst%3DP.%26aulast%3DPrichard%26aufirst%3DT.%26aulast%3DStefani%26aufirst%3DC.%26aulast%3DBasha%26aufirst%3DM.%2BT.%26aulast%3DSharpe%26aufirst%3DP.%2BC.%26aulast%3DJansson%26aufirst%3DP.%2BJ.%26aulast%3DKalinowski%26aufirst%3DD.%2BS.%26aulast%3DBernhardt%26aufirst%3DP.%2BV.%26aulast%3DRichardson%26aufirst%3DD.%2BR.%26atitle%3DNovel%2520second-generation%2520di-2-pyridylketone%2520thiosemicarbazones%2520show%2520synergism%2520with%2520standard%2520chemotherapeutics%2520and%2520demonstrate%2520potent%2520activity%2520against%2520lung%2520cancer%2520xenogrAFts%2520after%2520oral%2520and%2520intravenous%2520administration%2520in%2520vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D7230%26epage%3D7244%26doi%3D10.1021%2Fjm300768u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, F.</span></span> <span> </span><span class="NLM_article-title">Developing anticancer ferric prodrugs based on the N-Donor residues of human serum albumin carrier IIA subdomain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">7497</span>– <span class="NLM_lpage">7511</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00509</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00509" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1SktLrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=7497-7511&author=J.+Qiauthor=Y.+Gouauthor=Y.+Zhangauthor=K.+Yangauthor=S.+Chenauthor=L.+Liuauthor=X.+Wuauthor=T.+Wangauthor=W.+Zhangauthor=F.+Yang&title=Developing+anticancer+ferric+prodrugs+based+on+the+N-Donor+residues+of+human+serum+albumin+carrier+IIA+subdomain&doi=10.1021%2Facs.jmedchem.6b00509"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Developing Anticancer Ferric Prodrugs Based on the N-Donor Residues of Human Serum Albumin Carrier IIA Subdomain</span></div><div class="casAuthors">Qi, Jinxu; Gou, Yi; Zhang, Yao; Yang, Kun; Chen, Shifang; Liu, Li; Wu, Xiaoyang; Wang, Tao; Zhang, Wei; Yang, Feng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7497-7511</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To improve the selectivity, delivery, and activity of ferric (Fe) anticancer agents, the authors design prodrugs based on N-donor residues of the human serum albumin (HSA) carrier IIA subdomain.  The authors synthesized six Fe(III) compds. derived from 2-hydroxy-1-naphthaldehyde thiosemicarbazone (7-12).  HSA complex structure revealed that Fe compd. binds to the hydrophobic cavity in the HSA IIA subdomain.  Lys199 and His242 of HSA replace the two Cl atoms of Fe compd., coordinating with Fe3+.  In vivo data revealed that compd. 12 and HSA-12 complex inhibit the growth of the liver tumor and that the HSA-12 complex has stronger targeting ability and therapeutic efficacy than compd. 12 alone.  The authors' results showed that compd. 12 and HSA-12 complex induce Bel-7402 cell death possible by several mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgWEKbMYrXyrVg90H21EOLACvtfcHk0ljWlFH_RLhp7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1SktLrM&md5=6b9d962c4272056886c3525f2e7fcd1c</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00509&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00509%26sid%3Dliteratum%253Aachs%26aulast%3DQi%26aufirst%3DJ.%26aulast%3DGou%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DF.%26atitle%3DDeveloping%2520anticancer%2520ferric%2520prodrugs%2520based%2520on%2520the%2520N-Donor%2520residues%2520of%2520human%2520serum%2520albumin%2520carrier%2520IIA%2520subdomain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D7497%26epage%3D7511%26doi%3D10.1021%2Facs.jmedchem.6b00509" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muhammad, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Z.</span></span> <span> </span><span class="NLM_article-title">Metal-based anticancer chemo-therapeutic agents</span>. <i>Curr. Opin. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">144</span>– <span class="NLM_lpage">153</span>, <span class="refDoi"> DOI: 10.1016/j.cbpa.2014.02.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.1016%2Fj.cbpa.2014.02.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=24608084" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BC2cXntFymtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=144-153&author=N.+Muhammadauthor=Z.+Guo&title=Metal-based+anticancer+chemo-therapeutic+agents&doi=10.1016%2Fj.cbpa.2014.02.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Metal-based anticancer chemotherapeutic agents</span></div><div class="casAuthors">Muhammad, Nafees; Guo, Zijian</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">144-153</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Since the discovery of the cisplatin antitumor activity, great efforts have focused on the rational design of metal-based anticancer agents that can be potentially used in cancer chemotherapy.  Over the last four decades, a large no. of metal complexes have been extensively investigated and evaluated in vitro and in vivo, and some of them were at different stages of clin. studies.  Amongst these complexes, platinum (PtII and PtIV), ruthenium (RuII and RuIII), gold (AuI and AuIII) and titanium (TiIV) complexes are the most studied metals.  We describe here some most recent progresses on PtIV prodrugs which can be activated once enter tumor cells, polynuclear PtII complexes which have unique DNA binding ability and mode, anti-metastatic RuII/RuIII complexes, and AuI/AuIII and TiIV antitumor active complexes.  The key focuses of these studies lie in finding novel metal complexes which could potentially overcome the hurdles of current clin. drugs including toxicity, resistance and other pharmacol. deficiencies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqitR6wQhcA-LVg90H21EOLACvtfcHk0ljWlFH_RLhp7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXntFymtbk%253D&md5=f082fcbe7c5069a5606a3b0ede09122d</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2014.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2014.02.003%26sid%3Dliteratum%253Aachs%26aulast%3DMuhammad%26aufirst%3DN.%26aulast%3DGuo%26aufirst%3DZ.%26atitle%3DMetal-based%2520anticancer%2520chemo-therapeutic%2520agents%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2014%26volume%3D19%26spage%3D144%26epage%3D153%26doi%3D10.1016%2Fj.cbpa.2014.02.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jansson, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharpe, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernhardt, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, D. R.</span></span> <span> </span><span class="NLM_article-title">Novel thiosemicarbazones of the ApT and DpT series and their copper complexes: identification of pronounced redox activity and characterization of their antitumor activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">5759</span>– <span class="NLM_lpage">5769</span>, <span class="refDoi"> DOI: 10.1021/jm100561b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100561b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BC3cXotlSnsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5759-5769&author=P.+J.+Janssonauthor=P.+C.+Sharpeauthor=P.+V.+Bernhardtauthor=D.+R.+Richardson&title=Novel+thiosemicarbazones+of+the+ApT+and+DpT+series+and+their+copper+complexes%3A+identification+of+pronounced+redox+activity+and+characterization+of+their+antitumor+activity&doi=10.1021%2Fjm100561b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Thiosemicarbazones of the ApT and DpT Series and Their Copper Complexes: Identification of Pronounced Redox Activity and Characterization of Their Antitumor Activity</span></div><div class="casAuthors">Jansson, Patric J.; Sharpe, Philip C.; Bernhardt, Paul V.; Richardson, Des R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5759-5769</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The novel chelators 2-acetylpyridine-4,4-dimethyl-3-thiosemicarbazone (HAp44mT) and di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone (HDp44mT) have been examd. to elucidate the structure-activity relationships necessary to form copper (Cu) complexes with pronounced antitumor activity.  Electrochem. studies demonstrated that the Cu complexes of these ligands had lower redox potentials than their iron complexes.  Moreover, the Cu complexes where the ligand/metal ratio was 1:1 rather than 2:1 had significantly higher intracellular oxidative properties and antitumor efficacy.  Interestingly, the 2:1 complex was shown to dissoc. to give significant amts. of the 1:1 complex that could be the major cytotoxic effector.  Both types of Cu complex showed significantly more antiproliferative activity than the ligand alone.  We also demonstrate the importance of the inductive effects of substituents on the carbonyl group of the parent ketone, which influence the CuII/I redox potentials because of their proximity to the metal center.  The structure-activity relationships described are important for the design of potent thiosemicarbazone Cu complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhryQ9dAB5CLVg90H21EOLACvtfcHk0lg_dbEzSFA3Sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXotlSnsr4%253D&md5=7417f8c18eed7edddd542da369ecb5ab</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm100561b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100561b%26sid%3Dliteratum%253Aachs%26aulast%3DJansson%26aufirst%3DP.%2BJ.%26aulast%3DSharpe%26aufirst%3DP.%2BC.%26aulast%3DBernhardt%26aufirst%3DP.%2BV.%26aulast%3DRichardson%26aufirst%3DD.%2BR.%26atitle%3DNovel%2520thiosemicarbazones%2520of%2520the%2520ApT%2520and%2520DpT%2520series%2520and%2520their%2520copper%2520complexes%253A%2520identification%2520of%2520pronounced%2520redox%2520activity%2520and%2520characterization%2520of%2520their%2520antitumor%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D5759%26epage%3D5769%26doi%3D10.1021%2Fjm100561b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conde, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, X.</span></span> <span> </span><span class="NLM_article-title">Ferritin nanocarrier traverses the blood brain barrier and kills glioma</span>. <i>ACS Nano</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">4105</span>– <span class="NLM_lpage">4115</span>, <span class="refDoi"> DOI: 10.1021/acsnano.7b06969</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsnano.7b06969" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmvVaktLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2018&pages=4105-4115&author=K.+Fanauthor=X.+Jiaauthor=M.+Zhouauthor=K.+Wangauthor=J.+Condeauthor=J.+Heauthor=J.+Tianauthor=X.+Yan&title=Ferritin+nanocarrier+traverses+the+blood+brain+barrier+and+kills+glioma&doi=10.1021%2Facsnano.7b06969"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Ferritin nanocarrier traverses the blood brain barrier and kills glioma</span></div><div class="casAuthors">Fan, Kelong; Jia, Xiaohua; Zhou, Meng; Wang, Kun; Conde, Joao; He, Jiuyang; Tian, Jie; Yan, Xiyun</div><div class="citationInfo"><span class="NLM_cas:title">ACS Nano</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">4105-4115</span>CODEN:
                <span class="NLM_cas:coden">ANCAC3</span>;
        ISSN:<span class="NLM_cas:issn">1936-0851</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Over the last decades, considerable efforts have been put into developing active nanocarrier systems that cross the blood brain barrier (BBB) to treat brain-related diseases such as glioma tumors.  However, to date none have been approved for clin. usage.  Here, we show that a human H-ferritin (HFn) nanocarrier both successfully crosses the BBB and kills glioma tumor cells.  Its principle point of entry is the HFn receptor (transferrin receptor 1), which is overexpressed in both BBB endothelial cells (ECs) and glioma cells.  Importantly, we found that HFn enters and exits the BBB via the endosome compartment.  In contrast, upon specifically targeting and entering glioma cells, nearly all of the HFn accumulated in the lysosomal compartment, resulting in the killing of glioma tumor cells, with no HFn accumulation in the surrounding healthy brain tissue.  Thus, HFn is an ideal nanocarrier for glioma therapy and possesses the potential to serve as a therapeutic approach against a broad range of central nervous system diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrh1GasvY-QyLVg90H21EOLACvtfcHk0lg_dbEzSFA3Sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmvVaktLo%253D&md5=b5aacd421d7304f1043701926200437a</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Facsnano.7b06969&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsnano.7b06969%26sid%3Dliteratum%253Aachs%26aulast%3DFan%26aufirst%3DK.%26aulast%3DJia%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DK.%26aulast%3DConde%26aufirst%3DJ.%26aulast%3DHe%26aufirst%3DJ.%26aulast%3DTian%26aufirst%3DJ.%26aulast%3DYan%26aufirst%3DX.%26atitle%3DFerritin%2520nanocarrier%2520traverses%2520the%2520blood%2520brain%2520barrier%2520and%2520kills%2520glioma%26jtitle%3DACS%2520Nano%26date%3D2018%26volume%3D12%26spage%3D4105%26epage%3D4115%26doi%3D10.1021%2Facsnano.7b06969" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pelaz, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexiou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez-Puebla, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alves, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashraf, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balogh, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballerini, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bestetti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brendel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carril, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, W. C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dullin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escudero, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feliu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">George, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gogotsi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grünweller, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halas, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hampp, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hersam, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunziker, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jungebluth, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kadhiresan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kataoka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khademhosseini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kopeček, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotov, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krug, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehr, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leong, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ling, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liz-Marzán, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macchiarini, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Möhwald, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mulvaney, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nel, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nordlander, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okano, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliveira, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penner, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prato, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puntes, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rotello, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samarakoon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaak, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sjöqvist, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skirtach, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soliman, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sung, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, B. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tietze, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Udugama, B. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">VanEpps, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weil, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willner, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yue, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parak, W. J.</span></span> <span> </span><span class="NLM_article-title">Diverse applications of nanomedicine</span>. <i>ACS Nano</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">2313</span>– <span class="NLM_lpage">2381</span>, <span class="refDoi"> DOI: 10.1021/acsnano.6b06040</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsnano.6b06040" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BC2sXktV2isLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2017&pages=2313-2381&author=B.+Pelazauthor=C.+Alexiouauthor=R.+A.+Alvarez-Pueblaauthor=F.+Alvesauthor=A.+M.+Andrewsauthor=S.+Ashrafauthor=L.+P.+Baloghauthor=L.+Balleriniauthor=A.+Bestettiauthor=C.+Brendelauthor=S.+Bosiauthor=M.+Carrilauthor=W.+C.+W.+Chanauthor=C.+Chenauthor=X.+Chenauthor=X.+Chenauthor=Z.+Chengauthor=D.+Cuiauthor=J.+Duauthor=C.+Dullinauthor=A.+Escuderoauthor=N.+Feliuauthor=M.+Gaoauthor=M.+Georgeauthor=Y.+Gogotsiauthor=A.+Gr%C3%BCnwellerauthor=Z.+Guauthor=N.+J.+Halasauthor=N.+Hamppauthor=R.+K.+Hartmannauthor=M.+C.+Hersamauthor=P.+Hunzikerauthor=J.+Jianauthor=X.+Jiangauthor=P.+Jungebluthauthor=P.+Kadhiresanauthor=K.+Kataokaauthor=A.+Khademhosseiniauthor=J.+Kope%C4%8Dekauthor=N.+A.+Kotovauthor=H.+F.+Krugauthor=D.+S.+Leeauthor=C.+M.+Lehrauthor=K.+W.+Leongauthor=X.+J.+Liangauthor=L.+M.+Lingauthor=L.+M.+Liz-Marz%C3%A1nauthor=X.+Maauthor=P.+Macchiariniauthor=H.+Mengauthor=H.+M%C3%B6hwaldauthor=P.+Mulvaneyauthor=A.+E.+Nelauthor=S.+Nieauthor=P.+Nordlanderauthor=T.+Okanoauthor=J.+Oliveiraauthor=T.+H.+Parkauthor=R.+M.+Pennerauthor=M.+Pratoauthor=V.+Puntesauthor=V.+M.+Rotelloauthor=A.+Samarakoonauthor=R.+E.+Schaakauthor=Y.+Shenauthor=S.+Sj%C3%B6qvistauthor=A.+G.+Skirtachauthor=M.+G.+Solimanauthor=M.+M.+Stevensauthor=H.+W.+Sungauthor=B.+Z.+Tangauthor=R.+Tietzeauthor=B.+N.+Udugamaauthor=J.+S.+VanEppsauthor=T.+Weilauthor=P.+S.+Weissauthor=I.+Willnerauthor=Y.+Wuauthor=L.+Yangauthor=Z.+Yueauthor=Q.+Zhangauthor=Q.+Zhangauthor=X.+E.+Zhangauthor=Y.+Zhaoauthor=X.+Zhouauthor=W.+J.+Parak&title=Diverse+applications+of+nanomedicine&doi=10.1021%2Facsnano.6b06040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Diverse Applications of Nanomedicine</span></div><div class="casAuthors">Pelaz, Beatriz; Alexiou, Christoph; Alvarez-Puebla, Ramon A.; Alves, Frauke; Andrews, Anne M.; Ashraf, Sumaira; Balogh, Lajos P.; Ballerini, Laura; Bestetti, Alessandra; Brendel, Cornelia; Bosi, Susanna; Carril, Monica; Chan, Warren C. W.; Chen, Chunying; Chen, Xiaodong; Chen, Xiaoyuan; Cheng, Zhen; Cui, Daxiang; Du, Jianzhong; Dullin, Christian; Escudero, Alberto; Feliu, Neus; Gao, Mingyuan; George, Michael; Gogotsi, Yury; Gruenweller, Arnold; Gu, Zhongwei; Halas, Naomi J.; Hampp, Norbert; Hartmann, Roland K.; Hersam, Mark C.; Hunziker, Patrick; Jian, Ji; Jiang, Xingyu; Jungebluth, Philipp; Kadhiresan, Pranav; Kataoka, Kazunori; Khademhosseini, Ali; Kopecek, Jindrich; Kotov, Nicholas A.; Krug, Harald F.; Lee, Dong Soo; Lehr, Claus-Michael; Leong, Kam W.; Liang, Xing-Jie; Ling Lim, Mei; Liz-Marzan, Luis M.; Ma, Xiaowei; Macchiarini, Paolo; Meng, Huan; Moehwald, Helmuth; Mulvaney, Paul; Nel, Andre E.; Nie, Shuming; Nordlander, Peter; Okano, Teruo; Oliveira, Jose; Park, Tai Hyun; Penner, Reginald M.; Prato, Maurizio; Puntes, Victor; Rotello, Vincent M.; Samarakoon, Amila; Schaak, Raymond E.; Shen, Youqing; Sjoeqvist, Sebastian; Skirtach, Andre G.; Soliman, Mahmoud G.; Stevens, Molly M.; Sung, Hsing-Wen; Tang, Ben Zhong; Tietze, Rainer; Udugama, Buddhisha N.; VanEpps, J. Scott; Weil, Tanja; Weiss, Paul S.; Willner, Itamar; Wu, Yuzhou; Yang, Lily; Yue, Zhao; Zhang, Qian; Zhang, Qiang; Zhang, Xian-En; Zhao, Yuliang; Zhou, Xin; Parak, Wolfgang J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Nano</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">2313-2381</span>CODEN:
                <span class="NLM_cas:coden">ANCAC3</span>;
        ISSN:<span class="NLM_cas:issn">1936-0851</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The design and use of materials in the nanoscale size range for addressing medical and health-related issues continues to receive increasing interest.  Research in nanomedicine spans a multitude of areas, including drug delivery, vaccine development, antibacterial, diagnosis and imaging tools, wearable devices, implants, high-throughput screening platforms, etc. using biol., nonbiol., biomimetic, or hybrid materials.  Many of these developments are starting to be translated into viable clin. products.  Here, we provide an overview of recent developments in nanomedicine and highlight the current challenges and upcoming opportunities for the field and translation to the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWUllaG7Ak6LVg90H21EOLACvtfcHk0lgZveuKxUOL8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXktV2isLg%253D&md5=3441feba35a8ea371b661906e1d0813b</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Facsnano.6b06040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsnano.6b06040%26sid%3Dliteratum%253Aachs%26aulast%3DPelaz%26aufirst%3DB.%26aulast%3DAlexiou%26aufirst%3DC.%26aulast%3DAlvarez-Puebla%26aufirst%3DR.%2BA.%26aulast%3DAlves%26aufirst%3DF.%26aulast%3DAndrews%26aufirst%3DA.%2BM.%26aulast%3DAshraf%26aufirst%3DS.%26aulast%3DBalogh%26aufirst%3DL.%2BP.%26aulast%3DBallerini%26aufirst%3DL.%26aulast%3DBestetti%26aufirst%3DA.%26aulast%3DBrendel%26aufirst%3DC.%26aulast%3DBosi%26aufirst%3DS.%26aulast%3DCarril%26aufirst%3DM.%26aulast%3DChan%26aufirst%3DW.%2BC.%2BW.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DCheng%26aufirst%3DZ.%26aulast%3DCui%26aufirst%3DD.%26aulast%3DDu%26aufirst%3DJ.%26aulast%3DDullin%26aufirst%3DC.%26aulast%3DEscudero%26aufirst%3DA.%26aulast%3DFeliu%26aufirst%3DN.%26aulast%3DGao%26aufirst%3DM.%26aulast%3DGeorge%26aufirst%3DM.%26aulast%3DGogotsi%26aufirst%3DY.%26aulast%3DGr%25C3%25BCnweller%26aufirst%3DA.%26aulast%3DGu%26aufirst%3DZ.%26aulast%3DHalas%26aufirst%3DN.%2BJ.%26aulast%3DHampp%26aufirst%3DN.%26aulast%3DHartmann%26aufirst%3DR.%2BK.%26aulast%3DHersam%26aufirst%3DM.%2BC.%26aulast%3DHunziker%26aufirst%3DP.%26aulast%3DJian%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DJungebluth%26aufirst%3DP.%26aulast%3DKadhiresan%26aufirst%3DP.%26aulast%3DKataoka%26aufirst%3DK.%26aulast%3DKhademhosseini%26aufirst%3DA.%26aulast%3DKope%25C4%258Dek%26aufirst%3DJ.%26aulast%3DKotov%26aufirst%3DN.%2BA.%26aulast%3DKrug%26aufirst%3DH.%2BF.%26aulast%3DLee%26aufirst%3DD.%2BS.%26aulast%3DLehr%26aufirst%3DC.%2BM.%26aulast%3DLeong%26aufirst%3DK.%2BW.%26aulast%3DLiang%26aufirst%3DX.%2BJ.%26aulast%3DLing%26aufirst%3DL.%2BM.%26aulast%3DLiz-Marz%25C3%25A1n%26aufirst%3DL.%2BM.%26aulast%3DMa%26aufirst%3DX.%26aulast%3DMacchiarini%26aufirst%3DP.%26aulast%3DMeng%26aufirst%3DH.%26aulast%3DM%25C3%25B6hwald%26aufirst%3DH.%26aulast%3DMulvaney%26aufirst%3DP.%26aulast%3DNel%26aufirst%3DA.%2BE.%26aulast%3DNie%26aufirst%3DS.%26aulast%3DNordlander%26aufirst%3DP.%26aulast%3DOkano%26aufirst%3DT.%26aulast%3DOliveira%26aufirst%3DJ.%26aulast%3DPark%26aufirst%3DT.%2BH.%26aulast%3DPenner%26aufirst%3DR.%2BM.%26aulast%3DPrato%26aufirst%3DM.%26aulast%3DPuntes%26aufirst%3DV.%26aulast%3DRotello%26aufirst%3DV.%2BM.%26aulast%3DSamarakoon%26aufirst%3DA.%26aulast%3DSchaak%26aufirst%3DR.%2BE.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DSj%25C3%25B6qvist%26aufirst%3DS.%26aulast%3DSkirtach%26aufirst%3DA.%2BG.%26aulast%3DSoliman%26aufirst%3DM.%2BG.%26aulast%3DStevens%26aufirst%3DM.%2BM.%26aulast%3DSung%26aufirst%3DH.%2BW.%26aulast%3DTang%26aufirst%3DB.%2BZ.%26aulast%3DTietze%26aufirst%3DR.%26aulast%3DUdugama%26aufirst%3DB.%2BN.%26aulast%3DVanEpps%26aufirst%3DJ.%2BS.%26aulast%3DWeil%26aufirst%3DT.%26aulast%3DWeiss%26aufirst%3DP.%2BS.%26aulast%3DWillner%26aufirst%3DI.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DYue%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DX.%2BE.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DParak%26aufirst%3DW.%2BJ.%26atitle%3DDiverse%2520applications%2520of%2520nanomedicine%26jtitle%3DACS%2520Nano%26date%3D2017%26volume%3D11%26spage%3D2313%26epage%3D2381%26doi%3D10.1021%2Facsnano.6b06040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cerna, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stiborova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adam, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kizek, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckschlager, T.</span></span> <span> </span><span class="NLM_article-title">Nanocarrier drugs in the treatment of brain tumors</span>. <i>J. Cancer Metastasis Treat.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">407</span>– <span class="NLM_lpage">416</span>, <span class="refDoi"> DOI: 10.20517/2394-4722.2015.95</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.20517%2F2394-4722.2015.95" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlShu7rE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2016&pages=407-416&author=T.+Cernaauthor=M.+Stiborovaauthor=V.+Adamauthor=R.+Kizekauthor=T.+Eckschlager&title=Nanocarrier+drugs+in+the+treatment+of+brain+tumors&doi=10.20517%2F2394-4722.2015.95"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Nanocarrier drugs in the treatment of brain tumors</span></div><div class="casAuthors">Cerna, Tereza; Stiborova, Marie; Adam, Vojtech; Kizek, Rene; Eckschlager, Tomas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cancer Metastasis and Treatment</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">407-416</span>CODEN:
                <span class="NLM_cas:coden">JCMTCU</span>;
        ISSN:<span class="NLM_cas:issn">2454-2857</span>.
    
            (<span class="NLM_cas:orgname">OAE Publishing Inc.</span>)
        </div><div class="casAbstract">Nanoparticle-mediated targeted delivery of drugs might significantly reduce the dosage and optimize their release properties, increase specificity and bioavailability, improve shelf life, and reduce toxicity.  Some nanodrugs are able to overcome the blood-brain barrier that is an obstacle to treatment of brain tumors.  Vessels in tumors have abnormal architecture and are highly permeable; moreover, tumors also have poor lymphatic drainage, allowing for accumulation of macromols. greater than approx. 40 kDa within the tumor microenvironment.  Nanoparticles exploit this feature, known as the enhanced permeability and retention effect, to target solid tumors.  Active targeting, i.e. surface modification of nanoparticles, is a way to decrease uptake in normal tissue and increase accumulation in a tumor, and it usually involves targeting surface membrane proteins that are upregulated in cancer cells.  The targeting mols. are typically antibodies or their fragments; aptamers; oligopeptides or small mols.  There are currently several FDA-approved nanomedicines, but none approved for brain tumor therapy.  This review, based both on the study of literature and on the authors own exptl. work describes a comprehensive overview of preclin. and clin. research of nanodrugs in therapy of brain tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9AoNrO2ls_7Vg90H21EOLACvtfcHk0lgZveuKxUOL8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlShu7rE&md5=4aab07bc604698875a344a0b0877f32f</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.20517%2F2394-4722.2015.95&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.20517%252F2394-4722.2015.95%26sid%3Dliteratum%253Aachs%26aulast%3DCerna%26aufirst%3DT.%26aulast%3DStiborova%26aufirst%3DM.%26aulast%3DAdam%26aufirst%3DV.%26aulast%3DKizek%26aufirst%3DR.%26aulast%3DEckschlager%26aufirst%3DT.%26atitle%3DNanocarrier%2520drugs%2520in%2520the%2520treatment%2520of%2520brain%2520tumors%26jtitle%3DJ.%2520Cancer%2520Metastasis%2520Treat.%26date%3D2016%26volume%3D2%26spage%3D407%26epage%3D416%26doi%3D10.20517%2F2394-4722.2015.95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moos, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, E. H.</span></span> <span> </span><span class="NLM_article-title">Transferrin and transferrin receptor function in brain barrier systems</span>. <i>Cell Mol. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">77</span>– <span class="NLM_lpage">95</span>, <span class="refDoi"> DOI: 10.1023/A:1006948027674</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.1023%2FA%3A1006948027674" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10690503" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhtV2ltL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2000&pages=77-95&author=T.+Moosauthor=E.+H.+Morgan&title=Transferrin+and+transferrin+receptor+function+in+brain+barrier+systems&doi=10.1023%2FA%3A1006948027674"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Transferrin and transferrin receptor function in brain barrier systems</span></div><div class="casAuthors">Moos, Torben; Morgan, Evan H.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Neurobiology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">77-95</span>CODEN:
                <span class="NLM_cas:coden">CMNEDI</span>;
        ISSN:<span class="NLM_cas:issn">0272-4340</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic/Plenum Publishers</span>)
        </div><div class="casAbstract">A review with many refs.  Iron (Fe) is an essential component of virtually all types of cells and organisms.  In plasma and interstitial fluids, Fe is carried by transferrin.  Iron-contg. transferrin has a high affinity for the transferrin receptor, which is present on all cells with a requirement for Fe.  The degree of expression of transferrin receptors on most types of cells is detd. by the level of Fe supply and their rate of proliferation.  The brain, like other organs, requires Fe for metabolic processes and suffers from disturbed function when a Fe deficiency or excess occurs.  Hence, the transport of Fe across brain barrier systems must be regulated.  The interaction between transferrin and transferrin receptor appears to serve this function in the blood-brain, blood-CSF, and cellular-plasmalemma barriers.  Transferrin is present in blood plasma and brain extracellular fluids, and the transferrin receptor is present on brain capillary endothelial cells, choroid plexus epithelial cells, neurons, and probably also glial cells.  The rate of Fe transport from plasma to brain is developmentally regulated, peaking in the first few weeks of postnatal life in the rat, after which it decreases rapidly to low values.  Two mechanisms for Fe transport across the blood-brain barrier have been proposed.  One is that the Fe-transferrin complex is transported intact across the capillary wall by receptor-mediated transcytosis.  In the second, Fe transport is the result of receptor-mediated endocytosis of Fe-transferrin by capillary endothelial cells, followed by release of Fe from transferrin within the cell, recycling of transferrin to the blood, and transport of Fe into the brain.  Current evidence indicates that although some transcytosis of transferrin does occur, the amt. is quant. insufficient to account for the rate of Fe transport, and the majority of Fe transport probably occurs by the second of the above mechanisms.  An addnl. route of Fe and transferrin transport from the blood to the brain is via the blood-CSF barrier and from the CSF into the brain.  Iron-contg. transferrin is transported through the blood-CSF barrier by a mechanism that appears to be regulated by developmental stage and iron status.  The transfer of transferrin from blood to CSF is higher than that of albumin, which may be due to the presence of transferrin receptors on choroid plexus epithelial cells so that transferrin can be transported across the cells by a receptor-mediated process as well as by nonselective mechanisms.  Transferrin receptors have been detected in neurons in vivo and in cultured glial cells.  Transferrin is present in the brain interstitial fluid, and it is generally assumed that Fe which transverses the blood-brain barrier is rapidly bound by brain transferrin and can then be taken up by receptor-mediated endocytosis in brain cells.  The uptake of transferrin-bound Fe by neurons and glial cells is probably regulated by the no. of transferrin receptors present on cells, which changes during development and in conditions with an altered iron status.  This review focuses on the information available on the functions of transferrin and transferrin receptor with respect to Fe transport across the blood-brain and blood-CSF barriers and the cell membranes of neurons and glial cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMFzsMZ67jibVg90H21EOLACvtfcHk0lilLu9wNLNWGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhtV2ltL8%253D&md5=7e5d711f88eeb29cc1b7b074bda8a367</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1023%2FA%3A1006948027674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1006948027674%26sid%3Dliteratum%253Aachs%26aulast%3DMoos%26aufirst%3DT.%26aulast%3DMorgan%26aufirst%3DE.%2BH.%26atitle%3DTransferrin%2520and%2520transferrin%2520receptor%2520function%2520in%2520brain%2520barrier%2520systems%26jtitle%3DCell%2520Mol.%2520Neurobiol.%26date%3D2000%26volume%3D20%26spage%3D77%26epage%3D95%26doi%3D10.1023%2FA%3A1006948027674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bien-Ly, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bumbaca, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elstrott, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boswell, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luk, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dennis, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weimer, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watts, R. J.</span></span> <span> </span><span class="NLM_article-title">Transferrin receptor (TfR) trafficking determines brain uptake of TfR antibody affinity variants</span>. <i>J. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>211</i></span>,  <span class="NLM_fpage">233</span>– <span class="NLM_lpage">244</span>, <span class="refDoi"> DOI: 10.1084/jem.20131660</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.1084%2Fjem.20131660" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=24470444" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisFarurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=211&publication_year=2014&pages=233-244&author=N.+Bien-Lyauthor=Y.+J.+Yuauthor=D.+Bumbacaauthor=J.+Elstrottauthor=C.+A.+Boswellauthor=Y.+Zhangauthor=W.+Lukauthor=Y.+Luauthor=M.+S.+Dennisauthor=R.+M.+Weimerauthor=I.+Chungauthor=R.+J.+Watts&title=Transferrin+receptor+%28TfR%29+trafficking+determines+brain+uptake+of+TfR+antibody+affinity+variants&doi=10.1084%2Fjem.20131660"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Transferrin receptor (TfR) trafficking determines brain uptake of TfR antibody affinity variants</span></div><div class="casAuthors">Bien-Ly, Nga; Yu, Y. Joy; Bumbaca, Daniela; Elstrott, Justin; Boswell, C. Andrew; Zhang, Yin; Luk, Wilman; Lu, Yanmei; Dennis, Mark S.; Weimer, Robby M.; Chung, Inhee; Watts, Ryan J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">211</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">233-244</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-1007</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Antibodies to transferrin receptor (TfR) have potential use for therapeutic entry into the brain.  We have shown that bispecific antibodies against TfR and β-secretase (BACE1 [β-amyloid cleaving enzyme-1]) traverse the blood-brain barrier (BBB) and effectively reduce brain amyloid β levels.  We found that optimizing anti-TfR affinity improves brain exposure and BACE1 inhibition.  Here we probe the cellular basis of this improvement and explore whether TfR antibody affinity alters the intracellular trafficking of TfR.  Comparing high- and low-affinity TfR bispecific antibodies in vivo, we found that high-affinity binding to TfR caused a dose-dependent redn. of brain TfR levels.  In vitro live imaging and colocalization expts. revealed that high-affinity TfR bispecific antibodies facilitated the trafficking of TfR to lysosomes and thus induced the degrdn. of TfR, an observation which was further confirmed in vivo.  Importantly, high-affinity anti-TfR dosing induced redns. in brain TfR levels, which significantly decreased brain exposure to a second dose of low-affinity anti-TfR bispecific.  Thus, high-affinity anti-TfR alters TfR trafficking, which dramatically impacts the capacity for TfR to mediate BBB transcytosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNIVuFjhPwUbVg90H21EOLACvtfcHk0lilLu9wNLNWGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisFarurY%253D&md5=9f8de8cec4986bf07515425a44b79db9</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1084%2Fjem.20131660&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20131660%26sid%3Dliteratum%253Aachs%26aulast%3DBien-Ly%26aufirst%3DN.%26aulast%3DYu%26aufirst%3DY.%2BJ.%26aulast%3DBumbaca%26aufirst%3DD.%26aulast%3DElstrott%26aufirst%3DJ.%26aulast%3DBoswell%26aufirst%3DC.%2BA.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLuk%26aufirst%3DW.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DDennis%26aufirst%3DM.%2BS.%26aulast%3DWeimer%26aufirst%3DR.%2BM.%26aulast%3DChung%26aufirst%3DI.%26aulast%3DWatts%26aufirst%3DR.%2BJ.%26atitle%3DTransferrin%2520receptor%2520%2528TfR%2529%2520trafficking%2520determines%2520brain%2520uptake%2520of%2520TfR%2520antibody%2520affinity%2520variants%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2014%26volume%3D211%26spage%3D233%26epage%3D244%26doi%3D10.1084%2Fjem.20131660" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Saraiva, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Praça, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferreira, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferreira, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernardino, L.</span></span> <span> </span><span class="NLM_article-title">Nanoparticle-mediated brain drug delivery: overcoming blood–brain barrier to treat neurodegenerative diseases</span>. <i>J. Controlled Release</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>235</i></span>,  <span class="NLM_fpage">34</span>– <span class="NLM_lpage">47</span>, <span class="refDoi"> DOI: 10.1016/j.jconrel.2016.05.044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.1016%2Fj.jconrel.2016.05.044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=27208862" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BC28XovV2hsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=235&publication_year=2016&pages=34-47&author=C.+Saraivaauthor=C.+Pra%C3%A7aauthor=R.+Ferreiraauthor=T.+Santosauthor=L.+Ferreiraauthor=L.+Bernardino&title=Nanoparticle-mediated+brain+drug+delivery%3A+overcoming+blood%E2%80%93brain+barrier+to+treat+neurodegenerative+diseases&doi=10.1016%2Fj.jconrel.2016.05.044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Nanoparticle-mediated brain drug delivery: Overcoming blood-brain barrier to treat neurodegenerative diseases</span></div><div class="casAuthors">Saraiva, Claudia; Praca, Catarina; Ferreira, Raquel; Santos, Tiago; Ferreira, Lino; Bernardino, Liliana</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Controlled Release</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">235</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">34-47</span>CODEN:
                <span class="NLM_cas:coden">JCREEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-3659</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The blood-brain barrier (BBB) is a vital boundary between neural tissue and circulating blood.  The BBB's unique and protective features control brain homeostasis as well as ion and mol. movement.  Failure in maintaining any of these components results in the breakdown of this specialized multicellular structure and consequently promotes neuro inflammation and neurodegeneration.  In several high incidence pathologies such as stroke, Alzheimer's (AD) and Parkinson's disease (PD) the BBB is impaired.  However, even a damaged and more permeable BBB can pose serious challenges to drug delivery into the brain.  The use of nanoparticle (NP) formulations able to encapsulate mols. with therapeutic value, while targeting specific transport processes in the brain vasculature, may enhance drug transport through the BBB in neurodegenerative/ischemic disorders and target relevant regions in the brain for regenerative processes.  In this review, we will discuss BBB compn. and characteristics and how these features are altered in pathol., namely in stroke, AD and PD.  Addnl., factors influencing an efficient i.v. delivery of polymeric and inorg. NPs into the brain as well as NP-related delivery systems with the most promising functional outcomes will also be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaTfl3mFXDRLVg90H21EOLACvtfcHk0lilLu9wNLNWGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XovV2hsbY%253D&md5=9a656f4dfad25bb41b0d8e4996822031</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.jconrel.2016.05.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jconrel.2016.05.044%26sid%3Dliteratum%253Aachs%26aulast%3DSaraiva%26aufirst%3DC.%26aulast%3DPra%25C3%25A7a%26aufirst%3DC.%26aulast%3DFerreira%26aufirst%3DR.%26aulast%3DSantos%26aufirst%3DT.%26aulast%3DFerreira%26aufirst%3DL.%26aulast%3DBernardino%26aufirst%3DL.%26atitle%3DNanoparticle-mediated%2520brain%2520drug%2520delivery%253A%2520overcoming%2520blood%25E2%2580%2593brain%2520barrier%2520to%2520treat%2520neurodegenerative%2520diseases%26jtitle%3DJ.%2520Controlled%2520Release%26date%3D2016%26volume%3D235%26spage%3D34%26epage%3D47%26doi%3D10.1016%2Fj.jconrel.2016.05.044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bell, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ehlers, M. D.</span></span> <span> </span><span class="NLM_article-title">Breaching the blood-brain barrier for drug delivery</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">3</span>, <span class="refDoi"> DOI: 10.1016/j.neuron.2013.12.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.1016%2Fj.neuron.2013.12.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=24411725" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlt1enuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2014&pages=1-3&author=R.+D.+Bellauthor=M.+D.+Ehlers&title=Breaching+the+blood-brain+barrier+for+drug+delivery&doi=10.1016%2Fj.neuron.2013.12.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Breaching the Blood-Brain Barrier for Drug Delivery</span></div><div class="casAuthors">Bell, Robert D.; Ehlers, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-3</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Mol. "hitchhiking" through receptor-mediated transcytosis at the blood-brain barrier is a CNS drug delivery strategy.  In this issue of Neuron, Niewoehner et al. (2014) describe a modular anti-transferrin receptor Fab approach for shuttling therapeutic antibodies into the brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplP2Mq1NP0g7Vg90H21EOLACvtfcHk0lgke-yFkuR1JQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlt1enuw%253D%253D&md5=63d7326c8e49166317e8ca757461e608</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2013.12.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2013.12.023%26sid%3Dliteratum%253Aachs%26aulast%3DBell%26aufirst%3DR.%2BD.%26aulast%3DEhlers%26aufirst%3DM.%2BD.%26atitle%3DBreaching%2520the%2520blood-brain%2520barrier%2520for%2520drug%2520delivery%26jtitle%3DNeuron%26date%3D2014%26volume%3D81%26spage%3D1%26epage%3D3%26doi%3D10.1016%2Fj.neuron.2013.12.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Niewoehner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohrmann, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urich, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sade, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maier, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rueger, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stracke, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lau, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tissot, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loetscher, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freskgard, P.-O.</span></span> <span> </span><span class="NLM_article-title">Increased brain penetration and potency of a therapeutic antibody using a monovalent molecular shuttle</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">49</span>– <span class="NLM_lpage">60</span>, <span class="refDoi"> DOI: 10.1016/j.neuron.2013.10.061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.1016%2Fj.neuron.2013.10.061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=24411731" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlt1CmtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2014&pages=49-60&author=J.+Niewoehnerauthor=B.+Bohrmannauthor=L.+Collinauthor=E.+Urichauthor=H.+Sadeauthor=P.+Maierauthor=P.+Ruegerauthor=J.+O.+Strackeauthor=W.+Lauauthor=A.+C.+Tissotauthor=H.+Loetscherauthor=A.+Ghoshauthor=P.-O.+Freskgard&title=Increased+brain+penetration+and+potency+of+a+therapeutic+antibody+using+a+monovalent+molecular+shuttle&doi=10.1016%2Fj.neuron.2013.10.061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Increased Brain Penetration and Potency of a Therapeutic Antibody Using a Monovalent Molecular Shuttle</span></div><div class="casAuthors">Niewoehner, Jens; Bohrmann, Bernd; Collin, Ludovic; Urich, Eduard; Sade, Hadassah; Maier, Peter; Rueger, Petra; Stracke, Jan Olaf; Lau, Wilma; Tissot, Alain C.; Loetscher, Hansruedi; Ghosh, Anirvan; Freskgard, Per-Ola</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">49-60</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Although biotherapeutics have vast potential for treating brain disorders, their use has been limited due to low exposure across the blood-brain barrier (BBB).  We report that by manipulating the binding mode of an antibody fragment to the transferrin receptor (TfR), we have developed a Brain Shuttle module, which can be engineered into a std. therapeutic antibody for successful BBB transcytosis.  Brain Shuttle version of an anti-Aβ antibody, which uses a monovalent binding mode to the TfR, increases β-Amyloid target engagement in a mouse model of Alzheimer's disease by 55-fold compared to the parent antibody.  We provide in vitro and in vivo evidence that the monovalent binding mode facilitates transcellular transport, whereas a bivalent binding mode leads to lysosome sorting.  Enhanced target engagement of the Brain Shuttle module translates into a significant improvement in amyloid redn.  These findings have major implications for the development of biologics-based treatment of brain disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOzgePXqpPLrVg90H21EOLACvtfcHk0lgke-yFkuR1JQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlt1CmtQ%253D%253D&md5=61f31b943fb6b90c28bae76bef4ba5ce</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2013.10.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2013.10.061%26sid%3Dliteratum%253Aachs%26aulast%3DNiewoehner%26aufirst%3DJ.%26aulast%3DBohrmann%26aufirst%3DB.%26aulast%3DCollin%26aufirst%3DL.%26aulast%3DUrich%26aufirst%3DE.%26aulast%3DSade%26aufirst%3DH.%26aulast%3DMaier%26aufirst%3DP.%26aulast%3DRueger%26aufirst%3DP.%26aulast%3DStracke%26aufirst%3DJ.%2BO.%26aulast%3DLau%26aufirst%3DW.%26aulast%3DTissot%26aufirst%3DA.%2BC.%26aulast%3DLoetscher%26aufirst%3DH.%26aulast%3DGhosh%26aufirst%3DA.%26aulast%3DFreskgard%26aufirst%3DP.-O.%26atitle%3DIncreased%2520brain%2520penetration%2520and%2520potency%2520of%2520a%2520therapeutic%2520antibody%2520using%2520a%2520monovalent%2520molecular%2520shuttle%26jtitle%3DNeuron%26date%3D2014%26volume%3D81%26spage%3D49%26epage%3D60%26doi%3D10.1016%2Fj.neuron.2013.10.061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Watts, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dennis, M. S.</span></span> <span> </span><span class="NLM_article-title">Bispecific antibodies for delivery into the brain</span>. <i>Curr. Opin. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">393</span>– <span class="NLM_lpage">399</span>, <span class="refDoi"> DOI: 10.1016/j.cbpa.2013.03.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.1016%2Fj.cbpa.2013.03.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=23570979" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlsFejurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2013&pages=393-399&author=R.+J.+Wattsauthor=M.+S.+Dennis&title=Bispecific+antibodies+for+delivery+into+the+brain&doi=10.1016%2Fj.cbpa.2013.03.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Bispecific antibodies for delivery into the brain</span></div><div class="casAuthors">Watts, Ryan J.; Dennis, Mark S.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">393-399</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The blood-brain barrier (BBB) is a formidable obstacle preventing drug delivery to the brain, particularly for large protein therapeutics.  The utilization of endogenous brain endothelial transport pathways, however, represents a promising approach to cross the cellular barrier through receptor-mediated transcytosis.  Therapeutics designed to take advantage of this approach require at least 2 functionalities, one that facilitates transport and the other to provide therapeutic benefit, and bispecific antibodies are ideally suited for this task.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPiQMZjB0QArVg90H21EOLACvtfcHk0lgke-yFkuR1JQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlsFejurs%253D&md5=6f5758b62bff2edcc30213f89e807523</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2013.03.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2013.03.023%26sid%3Dliteratum%253Aachs%26aulast%3DWatts%26aufirst%3DR.%2BJ.%26aulast%3DDennis%26aufirst%3DM.%2BS.%26atitle%3DBispecific%2520antibodies%2520for%2520delivery%2520into%2520the%2520brain%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2013%26volume%3D17%26spage%3D393%26epage%3D399%26doi%3D10.1016%2Fj.cbpa.2013.03.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prior, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reifenberger, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wechsler, W.</span></span> <span> </span><span class="NLM_article-title">Transferrin receptor expression in tumors of the human nervous-system-relation to tumor type, grading and tumor-growth fraction</span>. <i>Virchows. Arch. A. Pathol Anat. Histopathol.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>416</i></span>,  <span class="NLM_fpage">491</span>– <span class="NLM_lpage">496</span>, <span class="refDoi"> DOI: 10.1007/BF01600299</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.1007%2FBF01600299" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=2110696" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A280%3ADyaK3c3ks1Oisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=416&publication_year=1990&pages=491-496&author=R.+Priorauthor=G.+Reifenbergerauthor=W.+Wechsler&title=Transferrin+receptor+expression+in+tumors+of+the+human+nervous-system-relation+to+tumor+type%2C+grading+and+tumor-growth+fraction&doi=10.1007%2FBF01600299"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Transferrin receptor expression in tumours of the human nervous system: relation to tumour type, grading and tumour growth fraction</span></div><div class="casAuthors">Prior R; Reifenberger G; Wechsler W</div><div class="citationInfo"><span class="NLM_cas:title">Virchows Archiv. A, Pathological anatomy and histopathology</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">416</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">491-6</span>
        ISSN:<span class="NLM_cas:issn">0174-7398</span>.
    </div><div class="casAbstract">The expression of transferrin receptor (Tr) was investigated by means of immunohistochemistry in 101 tumours of the human central and peripheral nervous system.  The results were compared with the proliferative activity of the tumours, determined by immunostaining for the proliferation-associated antigen Ki-67.  In addition to immunostaining of normal and proliferated blood vessel endothelium and of a fraction of tumour infiltrating lymphocytes, we observed staining for Tr in a variable fraction of neoplastic cells of all histological tumour types.  Immunoreactivity in the majority of tumour cells was found only in anaplastic tumours such as glioblastomas.  Furthermore, a positive correlation between Tr expression and the Ki-67 growth fraction was established for gliomas.  Non-glial tumours strongly expressing Tr included one metastatic rhabdomyosarcoma, one intracerebral malignant lymphoma, two of four plasmocytomas and seven of nine metastatic carcinomas.  Our results indicate that immunohistochemistry for Tr and Ki-67 can provide additional information about the biological behaviour of nervous system tumours, thus complementing conventional histopathological criteria for anaplasia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQqPOygotjA4cSzjBFCN0BJfW6udTcc2eb8EK4nyrWfILntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3c3ks1Oisw%253D%253D&md5=32d96b9a1425ef21d6097bd5f75aa456</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1007%2FBF01600299&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF01600299%26sid%3Dliteratum%253Aachs%26aulast%3DPrior%26aufirst%3DR.%26aulast%3DReifenberger%26aufirst%3DG.%26aulast%3DWechsler%26aufirst%3DW.%26atitle%3DTransferrin%2520receptor%2520expression%2520in%2520tumors%2520of%2520the%2520human%2520nervous-system-relation%2520to%2520tumor%2520type%252C%2520grading%2520and%2520tumor-growth%2520fraction%26jtitle%3DVirchows.%2520Arch.%2520A.%2520Pathol%2520Anat.%2520Histopathol.%26date%3D1990%26volume%3D416%26spage%3D491%26epage%3D496%26doi%3D10.1007%2FBF01600299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Recht, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torres, C. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raso, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, T. W.</span></span> <span> </span><span class="NLM_article-title">Transferrin receptor in normal and neoplastic brain-tissue-implications for brain-tumor immunotherapy</span>. <i>J. Neurosurg.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">941</span>– <span class="NLM_lpage">945</span>, <span class="refDoi"> DOI: 10.3171/jns.1990.72.6.0941</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.3171%2Fjns.1990.72.6.0941" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=2159987" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A280%3ADyaK3c3ltVCruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=1990&pages=941-945&author=L.+Rechtauthor=C.+O.+Torresauthor=T.+W.+Smithauthor=V.+Rasoauthor=T.+W.+Griffin&title=Transferrin+receptor+in+normal+and+neoplastic+brain-tissue-implications+for+brain-tumor+immunotherapy&doi=10.3171%2Fjns.1990.72.6.0941"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Transferrin receptor in normal and neoplastic brain tissue: implications for brain-tumor immunotherapy</span></div><div class="casAuthors">Recht L; Torres C O; Smith T W; Raso V; Griffin T W</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neurosurgery</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">941-5</span>
        ISSN:<span class="NLM_cas:issn">0022-3085</span>.
    </div><div class="casAbstract">The distribution of transferrin receptor (TfR) in normal human brain-tissue obtained at autopsy and in brain-tumor biopsy specimens from 27 patients was determined by immunohistochemistry using two specific murine monoclonal antibodies against human TfR.  The tumors studied included 10 glioblastomas multiforme (GBM's), nine other glial tumors, and eight meningiomas.  In normal brain, TfR was detected primarily in endothelial cells; rare glial cells also contained immunoreactive product.  All tumors contained TfR-positive cells, although the intensity (number of cells stained) and pattern (focal vs. diffuse) of staining varied with the histopathological type of the tumor.  Among gliomas, the most intense staining was seen in GBM's, especially in areas of pseudopalisading where virtually all cells were stained.  A rough correlation between tumor grade, number of positively stained cells, and staining pattern was seen in the other astrocytic tumors.  By contrast, all meningiomas demonstrated an identical and characteristic focal staining pattern.  Considering the differential immunostaining for TfR between normal and neoplastic tissue, the authors conclude that TfR may be an appropriate target for monoclonal antibody-directed brain-tumor immunotherapy, especially in more malignant tumors such as GBM's.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT6LX_O25TE_iXXDYhVZBdlfW6udTcc2eb8EK4nyrWfILntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3c3ltVCruw%253D%253D&md5=1c79831a095480e2f8665c5f3ce19ac9</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.3171%2Fjns.1990.72.6.0941&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3171%252Fjns.1990.72.6.0941%26sid%3Dliteratum%253Aachs%26aulast%3DRecht%26aufirst%3DL.%26aulast%3DTorres%26aufirst%3DC.%2BO.%26aulast%3DSmith%26aufirst%3DT.%2BW.%26aulast%3DRaso%26aufirst%3DV.%26aulast%3DGriffin%26aufirst%3DT.%2BW.%26atitle%3DTransferrin%2520receptor%2520in%2520normal%2520and%2520neoplastic%2520brain-tissue-implications%2520for%2520brain-tumor%2520immunotherapy%26jtitle%3DJ.%2520Neurosurg.%26date%3D1990%26volume%3D72%26spage%3D941%26epage%3D945%26doi%3D10.3171%2Fjns.1990.72.6.0941" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Todd, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowger, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, J.</span></span> <span> </span><span class="NLM_article-title">RGD-modified apoferritin NPs for efficient drug delivery to tumors</span>. <i>ACS Nano</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">4830</span>– <span class="NLM_lpage">4837</span>, <span class="refDoi"> DOI: 10.1021/nn305791q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/nn305791q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BC3sXosVejtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2013&pages=4830-4837&author=Z.+Zhenauthor=W.+Tangauthor=H.+Chenauthor=X.+Linauthor=T.+Toddauthor=G.+Wangauthor=T.+Cowgerauthor=X.+Chenauthor=J.+Xie&title=RGD-modified+apoferritin+NPs+for+efficient+drug+delivery+to+tumors&doi=10.1021%2Fnn305791q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">RGD-Modified Apoferritin Nanoparticles for Efficient Drug Delivery to Tumors</span></div><div class="casAuthors">Zhen, Zipeng; Tang, Wei; Chen, Hongmin; Lin, Xin; Todd, Trever; Wang, Geoffrey; Cowger, Taku; Chen, Xiaoyuan; Xie, Jin</div><div class="citationInfo"><span class="NLM_cas:title">ACS Nano</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">4830-4837</span>CODEN:
                <span class="NLM_cas:coden">ANCAC3</span>;
        ISSN:<span class="NLM_cas:issn">1936-0851</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Ferritin (FRT) is a major iron storage protein found in humans and most living organisms.  Each ferritin is composed of 24 subunits, which self-assemble to form a cage-like nanostructure.  FRT nanocages can be genetically modified to present a peptide sequence on the surface.  Recently, we demonstrated that Cys-Asp-Cys-Arg-Gly-Asp-Cys-Phe-Cys (RGD4C)-modified ferritin can efficiently home to tumors through RGD-integrin αvβ3 interaction.  Though promising, studies on evaluating surface modified ferritin nanocages as drug delivery vehicles have seldom been reported.  Herein, we showed that after being precomplexed with Cu(II), doxorubicin can be loaded onto RGD modified apoferritin nanocages with high efficiency (up to 73.49 wt %).  When studied on U87MG s.c. tumor models, these doxorubicin-loaded ferritin nanocages showed a longer circulation half-life, higher tumor uptake, better tumor growth inhibition, and less cardiotoxicity than free doxorubicin.  Such a technol. might be extended to load a broad range of therapeutics and holds great potential in clin. translation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvD-JvyIxsHrVg90H21EOLACvtfcHk0liTVdPrD3hoPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXosVejtbY%253D&md5=1db3611654b22ee0f93f2697ed92bfd3</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fnn305791q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnn305791q%26sid%3Dliteratum%253Aachs%26aulast%3DZhen%26aufirst%3DZ.%26aulast%3DTang%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DTodd%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DCowger%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DXie%26aufirst%3DJ.%26atitle%3DRGD-modified%2520apoferritin%2520NPs%2520for%2520efficient%2520drug%2520delivery%2520to%2520tumors%26jtitle%3DACS%2520Nano%26date%3D2013%26volume%3D7%26spage%3D4830%26epage%3D4837%26doi%3D10.1021%2Fnn305791q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tong, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lok, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fung, Y. M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, C. M.</span></span> <span> </span><span class="NLM_article-title">An anticancer gold(III)-activated porphyrin scaffold that covalently modifies protein cysteine thiols</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">1321</span>– <span class="NLM_lpage">1329</span>, <span class="refDoi"> DOI: 10.1073/pnas.1915202117</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.1073%2Fpnas.1915202117" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=31896586" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhsFKktL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2020&pages=1321-1329&author=K.+C.+Tongauthor=C.+N.+Lokauthor=P.+K.+Wanauthor=D.+Huauthor=Y.+M.+E.+Fungauthor=X.+Y.+Changauthor=S.+Huangauthor=H.+Jiangauthor=C.+M.+Che&title=An+anticancer+gold%28III%29-activated+porphyrin+scaffold+that+covalently+modifies+protein+cysteine+thiols&doi=10.1073%2Fpnas.1915202117"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">An anticancer gold(III)-activated porphyrin scaffold that covalently modifies protein cysteine thiols</span></div><div class="casAuthors">Tong, Ka-Chung; Lok, Chun-Nam; Wan, Pui-Ki; Hu, Di; Eva Fung, Yi Man; Chang, Xiao-Yong; Huang, Song; Jiang, Haibo; Che, Chi-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1321-1329</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Cysteine thiols of many cancer-assocd. proteins are attractive targets of anticancer agents.  Herein, we unequivocally demonstrate a distinct thiol-targeting property of gold(III) mesoporphyrin IX di-Me ester (AuMesoIX) and its anticancer activities.  While the binding of cysteine thiols with metal complexes usually occurs via M-S bond formation, AuMesoIX is unique in that the meso-carbon atom of the porphyrin ring is activated by the gold(III) ion to undergo nucleophilic arom. substitution with thiols.  AuMesoIX was shown to modify reactive cysteine residues and inhibit the activities of anticancer protein targets including thioredoxin, peroxiredoxin, and deubiquitinases.  Treatment of cancer cells with AuMesoIX resulted in the formation of gold-bound sulfur-rich protein aggregates, oxidative stress-mediated cytotoxicity, and accumulation of ubiquitinated proteins.  Importantly, AuMesoIX exhibited effective antitumor activity in mice.  Our study has uncovered a gold(III)-induced ligand scaffold reactivity for thiol targeting that can be exploited for anticancer applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJuhQj8AqhG7Vg90H21EOLACvtfcHk0lhOpFG73QJXcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhsFKktL4%253D&md5=58f9fb7cbcbb4da43df2f07f97b7d311</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1915202117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1915202117%26sid%3Dliteratum%253Aachs%26aulast%3DTong%26aufirst%3DK.%2BC.%26aulast%3DLok%26aufirst%3DC.%2BN.%26aulast%3DWan%26aufirst%3DP.%2BK.%26aulast%3DHu%26aufirst%3DD.%26aulast%3DFung%26aufirst%3DY.%2BM.%2BE.%26aulast%3DChang%26aufirst%3DX.%2BY.%26aulast%3DHuang%26aufirst%3DS.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DChe%26aufirst%3DC.%2BM.%26atitle%3DAn%2520anticancer%2520gold%2528III%2529-activated%2520porphyrin%2520scaffold%2520that%2520covalently%2520modifies%2520protein%2520cysteine%2520thiols%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2020%26volume%3D117%26spage%3D1321%26epage%3D1329%26doi%3D10.1073%2Fpnas.1915202117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mertens, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parkin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awuah, S. G.</span></span> <span> </span><span class="NLM_article-title">Cancer cell-selective modulation of mitochondrial respiration and metabolism by potent organogold(iii) dithiocarbamates</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">10465</span>– <span class="NLM_lpage">10482</span>, <span class="refDoi"> DOI: 10.1039/D0SC03628E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.1039%2FD0SC03628E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhvVGgs7zL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2020&pages=10465-10482&author=R.+T.+Mertensauthor=S.+Parkinauthor=S.+G.+Awuah&title=Cancer+cell-selective+modulation+of+mitochondrial+respiration+and+metabolism+by+potent+organogold%28iii%29+dithiocarbamates&doi=10.1039%2FD0SC03628E"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer cell-selective modulation of mitochondrial respiration and metabolism by potent organogold(III) dithiocarbamates</span></div><div class="casAuthors">Mertens, Randall T.; Parkin, Sean; Awuah, Samuel G.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">10465-10482</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Metabolic reprogramming is a key cancer hallmark that has led to the therapeutic targeting of glycolysis.  However, agents that target dysfunctional mitochondrial respiration for targeted therapy remains underexplored.  We report the synthesis and characterization of ten (10) novel, highly potent organometallic gold(III) complexes supported by dithiocarbamate ligands as selective inhibitors of mitochondrial respiration.  The structure of dithiocarbamates employed dictates the biol. stability and cellular cytotoxicity.  Most of the compds. exhibit 50% inhibitory concn. (IC50) in the low-micromolar (0.50-2.9 μM) range when tested in a panel of aggressive cancer types with significant selectivity for cancer cells over normal cells.  Consequently, there is great interest in the mechanism of action of gold chemotherapeutics, particularly, considering that DNA is not the major target of most gold complexes.  We investigate the mechanism of action of representative complexes, 1a and 2a in the recalcitrant triple neg. breast cancer (TNBC) cell line, MDA-MB-231.  Whole-cell transcriptomics sequencing revealed genes related to three major pathways, namely: cell cycle, organelle fission, and oxidative phosphorylation. 2a irreversibly and rapidly inhibits maximal respiration in TNBC with no effect on normal epithelial cells, implicating mitochondrial OXPHOS as a potential target.  Furthermore, the modulation of cyclin dependent kinases and G1 cell cycle arrest induced by these compds. is promising for the treatment of cancer.  This work contributes to the need for mitochondrial respiration modulators in biomedical research and outlines a systematic approach to study the mechanism of action of metal-based agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqy7PCLc_HGgrVg90H21EOLACvtfcHk0lhOpFG73QJXcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhvVGgs7zL&md5=bb3f230316d8b08686829a5b6fcc540d</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1039%2FD0SC03628E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FD0SC03628E%26sid%3Dliteratum%253Aachs%26aulast%3DMertens%26aufirst%3DR.%2BT.%26aulast%3DParkin%26aufirst%3DS.%26aulast%3DAwuah%26aufirst%3DS.%2BG.%26atitle%3DCancer%2520cell-selective%2520modulation%2520of%2520mitochondrial%2520respiration%2520and%2520metabolism%2520by%2520potent%2520organogold%2528iii%2529%2520dithiocarbamates%26jtitle%3DChem.%2520Sci.%26date%3D2020%26volume%3D11%26spage%3D10465%26epage%3D10482%26doi%3D10.1039%2FD0SC03628E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reeder, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parkin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awuah, S. G.</span></span> <span> </span><span class="NLM_article-title">Gold(I/III)-phosphine complexes as potent antiproliferative agents</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">12335</span>, <span class="refDoi"> DOI: 10.1038/s41598-019-48584-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.1038%2Fs41598-019-48584-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=31451718" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A280%3ADC%252BB3MrhvVGrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2019&pages=12335&author=J.+H.+Kimauthor=E.+Reederauthor=S.+Parkinauthor=S.+G.+Awuah&title=Gold%28I%2FIII%29-phosphine+complexes+as+potent+antiproliferative+agents&doi=10.1038%2Fs41598-019-48584-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Gold(I/III)-Phosphine Complexes as Potent Antiproliferative Agents</span></div><div class="casAuthors">Kim Jong Hyun; Reeder Evan; Parkin Sean; Awuah Samuel G</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">12335</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The reaction of gold reagents [HAuCl4•3H2O], [AuCl(tht)], or cyclometalated gold(III) precursor, [C NAuCl2] with chiral ((R,R)-(-)-2,3-bis(t-butylmethylphosphino) quinoxaline) and non-chiral phosphine (1,2-Bis(diphenylphosphino)ethane, dppe) ligands lead to distorted Au(I), (1, 2, 4, 5) and novel cyclometalated Au(III) complexes (3, 6).  These gold compounds were characterized by multinuclear NMR, microanalysis, mass spectrometry, and X-ray crystallography.  The inherent electrochemical properties of the gold complexes were also studied by cyclic voltammetry and theoretical insight of the complexes was gained by density functional theory and TD-DFT calculations.  The complexes effectively kill cancer cells with IC50 in the range of ~0.10-2.53 μΜ across K562, H460, and OVCAR8 cell lines.  In addition, the retinal pigment epithelial cell line, RPE-Neo was used as a healthy cell line for comparison.  Differential cellular uptake in cancer cells was observed for the compounds by measuring the intracellular accumulation of gold using ICP-OES.  Furthermore, the compounds trigger early - late stage apoptosis through potential disruption of redox homeostasis.  Complexes 1 and 3 induce predominant G1 cell cycle arrest.  Results presented in this report suggest that stable gold-phosphine complexes with variable oxidation states hold promise in anticancer drug discovery and need further development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS__ehwZ0OhMh0LsK7uFuY7fW6udTcc2eY1hH0QU9LVcrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MrhvVGrsw%253D%253D&md5=1d0a70644aa1bd4626a76bb96bda8c47</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1038%2Fs41598-019-48584-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-019-48584-5%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DReeder%26aufirst%3DE.%26aulast%3DParkin%26aufirst%3DS.%26aulast%3DAwuah%26aufirst%3DS.%2BG.%26atitle%3DGold%2528I%252FIII%2529-phosphine%2520complexes%2520as%2520potent%2520antiproliferative%2520agents%26jtitle%3DSci.%2520Rep.%26date%3D2019%26volume%3D9%26spage%3D12335%26doi%3D10.1038%2Fs41598-019-48584-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gukathasan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parkin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awuah, S. G.</span></span> <span> </span><span class="NLM_article-title">Cyclometalated gold(III) complexes bearing DACH ligands</span>. <i>Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">9326</span>– <span class="NLM_lpage">9340</span>, <span class="refDoi"> DOI: 10.1021/acs.inorgchem.9b01031</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.inorgchem.9b01031" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BC1MXht1eru7jM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2019&pages=9326-9340&author=S.+Gukathasanauthor=S.+Parkinauthor=S.+G.+Awuah&title=Cyclometalated+gold%28III%29+complexes+bearing+DACH+ligands&doi=10.1021%2Facs.inorgchem.9b01031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclometalated Gold(III) Complexes Bearing DACH Ligands</span></div><div class="casAuthors">Gukathasan, Sailajah; Parkin, Sean; Awuah, Samuel G.</div><div class="citationInfo"><span class="NLM_cas:title">Inorganic Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">9326-9340</span>CODEN:
                <span class="NLM_cas:coden">INOCAJ</span>;
        ISSN:<span class="NLM_cas:issn">0020-1669</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis of a novel class of cyclometalated gold(III) complexes supported by benzoylpyridine, benzylpyridine, and (1R,2R)-(+)-1,2-diaminocyclohexane (DACH) ligands, along with their crystal structures, is reported.  These compds. provide a new scaffold to investigate biol. properties of gold(III) complexes.  The six complexes were prepd. and characterized, following reactions of (C,N) cyclometalated gold(III) scaffolds, [Au(C N)Cl2] with DACH, which yielded a new series of cyclometaled gold(III), 3-5, of the type [Au(C NH)(DACH)2]+ and the nitrogen-substituted cyclometalated Au(III), 6-8, of the type [Au(C N)(DACH)]2+.  Antiproliferative activity of these complexes in a panel of cancer cells showed promising results with IC50 in the micromolar range and selectivity over normal epithelial cells, MRC5.  Whereas 8 shows minimal interaction with superhelical DNA except at high gold concns. of 500μM, complex 5 does not show interaction even at 1000μM.  The complexes display significant uptake in OVCAR8 cancer cells within 200-1200 pmol/million cells with the exception of complex 4.  Differential cellular uptake was obsd. for the complexes; for example, while 3 and 8 display significant uptake, 4 showed minimal uptake.  The compds. proved to be stable under physiol. conditions and were minimally affected by either glutathione or sodium ascorbate.  Cell cycle studies reveal a G1 arrest induced by representative complexes.  The results reveal that enhanced Au(III) stabilization promoted by combined cyclometalated and DACH ligands may offer ligand tuning insights for novel anticancer drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxUSNZnA3_YLVg90H21EOLACvtfcHk0li9cKv20c6xxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXht1eru7jM&md5=2653b7cab5e02eca231c79b09061c995</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Facs.inorgchem.9b01031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.inorgchem.9b01031%26sid%3Dliteratum%253Aachs%26aulast%3DGukathasan%26aufirst%3DS.%26aulast%3DParkin%26aufirst%3DS.%26aulast%3DAwuah%26aufirst%3DS.%2BG.%26atitle%3DCyclometalated%2520gold%2528III%2529%2520complexes%2520bearing%2520DACH%2520ligands%26jtitle%3DInorg.%2520Chem.%26date%3D2019%26volume%3D58%26spage%3D9326%26epage%3D9340%26doi%3D10.1021%2Facs.inorgchem.9b01031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Z.</span></span> <span> </span><span class="NLM_article-title">Encapsulation of platinum anticancer drugs by apoferritin</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">3453</span>– <span class="NLM_lpage">3455</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.1039%2Fb705326f" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2007&pages=3453-3455&author=Z.+Yangauthor=X.+Wangauthor=H.+Diaoauthor=J.+Zhangauthor=H.+Liauthor=H.+Sunauthor=Z.+Guo&title=Encapsulation+of+platinum+anticancer+drugs+by+apoferritin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1039%2Fb705326f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb705326f%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DDiao%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DGuo%26aufirst%3DZ.%26atitle%3DEncapsulation%2520of%2520platinum%2520anticancer%2520drugs%2520by%2520apoferritin%26jtitle%3DChem.%2520Commun.%26date%3D2007%26volume%3D103%26spage%3D3453%26epage%3D3455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xing, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Z.</span></span> <span> </span><span class="NLM_article-title">Characterization and cellular uptake of platinum anticancer drugs encapsulated in apoferritin</span>. <i>J. Inorg. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">1039</span>– <span class="NLM_lpage">1044</span>, <span class="refDoi"> DOI: 10.1016/j.jinorgbio.2009.05.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.1016%2Fj.jinorgbio.2009.05.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=19501911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnvVWltr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2009&pages=1039-1044&author=R.+Xingauthor=X.+Wangauthor=C.+Zhangauthor=Y.+Zhangauthor=Q.+Wangauthor=Z.+Yangauthor=Z.+Guo&title=Characterization+and+cellular+uptake+of+platinum+anticancer+drugs+encapsulated+in+apoferritin&doi=10.1016%2Fj.jinorgbio.2009.05.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization and cellular uptake of platinum anticancer drugs encapsulated in apoferritin</span></div><div class="casAuthors">Xing, Ruimin; Wang, Xiaoyong; Zhang, Changli; Zhang, Yangmiao; Wang, Qi; Yang, Zhen; Guo, Zijian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Inorganic Biochemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1039-1044</span>CODEN:
                <span class="NLM_cas:coden">JIBIDJ</span>;
        ISSN:<span class="NLM_cas:issn">0162-0134</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Clin. application of platinum-based anticancer drugs is largely limited by severe general toxicity and drug resistance.  Drug delivery systems with tumor-targeting potential are highly desired for improving the efficacy and applicability of these drugs.  This study describes an alternative strategy for the delivery of platinum drugs (cisplatin, carboplatin and oxaliplatin) by encapsulating each of them in the cavity of apoferritin (AFt).  The encapsulation was achieved through manipulating the pH-dependent unfolding-refolding process of AFt at pH 2.0 and 7.4, resp., in satd. drug soln.  UV-vis spectrometry, CD spectrometry, dynamic light scattering, and inductively coupled plasma mass spectrometry were used to characterize the AFt-drug complexes.  The loading capacity of AFt varies with resp. drugs and the structural integrity of the protein shell remains intact after encapsulation.  In vitro assays on the rat pheochromocytoma cell line (PC12) show that AFt-cisplatin inhibits the cells in a slow but sustaining mode and the cellular uptake of platinum is enhanced by AFt.  AFt-carboplatin and AFt-oxaliplatin complexes only exhibit a marginal cytotoxicity towards this cell line under similar concns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoi1Rq7ZN9k0LVg90H21EOLACvtfcHk0li9cKv20c6xxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnvVWltr0%253D&md5=5b333de0d4b8dc737865a7377596b4da</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.jinorgbio.2009.05.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jinorgbio.2009.05.001%26sid%3Dliteratum%253Aachs%26aulast%3DXing%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DGuo%26aufirst%3DZ.%26atitle%3DCharacterization%2520and%2520cellular%2520uptake%2520of%2520platinum%2520anticancer%2520drugs%2520encapsulated%2520in%2520apoferritin%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D2009%26volume%3D103%26spage%3D1039%26epage%3D1044%26doi%3D10.1016%2Fj.jinorgbio.2009.05.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hotchkiss, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strasser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDunn, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swanson, P. E.</span></span> <span> </span><span class="NLM_article-title">Cell death</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>361</i></span>,  <span class="NLM_fpage">1570</span>– <span class="NLM_lpage">1583</span>, <span class="refDoi"> DOI: 10.1056/NEJMra0901217</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.1056%2FNEJMra0901217" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=19828534" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1OrurzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=361&publication_year=2009&pages=1570-1583&author=R.+S.+Hotchkissauthor=A.+Strasserauthor=J.+E.+McDunnauthor=P.+E.+Swanson&title=Cell+death&doi=10.1056%2FNEJMra0901217"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of disease: cell death</span></div><div class="casAuthors">Hotchkiss, Richard S.; Strasser, Andreas; McDunn, Jonathan E.; Swanson, Paul E.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">361</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1570-1583</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review, discussing classifications of cell death and mechanisms in health and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxQNrCODaf3rVg90H21EOLACvtfcHk0li9cKv20c6xxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1OrurzP&md5=a0a119908df325aa6a008c7654fccf43</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1056%2FNEJMra0901217&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra0901217%26sid%3Dliteratum%253Aachs%26aulast%3DHotchkiss%26aufirst%3DR.%2BS.%26aulast%3DStrasser%26aufirst%3DA.%26aulast%3DMcDunn%26aufirst%3DJ.%2BE.%26aulast%3DSwanson%26aufirst%3DP.%2BE.%26atitle%3DCell%2520death%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2009%26volume%3D361%26spage%3D1570%26epage%3D1583%26doi%3D10.1056%2FNEJMra0901217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Simon, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haj-Yehia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levi-Schaffer, F.</span></span> <span> </span><span class="NLM_article-title">Role of reactive oxygen species (ROS) in apoptosis Induces</span>. <i>Apoptosis.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">415</span>– <span class="NLM_lpage">418</span>, <span class="refDoi"> DOI: 10.1023/A:1009616228304</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.1023%2FA%3A1009616228304" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=11256882" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitV2ru7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2000&pages=415-418&author=H.+U.+Simonauthor=A.+Haj-Yehiaauthor=F.+Levi-Schaffer&title=Role+of+reactive+oxygen+species+%28ROS%29+in+apoptosis+Induces&doi=10.1023%2FA%3A1009616228304"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Role of reactive oxygen species (ROS) in apoptosis induction</span></div><div class="casAuthors">Simon, H.-U.; Haj-Yehia, A.; Levi-Schaffer, F.</div><div class="citationInfo"><span class="NLM_cas:title">Apoptosis</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">415-418</span>CODEN:
                <span class="NLM_cas:coden">APOPFN</span>;
        ISSN:<span class="NLM_cas:issn">1360-8185</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">A review with 49 refs.  Reactive O species (ROS) and mitochondria play an important role in apoptosis induction under both physiol. and pathol. conditions.  Interestingly, mitochondria are both source and target of ROS.  Cytochrome c release from mitochondria, that triggers caspase activation, appears to be largely mediated by direct or indirect ROS action.  On the other hand, ROS have also anti-apoptotic effects.  This review focuses on the role of ROS in the regulation of apoptosis, esp. in inflammatory cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPu13B3_9rGLVg90H21EOLACvtfcHk0lg-aXvEbUFTEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitV2ru7k%253D&md5=752558ae104d1b8446ab51c6a63c8331</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1023%2FA%3A1009616228304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1009616228304%26sid%3Dliteratum%253Aachs%26aulast%3DSimon%26aufirst%3DH.%2BU.%26aulast%3DHaj-Yehia%26aufirst%3DA.%26aulast%3DLevi-Schaffer%26aufirst%3DF.%26atitle%3DRole%2520of%2520reactive%2520oxygen%2520species%2520%2528ROS%2529%2520in%2520apoptosis%2520Induces%26jtitle%3DApoptosis.%26date%3D2000%26volume%3D5%26spage%3D415%26epage%3D418%26doi%3D10.1023%2FA%3A1009616228304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, C.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, L.-N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, Z.-W.</span></span> <span> </span><span class="NLM_article-title">Phosphorescent iridium(III)-bis-N-heterocyclic carbene complexes as mitochondria-targeted theranostic and photodynamic anticancer agents</span>. <i>Biomaterials</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">95</span>– <span class="NLM_lpage">104</span>, <span class="refDoi"> DOI: 10.1016/j.biomaterials.2014.10.070</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.1016%2Fj.biomaterials.2014.10.070" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=25477176" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVyhsrjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2015&pages=95-104&author=Y.+Liauthor=C.-P.+Tanauthor=W.+Zhangauthor=L.+Heauthor=L.-N.+Jiauthor=Z.-W.+Mao&title=Phosphorescent+iridium%28III%29-bis-N-heterocyclic+carbene+complexes+as+mitochondria-targeted+theranostic+and+photodynamic+anticancer+agents&doi=10.1016%2Fj.biomaterials.2014.10.070"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphorescent iridium(III)-bis-N-heterocyclic carbene complexes as mitochondria-targeted theranostic and photodynamic anticancer agents</span></div><div class="casAuthors">Li, Yi; Tan, Cai-Ping; Zhang, Wei; He, Liang; Ji, Liang-Nian; Mao, Zong-Wan</div><div class="citationInfo"><span class="NLM_cas:title">Biomaterials</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">95-104</span>CODEN:
                <span class="NLM_cas:coden">BIMADU</span>;
        ISSN:<span class="NLM_cas:issn">0142-9612</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Mitochondria-targeted compds. represent a promising approach to target tumors selectively and overcome resistance to current anticancer therapies.  In this work, 3 cyclometalated iridium(III) complexes (1-3) contg. bis-N-heterocyclic carbene (NHC) ligands were explored as theranostic and photodynamic agents targeting mitochondria.  These complexes display rich photophys. properties, which greatly facilitates the study of their intracellular fate.  All 3 complexes are more cytotoxic than cisplatin against the cancer cells screened. 1-3 can penetrate into human cervical carcinoma (HeLa) cells quickly and efficiently, and they can carry out theranostic functions by simultaneously inducing and monitoring the morphol. changes in mitochondria.  Mechanism studies show that these complexes exert their anticancer efficacy by initiating a cascade of events related to mitochondrial dysfunction.  Addnl., they display up to 3 orders of magnitude higher cytotoxicity upon irradn. at 365 nm, which is so far the highest photocytotoxic responses reported for iridium complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqD_Mn-JAwZeLVg90H21EOLACvtfcHk0lg-aXvEbUFTEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVyhsrjM&md5=cd8df6801aa88858a2a63a39d6727384</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.biomaterials.2014.10.070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biomaterials.2014.10.070%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%26aulast%3DTan%26aufirst%3DC.-P.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DHe%26aufirst%3DL.%26aulast%3DJi%26aufirst%3DL.-N.%26aulast%3DMao%26aufirst%3DZ.-W.%26atitle%3DPhosphorescent%2520iridium%2528III%2529-bis-N-heterocyclic%2520carbene%2520complexes%2520as%2520mitochondria-targeted%2520theranostic%2520and%2520photodynamic%2520anticancer%2520agents%26jtitle%3DBiomaterials%26date%3D2015%26volume%3D39%26spage%3D95%26epage%3D104%26doi%3D10.1016%2Fj.biomaterials.2014.10.070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stock, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leslie, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, J. E.</span></span> <span> </span><span class="NLM_article-title">Molecular architecture of the rotary motor in ATP synthase</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>286</i></span>,  <span class="NLM_fpage">1700</span>– <span class="NLM_lpage">1705</span>, <span class="refDoi"> DOI: 10.1126/science.286.5445.1700</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.1126%2Fscience.286.5445.1700" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10576729" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADyaK1MXnslKntr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=1999&pages=1700-1705&author=D.+Stockauthor=A.+G.+Leslieauthor=J.+E.+Walker&title=Molecular+architecture+of+the+rotary+motor+in+ATP+synthase&doi=10.1126%2Fscience.286.5445.1700"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular architecture of the rotary motor in ATP synthase</span></div><div class="casAuthors">Stock, Daniela; Leslie, Andrew G. W.; Walker, John E.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">5445</span>),
    <span class="NLM_cas:pages">1700-1705</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">ATP synthase contains a rotary motor involved in biol. energy conversion.  Its membrane-embedded F0 sector has a rotation generator fueled by protonmotive force, which provides the energy required for the synthesis of ATP by the F1 domain.  An electron d. map obtained from crystals of a subcomplex of yeast mitochondrial ATP synthase shows a ring of 10 c subunits.  Each c subunit forms an α-helical hairpin.  The interhelical loops of 6-7 of the c subunits are in close contact with the γ and δ subunits of the central stalk.  The extensive contact between the c ring and the stalk suggests that they may rotate as an ensemble during catalysis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojmVflzjYsVbVg90H21EOLACvtfcHk0lg-aXvEbUFTEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnslKntr8%253D&md5=7ba1357b50d872513b7f0c4c3823019a</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1126%2Fscience.286.5445.1700&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.286.5445.1700%26sid%3Dliteratum%253Aachs%26aulast%3DStock%26aufirst%3DD.%26aulast%3DLeslie%26aufirst%3DA.%2BG.%26aulast%3DWalker%26aufirst%3DJ.%2BE.%26atitle%3DMolecular%2520architecture%2520of%2520the%2520rotary%2520motor%2520in%2520ATP%2520synthase%26jtitle%3DScience%26date%3D1999%26volume%3D286%26spage%3D1700%26epage%3D1705%26doi%3D10.1126%2Fscience.286.5445.1700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weinberg, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandel, N. S.</span></span> <span> </span><span class="NLM_article-title">Targeting mitochondria metabolism for cancer therapy</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">9</span>– <span class="NLM_lpage">15</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1712</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.1038%2Fnchembio.1712" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=25517383" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFCqsr%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=9-15&author=S.+E.+Weinbergauthor=N.+S.+Chandel&title=Targeting+mitochondria+metabolism+for+cancer+therapy&doi=10.1038%2Fnchembio.1712"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting mitochondria metabolism for cancer therapy</span></div><div class="casAuthors">Weinberg, Samuel E.; Chandel, Navdeep S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-15</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Mitochondria have a well-recognized role in the prodn. of ATP and the intermediates needed for macromol. biosynthesis, such as nucleotides.  Mitochondria also participate in the activation of signaling pathways.  Overall, accumulating evidence now suggests that mitochondrial bioenergetics, biosynthesis and signaling are required for tumorigenesis.  Thus, emerging studies have begun to demonstrate that mitochondrial metab. is potentially a fruitful arena for cancer therapy.  In this Perspective, we highlight recent developments in targeting mitochondrial metab. for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXSbrOBwYo37Vg90H21EOLACvtfcHk0lgjHIJxbvHMSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFCqsr%252FN&md5=5774621d8403ea5749b4f27e0e2a0b48</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1712&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1712%26sid%3Dliteratum%253Aachs%26aulast%3DWeinberg%26aufirst%3DS.%2BE.%26aulast%3DChandel%26aufirst%3DN.%2BS.%26atitle%3DTargeting%2520mitochondria%2520metabolism%2520for%2520cancer%2520therapy%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2015%26volume%3D11%26spage%3D9%26epage%3D15%26doi%3D10.1038%2Fnchembio.1712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Klionsky, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuervo, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seglen, P. O.</span></span> <span> </span><span class="NLM_article-title">Methods for monitoring autophagy from yeast to human</span>. <i>Autophagy</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">181</span>– <span class="NLM_lpage">206</span>, <span class="refDoi"> DOI: 10.4161/auto.3678</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=10.4161%2Fauto.3678" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=17224625" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVGrtLvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2007&pages=181-206&author=D.+J.+Klionskyauthor=A.+M.+Cuervoauthor=P.+O.+Seglen&title=Methods+for+monitoring+autophagy+from+yeast+to+human&doi=10.4161%2Fauto.3678"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Methods for monitoring autophagy from yeast to human</span></div><div class="casAuthors">Klionsky, Daniel J.; Cuervo, Ana Maria; Seglen, Per O.</div><div class="citationInfo"><span class="NLM_cas:title">Autophagy</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">181-206</span>CODEN:
                <span class="NLM_cas:coden">AUTOC9</span>;
        ISSN:<span class="NLM_cas:issn">1554-8627</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">A review.  The increasing interest in autophagy in a wide range of organisms, accompanied by an ever-growing influx of researchers into this field, necessitates a good understanding of the methodologies available to monitor this process.  In this review we discuss current approaches that can be used to follow the overall process of autophagy, as well as individual steps, from yeast to human.  The majority of the review considers methods that apply to macroautophagy; however, we also consider alternative types of degrdn. including chaperone-mediated autophagy and microautophagy.  This information is meant to provide a resource for newcomers as well as a stimulus for experienced researchers who may be prompted to develop addnl. assays to examine autophagy-related pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNrp8-VBeLWbVg90H21EOLACvtfcHk0lgjHIJxbvHMSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVGrtLvF&md5=38362110dcbfcc852eb2680e455ada1d</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.4161%2Fauto.3678&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fauto.3678%26sid%3Dliteratum%253Aachs%26aulast%3DKlionsky%26aufirst%3DD.%2BJ.%26aulast%3DCuervo%26aufirst%3DA.%2BM.%26aulast%3DSeglen%26aufirst%3DP.%2BO.%26atitle%3DMethods%2520for%2520monitoring%2520autophagy%2520from%2520yeast%2520to%2520human%26jtitle%3DAutophagy%26date%3D2007%26volume%3D3%26spage%3D181%26epage%3D206%26doi%3D10.4161%2Fauto.3678" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i48"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01257">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_30185"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c01257?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01257</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Experimental methods; crystal data and detailed structural refinement for Au compounds C1–C6; DLS and CD spectra of AFt and AFt-C6 NPs; AFt uptake by HL-7702 and U87MG cells and expression of TfR1 on the surface of HL-7702 and U87MG cells; cellular uptake of C6 and AFt-C6 NPs and the accumulation of the Au agent in the nuclei and mitochondria; western blot analysis of mitochondria-mediated apoptosis markers; inhibition of the antitumor activity of AFt-C6 NPs by 3-MA; effects of autophagy inhibition on AFt-C6 NP-induced caspase-3 cleavage in U87MG cells; serological analysis of mice injected with NaCl; NMR spectra of L1–L6 and C1–C6; and ESI-MS spectra of L1-L6 and C1-C6 (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01257/suppl_file/jm0c01257_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01257/suppl_file/jm0c01257_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01257/suppl_file/jm0c01257_si_001.pdf">jm0c01257_si_001.pdf (1.6 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01257/suppl_file/jm0c01257_si_002.csv">jm0c01257_si_002.csv (0.88 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c01257&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c01257%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-22" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c01257" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                11MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679ac5e42b922362","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
